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P1 A new adjunctive system to obtain higher PaO2 with nasal cannula or catheter: double trunk mask
G Bodur, F Duprez, A Laghmiche, E Gatera
ICU-CH Hornu-Frameries, 63 Route de Mons, 7301 Hornu, Belgium
Introduction: In our experience, very often, even with a non-
rebreathing mask (NRM), high oxygen delivery to patient with the
existent materials is insufficient. However, many of these patients
need high oxygen therapy for a limited period of time. In this study
we report our experience with a new device that serves to increase
the concentration of oxygen delivered by a classical nasal cannula
or catheter. It is not an oxygen mask.
Aim: To demonstrate how a simple adjunctive system to classical
nasal cannula or catheter improves considerably the oxygenation of
patients at constant O2 flow rate.
Design: Prospective, observational study.
Method: The double trunk mask (DTM) is a modified tusk mask
described by Hnatiuk. It is composed by a normal aerosol mask
with 22 mm of diameter lateral holes, 38 cm of long flexible tubing
are inserted to each side of the mask. The DTM is just applied to
the face of the patients who already receive O2 through a nasal
cannula or catheter. Forty-five consecutive patients, admitted in the
ER or ICU, and needing oxygen delivery, are included in our study.
The data collected are: PaO2, PaCO2, breathing rate with a mean
flow rate of 3.58 l/min, at t0, t30 min prior to DTM and then 30 min
after DTM application.
Results:
Nasal cannula DTM P value
PaO2 68.65 152.2 < 0.01
PaCO2 41.4 45.3 NS
BR 25.4 24.88 NS
Conclusions: In patients who remain insufficiently oxygenated
although receiving O2 with classical nasal cannula or catheter, the
DTM is a new, simple and efficient system to obtain high PaO2 at the
same O2 flow rate and without significant change in PaCO2.
P2 Model-based neuro-fuzzy control of FiO2 for intensive care mechanical ventilation
HF Kwok*†, GH Mills*, M Mahfouf†, DA Linkens†
*Department of Surgical & Anaesthetic Sciences, Sheffield University, and the Intensive Care Unit, Royal Hallamshire Hospital, Sheffield
S10 2JF, UK; †Department of Automatic Control and Systems Engineering, Sheffield University, Sheffield S1 3JD, UK
The knowledge-based approach to fuzzy logic control of mechani-
cal ventilation on the ICU can be prone to bias in the experts’
knowledge and errors resulting from poor communication during
rule-base derivation. Therefore, a different approach was explored
in the development of a fuzzy controller to control the inspired
oxygen fraction (FiO2). The performance of such a controller was
compared with the performance of the clinicians.
Method: (1) The development of a neuro-fuzzy controller. This
was developed by training a neural network to generate an optimal
change in the FiO2 in order to achieve a target arterial oxygen
tension (PaO2) on a mathematical model of the gas exchange
system (SOPAVent). The neural network learnt the relationship
between the blood gases, FiO2 and PEEP and other ventilator set-
tings. This was done by exposing the neural network to the blood
gas results produced by applying a range of FiO2 and PEEP values
to the SOPAVent model. This first neural network was then com-
bined with another neural network which represented a fuzzy logic
rule-base. The fuzzy rule-base consists of a set of ‘If …, Then …’
statements based around combinations of FiO2, PEEP and PaO2.
The fuzzy rule-base was then adjusted by changing the weights of
the neuro-controller (which correspond to the ‘Then …’ part of the
fuzzy rules) during neural network training. The neuro-controller
output is equivalent to the output from a fuzzy inference system of
three inputs (the difference between the actual PaO2 and the
target, the PEEP level and the FiO2).
(2) Comparing neuro-fuzzy and clinicians’ control. The scenarios
were based on the data from three real patients with sepsis in the
ICU. Seventy-one blood gases, ventilatory settings and respiratory
parameters at the sampling times were presented to nine consultant
intensivists. They were asked to optimise the PaO2 of the patient sce-
narios in the simulator by adjusting the FiO2. Similarly, the neuro-fuzzy
controller was presented with the same data and asked to adjust the
FiO2. The impact of these changes on the patient’s PaO2 was then
calculated using the SOPAVent model. The FiO2 adjustments and
corresponding new PaO2 levels were compared to see how close
were the decisions of the clinicians and the neuro-fuzzy controller.
Results: These are shown in Table 1. The differences were not
statistically significant.
Conclusion: The control of PaO2 provided by the neuro-fuzzy con-
troller was similar to the clinicians’ control. Neural networks can
provide an alternative means for fuzzy rule-base derivation and
tuning for ventilator control.
This project was funded by EPSRC Grant no. R/M96483.
Table 1
FiO2 (%) PaO2 (kPa)
Mean Median Mean Median
Clinicians 44.60 ± 11.63 45.00 14.62 ± 4.08 13.78
Neuro-fuzzy  43.95 ± 11.03 42.20 14.12 ± 2.69 14.43
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P3 Comparison of closed with open tracheal aspiration system
A Sanver, A Topeli, Y Çetinkaya, S Kocagöz, S Ünal
Hacettepe University School of Medicine, Department of Internal Medicine, Intensive Care and Infectious Disease Units, Ankara, Turkey
The aim of the study was to compare colonization rates of the ven-
tilator tubings, frequency of ventilator associated pneumonia (VAP)
and mortality in the intensive care unit (ICU) in mechanically venti-
lated patients for whom closed or open tracheal aspiration systems
were used in a randomized fashion.
The study was started in 1 April 2000 and patients who received
mechanical ventilation (MV) for at least 48 hours were included.
The results (mean ± SE or n [%]) of the analysis of the first 7
months are presented in the Table.
In conclusion, in the preliminary analysis of this study the rate of
colonization tended to be increased in the closed aspiration
system group when compared with the open aspiration system
group. However, there was no difference between the groups in
terms of the development of VAP and mortality in the ICU.
Open (n = 24) Close (n = 20) P
Age 64.7 ± 3.9 63.6 ± 3.0 0.83
Male gender 9 (37.5%) 12 (60%) 0.22
APACHE II 23.6 ± 1.4 27.4 ± 1.6 0.08
Duration of MV 6.6 ± 0.9 8.7 ± 1.2 0.16
Rate of colonization* 11 (57.9%) 14 (82.4%) 0.16
Development of VAP 6 (25%) 7 (35%) 0.52
Length of stay in the ICU 10.1 ± 1.5 12.2 ± 1.7 0.36
Mortality in the ICU 18 (75%) 16 (80%) 0.73
* n = 19 in the open aspiration system group and n = 17 in the closed
aspiration system group.
P4 A laboratory assessment of the learning and retention of skills required to use the Combitube and Laryngeal Mask Airway
by non-anaesthetists
C Coles, C Elding, M Mercer
Department of Anaesthesia, Frenchay Hospital, Bristol BS16 1LE, UK
Both the Combitube and Laryngeal Mask Airway (LMA) have been
successfully used by non-anaesthetists during resuscitation [1–5].
However, only one study (using the Combitube) has assessed how
well these skills are retained after the initial training period. Here,
nine of 11 paramedics demonstrated inadequate skill retention in
the follow-up study at 15 months [6].
Study purpose: To assess and compare the ability of non-anaes-
thetists to learn and retain the skills necessary to use the Com-
bitube and Laryngeal Mask Airways.
Method: With no prior warning, 10 non-anaesthetists (3 student
nurses, 2 qualified nurses and 5 trainee operating department
practitioners) took part in a study morning covering theoretical
aspects of Combitube and LMA insertion and use, and a practical
demonstration and practice session. This was followed by a written
examination of 30 yes/no questions and a practical assessment for
each airway device. Eight weeks later, again with no prior warning,
the same 10 people retook the same written examinations and
practical assessments.
Results: The mean decrease in score between the first and
second visits was –1.3 (95% confidence limits, –0.13 to –2.47;
P < 0.05) for the Combitube, and –0.5 (95% confidence limits,
0.63 to –1.63; P < 0.5) for the LMA.
Conclusion: This study suggests that the practical use of the
Combitube is an easier skill to acquire than the LMA. Not surpris-
ingly retention of theoretical and practical skills for both the Com-
bitube and LMA deteriorated over a short time span (although not
reaching statistical significance for theoretical LMA scores). There-
fore, whatever airway device non-anaesthetists are taught to use,
regular refresher courses will be needed.
However, larger numbers need to be studied to corroborate these
findings.
Table 1
Results of written examinations (means quoted)
First visit Second visit
Combitube 83.3% 25/30 79% 23.7/30
LMA 91.3% 27.4/30 89.7% 26.9/30
Table 2
Results of practical assessments
Combitube (n = 10) LMA (n = 10)
First Second First Second
visit visit visit visit
Successful insertions 10 10 10 9
Successful insertions  10 8 8 7
within 60 seconds
Required number of insertion attempts before success
11 0 8 5 7
22 4 2
31
Number using correct 
cuff volumes 10 10 10 8 (n = 9)
Number showing evidence 
of ventilation 10 10 10 9 (n = 9)S3
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P5 Pediatric airway exchange catheter can be a life-saving device for the adult patients who have risk factors for difficult
tracheal reintubation
L Dosemeci, F Gurpinar, M Yilmaz, A Ramazanoglu
Department of Anaesthesiology and Intensive Care, Hospital of Akdeniz University, Antalya, Turkey
Introduction: Reintubation of the critically ill patients who have risk
factors for difficult intubation can be extremely challenging, often
resulting in considerable morbidity and mortality. The aim of this
study is to determine the usefulness of a pediatric airway exchange
catheter (PAEC) prior to tracheal extubation of adult patients who
were known to have difficult tracheal intubations and/or have risk
factors such as airway obstruction for difficult reintubation.
Patients and methods: Twenty-five study patients at risk for diffi-
cult tracheal reintubation were extubated using a No. 11 Cook
PAEC. Humidified oxygen was insufflated through the central lumen
of PAEC. Signs of respiratory system and tolerance of the patients
were also assessed. The PAEC was removed when it became clini-
cally apparent that the need for tracheal reintubation was unlikely.
When patients failed to respond to tracheal extubation, the PAEC
was used to facilitate reintubation of these difficult airways.
Results: The study population consisted of seven patients under-
gone neck surgery, seven postoperative patients with maxillofacial
trauma, five patients with cerebral infarct, three patients undergone
maxillofacial cancer surgery, two patients with head injury and one
patient with ankylosing spondylitis. Following tracheal extubation, 2
of 25 patients who undergone neck surgery required reintubation
because of excessive airway obstruction due to surgical bleeding
and bronchospasm related to aspiration. These patients desatu-
rated progressively and they could not be ventilated properly by
face mask after sedatives were given for reintubation. Reintubation
was urgently achieved over the Cook PAEC and was easily accom-
plished on the first attempt without the need of an alternate method.
Discussion: Extubation of a patient with risk factors for difficult tra-
cheal reintubation is approached with concern, even in the experi-
enced hands of the critical care physician. Mask ventilation and
tracheal intubation may be difficult or impossible due to airway
obstruction, an agitated patient or cervical immobility. Even under
the most controlled circumstances, considerable time may be
needed to secure a difficult airway [1].
Conclusion: The Cook PAEC is a life-saving device for re-
intubation in patients not only who are known to have difficult tra-
cheal intubation but also who have risk factors for difficult
reintubation that include airway obstruction secondary to surgical
manipulation or hematoma.
Reference:
1. Loudermilk EP: A prospective study of the safety of tracheal extu-
bation using a pediatric airway exchange catheter for patients
with a known difficult airway. Chest 1997, 111:1660.
P6 Cricothyroidotomy for elective airway management in critically ill trauma patients
SM Wanek, EB Gagnon, C Rehm, RJ Mullins
Oregon Health Sciences University, 3181 SW Sam Jackson Park Road, L223A, Portland, OR 97201-3098, USA
Objective: To assess the value of elective cricothyroidotomy for
airway management in critically ill trauma patients with technically
challenging neck anatomy.
Design and setting: A retrospective chart review of patients
admitted to the Trauma Service at a Level I Trauma Center who
underwent cricothyroidotomy for elective airway management over
a 40 month period from January 1997 to April 2000. Comparison
was made to a cohort of Trauma Service patients who received a
tracheostomy. Selection was based on a list generated chronologi-
cally and selecting each tracheostomy procedure immediately prior
to the cricothyroidotomy.
Results: Eighteen patients met study criteria and unpaired t-test
revealed significance (P < 0.05) for age only. There was no difference
with Injury Severity Score, ICU days, number of days requiring ventila-
tion post procedure or number of days intubated prior to procedure.
The major difference was the more technically challenging neck
anatomy in the patients undergoing cricothyroidotomy. Five of 18
patients undergoing cricothyroidotomy died prior to discharge and
2/18 after discharge from complications unrelated to their airway.
Two of 18 patients undergoing tracheostomy died prior to discharge
from complications unrelated to their airway. For a period of 1 week to
15 months, average 5.5 months, notes in subsequent clinic appoint-
ments were reviewed for subjective assessment of wound healing,
breathing and swallowing difficulties, and voice changes. One patient
with a cricothyroidotomy required silver nitrate to treat some granula-
tion tissue otherwise no complications were identified. Telephone
interviews were conducted from 12 to 46 months, average
30 months, with 8 of the 11 surviving cricothyroidotomy patients and
9 of the 16 surviving tracheostomy patients. One tracheostomy
patient required surgical closure 3 months after discharge; otherwise,
the only noted change was minor voice changes in 3 patients in each
group. All six patients denied this compromised them in any way.
Conclusion: Elective cricothyroidotomy has a low complication rate
and is a reasonable, technically less demanding option in critically ill
patients with challenging neck anatomy requiring a surgical airway.
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P7 Comparison of two percutaneous tracheostomy techniques
I
.
Ö Akinci, P Ozcan, S Tug
vrul, N Çakar, F Esen, L Telci, K Akpir
University of Istanbul, Medical Faculty of Istanbul, Anesthesiology and Intensive Care Department, Istanbul, Turkey
Introduction: Since the first report of dilatational percutaneous tra-
cheostomy (PDT) many favorable reports have been published
which accepted this technique as a safe alternative to surgical tra-
cheostomy. In this study we want to evaluate two different kinds of
techniques’ advantages and complications.
Methods: We evaluated 90 patients who tracheostomized with
PDT, 45 of them with dilating forceps technique (DFT) (SIMS
Portex Kent, UK) and 45 of them with multi dilatational technique
(MDT) (Cook Critical Care Systems Bloomington, USA). Indica-
tions were prolonged ventilator dependence, facilitation of weaning
from mechanical ventilation, and prolonged coma. Prior to clinical
application, informed consent from the patient or next of kin was
obtained in all cases. The PDT procedure was chosen randomly.
All patients were in routine ICU monitoring (ECG, SpO2, invasive
arterial monitoring). Two techniques were performed as previously
described [1,2].
Results: We observed one tracheoeosephageal fistula, but it did
not necessitate surgical repair, besides one peristomal infection,
cuff rupture and late bleeding (in 5th day) in DFT group. Stomal
fistula seen after decanulation in MDT group, peristomal infection
and bleeding were also observed. Other demographic data are in
the Table.
Conclusion: We have not seen any mortality due to PT in our
cases and there were no differences in complication rates and
other data except duration of PT. Tracheoeosephageal fistula is
seen in DFT, however we need larger patient series to decide
exactly which technique will be safer.
Table
Age (years) APACHE II Day of performing PT ICU stay (days) Duration of PT (minutes) Complication rate
DFT MDT DFT MDT DFT MDT DFT MDT DFT MDT DFT MDT
52 ± 20.2 46.6 ± 21.8 14.8 ± 7.6 13.1 ± 5 10.9 ± 6.4 8.5 ± 6.8 45.4 ± 30.8 39.6 ± 24.1 4.5 ± 2.5 7.2 ± 3.5 12% 10.3%
P = 0.16 P = 0.15 P = 0.08 P = 0.20 P = 0.001
P8 Percutaneous tracheostomy in patients with ARDS on HFOV
S Shah, M Read, P Morgan
Intensive Care, University Hospital of Wales, Cardiff, CF4 4XW, UK
Introduction: High Frequency Oscillator Ventilation (HFOV) is a
novel lung protective strategy in the treatment of patient with acute
respiratory distress syndrome (ARDS). Percutaneous tracheostomy
(PCT) has become the preferred mode of achieving long-term airway
in ventilated patients, to facilitate weaning and airway toileting.
Aim: To demonstrate the safety and practicability of performing a
percutaneous tracheostomy on patients with ARDS whilst on a
high frequency oscillator ventilator (HFOV).
Patient no. 1 2 3 4 5
Age/sex 56/M 79/M 50/F 69/M 39/F
Days intubated pre-PCT 5 4 9 4 3
Days on HFOV 6 5 13 6 8
Total days ventilated 8 9 40 8 8
Complication of PCT None None None None None
PCT technique Serial Serial CBR CBR CBR
Mean airway pressure pre/post PCT 19/18  27/28 18/16 19/18 20/21
Amplitude (DP) pre/post PCT 60/55  61/70  56/61 55/56 62/65
PaO2/FiO2 ratio pre/post PCT 210/215 177/202 200/205 240/268 220/200
References:
1. Cakar N, Tütüncü AS, Esen F, Telci L, Denkel T, Akpir K, Kesecioglu J:
Percutanous dilational tracheostomy: safety and ease of perfor-
mance at the badside in the ICU. Clin Int Care 1997, 8:4–9.
2. Griggs WM, Myburgh JA, Worthley LIG: A prospective comparison
of percutaneous tracheostomy technique with standard surgical
tracheostomy. Intensive Care Med 1971, 17:261–263.S5
P9 The dilatational tracheotomy — minimally-invasive, bed-side, inexpensive — but safe?
MG Baacke*, I Roth†, M Rothmund†, L Gotzen*
*Klinik für Unfallchirurgie and †Klinik für Allgemeinchirurgie der Philipps-Universität, Marburg, Germany
Introduction: The dilatational tracheotomy becomes more and more
a standard procedure in many ICUs. Complications of the dilatational
tracheotomy are subject of controversial discussions. The estimation
leads from ‘inappropriate for the critically ill’ up to ‘even without surgi-
cal background to practice easily and safely’.
On the bases of the experience of 80 self-practiced dilatational tra-
cheotomies we critically report observed complications, possible
complications and in conclusion we present the ‘quality-standard
for dilatational tracheotomy’.
Patients and methods: Between 12/98 to 8/2000 we initiated a
prospective trial on 80 patients of a 12 bed surgical intensive care
unit in a 1100-bed primary care hospital, undergoing a dilatational
tracheotomy. The free available tracheotomy-sets by Portex (one-
step-dilatational-system) and Cook (more-step-system) have been
used. All occuring complications were documented, such as frac-
tures of the cartilagines, transfusion requiring bleeding, infection,
cubcutaneus emphysema, dislocations of the oral tube, necessity of
oral tube change and perforation of the cuff during the punction pro-
cedure, injuries of the pars membranaceus tracheae or the esopha-
gus with possible following mediastinitis, rate of conversion to
conventional tracheotomy, decrease of SpO2 during the procedure.
Results: In four patients we found a subcutaneus emphysema
which receded spontaneously. Fractures of tracheal cartilagine,
dependent on the age of patients were observed in six patients.
Dislocation of the oral tube occured in 21 (26%) patients and
required immediate reposition of the oral tube but led just in one
case to a short-time decrease of the SpO2 down to 70 mmHg. In
the tube-cuff was perforated by punction six times, but just in one
patient the tube had to be changed before continuing the tra-
cheotomy. In one patient we detected the punction through the
esophagus, the patient remained asymptomatic. In two patients the
procedure had to be converted to a bed-side conventional tra-
cheotomy. In one case due to obesity, in the other case caused by
post-traumatic collar hematoma the insertion of the canule, follow-
ing successful punction, was made impossible. Transfusion requir-
ing bleeding neither occurred during insertion, nor at the following
change of the canule. We never had a Stoma-infection which
required surgical or pharmacological treatment.
Conclusion: We established the dilatational tracheotomy in a one-
step, or a more-step-technique as a standard procedure in our
ICU. The small account of complications must not deceive us by
the fact that an abundance of complications may occur. We con-
sider the experience in conventional tracheotomy as a salvage pro-
cedure in difficult cases and security in emergency re-intubation
just like the experience in bronchoscopy as the standard qualifica-
tion for everyone who starts the tracheotomy-procedure.
Method: Percutaneous tracheostomy was performed using either
Ciaglia serial dilatation or Ciaglia ‘Blue Rhino’ (CBR) techniques,
once there was an improvement in gas exchange.
Results: See Table.
Discussion: In our group of five patients we performed a percuta-
neous tracheostomy once we were sure that their lung injury was
improving i.e. improved P/F ratio, with a decreasing mean airway
pressure to achieve it. There was no worsening of gas exchange
perioperatively, nor was there complication associated with the
percutaneous tracheostomy.
Conclusion: It is safe to perform a PCT in patient with resolving
ARDS on HFOV.
Reference:
Colan AA, Kopec SE. Tracheostomy in ICU. A review. J Intensive Care
Med 2000, 15:1–13.
P10 Combination stenting for central airway stenosis
J Nitadori, K Furukawa, N Ikeda, H Tsutsui, H Shimatani, C Konaka, H Kato
Department of Surgery, Tokyo Medical University, Tokyo, Japan
Objectives: Airway stentings for tracheobronchial stenosis have
been performed in our institution. We have experienced the
patients who underwent insertions of more than two stents using
combination of some kind of stents. We demonstrated here the
utility of combination stenting for severe endobronchial stenosis
from our experiences.
Methods: From 1985 to May 2000, we have experienced 125 cases
of stenting for central airway stenosis (malignant: 98 cases, benign:
27 cases). Nd-YAG laser vaporization, balloon dilatation, argon
plasma coagulator and/or core out were performed to dilate the
bronchial lumen before stentings. T-tube, Dumon stent, self-expand-
able metallic stent (SEMS) and Dynamic Stent were used. All stent-
ings were performed under a fluoroscope. A rigid bronchoscope was
used for all cases of Dumon stent and some cases of SEMS.
Result: The number of combination stentings was 20 cases (male:
14, female: 6) out of 125 cases (16.0%). A total of 45 stents were
placed in 20 cases. Mean age was 58.5 years old. Nineteen out of
20 cases were malignant stenosis (lung cancer: 10, esophageal
cancer: 6, Mets: 3). Four cases of tracheal-esophageal fistula were
observed. One case of benign stenosis was bronchial malacia. The
cases of synchronous insertions were 13, metachronous 5, syn-
chronous and metachronous 2. SEMS were frequently selected in
17 out of 20 cases (85.0%) because of its easy procedure (SEMS
+ SEMS: 8, SEMS + Dumon: 6, SEMS + Dynamic Stent: 2,
SEMS + Eso.Stent: 1, Dumon + Dumon: 2, Dynamic + Eso.Stent:
1). Rigid bronchoscope was used for stent insertion in 80.0% (36
out of 45 stents) because of severe and complicated stenosis. Nd-
YAG laser was used in 37.8% (17/45 stents). After stenting,
chemotherapy and/or radiation could be done in 4 out of 10 cases
of lung cancer, in 3 out of 6 cases of esophageal cancer. Improve-
ment of QOL and lung function were obtained after stentings (PS:
3.3–2.0, Hugh-Jones: 4.1–2.7, PO2: 79.7–84.7 Torr in room air,
%VC: 77.6–84.7%, FEV1.0%:61.0–63.6%, PF: 2.13–2.73 l/s).
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Conclusions: Reconstruction of tracheobronchial stenosis by
combination stenting was a very useful modality for end stage lung
patients with severe central airway stenosis for the purpose of
improving pulmonary functions and quality of life. Selection of
stents should be done after careful consideration of the character-
istics of stents and tracheobronchial stenosis.
P11 Ulcerative laryngitis in children admitted to intensive care
M Hatherill, Z Waggie, L Reynolds, A Argent
PICU, Red Cross War Memorial Children’s Hospital, Cape Town, 7701, South Africa
Background: Severe ulcerative laryngitis is rarely documented in
children.
Objective: To present our experience of ulcerative laryngitis over a
5 year period.
Setting: Paediatric Intensive Care Unit (PICU) of a university hospital.
Methods: Retrospective case note review of 263 children admit-
ted to PICU with severe upper airway obstruction and a clinical
diagnosis of croup. Data are presented as median (range) and
analysed by the Fisher’s Exact test.
Results: One hundred and forty-eight children (56%) underwent
microlaryngoscopy (Storz 3.0 rigid telescope), usually at the time
of airway intervention for failed medical treatment of severe croup
(n  = 147). Laryngeal ulceration, with or without exudation,
oedema and erythema, was documented in 15 of these children
(10%), median age 14 months (10–36) and median weight 10 kg
(6–12). Twenty-seven of the children who underwent microlaryn-
goscopy (18%) also had ulcerative gingivostomatitis consistent
with Herpes simplex virus. Ulcerative laryngitis was documented
in 9 of 27 (33%) children with, and in 6 of 121 (5%) children
without, co-existent ulcerative gingivostomatitis (P < 0.002). The
presence of oral ulcers predicted ulcerative laryngitis with sensi-
tivity and specificity of 80% and 86%, and positive and negative
predictive values of 33% and 95%. Viral culture was available in
6 of the 15 children with ulcerative laryngitis, confirming Herpes
simplex (n = 3) and cytomegalovirus (n = 1). All children with oral
or laryngeal ulceration received acyclovir therapy.
One of the 15 children did not require airway intervention. Nine
children required nasotracheal intubation for a median of 4 days
(3–11) and median ICU stay of 6 days (4–14). Five children
required tracheostomy ab initio, with a median ICU stay of 30 days
(20–36), and duration of tracheostomy in situ for a median of 19
days (15–253). All 15 children survived.
Conclusion: Ulcerative laryngitis is more common in our patient
population than the few reports suggest. Early microlaryngoscopy
is recommended in children with severe croup who follow an atypi-
cal course.
P12 Bronchial asthma in intensive care department: the factors influencing on exacerbation severity
TA Pertseva, KE Bogatskaya, KU Gashynova
Dniepropetrovsk State Medical Academy, Dzerginsky st. 9, Dniepropetrovsk, Ukraine 49044
The high frequency of severe exacerbation of bronchial asthma
(BA) is still one of the main problems for pulmonologists in
Ukraine.
Ninety-eight of 620 asthmatics, surveyed in the diagnostic center
‘Pulmis’ in Dniepropetrovsk during 10 months of 2000, were
referred to the intensive care department because of severe exac-
erbation of disease.
The aim of present research was to study and to estimate the
reasons for patients with BA hospitalizations in the intensive care
department.
Ninety-eight patients of intensive care department (63 men, mean
age 45.5 ± 3.2 years, mean duration of disease 8.3 ± 1.7 years)
with severe BA (according to GINA classification) were enrolled
into the study.
We evaluate patients’ educational level, their medication and com-
pliance. According to the results of our research, 34 patients
(34.7%) did not receive any antiinflammatory medicine, 17 (17.3%)
used only systemic corticosteroids.
Medication of 38 (38.8%) patients consist of short-acting b2-
agonists only.
Eighty-three (84.7%) patients have never applied long-acting b2-
agonists. Thirteen (13.2%) of them visited ‘Asthma-school’, 4 (4.1%)
patients monitor their peak expiratory flow every day, 12 (12.2%)
used additional methods of drug delivery (spasers, etc.).
The results show that inadequate anti-inflammatory and bron-
chodilator therapy, low educational level of the patients, absence
of compliance have significant importance in the development of
BA severe exacerbation.
P13 Severe BOOP
M Mer, R Taylor, GA Richards
Intensive Care Unit, Department of Medicine, Johannesburg Hospital and the University of the Witwatersrand Medical School, 7 York Road,
Parktown 2193, Johannesburg, South Africa
Background: A subgroup of BOOP has recently emerged as an
important cause of severe respiratory disease which is often pro-
gressive and is associated with a significant morbidity and mortality.
Methods: Retrospective and prospective study of ten patients with
respiratory failure due to histopathologically confirmed BOOP. End
points included determination of markers for severe BOOP,S7
outcome and follow up. Patient demographics, clinical, radi-
ographic and laboratory features, necessity for mechanical ventila-
tion, therapy, associations and hospital stay were also reviewed.
Results: The median age of the study group was 41.5 years
(range 7–62) and included five males and five females. Five
(50%) required mechanical ventilation. Three (30%) demised in
hospital and one died following hospital discharge. Overall mortal-
ity was 40%. The median PaO2/FiO2 ratio for the whole group
was 139 (range 61–250) with the median LDH level, on admis-
sion, 612 m/l (range 375–2638). Those patients who were dis-
charged from hospital had a median LDH level of 521 m/l (range
375–1599) versus a median level of 2154 m/l (range
2100–2638) for those who died in hospital (P = 0.016). Patients
who required mechanical ventilation had a median LDH level of
2100 m/l (range 691–2638) versus a median LDH level of 504 m/l
(range 375–534) for non-ventilated patients (P = 0.008). The
most common chest radiographic appearance was a mixed alveo-
lar–interstitial pattern in six patients (60%). In addition to the char-
acteristic histopathological features of BOOP, this group of
patients universally demonstrated alveolar septal expansion.
Increased reticulin was also noted. The median hospital stay was
25 days (range 9–127) with follow up ranging from one to
28 months.
Conclusion: BOOP may manifest as a severe illness with an asso-
ciated significant morbidity and mortality. LDH may be useful as a
marker of disease severity and outcome.
P14 Facial continuous positive airway pressure therapy for cardiogenic pulmonary oedema: a study to assess its efficacy in an
emergency department setting within the UK
C Read, JJ McInerney, N O’Connor, M Norwood, PA Evans
Accident & Emergency, The Leicester Royal Infirmary, Infirmary Close, Leicester LE1 5WW, UK
Introduction: Recent studies outside the UK suggest that patients
with acute cardiogenic pulmonary oedema (CPO) may benefit from
the application of facial continuous positive airway pressure
(CPAP) support in emergency departments. The aim of this pilot
study was to assess the impact of facial CPAP on patients with
CPO within a UK Emergency department and to determine the
sample size needed for a definitive randomised controlled study.
Methods: A prospective powered study comparing CPAP to sup-
plemental oxygen at ambient pressure, using historical controls
matched for CPO severity. Forty patients with internationally
accepted criteria for CPO were included. Twenty patients received
20 min of facial CPAP using a dedicated Drager CPAP system
with a 5 cmH2O positive end-expiratory pressure valve and
maximal inspired oxygen (Group CPAP). Twenty controls received
identical therapy but received maximal inspired oxygen via a non-
rebreathing mask (Group C). Outcome measures compared were
arterial partial pressures of oxygen and carbon dioxide, objective
clinical signs, intubation rate and death. Statistical analysis was by
a t-test and 95% Confidence intervals (CI).
Results: Patients receiving CPAP had a better improvement in
arterial blood gas indices compared to controls, with higher mean
oxygenation (CPAP = 8.4 kPa & C = 3.5kPa, P = 0.017, CI =
0.92–8.77), and better mean excretion of CO2 (CPAP = –0.9kPa
& C = +0.9 kPa, P = 0.011, CI = –3.27 to –0.45). CPAP pro-
duced a higher mean reduction in respiratory rate, and lower mean
reductions in blood pressure/pulse rate, although these were not
statistically significant. The median length of in-patient stay (CPAP
= 4, C = 5 days) and intubation rates (CPAP = 0, C = 3) differed
between groups, but were not statistically significant. There was no
difference in hospital mortality between groups (CPAP = 3, C = 3).
Conclusions: CPAP utilisation in the emergency department
impacts favourably on the physiological manifestations of CPO.
Consequently to achieve a statistical power of 90% in a future ran-
domised study, a sample size of 913 patients is required to show a
5% difference in mortality.
P15 Prospective evaluation of noninvasive positive pressure ventilation (NPPV) in acute hypoxemic respiratory failure (AHRF)
following lung resection
I Auriant, AA Jallot, P Hervé, J Cerrina, F Le Roy Ladurie, JL Fournier, B Lescot, F Parquin
Surgical ICU, CCML, 133 ave de la Résistance, 92350 le Plessis Robinson, France
The mortality associated with AHRF after lung resection may reach
50% mainly in relationship with complication of endotracheal intu-
bation and mechanical ventilation. We compared NPPV and con-
ventional therapy in avoiding endotracheal intubation in patients
with AHRF after lung resection.
Methods: On 2280 patients who had undergone thoracic surgery
between May 1999 and July 2000, those who had pulmonary
resection and experienced AHRF were prospectively recruited.
Patients were enrolled if they met at least three of the following cri-
teria: dyspnea at rest defined by a respiratory rate of 25
Conventional therapy (n = 23) Noninvasive ventilation (n = 23) P
Endotracheal intubation 11 (47.82%) 4 (17.39%) 0.0277
In hospital mortality 8 (34.7%) 2 (8.69%) 0.0275
Fiberoptic bronchoscopy (no.) 3.72 ± 2.86 3.43 ± 4.24 0.1841
Length of stay in ICU (days)  14 ± 11.8 16.65 ± 23.59 0.5241
Length of stay in hospital (days) 22.82 ± 10.67 27.13 ± 19.52 0.6134
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P16 Noninvasive positive pressure ventilation in patients with blunt chest trauma and acute respiratory failure
S Milanov, M Milanov
Emergency Institute ‘Pirogov’, General ICU, Totleben 21, Sofia, Bulgaria
Background and objective: Noninvasive positive pressure ventila-
tion (NPPV) has been reported to be beneficial in the treatment of
acute exacerbation of chronic obstructive pulmonary disease
(COPD), and to facilitate weaning. In this trial we assessed the
possible benefit of early NPPV in patients with blunt chest trauma
and acute respiratory failure.
Methods and design: Eighteen patients admitted to ICU were
enrolled in this prospective randomized study. Inclusion criteria
were isolated blunt chest trauma with respiratory failure and ICU
stay more than 7 days. Exclusion criteria were history of COPD
and conditions when NPPV was contraindicated. The patients
were randomized into two groups. Group 1 (n = 9) received stan-
dard therapy (oxygen, regional analgesia, fluid and nutritional
support, pulmonary physiotherapy/rehabilitation) including tracheal
intubation and mechanical ventilation when indicated. Group 2 (n
= 9) received standard therapy along with NPPV. In Group 2 we
used NPPV with face mask and Pressure Support (7–21
cmH2O)/CPAP (3–10 cmH2O) ventilation. The need for tracheal
intubation was assessed and the number of intubated patient in
both groups was recorded on the 12, 24, 48, 96th hour and 7th
day. The effect of the therapy was assessed on the 1, 6 and 12th
hour using PO2/FiO2 index, frequency/tidal volume index (f/Vt),
dispnea score, hemodynamics and the tolerance to pulmonary
physiotherapy/rehabilitation.
Results and discussion: The main results suggest the possible
beneficial effect of NPPV in decreasing the need for tracheal intu-
bation and mechanical ventilation (Group 1 — intubated 7 [78%],
Group 2 — intubated 3 [34%]). We found a significant statistical
difference with improvement in all parameters (PO2/FiO2 index, fre-
quency/tidal volume index (f/Vt), dispnea score, hemodynamics
and the tolerance to pulmonary physiotherapy/rehabilitation) in the
NPPV group. The results show that NPPV should be considered as
systemic approach in management of all patients with blunt chest
trauma and acute respiratory failure.
P17 Helium–oxygen (He–O2) enhances oxygenation and increases carbon dioxide clearance in mechanically ventilated patients
JAS Ball, R Cusack, A Rhodes, RM Grounds
Intensive Care Unit, 1st Floor, St James’ Wing, St. George’s Hospital, Blackshaw Road, London SW17 0QT, UK
Introduction: Helium is eight times less dense than nitrogen and
only 10% more viscous. As a result of these physical properties it
produces significantly higher gas flows for the same differential
pressure gradient. This coupled with the fact that as a carrier gas
He facilitates faster diffusion makes it a potentially useful adjunct in
the ventilatory support of patients with acute respiratory failure.
Substituting He for nitrogen has been shown to be of considerable
benefit in the management of acute upper airway obstruction from a
wide variety of causes. There is also a growing body of evidence for
its use in acute severe asthma and decompensated COPD. We
previously conducted a pilot study of He–O2 in patients with acute
respiratory distress syndrome (ARDS) and found that it led to a sig-
nificant improvement in gas exchange in the majority of subjects.
Having resolved a number of technical problem regarding the use of
He–O2 we have gone on to perform a larger cross over study in a
wider variety of patients and present our preliminary findings here.
Methods: All patients who were mechanically ventilated on our
unit were eligible. Exclusion criteria included haemodynamic insta-
bility, active weaning of respiratory support and imminent deterio-
ration. All patients were ventilated in a pressure control mode.
Patients were observed for a 15 min period on their established
ventilatory regime of N2–O2. They were then switched to He–O2
and observations repeated after 15 and 60 min and then every 60
min for a maximum of 360 min. The trial was terminated when no
further change in the partial pressures of arterial oxygen (PaO2)
and carbon dioxide (PaCO2) were scene. Patients were then re-
established on N2–O2 and observed for a further 60–120 min. No
alterations in ventilatory parameters were made unless warranted
by changes in arterial blood gases. Ventilatory and haemodynamic
parameters were continuously monitored throughout. The ventila-
tor flowmeter was calibrated for use with He–O2 as previously
described.
Results: Six out of eight patients showed a significant improve-
ment in PaO2 and PaCO2 within 15 min. Most of those studied
showed further improvements at the successive observation time
points. There were small improvements in respiratory mechanics,
but these were insufficient to explain the improvements in gas
exchange. There were no significant haemodynamic changes seen.
The worse the derangement of gas exchange at study outset, the
greater the magnitude of improvement seen on He–O2.
Conclusions: This study adds to the growing body of evidence
that He–O2 may be a useful adjunct to mechanical ventilation,
especially in the most severe cases of respiratory failure.
breaths/min or more, active contraction of the accessory respira-
tory muscles or abdominal paradox, a ratio PaO2/FiO2 < 200 and
radiologic lesions on the chest radiograph. They were randomly
assigned to receive either conventional therapy or conventional
therapy and noninvasive positive pressure ventilation (NPPV)
through a nasal mask. NPPV was provided with the BiPAP® Vision
Ventilator System (Respironics Inc., Murrysville, PA, USA). The
primary end point of the study was ‘need for endotracheal intuba-
tion’. Secondary endpoints included: in-hospital mortality, the
length of stay in the ICU, length of stay in the hospital, and the
need for fiberoptic bronchoscopy. An interim analysis was
designed at the middle of the study.
Results: Over this 16 month period, 912 patients were admitted to
the Intensive Care Unit. Forty-eight patients were enrolled.
Conclusion: Because endotracheal intubation is the most important
predisposing factor for ventilator associated pneumonia, bronchial
stump disruption and bronchopleural fistula, postoperative re-intuba-
tion must be avoided. This is the first prospective, randomized study
which demonstrates an improvement in survival and in avoiding
endotracheal intubation in the postoperative care of patients under-
going lung resection surgery.S9
P18 Optimal method of flow and volume monitoring in patients mechanically ventilated with helium–oxygen (He–O2) mixtures
JAS Ball, A Rhodes, RM Grounds
Intensive Care Unit, 1st Floor, St James’ Wing, St. George’s Hospital, Blackshaw Road, London SW17 0QT, UK
In mechanically ventilated patients reducing the density of the
inspired gas by substituting helium (He) for nitrogen offers
several theoretical benefits. However, accurately monitoring tidal
volumes of He–oxygen (O2) mixtures with conventional flowme-
ters is problematic, as all commonly employed devices are
adversely affected by changes in gas density. We tested two
widely available flowmeters, to ascertain whether reliable and
reproducible correction factors could be obtained.
We used an unadapted Galileo ventilator (Hamilton Medical,
Switzerland), to which heliox (21% O2 79% He) was connected
via the air inlet. This ventilator measures flow/ volume utilising a
variable orifice pneumotachogrpah (VOP). The circuit was then
connected to a Pitot tube flowmeter (PT) (MCOVX, Datex-
Ohmeda, Finland) which in addition, contains a side stream gas
sampler to monitor gas composition. In place of a patient, a
mechanical lung (BIO-TEK Instruments Inc., USA) was employed,
which accurately measures delivered gas volumes independent of
gas density. Carbon dioxide (CO2) was entrained, distal to the
flowmeters, just proximal to the mechanical lung, to simulate the
clinical setting. Both flowmeters were repeatedly tested across a
range of tidal volumes (Vt) (200–1200 ml).
This method proved to be reliable and reproducible. Inspired and
expired Vt as measured by the two devices, when plotted against
that measured by the mechanical lung, showed excellent linear corre-
lation (R2 = 0.99 for all). From the equations of these lines we calcu-
lated a set of correction factors (CF) and ordinates (ord). All
measurements were repeated five times and means (Av) and stan-
dard deviations (SD) derived; results are tabulated.
We conclude that both of these devices can be reliably employed
to monitor respiratory variables in patients mechanically ventilated
with He–O2 provided gas composition, temperature and relative
humidity are accounted for. However, the consistency of ord values
for the VOP are advantageous and make this the preferred device.
P19 Lessons learned from airway pressure release ventilation
LJ Kaplan, H Bailey
MCP-Hahnemann University, 3300 Henry Avenue, Philadelphia, PA 19129, USA
Objective: To review a single institution’s experience with APRV
with respect to safety, complication detection, and efficacy at cor-
recting hypercarbia and hypoxemia.
Methods: Consecutive patients transitioned from either volume or
pressure targeted ventilation to APRV in a University hospital ICU
were retrospectively reviewed. Patients initially ventilated with
APRV were excluded. Initial APRV settings for correction of hypox-
emia (pO2 £ 60 on FIO2 ³ 0.9) were a Phigh at the prior plateau
pressure, a Thigh of 6.0 s and a Tlow of 0.8 s. Hypercarbic (pCO2
³ 55 and pH £ 7.3) patients were set at a Thigh of 5.0 s with a
Tlow of 1.0 s. IRB approved data included principal diagnoses,
ventilation parameters, laboratory values, and ventilator associated
complications. Data before and after APRV were compared using
an unpaired two-tailed t-test; significance at P < 0.05 (*).
Results: Patient mix was 43% trauma, 32% sepsis, 8% cardiac
surgery, 12% vascular surgery and 5% other. Transitioning to
APRV was most frequent for hypoxemia (88%) and hypercarbia
less often (12%). The mean time to correct hypoxemia (SaO2 ³
92%) was 7 ± 4 min while the mean time to correct pCO2 (pCO2
£ 40 Torr) was 42 ± 7 min. Maximal CO2 clearance was achieved
by 76 ± 12 min. The mean minute ventilation on APRV decreased
by 3.3 ± 0.9 l/min (*) but achieved superior CO2 clearance and
FiO2 0.21 0.30 0.40 0.50 0.60 0.70 0.80 0.90 1.00 Air
Inspired Vt
PT Av CF 1.44 1.29 1.18 1.09 1.02 0.96 0.91 0.88 0.85 0.89
SD 0.03 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.00 0.01
Av ord –25 –16 –15 –11 –13 –13 –1 –12 –3 2
S D 7767321137
VOP Av CF 1.71 1.51 1.36 1.25 1.17 1.09 1.04 0.98 0.94 0.98
SD 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Av ord 13.3 16.5 18.0 15.3 14.6 13.7 12.6 12.2 10.0 13.0
SD 10.3 11.3 11.6 9.7 10.9 12.8 11.2 14.4 13.4 12.3
Expired Vt (+ 5% CO2)
PT Av CF 1.50 1.36 1.25 1.16 1.11 1.07 0.98 0.96 0.92 0.96
SD 0.01 0.01 0.02 0.02 0.01 0.03 0.03 0.03 0.01 0.01
Av ord –64 –40 –30 –15 –18 –33 –2 –21 –1 5
SD 4 8 10 11 1 26 14 17 9 11
VOP Av CF 1.48 1.34 1.22 1.14 1.06 1.01 0.95 0.91 0.88 0.92
SD 0.04 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Av ord –4 –8 –1 –5 –2 –11 –3 –12 –11 –11
SD 10 7 9 13 6 5 10 8 4 10
Available online http://ccforum.com/supplements/5/S1Conclusions: Patient controlled PSV could be a useful technique
in ventilatory management of critically ill awake patients.
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oxygenation. The mean time to achieve FIO2 £ 0.6 was 5.2 ± 0.9
hours. Four of 38 patients developed a pneumothorax although
none developed hypotension; one had bilateral pneumothoraces.
All four patients evidenced decreased CO2 clearance and
decreased release phase volumes as their only manifestation of a
pneumothorax. 97% of patients on APRV with a Phigh ³ 20
cmH2O pressure who were transported out of the ICU using bag-
valve ventilation developed hypoxemia within 5 min. 100% of
patients with a Phigh £ 20 cmH2O pressure were safely hand ven-
tilated during transport without developing hypoxemia.
Conclusion: APRV is a safe rescue mode of ventilation for hypox-
emic or hypercarbic respiratory failure and requires a lower minute
ventilation than does conventional modes. Decreasing release
phase volumes and a rising pCO2 are excellent clues of a pneu-
mothorax in a patient on APRV. Thus, routine end-tidal CO2 moni-
toring is recommended for patients on APRV. Preparations for safe
intra-hospital transport may be keyed to the Phigh required for ade-
quate ventilation and oxygenation.
P20 Patient controlled pressure support ventilation
D Chiumello, P Taccone, L Civardi, E Calvi, M Mondino, N Bottino, P Caironi
Istituto di Anestesia e Rianimazione, Ospedale Policlinico, IRCCS, Universita’ di Milano, Italy
Introduction: Pressure support ventilation is mostly used in
weaning from mechanical ventilaton in acute respiratory failure.
There are no data regarding the optimal level of assistance for
each patient in different clinical conditions. We approach a new
method that allows patients to set their own PSV level by a remote
control connected to the ventilator.
Materials and methods: In 9 awake intubated patients (age 57 ± 17
years, BMI 24 ± 3 kg/m2, PaO2/FiO2 283 ± 51, Ramsey 1.9 ± 0.4)
we measured the breathing pattern (VT, RR), the work of breathing
(WOB J/min, estimated from a modified Campbell diagram [1]) and
the dyspnea sensation using the Borg visual scale [2]. Patients were
studied at three fixed levels of PSV (5–15–25 cmH2O). At the end of
each step we gave the patient the possibility to change the level of
PSV using the remote control. Patients were previously instructed by
attendant physician about the use of the remote control.
Results: See Table and Figure. It appears that increasing the pres-
sure support level, the patient work of breathing decreases while
the Borg dyspnea scale shows no significant differences.
Table
PSV 5 PSV 15 PSV 25
VT (ml) 331 ± 150* 524 ± 222 884 ± 362
RR (bpm) 25 ± 1* 19 ± 6† 13 ± 6
WOB (J/min) 8.2 ± 0.3* 2.2 ± 2.2 1.8 ± 2
Borg (cm) 3.3 ± 2 2 ± 1.6 3 ± 1.4
One way RM Anova * P < 0.05 vs others; † P < 0.05 vs PSV 25.
Figure
The dyspnea sensation when patient is allowed to set the pressure
support level.
P21 Impact of weaning failure in the evolution of patients under mechanical ventilation
A Bruhn, F Apablaza, F Bernucci, V Segovia, P Zúñiga, G Hernández, L Castillo, G Bugedo
Programa de Medicina Intensiva, Departamento de Anestesiología, Facultad de Medicina, Pontificia Universidad Católica de Chile, PO Box
114-D, Santiago, Chile
Introduction: Weaning period is critical in the evolution of patients
with acute respiratory failure (ARF) and mechanical ventilation
(MV). Weaning failure has been associated with increased morbid-
ity and mortality. We evaluated the impact of weaning failure on
mortality, and MV and ICU length of stay.
Methods: Patients who were admitted to our 8-bed surgical-ICU
and stayed more than 24 hours on MV were prospectively evalu-
ated from June 1999 to June 2000. Demographics, ARF etiology,
APACHE II and gas exchange and mechanical parameters were
assessed. Weaning failure was defined as reintubation within 48S11
hours after extubation. Weaning failure (WF) patients were com-
pared with those who were successfully extubated (SE) and the
total group (TG = SE + WF). Outcome measures were mortality,
MV and ICU length of stay and MV free days.
Results: 155 patients required MV for more than 24 hours, of
which 103 (66%) were successfully extubated, 19 (12%) had
weaning failure, and 33 (21%) died before weaning could be
attempted. There were no differences in age, sex, APACHE II
scores, or etiology between WF and other groups. However, WF
patients had longer ICU and MV length of stay than TG (14 ± 6.2
vs. 9.2 ± 7.4 days, P = 0.005; and 9.1 ± 4.8 vs. 5.5 ± 5.6, P =
0.002, respectively) and SE patients (8.8 ± 6.4, P = 0.003; and
4.6 ± 4.3, P = 0.001). WF patients had also less MV free days
than SE patients (15 ± 11.2 vs. 25 ± 5.5, P = 0.001).
There was no difference in mortality between WF and GT patients
(32% vs. 26%, P = NS). However, SE patients had 2% mortality,
which was lower than WF and GT patients (P < 0.05).
Conclusion: Weaning failure is associated with longer MV and
ICU length of stay, but does not increase mortality compared with
the total group of patients. Weaning failure patients had the same
risk of death as patients being connected for the first time to
mechanical ventilation.
P22 Abstract withdrawn
P23 Rapid reduction of oxygenation index by employment of a recruitment technique in patients with severe ARDS
GA Richards, H White, M Hopley
University of the Witwatersrand Medical School, Department of Medicine, 7 York Road, Parktown 2193, Johannesburg, South Africa
Background: Mechanical ventilation of patients with ARDS may
contribute to pulmonary injury and systemic inflammation. The
objective of this study was to examine the safety and efficacy of a
recruitment maneuver which, if successful, would rapidly improve
atelectasis and oxygenation and in so doing reduce the potential
for ventilator induced lung injury.
Methods: Nineteen patients with severe ARDS (defined as
PaO2/FiO2 £ 150) from diverse etiologies were turned prone and a
positive pressure of 40 cmH2O was applied for a period of 90 s.
This pressure was increased in 5 cmH2O increments in subse-
quent maneuvers to a maximum of 50 cmH2O if there was an inad-
equate initial response. Subsequently, pressure limited mechanical
Available online http://ccforum.com/supplements/5/S1S12
Critical Care    Vol 5 Suppl 1 21st International Symposium on Intensive Care and Emergency Medicine
ventilation with a PEEP of 15 cmH2O was instituted to prevent
derecruitment. Peak pressures were maintained at £ 35 cmH2O.
Outcome measures were oxygenation index, PaO2/FiO2 ratio and
alveolar-arterial oxygen difference.
Results: The oxygenation index decreased from a median of
31 cmH2O to 14 cmH2O/mmHg immediately post recruitment and
to 11 cmH2O/mmHg (P < 0.0001) 24 hours later. The A-aDO2
improved from 454 mmHg to 128 mmHg (P < 0.0001) and the
PaO2/FiO2 ratio from 75 to 218 (P < 0.0001) 24 hours later. 25%
of patients had PaO2/FiO2 ratio of 300 mmHg at 24 hours. Mean
airway pressure increased by 3 cmH2O initially, from 23 cmH2O to
26 cmH2O (NS) as a consequence of the increase of PEEP but his
had decreased to 25 cmH2O after 24 hours. There were no signifi-
cant complications.
Conclusion: Rapid reductions in FiO2 can be achieved safely by
the implementation of a relatively simple recruitment technique.
P24 The effects of recruitment maneuver on oxygenation in primary and secondary adult respiratory distress syndrome
S Tug
vrul, N Çakar, I
.
Ö Akinci, P Ergin Özcan, M Tug
vrul, F Esen, L Telci, K Akpir
University of Istanbul, Medical Faculty of Istanbul, Department of Anesthesiology, Istanbul, Turkey
Introduction: Recruitment maneuvers (RM), as an adjunt to
mechanical ventilation, have been shown to be capable of reopen-
ing collapsed alveolar units in ARDS, providing better ventilatory
parameters and improvement in oxygenation. The aim of our study
is to investigate and to compare the response of patients with pul-
monary and extrapulmonary ARDS to recruitment maneuver.
Methods: We studied 18 patients with severe ARDS of varying
etiology admitted to the intensive care unit of Istanbul University,
Istanbul Medical Faculty. The diagnosis of ARDS was based on the
criteria proposed by the American–European Consensus Confer-
ence on ARDS. The patients who demonstrated impaired oxygena-
tion, during pressure regulated volume-controlled ventilation with
10 ml/kg tidal volume and 12/min frequency comprised our study
population. The patients were presented to four members of the
ICU team individually and assigned to primary (ARDSP) and sec-
ondary (ARDSS) ARDS groups according to the patient’s history
and clinical presentation, along with the results of microbiological
tests. During the recruitment maneuver, we applied sustained infla-
tion (SI), which consisted of 40 cmH2O CPAP. After 30 s we
returned to the previous tidal volume with 20 cmH2O PEEP levels.
Keeping peak airway pressure below 45 cmH2O, we adjusted the
optimal PEEP level, between 10–20 cmH2O, by matching the satu-
ration on pulse oximeter with the lowest PEEP. Following the
setting of PEEP level, we recorded arterial blood gas values, venti-
latory parameters and hemodynamic measurements at 15 min, 1st,
4th and 6th hours of post-RM period.
Results: The clinical defining scores of patients are summarized in
Table 1. Over 6-hour period of time following RM, there was no
statistically significant change in both hemodynamic and ventilatory
measurements, except PaO2/FiO2 ratios (Table 2). Mean values of
PEEP before and after RM were 10 ± 3.4 cmH2O and
14.6 ± 2.8 cmH2O in ARDSP (P = 0.04), 12 ± 5 and 17 ± 2.8 in
ARDSS (P = 0.01). The mean values of PaO2/FiO2 ratio difference
between the baseline and the value at the end of the study were
41 ± 30 % in ARDSP, and 89 ± 111% in ARDSs (P  = 0.6).
PaO2/FiO2 ratios started to increase significantly mainly 15 min fol-
lowing RM in ARDSS, and 4 hours after RM in ARDSP.
Conclusion: The response of patients with secondary ARDS to
RM was observed earlier than the response of patients with
primary ARDS.
Table 2
Before RM  15 min 1st hour 4th hour 6th hour ANOVA P
PaCO2 (mmHg) ARDSP 47 ± 10 51 ± 12 49 ± 10 47 ± 11 50 ± 7 0.7
ARDSS 48 ± 10 47 ± 11 43 ± 17 47 ± 13 46 ± 12 0.9
PaO2/FiO2 ARDSP 117 ± 24 144 ± 37 134 ± 28 155 ± 34 * 162 ± 38 * 0.006
ARDSS 111 ± 44 181 ± 116 * 193 ± 91** 191 ± 95 ** 190 ± 99 ** 0.01
* P < 0.05 when compared to the values before RM. ** P < 0.01 when compared to the values before RM.
Table 1
ARDSP ARDSS P
APACHE II 14.5 ± 6.2 16.8 ± 9.5 0.7
Marshall MODS 4.8 ± 3.4 6.2 ± 2.3 0.06
Murray Score 11 ± 1.8 11 ± 1.5 0.8
P25 Comparison of the P/V curve obtained by the supersyringe and the optoelectronic plethysmography
D Chiumello*, E Calvi*, E Noe’*, L Civardi*, E Carlesso*, A Aliverti†, R Dellacà†
*Istituto di Anestesia e Rianimazione, Ospedale Policlinico, IRCCS, Università di Milano; †Dipartimento di Bioingegneria, Politecnico di
Milano, Centro di Bioingegneria, Fondazione Don Gnocchi IRCCS, Milano, Italy
The pressure volume (P–V) curve of the total respiratory system is
drawn assuming the changes of chest wall (DVcw) equal to the
volume displaced from the syringe (DVgas). We compared DVgas
and DVcw during P–V curves obtained by supersyringe and opto-
electronic plethysmography [1]. Eight sedated paralysed intubated
ALI/ARDS patients (5 M/3 F, age 70 ± 13 years, BMI 25.6 ± 3S13
kg/m2, PaO2/FiO2 220 ± 76) were studied. During the manoeuvre
DVcw was recorded by optoelectronic plethysmography. The
volume injected and withdrawn by the supersyringe step by step
(100 ml) was corrected by temperature, humidity, pressure and
gas exchange [2]. The discrepancy was computed as the differ-
ence between the volume of air inflated and the chest volume mea-
sured. The compliance of the total respiratory system was
measured between zero and maximum airway pressure values on
the inflation (Crsinf) and deflation (Crsdef) limbs of the P–V curves.
Hysteresis loops of the corrected P–Vgas and P–Vcw curves were
calculated as the percentage ratio between the area of the P–V
curves and the product of maximal volume by maximal pressure.
Even considering thermodynamics and gas exchange correction,
DVgas values were systematically higher than DVcw probably due to
blood shifts from the thorax to the extremities. As a consequence,
the standard supersyringe method provides an overestimation of the
inspiratory and expiratory compliance of the total respiratory system
on the inflation limb and an overestimation of the hysteresis area.
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Discrepancy Crsinf Crs def Hysteresis 
(ml) (ml/cmH2O) (ml/cmH2O) (%)
Pvgas 130 ± 83 66 ± 21* 63 ± 21* 19.2 ± 5.9*
PVcw – 59 ± 19 58 ± 18 15.2 ± 5.4
The data are expressed as mean ±SD.* Paired t-test P < 0.05 vs PVCW.
P26 Assessment of static compliance and estimated lung recruitment as a tool for PEEP setting in ARDS patients
P Dostal, V Cerny, R Parizkova
Department of Anaesthesia and Intensive Care, University Hospital, Hradec Kralove, 500 05, Czech Republic
Introduction: Different techniques to determine optimal PEEP
setting in patients with ARDS have been suggested. The aim of our
study was to evaluate assessment of static compliance of respira-
tory system in combination with estimated lung recruitment [1] for
selection of PEEP setting with minimal Qs/Qt.
Methods: Seven patients with early ARDS (intubation time
< 7 days) with pulmonary artery catheter in place were studied.
During the study all patients were ventilated at different PEEP
levels using CMV with constant inspiratory flow, tidal volume was
5–7 ml/kg IBW, inspiratory/exspiratory time and respiratory rate
was adjusted to avoid presence of intrinsic PEEP. On each level of
PEEP arterial and mixed venous blood gases, hemodynamic para-
meters, static compliance of respiratory system Crs and difference
in endexpiratory lung volumes DEELVPEEPtest between tested and
baseline level of PEEP (minimal level of PEEP used during the
study, usually 8 cmH2O) were recorded. Volumes and pressures
were measured using CP-100 pulmonary monitor (BICORE moni-
toring systems, USA) at the end of airway. Estimated lung recruit-
ment ELR (ELRPEEPtest = DEELVPEEPtest – CrsPEEPtest x [PEEPtest –
PEEPbaseline]) was calculated for each tested level of PEEP. Ability
to predict the PEEP level with minimal shunt was tested for minimal
PEEP with maximal Crs, for maximal PEEP with maximal Crs and
for algorithm based on static compliance and the amount of esti-
mated lung recruitment. Sensitivity, specificity and likelihood ratio
(LR) for prediction of PEEP level with minimal shunt were calcu-
lated, Fisher exact test was used for statistical analysis, P < 0.05*
was considered statistically significant.
Results:
Sensitivity Specificity LR
Maximal PEEP with maximal Crs 0.143 0.7 0.4
Minimal PEEP with maximal Crs 0.571 0.850 3.8
Minimal PEEP with ELR > ELRmax –  0.857*  0.95 17.14
150 ml and maximal Crs 
Conclusion: Despite limited number of patients and possible influ-
ence of used equipment on critical value of ELR we found that
combined assessment of compliance and recruited lung volume
enables better prediction of PEEP setting with minimal Qs/Qt.
Reference:
1. Gattinoni L et al: Am J Respir Crit Care Med 1995, 151:1807–1814.
P27 Positive end-expiratory pressure does not increase intraocular pressure in patients with intracranial pathology
K Kokkinis*, P Manolopoulou*, J Katsimpris†, S Gartaganis†
*Department of Anaesthesiology and Critical Care Medicine, and †Department of Ophthalmology, University Hospital of Patras, Patras, Greece
Introduction: Mechanical ventilation with PEEP is the cornerstone
of treatment of patients with ALI and ARDS, but it is not free of
adverse effects. This study aims to examine the effect of varying
levels of PEEP on the intraocular pressure in critically ill patients
with intracranial pathology.
Materials and methods: We studied 40 patients with intracranial
pathology and respiratory failure, without history of glaucoma and
not receiving drugs known to affect intraocular pressure. Twenty-
one patients had head injury (GCS £ 8 on admission), 11 had sub-
arachnoid hemorrhage (III-IV Hunt and Hess) and 8 had
intracerebral hemorrhage. Measurement of intraocular pressures
where done while the patients were mechanically ventilated with
different levels of PEEP. These patients were divided in four
groups (A, B, C, D) of 10 patients. Each group had different PEEP
values according to the attending physician for at least > 24 hours
(see Table). Mean systemic arterial pressure, peak airway pressure,
central venous pressure and arterial oxygen saturation were
recorded (see Table).
Results: In all groups there was no difference in intraocular pres-
sure values between the right and left eye. In patients subjected in
different levels of PEEP no effect on intraocular pressure was
observed.
Available online http://ccforum.com/supplements/5/S1S14
Critical Care    Vol 5 Suppl 1 21st International Symposium on Intensive Care and Emergency Medicine
Conclusion: Mechanical ventilation with PEEP values of
£ 15 cmH2O do not cause an increase in intraocular pressure in
patients with intracranial pathology.
Table
Group A B C D
PEEP 0 PEEP 5 PEEP 10 PEEP 15
Paw (cmH2O) 32 ± 5 35 ± 1 37 ± 3 40 ± 4
MAP (mmHg) 90 ± 15 92 ± 16 95 ± 17 93 ± 18
CVP (mmHg) 6 ± 3 5 ± 4 5 ± 3 6 ± 4
IOP (od) (mmHg) 13.4 ± 3.4 14.1 ± 4.1 13.4 ± 3.4 12.5 ± 3.0
IOP (os) (mmHg) 13.7 ± 3.3 14.5 ± 3.7 14.2 ± 3.4 12.8 ± 3.1
SaO2 (%) 98 ± 2 98 ± 2 98 ± 2 98 ± 1
P28 Effects of lung recruitment and PEEP after CPB on pressure–absolute volume curves
T Dyhr, A Larsson
Department of Anesthesiology, Gentofte Hospital, DK-2900 Hellerup, Denmark
Introduction: Impaired lung function is common after cardiopul-
monary bypass (CPB). We hypothesized that due to collapse ten-
dency 1) the effect of a lung recruitment maneuver (LR) on a
pressure–absolute lung volume (P–V) curve would be minimal, 2)
but if LR is followed immediately by PEEP the curve would shift
upwards and the slope would be steeper.
Methods: Sixteen patients (48–75 years) after CABG in CPB
were studied postoperatively every 0.5 h during 3 h while mechani-
cally ventilated (FiO2 1.0) with measurements of end-expiratory
lung volume (EELV) and blood gases. Eight patients were random-
ized to LR (45 cmH2O airway pressure 2 x 20 s) after which PEEP
was set 1 cmH2O > LIP obtained from a static P–V curve (PEEP
group), while the 8 other were randomized to LR only (ZEEP
group). Three inspiratory P–V (including EELV) curves were
obtained in both groups. In the PEEP-group, the first curve (A l)
was obtained before LR and PEEP, the second (B ¡) during PEEP
(14 ± 3 cmH2O, mean ± SD) 2.5 h after LR, and the third (C s)
0.5 h after removal of PEEP, i.e. 3 h after LR. In the ZEEP group,
P–V curves were obtained at similar times.
Statistics: ANOVA and Wilcoxon signed rank test.
Results: In the ZEEP group, no change in PaO2, lung volume or
PV-relations occurred during the study. In the PEEP group, PaO2
increased by 16 ± 15 kPa (P < 0.002) after LR and PEEP and was
unchanged during the study. EELV increased by 1120 ± 235 ml
(P < 0.0001) and remained stable until removal of PEEP. The 3
P–V curves are shown in the figure (A ¹ B or C, P < 0.03).
Discussion: In patients after CPB, LR without subsequent PEEP
had no effect. However, when LR was followed by PEEP, EELV
increased and the P–V curve became steeper and shifted upwards.
Furthermore, the curve remained the same 0.5 h after PEEP-removal.
This and the unchanged PaO2 indicate that no new lung collapse
occurred after removal of PEEP and suggest that PEEP might have a
sustained stabilizing effect on lung structures in these patients.
Figure
Our aim was to compare the effects of LV + ZEEP, LV + Sigh
and LV + PEEP on histopathological changes with healthy rabbit
lungs. Fifteen New Zeland rabbits were randomly divided into
three groups (n = 5). Animals were ventilated for 3 hours with
FiO2:1.0, f:80/dk. Group1: Low volume (5 ml/kg) + ZEEP,
Group 2: Low volume (5 ml/kg) + 10 cmH2O PEEP, Group 3:
ç
P29 The histopathological changes comparison in healthy rabbit lung ventilated with ZEEP, Sigh and PEEP
Ç Yardimci, G Meyanci, H Öz, I Paksoy
IU Cerrahpasa Medical Faculty, Department of Anaesthesiology, 34303 Istanbul, TurkeyS15
Low volume (5 ml/kg) + Sigh. At the end of 3 hours the animals
were sacrificed for histopathological evalotion. Lungs were
removed and fixed in 10% buffered formaldehyde. Tissue sec-
tions were processed in the usual manner for light microscopic
examination with Hematoxylin–Eosin stain. The pathological
lesions were classified ranging from 0 to ++++. There were sta-
tistically significant differences between ZEEP and PEEP
groups, ZEEP and Sigh groups (P < 0.05). The damage were
prominent in the ZEEP group for alveolar hemorrhage and con-
gestion. There were no statistically significance within groups
for notrofill infiltration and density. But the damage were more
significant than the others in the ZEEP group. We saw atelecta-
sia only in the Sigh group.
The damage was more significant than the others in the ZEEP
group. The atelectasia was seen only in the Sigh group. We con-
clude that adding Sigh and PEEP to low volume may decrease the
damage and PEEP may be more effective to prevent atelectasia.
P30 The pattern of breathing and chest wall movements at different levels of pressure support and PEEP
D Chiumello*, P Pelosi*, P Taccone*, E Carlesso*, A Aliverti†, R Dellaca’†, L Gattinoni*
*Istituto di Anestesia e Rianimazione, Ospedale Policlinico, IRCCS, Universita’ di Milano; †Dipartimento di Bioingegneria, Politecnico di
Milano, Centro di Bioingegneria Fondazione Don Gnocchi IRCCS, Milano, Italy
We previously found that optoelectronic plethysmography can be
used to measure the chest wall volume and its compartments: rib
cage and abdomen [1]. We evaluated the breathing pattern and
the chest wall displacement during pressure support (PSV) in
patients with acute respiratory failure. Nine intubated patients (age
57 ± 12 years, BMI 26 ± 5 kg/m2, PaO2/FiO2 293 ± 67) were
studied first at four levels of PSV (5, 10, 15, 25 cmH2O) at 10
cmH2O of PEEP and then at three levels of PEEP (5, 10, 15
cmH2O) at 10 of PSV. We measured the breathing pattern, the rib
cage contribution to tidal volume (RC/VT) and the inspiratory asyn-
chrony (IA) [2]. IA was calculated as the area enclosed by the
inspiratory portion of rib cage abdomen loop and the line connect-
ing the commencement and the terminal of inspiration.
Our results suggest that only the level of PSV affects the breathing
pattern.
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Effects of PSV levels
5 cmH2O 10 cmH2O 15 cmH2O 25 cmH2O
RR (bpm) 27 ± 12* 25 ± 12* 19 ± 14 12 ± 6
VT (ml) 405 ± 153 474 ± 184 664 ± 25† 1043 ± 371‡
RC/VT (%) 38 ± 13* 34 ± 13 33 ± 12† 32 ± 9
IA (ml/ml2) 13 ± 6 11 ± 9 9 ± 5 7 ± 4
Effects of PEEP levels
5 cmH2O 10 cmH2O 15 cmH2O
RR (bpm) 27 ± 11 25 ± 12 27 ± 11
VT (ml)  423 ± 217 474 ± 184 454 ± 205
RC/VT (%)  36 ± 10 34 ± 10 41 ± 12
IA (ml/ml2) 10 ± 12 11 ± 9 11 ± 7
* P < 0.05 vs PSV 25, † P < 0.05 vs PSV 5, ‡ P < 0.05 vs others PSV
levels.
P31 Effect of prone position on pulmonary vascular permeability in acute respiratory distress syndrome
D McAuley, S Giles, F Gao
Intensive Care Unit, Birmingham Heartlands Hospital, Birmingham B9 5SS, UK
In early acute respiratory distress syndrome (ARDS), alteration in the
pulmonary capillary permeability is associated with outcome [1].
Alteration in the relation of extravascular lung water to intrathoracic
blood volume (EVLW/ITBV) derived from thermal-dye dilution curves
indicates changes in the pulmonary vascular permeability. Prone
positioning improves gas exchange in most patients with ARDS,
however whether this improvement is related to effects on pulmonary
vascular permeability has not been evaluated. This prospective pilot
study was designed to investigate whether prone positioning would
alter EVLW/ITBV as a measure of pulmonary vascular permeability.
Patients with ARDS on inverse ratio pressure-controlled ventilation
with PEEP > 10 cmH2O for at least 24 hours were recruited.
Patients were turned prone for 18 hours. Except for FiO2, ventila-
tory settings remained unchanged during the study period. Values
of EVLW and ITBV were obtained using a single transpulmonary
arterial thermodilution technique with a 5F-fibreoptic thermistor
femoral artery catheter. Measurements of EVLW and ITBV were
taken at pre-prone, 1, 2, 6, 12 and 18 hours after proning and
1 hour after supine. EVLW/ITBV while prone was normalised to
pre-prone values as a baseline to illustrate differences during
prone and supine. Data were expressed as mean (SEM). Repeated
measures ANOVA was used for statistical analysis.
Twelve episodes of proning in 11 patients were studied. Although
mean PaO2/FiO2 improved within 1 hour, it continued to improve
Changes in EVLW/ITBV after prone positioning in ARDS
1 h 2 h 6 h 12 h 18 h Supine
EVLW/ITBV 0.015 ± 0.0024 0.015 ± 0.0016 0.014 ± 0.0017 0.014 ± 0.0017 0.013 ± 0.0012 0.013 ± 0.0017 0.012 ± 0.0013
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during the period studied and only reached significance 12 hours
after proning (17.9 ± 2.9 v 35.1 ± 4.2, P < 0.05). Mean
EVLW/ITBV did not change significantly.
At least 12 hours may be needed for maximal benefit with prone
positioning. Changes in pulmonary vascular permeability in ARDS
do not appear to be an important mechanism to account for the
improvement in gas exchange seen following prone positioning.
Reference:
1. Pallister I, Gosling P, Alpar K, Bradley S. J Trauma 1997,
42:1056–1061.
P32 Prospective study to evaluate the kind of prone position concerning nursing, pulmonary outcome and material and
personnel resources
TR Neubert, R Stiletto, L Gotzen
Center of Operative Medicine, ICU I1 Department of Trauma Surgery, Philipps-University Marburg, Baldingerstraße, 35043 Marburg, Germany
Introduction: Acute Respiratory Distress Syndrome (ARDS) is one
of the most common, potentially lethal disease processes encoun-
tered in critical care with extremely high mortality of about 60%.
Researchers have found that a significant improvement in gas
exchange often occurs when ARDS patients are turned from the
supine to the prone position. But there are a lot of difficulties in
nursing these patients in dependence of the kind of kinetic therapy.
So the major goal is, to find out the best kind of kinetic therapy.
The available study is designed by physicians and nurses. Besides
the question of patients benefit concerning the gas exchange the
handling, the acceptance of the nurses and economical conse-
quences are proofed.
Methods and materials: Patients with ARDS, or those patients
identified as requiring to be nursed in the prone position with a
Horowitz-Quotient (PaO2/FiO2) < 250 were treated by different
kinds of kinetic therapy in order to compare the efficiency concern-
ing clinical outcome, personnel and material resources and the
incidence of complications. Patient were turned into face down
prone position, in near side prone position or they were treated in a
Rotation bed. Gas analysis defined the clinical effect of the posi-
tion on gas exchange. Also changes in skin integrity, skin status
and clinical outcome of prone positioning were documented. Addi-
tionally number of nurses/physicians being involved in positioning
the patient and the duration of time was documented.
Results: Ten patients were positioned in near side prone position
(NSPP). Eight patients were positioned in 180°-position and 10
patients were treated in rotation bed. In handling, nursing and
observing the NSPP is the preferred kind of kinetic therapy. The
pulmonary outcome is comparable to the other forms of kinetic
therapy but less need of personnel and material resources and the
very small risk of complication (skin damages, oedema formation,
lost of catheter or tube) are advantages of the NSPP. So at every
point of time position changing can occur. Also the patients treated
in rotation bed shows a similar clinical outcome concerning the gas
exchange but the need of material resources is disproportionately
high and the availability is to be estimated very low.
P33 Effect of prone position on hepato-splanchnic hemodynamics in acute lung injury
M Matejovic*, R Rokyta*, P Radermacher†, A Krouzecky*, V Sramek*, I Novak*
*ICU, Department of Internal Medicine I, Charles University Hospital Plzen, Alej svobody 80, CZ-30460 Plzen, Czech Republic;
†Department of Anesthesia, University Hospital, D-89073 Ulm, Germany
Objective: Ventilation in prone position (PP) is a common method
to improve gas exchange in patients with acute lung injury (ALI).
Although no significant changes in systemic hemodynamics were
observed [1], the question remains as to whether the PP may alter
the hepato-splanchnic perfusion and oxygen exchange. Therefore,
we studied the effects of PP on hepato-splanchnic hemodynamics
in patients with ALI.
Patients and methods: Up to now five patients with ALI fulfilling
criteria for PP (PaO2/FiO2 < 250, FiO2 > 0.55, PEEP > 10) were
studied. In addition to systemic hemodynamics (radial and PA
catheters) and gas exchange, hepatosplanchnic blood flow (HSBF,
steady state indocyanine green technique) and hepatic venous
pressure (HVP) were measured using hepatic vein catheter.
Gastric intramucosal-arterial PCO2 gap was determined using air
tonometry (Tonocap) and intravesical pressure was recorded to
monitor intra-abdominal pressure (IAP). Data collection was per-
formed at the supine position (SP1), after 90 min of PP, and after
90 min of supine repositioning (SP2).
Results: Data are median and interquartile range (RM-ANOVA).
Conclusion: Our preliminary results suggest that the prone posi-
tion, provided that IAP remains unaffected [2], compromises
neither the perfusion of the hepato-splanchnic area nor the gut
mucosal energy status in patients with ALI [3].
SP1 PP SP2 P value
MAP (mmHg) 91 (82–104) 90 (86–116) 92 (85–113) 0.52
CI (l/min/m2) 3.5 (2.9–4.0) 3.4 (3.1–4.0) 3.2 (2.7–3.5) 0.36
HSBF (l/min/m2) 1.17 (1.12–1.4) 1.26 (1.06–1.51) 1.22 (1.03–1.43) 0.95
HVP (mmHg) 14 (13.16) 15 (14–17) 14 (14–15) 0.95
PCO2 gap (mmHg) 7.5 (5.3–10.9) 7.9 (5.3–8.3) 7.5 (6.9–9.8) 0.94
IAP (mmHg) 10 (9–13) 13 (10–16) 14 (11–14) 0.09S17
Supported by a grant IGA MZ ND5649-3. References:
1. Jolliet et al: Crit Care Med 1998, 26:1977–1985.
2. Kiefer et al: Crit Care 2000, Suppl 1:S87–S88.
3. Sugrue et al: World J Surg 1996, 20:988–991.
P34 Alterations in bronchoalveolar lavage fluid after experimental fulminant hepatic failure
C Routsi*, G Kostopanagiotou†, B Smyrniotis†, EI Kitsiouli‡, ME Lekka‡, G Nakos§
*Department of Critical Care, University of Athens, Evangelismos Hospital, Athens, Greece; †Department of Anaesthesiology and 2nd
Department of Surgery, University of Athens, Aretaieion Hospital, Athens, Greece; ‡Department of Chemistry, and §Department of Critical
Care, University of Ioannina, Ioannina, Greece
The fulminant hepatic failure (FHF) could be a risk factor for acute
lung injury (ALI). However, there is little information on the patho-
physiology of pulmonary involvement during the early course of
acute liver failure. Alterations in lung permeability, surfactant
metabolism and local inflammation are significant markers of acute
lung injury. The objective of this study was to evaluate alterations of
protein as a marker of permeability, phospholipid as a marker of
surfactant alterations and PAF-acetylhydrolase (PAF-AcH) as
inflammatory marker in bronchoalveolar lavage (BAL) fluid from
pigs in an experimental surgical model of FHF.
Methods: Twelve anesthetized, intubated and mechanically venti-
lated pigs weighting 20–25 kg, with a pulmonary artery in place
were studied. In seven pigs FHF was induced by surgical devas-
cularization of the liver and the other five animals were sham-
operated. BAL was performed by fiberoptic bronchoscopy
before, 4 hours and 7 hours after the surgical procedure respec-
tively using 4 × 20 aliquots of normal saline after the first aspi-
rated fluid. BAL fluids were collected in ice-cold tubes (4°C).
Total protein concentration, phospholipids and PAF-AcH were
subsequently measured.
Results: Total protein was found significantly higher in animals
with FHF, while the protein concentration of the BAL fluid in sham-
operated animals was not changed. Reduction of total BAL phos-
pholipids was observed in animals with FHF. In contrast,
pospholipids increased in sham animals during mechanical ventila-
tion. PAF-AcH was also reduced in FHF (Table 1). Pulmonary
wedge pressure remained low in both groups during the study.
Conclusion: Experimental FHF is associated with an increase of
pulmonary permeability as indicated by increased proteins in BAL
fluid, and surfactant alteration as indicated by the change in total
BAL phospholipids. The decreased PAF-AcH, an anti-inflammatory
factor, implies an inflammatory process. These findings suggest
that lung injury occurs early in the course of FHF.
Table 1
Biochemical characteristics of BAL fluid from animals with FHF and those sham-operated
Sham FHF
Initial 4 h 7 h Initial 4 h 7 h
Protein (mg/ml BAL) 4.9 ± 2.1 4.1 ± 1.4 5.3 ± 3.2 6.2 ± 3.7 8.8 ± 4.4 11.2 ± 5.4*
Total phospholipids (mgP/ml BAL) 7.7 ± 3.6 10.5 ± 3 15.5 ± 2.5* 10.0 ± 1.9 8.9 ± 3 6.9 ± 1.0*
PAF-AcH (nmol/mg pt/min 0.24 ± 0.25 0.4 ± 0.05 0.5 ± 0.05 0.13 ± 0.05 0.04 ± 0.04* 0.04 ± 0.04*
* P < 0.05 from initial value.
P35 Selective phosphodiesterase type 5 inhibition improves responsiveness to inhaled nitric oxide in endotoxin-challenged rats
U Zils*, A Holzmann*, MM Gebhardt†, H Schmidt*, E Martin*
*Department of Anaesthesiologie, and †Department of Experimental Surgery, Ruprecht-Karls-Universität, Im NeuenheimerFeld 110, 69120
Heidelberg, Germany
Introduction: Inhaled nitric oxide (NO) improves arterial oxygena-
tion and decreases pulmonary artery pressure (PAP) in ARDS.
However, up to 60% of septic patients with ARDS show no or only
minimal response to inhaled NO. NO induces relaxation of smooth
muscle cells via the second messenger 3¢,5¢-cyclic monophos-
phate (cGMP) which is metabolized by phosphodiesterase (PDE)
type 5. Zaprinast and sildenafil are inhibitors of PDE type 5 and
have been shown to decrease PAP in sheep with thromboxane
analog U46619-induced pulmonary hypertension [1,2]. Because
pulmonary PDE activity is increased in rats exposed to endotoxin
[3], we hypothesised that inhibition of PDE type 5 with zaprinast or
sildenafil improves responsiveness to inhaled NO in isolated-per-
fused lungs from rats challenged with endotoxin.
Methods: Adult Sprague–Dawley rats (400–450 g BW) were
injected intraperitoneally with 0.5 mg/kg E. coli 0111:B4 endotoxin.
Sixteen to 20 hours later, lungs were isolated, ventilated and per-
fused in situ. Lungs were perfused using a modified Hank’s bal-
anced salt solution containing 5% dextran, 5% bovine albumine,
30 mM indomethacin, and 580 mM L-NAME to inhibit endogenous
nitric oxide synthesis. Then, U46619 was employed to increase PAP
by 5 to 8 mmHg. After a stable elevated PAP was reached, 4 or 10
ppm NO with or without zaprinast (50 mg) or sildenafil (10 ng) was
administered for 3 min and the decrease of PAP was measured.
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Results: Conclusion: These data demonstrate that specific inhibition of
PDE type 5 improves responsiveness to inhaled nitric oxide in
lungs obtained from endotoxin-challenged rats. In our model,
decreased responsiveness to inhaled nitric oxide is at least in part
attributable to increased pulmonary PDE type 5 activity.
References:
1. Weimann et al: Anesthesiology 2000, 92:1702–1712.
2. Ichinose et al: Anesthesiology 1998, 88:410–416.
3. Holzmann A et al: Am J Physiol 1996, 271:L981–L986.
NO 4 ppm NO 10 ppm
Decrease of PAP (mmHg) –0.7 ± 0.1 (n = 6) –1.0 ± 0.1† (n = 6)
Zaprinast (50 mg) –1.9 ± 1.8* (n = 14) –2.9 ± 1.3* (n = 4)
Sildenafil (10 ng) –1.8 ± 1.1* (n = 6) –2.4 ± 0.5* (n = 5)
†P < 0.05 vs NO ppm and * P < 0.05 vs NO 4 ppm and NO 10 ppm,
respectively; ANOVA.
P36 Partial liquid ventilation (PLV) vs conventional mechanical ventilation (CMV) with high PEEP and moderate tidal volume
(Vt) in acute lung injury in piglets
G Zobel, S Rödl, B Urlesberger, I Knez, D Dacar
Departments of Pediatrics, Neonatology, and Cardiac Surgery, University of Graz, Austria
Objective: To test the hypothesis that PLV combined with a high
PEEP and a moderate Vt results in improved gas exchange and
lung mechanics compared to CMV in acute lung injury in piglets.
ALI was induced in 12 piglets weighing 9.0 ± 2.4 kg by repeated
intravenous injections of oleic acid and repeated lung lavages.
Thereafter the animals were randomly assigned either for PLV
(n = 6) or CMV (n = 6) at a FiO2 of 1.0, a PEEP of 1.2 kPa, a tidal
volume < 10 ml/kg, a respiratory rate of 24 breaths/min, and an I:E
ratio of 1:2. Perfluorocarbon liquid (30 ml/kg b.w.) was instilled into
the endotracheal tube over 10 min followed by 5 ml/kg b.w./h.
Cardiorespiratory monitoring was done at baseline, after induction
of ALI, and every 30 min up to 120 min. When compared with
control animals, PLV resulted in significant better oxygenation, sig-
nificant lower dead space ventilation, and significant better CO
and DO2.
Conclusions: PLV combined with high PEEP and moderate tidal
volume significantly improves oxygenation, dead space ventilation,
cardiac output, and oxygen delivery in piglets with ALI, but has no
significant influence on lung mechanics.
Table 1
PA-aO2 and DO2 in 12 piglets with ALI during PLV or CMV
Parameters Group Baseline ALI t-60 t-120
PA-aO2 (kPa) Control 5.8 ± 2.3† 80.2 ± 2.9 72.7 ± 6.3* 71.9 ± 7.2*
PLV 7.5 ± 4.1† 80.5 ± 2.3 47.9 ± 20.0†§ 45.6 ± 21.3†§
DO2 (ml/min) Control 18.7 ± 3.5† 11.3 ± 2 11.7 ± 4.0 10.5 ± 2.6
PLV 22.5 ± 4.1† 15.3 ± 4.5 18.9 ± 6.9‡ 18.7 ± 7.2‡
* P < 0.05, † P < 0.01 vs ALI levels within the groups, ‡ P < 0.05, § P < 0.01 between groups.
P37 Acute versus subacute haemorrhagic shock evaluated in an isolated perfused rat lung model
M Chalier, M Licker, M Jorge-Costa, J Hantson, DR Morel
Division of Anaesthesiology Investigations, CMU, 1 Rue Michel Servet, CH 1211 Genève 14, Switzerland
Introduction: Volume resuscitation of haemorrhagic shock (HS)
may lead to delayed apparition of shock lung. We compared acute
versus subacute grade IV HS with and without volume resuscita-
tion in an isolated blood-perfused and ventilated lung rat model.
Methods: Male Sprague Dawley rats were anaesthetised with
isoflurane, fentanyl and pancuronium, tracheotomised and venti-
lated with a volume controlled ventilator. After 300 U/kg i.v.
heparin, grade IV HS was induced by withdrawing 30 ml/kg blood
with a roller pump in four groups of 10 rats (acute HS with and
without volume resuscitation, subacute HS with and without
volume resuscitation). A 5th group without HS served as control.
Volume resuscitation consisted of infusion of Ringer Lactate (three
times the volume of blood withdrawn) over 30 min, starting 60 min
after initiation of HS. Mean arterial pressure (MAP) dropped from
75 mmHg to 10 mmHg in the acute HS, and from 75 to 25 mmHg
in the subacute HS. MAP recovered initial values at the end of
resuscitation in the rats submitted to the subacute but not to the
acute HS. Ventilation parameters were maintained constant. The
isolated lung circuit was primed and perfused with the blood of a
donor rat.
Results: Acute HS with volume resuscitation was not associated
with significant alterations in any of the measured variables of the
perfused lung. In contrast, acute HS without volume resuscitation
resulted in the most striking alterations in lung mechanics, haemo-
dynamics, as well as weight changes. Subacute HS independently
of volume resuscitation showed only moderate and non significant
changes. See Figure 1 opposite.
Conclusions: Our results demonstrate that pulmonary injury fol-
lowing non resuscitated HS depends principally on the intensity
and not on the volume of blood loss, and that during subacute HS
even of grade IV, volume resuscitation is of minimal benefit.S19
Figure 1
Mean ± SE values of data measured at 60 min after reperfusion of the isolated lungs of control rats (Black bars), acute HS with resuscitation (white
bars), acute HS without resuscitation (light grey bars), subacute HS with resuscitation (dark grey bars), subacute HS without resuscitation
(hatched bars). VPEF/VT = volume of peak expiratory flow over tidal volume, an index of airway resistance. *P < 0.05.
P38 The influence of enteral feeding on ventilator associated pneumonia (VAP) in trauma mechanically ventilated patients in
ICU
W Djazmati, ZA Memish, GA Oni, G Cunningham, Y Beyene, A Al Shimemeri
King Fahad National Guard Hospital, ICU (1425), PO Box 22490, Riyadh, 11426, Saudi Arabia
Introduction: Enteral feeding is a well known risk factor for devel-
oping Ventilated Associated Pneumonia (VAP) [1,2]. In this study
we compared the incidence of VAP in trauma and non-trauma
patients. Both groups were mechanically ventilated and enterally
fed, in a 12 bed adult medical surgical ICU in a tertiary/ trauma
center in Riyadh, Saudi Arabia.
Methods: A prospective study, all patients intubated and ventilated
for more than 48 hours receiving enteral feeding by oral or nasal
gastric tube were included during a period of 1 year. Diagnosis of
VAP was made according to CDC criteria (Atlanta).
Results: The total number of patients included in this study was
141. Sixty-one (61) patients (43.3%) were trauma ventilated
patients, and the remaining 80 patients (57.7%) were non-trauma
ventilated patients. The VAP rate among the trauma patients was
45.9% compared to 26.3% in the non-trauma patients. The differ-
ence was significant (RR = 2.5, 95% CI = 1.1–5.2, P = 0.024).
The table below compares trauma and non trauma patients who
had enteral feeding with respect to APACHE, H2 antagonist, seda-
tion, and gastric tubes days. The APACHE score was the only vari-
able significantly higher among non-trauma patients than trauma
patients (19.3 vs 11.6, P < 0.001).
Conclusion: In this study we showed that enteral feeding could be
a risk factor for developing VAP in trauma patients in spite of being
less critically ill than other medical or surgical (non-trauma) patients
in ICU. However further studies are needed to elaborate more in
the mechanism of VAP in trauma patients.
References:
1. Pingleton SK et al: Enteral nutrition as a risk factor for nosocomial
pneumonia. Eur J Clin Micro Inf Dis 1989, 8:551–555.
2. Memish Z et al: The incidence and risk factors of VAP in a Riyadh
hospital. Inf Cont Hosp Epid 2000, 21:271–273.
Trauma patients Non-trauma patients
Variable Mean SD Mean SD P value
APACHE 11.64 6.01 19.25 8.20 0.0001
H2 antagonist days 7.77 12.38 7.64 15.59 0.950
Sedation days  21.90 16.50 18.16 15.00 0.162
Gastric tube days 20.85 15.08 16.40 14.60 0.079
P39 The effect of lactulose in prevention of ventilator associated pneumonia (VAP)
V Zvonicek, P Sevcik, M Votava, P Ondrovcik, S Zabranska, I Sas, R Kraus, V Sramek
Department of Anaesthesia and Intensive Care, St Ann’s University Hospital, Pekarska 53 Brno, CZ-65691, Czech Republic
Introduction: Lactulose favourably influences microbial colonisa-
tion of colon and may therefore prevent ascending colonisation of
the gut and consequently decrease the incidence of VAP. Double
blind placebo controlled study using lactulose 4 × 15 ml daily or
saline given into the stomach for prevention of VAP was performed
in our ICU during 1999–2000.
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Materials and methods: Forty-eight patients without pulmonary
infiltrates and mechanically ventilated for < 24 hours entered the
study. Gastric, oral and tracheal aspirates and rectal swabs were
taken for semiquantitive analysis within 24 hours and in 3 days inter-
vals thereafter up to 21 days of ICU stay. For aspirates, the amount
of pathogens > 105/ml was considered significant. Metoclopramide
and sucralfate were used in all patients. Cyclic enteral nutrition was
given into the stomach according to standard protocol.
Statistics: Chi-squared and Fisher exact tests were used, P <
0.05 was considered significant.
Results: Thirty-eight patients (15 lactulose — L and 23 placebo —
P) stayed in the ICU > 4 days and were further analysed. L and P
groups did not differ in age, APACHE II, ICU survival, LOS, ventila-
tory and antibiotic days. The frequency of stools was significantly
higher in L group. On day 1 gastric aspirates were positive in 1 L
and 2 P patients. On day 4 gastric colonisation increased to 4
(27%) and 7 (30%), respectively (NS). During further ICU stay the
colonisation remained in range 20–35% and did not differ
between the groups. Candida albicans was the most often
pathogen isolated. On day 1 tracheal aspirates were positive in 1
(L group) and 3 (P group) patients. Later on the frequency in both
groups increased to and remained in the range of 40–75% (NS).
VAS was diagnosed in 6 (40%) and 8 (35%) in L and P groups,
respectively (NS). In 9 (L) and 12 (P) patients the pathogen was
primarily isolated from oral cavity with Pseudomonas aeruginosa
and coagulase negative Staphylococcus being the most often
pathogens. The consecutive appearance of pathogen in stomach,
oral cavity and trachea was clearly present in 2 patients. In further
5 patients the pathogens were isolated on the same day from all
three sites.
Conclusions: Lactulose failed to prevent gastric colonisation in
patients on mechanical ventilation. The most often source of
pathogens in trachea and VAP in our conditions is the oral cavity.
This study was performed with support grant IGA 4072-3
P40 Fiberoptic bronchoscopy and bronchoalveolar lavage in patients with a haematological malignancy with bilateral
pulmonary infiltrates
S Shah*, P Mehta†, J Salmon‡, N Stallard*
*Critical Care Directorate, †Department of Haematology and ‡Department of Microbiology, University Hospital of Wales, Cardiff, UK
Introduction: Pulmonary infiltrates in patients with a haematologi-
cal malignancy presents a special challenge for both diagnostic
approach and clinical management.
Aim: To analyse the utility and impact of Fiberoptic bronchoscopy
(FOB) and bronchoalveolar lavage (BAL) in patients with haemato-
logical malignancy and bilateral pulmonary infiltrates.
Method: A FOB with BAL was performed using three 50 ml
aliquot of 0.9% sterile saline solution and aspiration under contin-
uos monitoring of the saturations, over a 24 month period.
Results: Data as median (range).
Discussion: We studied 35 patients with haematological malig-
nancy with evolutive pneumonia despite treatment with appropriate
empirical antimicrobial therapy. The overall diagnostic yield was
80%, which was identical in both neutropenic and non-neutropenic
patients. This resulted in a change or rationalisation of antimicrobial
therapy for both groups of patients.
Conclusion: FOB with a BAL is a beneficial investigative tool in
patients with haematological malignancy with an evolutive pneumo-
nia as manifested by bilateral pulmonary infiltrates.
Reference:
Gruson D, Hilbert G, Valentino R, et al: Utility of fiberoptic bronchoscopy
in neutropenic patients admitted to the intensive care unit with bilateral
pulmonary infiltrates. Crit Care Med 2000, 28:2224–2229.
Neutropenic Non-neutropenic 
n  = 35 patients (n = 10) patients (n = 25)
Baseline APACHE II scores 13.5 (9–33) 14 (9–27)
Positive results 8 (80%) 20 (80%)
Bacterial 8 11
Viral 5 5
Fungus/PCP 1 2/1
No growths 2 (20%) 5 (20%)
P41 Hospital-acquired respiratory infection in patients admitted in ICU
T Cardoso, LM Lopes, AH Carneiro
Intensive Care Unit, Hospital Geral de Santo António, Largo Abel Salazar 4050, Porto, Portugal
Background: Hospital-acquired respiratory infection is frequent in
ICU patients, especially in those that are submitted to invasive pro-
cedures.
Objectives: To study comorbidities and risk factors for the devel-
opment of hospital-acquired respiratory infection (HARI) and the
microbiological profile.
Methods: Retrospective clinical study of 385 patients admitted to
our ICU, from January to September 2000. Respiratory infection
was defined by ‘new’ purulent bronchial secretions, with fever
(> 38.5°C, axilar) and leucocytosis (>10,000) with or without
‘new’ pulmonary infiltrate. Patients developing infection after 72
hours of hospitalisation were identified and studied for comorbidi-
ties: cancer, imunodepression, HIV positive, diabetes mellitus, pul-
monary, cardiac, renal, hepatic and central nervous illnesses,
alcohol and drug abuses and cigarette smoking; and risk factors:
non-elective oro-tracheal entubation (OTE), re-entubation or
traqueostomy, depression of conscience level (8 < ECG < 15),
coma (8 £ ECG), intoxication, seizures, vomiting, documented tra-
cheal aspiration and respiratory or cardiopulmonary arrest.
Results: During this period 78 (20.3%) patients had the diagnosis
of HARI, with a mean age of 55.8 years. 62.8% had comorbidities.
This group was compared with an equivalent group of 20 patients,
without respiratory infection in the same period (mean ageS21
43 years) — only 40% of these patients had comorbidities. In
patients with HARI — 84.6% had at least one risk factor. Non-elec-
tive OTE occurred in 73.1% and in 25.6% it was necessary a new
invasive procedure of the airway. For those without infection only in
10% it was necessary for new invasion of the airway. The mean
time of admission was 15.1 days for those with HARI and 6.85
days for those without. The mortality rate was similar in both
(24–25%). A total of 114 organisms were isolated, in 58 patients
(74.4%). First intention treatment was proposed according to
microbiological profile in only 20% of the patients. In 24% the
initial therapeutic option was changed according to the microbial
resistences. Only in 9.7% patients it was necessary to change the
antibiotic without microbiological guidance.
Conclusions: HARI was diagnosed in 20.3% of the patients
admitted to our unit. The infected patients are significantly older
than those without infection (P = 0.008) and had more comorbidi-
ties (especially chronic restrictive pulmonary illness — P = 0.041).
In these patients there were more non-elective OTE and subse-
quent invasive procedures of the airway. The occurrence of HARI
prolonged significantly ICU-hospitalisation (P = 0.024), but did not
cause a significant difference in the mortality rate.
P42 Risk factors for early-onset respiratory infection in a general intensive care unit (ICU)
LM Lopes, T Cardoso, AH Carneiro
ICU, Hospital Geral de Santo António, Porto, Portugal
Background: Early-onset respiratory infection (EORI) is frequent in
the ICU setting. Its incidence maybe related with the presence of
some risk factors.
Objective: The aim of this study was to identify risk factors and
describe the epidemiological patterns of those patients who are diag-
nosed with respiratory infection within 72 hours of ICU admission.
Methods: The authors retrospectively studied potential risk factors
and epidemiological data at the time of ICU admission among all
patients admitted during the period from January to September
2000. Patients were considered to have EORI when they met the fol-
lowing clinical criteria, within 72 h of ICU admission: 1 — Fever
(³ 38.5°C, axilar); 2 — Leucocytosis (³ 10,000 per mm3); 3 — Puru-
lent respiratory secretions. Pneumonia was defined as the same cri-
teria plus the detection by chest X-ray of new and persistent infiltrate.
Results: During the study period 385 patients were admitted to
our unit. The ICU length of stay was longer for patients with EORI
(8.8 ± 9.2 day; P < 0.001) and LORI (14.0 ± 9.7 days) as com-
pared to patients without respiratory infection (2.7 ± 2.8 days).
Multivariate analysis selected the presence of one co morbidity
(OR: 2.4; CI: 1.0–5.6); the existence of one risk factor (OR: 2.4;
CI: 1.1–5.3) or at least two risk factors (OR: 4.1; CI: 1.7–9.8); the
presence of two or more conditions that altered ventilatory
mechanics (OR: 6.1; CI: 1.3–28.1) and emergency intubation
(OR: 3.2; CI: 1.0–10.3) as significant factors for the development
of EORI. Depressed level of consciousness (OR: 1.9;
CI: 1.0–3.8) and documented aspiration (OR: 4.4; CI: 1.0–20.4)
were the only studied risk factors that were independently associ-
ated with EORI.
Conclusions: EORI has a high prevalence (45.1%) in our unit.
Both EORI and LORI are associated with prolonged ICU lengths of
stay. The presence of more than one risk factor has a strong asso-
ciation with EORI but depressed level of consciousness and docu-
mented aspiration were the only risk factors independently related
to EORI. The existence of two or more conditions that disrupt ven-
tilatory mechanics is a significant risk factor for EORI. Emergency
intubation was also identified as a significant risk factor for EORI.
P43 Failure of bacterial filters to reduce respiratory infection incidence
L Lorente Ramos*, J Málaga Gil*, M Lecuona Fernández†, C Revert Gironés†, P Revuelta Rabasa*, ML Mora Quintero*
*Department of Intensive Care, and †Department of Microbiology, Hospital Universitario de Canarias, La Laguna, Tenerife, Spain
Objective: To evaluate the efficacy of bacterial filters (BF) in
breathing circuits to reduce the incidence of tracheal colonization
(TC), tracheobronchitis (TB) and pneumonia (PN) in patients
undergoing mechanical ventilation (MV).
Design: Prospective, randomized study.
Setting: A 20-bed medical-surgical Intensive Care Unit (ICU).
Patients: All patients admitted in ICU from 16-6-2000 to 16-10-
2000 and who required mechanical ventilation for 24 hours or
more.
Intervention: At admission to the ICU, patients were randomly
assigned to one of two groups. In one group, patients were venti-
lated with bacterial filter, in the other group, were ventilated without
bacterial filter. We collected data on surveillance samples from
throat on admission and afterwards twice weekly, and respiratory
infections during the ICU stay. Infections were diagnosed accord-
ing to the criteria of the CDC and classified bassed on throat flora
[1] in: primary endogenous, secondary endogenous and exoge-
nous (Ex).
Statistical analysis: The statistical significance of the variables
was tested using Chi-square test or Student’s t-test where appro-
priate. Values P < 0.05 were considered statistically significant
(S).
Results: Eighty-seven patients fulfilled all criteria (62.06% man).
Mean age was 57.58 ± 16.56 years, APACHE-II 15.99 ± 5.66.
Mortality was 21.83%. Patients ventilated with bacterial filter were
45 and 42 patients were ventilated without bacterial filter. Both
groups of patients were similar in age, sex, mortality, days of
mechanical ventilation and APACHE-II. Patients ventilated with
bacterial filter (62.22% males) had APACHE-II 16.27 ± 5.90, with
13.13 ± 14.29 days of mechanical ventilation (total = 591 days)
and mortality was 22.22%. Patients ventilated without bacterial
filter (61.90% males) had APACHE-II 15.72 ± 5.42, with 18.50 ±
23.66 days of mechanical ventilation (total = 777 days) and mortal-
ity 21.42%. Developed pneumonia in 31.11% patients with BF and
33.33% without BF (P = no S). The number of tracheal coloniza-
tion (TC), tracheobronchitis (TB) and pneumonia (PN) in patients
undergoing mechanical ventilation (MV) with bacterial filter (BF)
and without bacterial filter (no BF) per 1000 mechanical ventila-
tion-days were the following:
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Conclusions: Bacterial filter in breathing circuits do not reduce the
incidence of tracheal colonization, respiratory infections or exoge-
nous events.
Reference:
1. van Saene HK, Damjanovic V, Murray AE, de la Cal MA: How to clas-
sify infections in intensive care units—the carrier state, a criterion
whose time has come? J Hosp Infect 1996, 33:1–12.
Number PN, TB  
Number PN per   Number TB per  Number TC per  Number PN and TB and TC per  Number Ex events 
1000 MV-days 1000 MV-days 1000 MV-days per 1000 MV-days 1000 MV-days per 1000 MV-days
BF 25.38 10.15 3.38 35.53 38.91 5.07
No BF 19.30 6.43 11.58 25.73 37.32 3.86
P No S No S No S No S No S No S
P44 Risk factors for broncho-pulmonary nosocomial infection in medical intensive care unit
S Nseir*, C Dipompeo†, T Onimus*, S Beague*, B Grandbastien‡, M Erb‡, F Saulnier*†, D Mathieu*, A Durocher*†
*Intensive Care Department, and ‡Hygiene Unit, Calmette Hospital, bd du Pr Leclercq, 59037 Lille Cedex, France; †Medical Assessment
Labaratory, University of Lille II, Lille, France
Broncho-pulmonary nosocomial infection (BPNI) has the highest
incidence of nosocomial infection in intensive care unit (ICU) and is
associated with substantial morbidity and mortality. The objective
of this study is to determine the risk factors for BPNI and improve
the prevention of this infection.
Patients and methods: Characteristics of all patients admitted in
a 30-beds university medical ICU were prospectively collected
from 03/93 to 09/99. The diagnosis criteria for nosocomial pneu-
monia and bronchitis were those published by the CDC. Patients
with first BPNI were compared to the others by univariate and mul-
tivariate analysis.
Results: We diagnosed 517 first BPNI representing: 12% of the
3681 patients hospitalised in our unit, 11.6 episodes/1000 days of
hospitalization and 16 episodes/1000 days of ventilation. Microbi-
ology studies were positives for 455 (88%) BPNI: Acinetobacter
(28.1%), P. aeruginosa (23.1%), Staphylococcus aureus (12.6%).
The 517 BPNI included 282 (54.5%) pneumonia and 235 (45.5%)
bronchitis.
Conclusion: Prevention of BPNI should consider all measures to
decrease ICU stay, length of mechanical ventilation and the use of
steroids, sedatives, H2-blockers, omeprazole, sucralfate and ATB
therapy; especially in patients with renal failure.
Patient characteristics General population  BPNI 
(n = 3681) (n = 517)
Age (years) 58 62
Sex ratio (M/F) 1.84 2.54
Mortality (%) 35.9 53.5
Mechanical ventilation (%) 85.1 97
ICU stay (days) 12.2 32.6
Length of mechanical ventilation (days) 10.5 26.5
SAPS II 37.1 36.5 NS
Total Omega 245 347
Surgical patients (%) 15.3 20.3
Univariate analysis identified the following risk factors (P < 0.05): At
admission: Male gender, age > 60, chronic lung disease antecedent,
previous corticosteroid treatment, antibiotics (ATB) in the previous 2
weeks, surgery or trauma < 24 hours, secondary hospitalization,
broncho-pulmonary infection, sedatives use; respiratory, renal or
digestive distress. During hospitalization: Mechanical ventilation, total
omega score; ATB, omeprazole, ranitidine or sucralfate use.
Multivariate analysis Odds ratio IC (95%)
H2-blockers or omeprazole use 5.53  3.35–9.12
Sucralfate use 2.66  2.05–3.46
Previous corticosteroid treatment 1.93 1.46–2.56
Renal failure 1.52 1.10–2.10
Number of ATB 1.27 1.12–1.44
Length of mechanical ventilation 1.06 1.05–1.08
Stay in ICU 1.05 1.03–1.06
P45 Surveillance tracheal aspirate in ventilator associated pneumonia (VAP)
L Lampati, E Maggioni, C Dominoni, S Bufano, A Pesenti
Anestesia e Rianimazione, Ospedale S. Gerardo, Via Donizetti 106, 20052 Monza, Italy
VAP is associated with increased ICU stay and mortality, particularly
when treatment is delayed or inappropriate [1]. When a clinical sus-
picion of VAP is justified, specific diagnostic tests are usually con-
ducted: bronchoalveolar lavage (BAL), protected specimen
brushing (PSB), diagnostic tracheal aspirate (dTA), blood cultures
and pleural fluid. We evaluated the concordance between specific
diagnostic tests and the surveillance tracheal aspirates (sTA).
Methods: In our ICU routine sTA are performed weekly. The sTA
and the specific diagnostic tests were considered concordant ifS23
the isolated bacteria were of the same strain and species, with
identical sensitivity.
Results: From January 1999 to June 2000, 256 patients were intu-
bated longer than 48 h. 150 clinical episodes of VAP were identi-
fied and in 139 a diagnostic test was performed (80 BAL, 3 PSB,
50 dTA, 3 blood cultures and 3 pleural fluid). Eighty-two resulted in
a positive culture. In 56 of these microbiologically confirmed VAP, at
least one sTA less than 8 days old was available, for a total of 65
sTA. The specific diagnostic specimen and sTA were concordant in
35/65 cases (54%). When negative or contaminated sTA were
omitted concordance reached 78% (in order to consider the value
of sTA to target therapy). In sTA taken £ 4 days before the clinical
suspicion of VAP, concordance was better than for sTA taken more
than 4 days before the specific tests (83% vs 55.6%; P = 0.07). In
addition, mean colony counts ³ 106 cfu/ml (96%) were more fre-
quently concordant than colony counts < 106 cfu/ml (50%)
(P = 0.0003). Concordance rate was not significantly different in
Early Onset Pneumonia (within 4 days after intubation-EOP) and
Late Onset Pneumonia (that occurs more than 4 days after intuba-
tion-LOP). In EOP, a mean colony counts ³ 106 was associated
with high rate of concordance. In LOP, even low colony counts
specimens identified the correct pathogen in 56% of cases.
Conclusions: The concordance between sTA and diagnostic test
was function of mean colony count and of time interval between
the sTA and VAP onset. In LOP concordance was acceptable
(56%) even with a low bacterial count. Surveillance TA may be a
useful guide to improve early empiric therapy in suspected VAP.
Reference:
1. Luna et al: Chest 1997, 111:676–685.
P46 Comparison between quantitative and qualitative culture of tracheal aspirates in the diagnosis of ventilator associated
pneumonia
FVC De Marco, LFA Camargo, CSV Barbas, C Hoelz, J Pasternack, MAS Bueno, M Martino, M Rodrigues, R Caserta, V Amado, 
E Knobel
ICU, Hospital Israelita Albert Einstein, 627/701 Av. Albert Einstein, CEP 05651-901 São Paulo SP, Brazil
Objectives: Tracheal aspirates cultures play an important role in
the diagnosis of ventilator associated pneumonia, but there are
scarce data on the utility of quantification of the bacterial colonies
recovered. Our objective was to compare, in the same group of
patients, the positive and negative predictive values (PPV and
NPV) of qualitative and quantitative (105 and 106 cfu/ml) cultures
of tracheal aspirates in the diagnosis of VAP.
Patients and methods: Between March and December 2000,
ventilated patients (>48 hours on ventilatory support) in a clini-
cal/surgical intensive care unit (ICU) were evaluated every Monday
for the presence or absence of VAP based on clinical and radiolog-
ical criteria (concordance of at least two out of three ICU physi-
cians). In the same day, tracheal aspirates were collected
aseptically and assayed for quantitative results with standard tech-
niques. The physicians were unaware of the culture results.
Results: The 76 patients enrolled yielded 154 opportunities for
evaluating the presence or absence of VAP. Overall concordance
between ICU physicians was 94% and radiological criteria was the
major reason for discordance. There were 26 episodes of VAP
(85% of concordance) and the major pathogens were P. aerugi-
nosa (27%) and S. aureus (23%). Sensitivity, specificity, positive
and negative predictive values of qualitative and quantitative cul-
tures of traqueal aspirates are shown in the table.
Qualitative culture ³ 105 cfu/ml ³ 106 cfu/ml
Sensitivity (%) 92 69 26
Specificity (%) 11 41 76
PPV (%) 17 19 19
NPV (%) 88 87 83
Conclusions: Based on our preliminary results, quantification of
tracheal aspirates for the purpose of improving the diagnosis of
VAP is useless and may not be cost-effective.
P47 Specific multigenotypic diagnosis of nosocomial pneumonia in ICU
M Pirard*, P-F Laterre†, M Bouyer‡, M Reynaert†, J-L Gala*‡
*Laboratory of Applied Molecular Technology, Université Catholique de Louvain, Belgium; †Department of Intensive Care, St. Luc University
Hospital, Belgium; ‡Section MSW, Operational Epidemiology and Infections Diseases, Queen Astrid Military Hospital, Brussels, Belgium
Mortality rate of nosocomial pneumonia in ventilated ICU patients
(pts) is about 20–25%. Despite advances in critical care, standard
criteria for pneumonia are still inaccurate. Antibiotherapy is often
started on a ‘best guess’ basis to anticipate frequently negative
bacteriological results (Ba-cul). Main etiological pathogens are
staphylococci, streptococci, pseudomonads and enterobacteri-
aceae. A multigenotypic and sequential molecular identification
(Mol-id) was applied on bronchoalveolar lavages (BAL) from 12 pts
with clinical-radiological evidence of infection with (n = 9)/without
(n = 3) positive Ba-cul. DNA extraction and duplicate specific ampli-
fication of 16S rDNA from BAL was first used to identify signals
corresponding to the presence of Gram + (G+), Gram – (G–), or
mixed G+/G–. Any G+ signal was followed by femA and mecA mul-
tiplex (mpx)-PCR for species-specific identification of staphylococci
and methicillin resistance, and by mpx-PCR for S. pneumoniae. Any
G– signal was followed by mpx-PCR for species-specific identifica-
tion of Pseudomonads (aeruginosa, cepacia, maltophilia) vs other
G– for which the 16S rDNA amplicon was sequenced.
Mol-id identified mixed G+/G– in 2/3 negative Ba-cul. Ba-cul gave
G+ or G– only in 3 and 4/12 pts, respectively. Among these, Mol-id
confirmed either G+ (2/3) or G– (2/4), and found a mixed signal in
3/7 pts. Mixed G+/G– was found by Ba-cul and Mol-id in 2/12
BAL, but in one case, S. epidermidis was found by Mol-id and ente-
rococci by Ba-cul. Staphylococci (MRSA, other) and Ps. aerugi-
nosa were found by Ba-cul and Mol-id in 2 and 3 pts, respectively.
Current results suggest that Mol-id is a useful adjunct bringing
more insight to standard criteria of nosocomial pneumoniae in ICU
and can be a timely relevant guide for antibiotherapy.
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P48 ICU-acquired nosocomial infection: impact of delay in adequate antibiotic treatment
T Mathevon, B Souweine, O Traoré, B Aublet, G Mahnès, PY Glanddier, P Deteix, D Caillaud
Hôpital G Montpied, BP 69, 63003 Clermont-Ferrand Cedex 1, France
Objective: To evaluate the impact of the delay in adequate antibi-
otic treatment (AAT) on outcome in ICU patients with nosocomial
pneumonia (NP) or bloodstream infection (NBSI).
Design: Retrospective cohort study.
Setting: A 6-bed medical ICU in a university hospital.
Methods: Patients with first NP (bronchoalveolar lavage culture
³ 104 CFU/ml or protected specimen brush culture ³ 103 CFU/ml)
or first NBSI (CDC definition) were included between May 1998
and September 1999. The organ failure score (Fagon criteria) at
the time of sampling (day 0) and the interval between sampling and
the start of AAT were recorded. Antibiotic treatment was consid-
ered to be adequate when all etiologic organisms isolated from the
culture specimen were found to be sensitive to the initial empiric
antibiotics. Mortality was compared according to the time of AAT
and the organ failure score on day 0.
Results: A total of 25 patients (mean SAPSII = 44) were included
in the study. Seventeen of them presented with a first NP and
eight with a first NBSI. The infection occurred 6.5 ± 4.6 days after
ICU admission, 23 patients were receiving mechanical ventilation
on day 0. The ICU mortality was 48% (12/25) and was not differ-
ent between NP patients and NBSI patients: 9/17 vs 3/8
(P = 0.47). Mortality increased with the duration without AAT
(P = 0.011) and was reduced when AAT was started on day 0
(P = 0.016) or day 1 (P = 0.036). A subsequent change from
inadequate to adequate antibiotic treatment had no impact on sur-
vival. Mortality was also associated with the number of organ fail-
ures on day 0 (P = 0.017).
Conclusions: The mortality rate in patients developing NP or NBSI
can be reduced when AAT is started before day 2. When the
results of the bronchoscopy specimen and blood cultures are
obtained early, they can therefore be helpful to start AAT and influ-
ence survival.
P49 Systemic inflammatory response during ventilator-associated pneumonia
C Lepousé, B Hamou Ouali, A Zohir, J Cousson, JL Suinat, A Léon
Hôpital R. Debré, 51092 Reims cedex, France
Introduction: Diagnosis of ventilator-associated pneumonia (VAP)
can be difficult which often a large associated infectious or inflam-
matory diseases. The aim of our study was to describe systemic
inflammatory response to VAP with the help of procalcitonin (PCT),
CRP and cytokines.
Methods: In a prospective study, we studied all patients in our ICU
with VAP between January 2000 and September 2000. PCT, CRP
and cytokines (TNF, IL-6, IL-8) were measured at admission (J0),
on second day (J2) and on fourth and seventh day (J4, J7). Prog-
nostic indicators of severity were recorded on admission: Apache
II, IGS II and SOFA score.
Results: Twenty-four consecutive patients (mean age 52 ± 17
years, mean IGS II 38 ± 15, mean Apache II 15 ± 6) were admit-
ted in ICU. Mortality rate was 45% (11 patients).
Discussion: PCT seems to be a good marker of the intensity of
inflammatory response to infection during VAP with PCT values
often under 5 ng/ml. So higher PCT levels may be related to
another sepsis and another aetiology must be researched.
J0 J2 J4 J7 J14
PCT (ng/ml) 5.27 ± 14.14 6.01 ± 12.65 10.79 ± 26.26 10.52 ± 26.52 2.99 ± 8.44
CRP (mg/ml) 191 ± 68 215 ± 62 163 ± 92 147 ± 106 68 ± 84
TNF (pg/ml) 10 ± 9 8 ± 8 10 ± 9 – –
IL-6 (pg/ml) 628 ± 1491 611 ± 1703 328 ± 602 – –
IL-8 (pg/ml) 111 ± 248 78 ± 183 66 ± 129 – –
P50 Procalcitonin (PCT) versus IL-6 levels in bronchoalveolar lavage (BAL) fluids of trauma victims with severe lung contusion
M Baacke*, L Gotzen*, R Lefering†, R Stiletto*
*Philipps-University, Marburg, Germany; †Department of Theoretical Surgery, University of COlogne, Cologne, Germany
Objective: To examine whether measurement of procalcitonin
(PCT) in comparison to Interleukin 6 (IL-6) is a reliable marker to
score the extent of lung contusion in bronchoalveolar lavage (BAL)
fluids in polytrauma patients.
Design: Prospective, non-randomized observational study.
Setting: Twelve-bed ICU in a 1100-bed primary care university
hospital.
Patients:  n = 14 trauma victims presenting with severe lung contu-
sion and acute lung injury (ALI) or acute respiratory distress syn-
drome (ARDS) were enrolled in the study.S25
Interventions: Bronchoscopy with collection of lavage fluid and
serum blood samples. Samples were obtained on day 1 and day 2
after severe chest trauma, and lung contusion was assessed by
CT scan.
Measurements and main results: PCT was detectable in bron-
choalveolar lavage (BAL) fluids of all 14 patients. A significant cor-
relation for PCT serum and BAL levels was found on day 2
(P = 0.0063). For PCT no significant correlations (Spearman rank)
were found to the lung injury score (LIS) (P = 0.93), the abbrevi-
ated injury scale (AIS-lung) (P = 0.33) and the sepsis-related
organ failure assessment score (SOFA-lung) (P = 0.38). Also for
IL-6 there was no significant correlation to the LIS score
(P = 0.62), AIS-score lung (P = 0.45) and to the SOFA-score
lung (P = 0.54).
Conclusions: PCT and IL-6 BAL levels cannot be considered as
reliable parameters to assess the extent of lung contusion.
P51 Procalcitonin, a marker of systemic inflammation response to peritonitis which contribute to therapies strategy
C Lepousé, G Mériau, J Delcourt, J Cousson, P Raclot, A Léon
Hôpital R Debré, 51092 Reims cedex, France
Introduction: Procalcitonin (PCT) was reported to be a specific
marker for infection with a half-time of 25 hours. In ICU, differentia-
tion between acute bacterial infection from other types of inflam-
mation is often difficult in particular in postoperative period. The
aim of this study was to assess the profile of time course of PCT in
peritonitis patient after surgical and anti-effective therapies in ICU.
Methods: In a prospective study, we studied patients admitted in
our ICU with peritonitis just after surgical procedure, between
January 2000 and September 2000. PCT, CRP and cytokines
(TNF, IL-6, IL-8) were measured at admission (J0), on second day
(J2) and on fourth and seventh day (J4, J7). Prognostic indicators
of severity were recorded on admission: Apache II, IGS II and
SOFA score.
Results: Thirty-three consecutive patients (15 males and 18 females,
mean age 60 ± 21 years, mean IGS II 47 ± 20, mean Apache II 20 ±
7, mean SOFA score 7 ± 4) were admitted in ICU. Mortality rate was
33% (11 patients), mean length of ICU stay was 15 ± 14 days.
Discussion: In peritonitis, PCT seems to be a specific marker of
the intensity of inflammatory response to infection. Persistence of
high PCT levels may be related to inefficacy of anti-infective thera-
pies and therapeutic strategy must be discussed.
J0 J2 J4 J7
PCT (ng/ml) 45 ± 70 23 ± 38 28 ± 76 17 ± 40
CRP (mg/ml) 205 ± 91 280 ± 83 178 ± 73 154 ± 71
IL-6 (pg/ml) 15,922 ± 43,546 761 ± 1621 300 ± 437
IL-8 (pg/ml) 2161 ± 5085 145 ± 210 97 ± 120
TNF (pg/ml) 26 ± 41 12 ± 12 9 ± 6
P52  Procalcitonin in autoimmune disease with sepsis
U Leonhardt*, M Werner†, L Engelmann*
*Department of Internal Intensive Care, University Leipzig, Medical Clinic I, Leipzig, Germany; †Centre of Surgery, Clinic II, Philipp-
Rosenthal Str 27a, 04103 Leipzig, Germany
Introduction: Procalcitonin (PCT), the precurser of calcitonin, is
important as a marker of systemic bacterial, fungal and parasite
infections. In patients with autoimmune diseases is the response of
invasive infection difficult to discriminate from the underlying
disease activity. To determine the specificity of procalcitonin, the
present study investigated the relationship of immmunologic
markers to PCT in systemic autoimmune diseases with sepsis.
Methods: Ten patients with systemic autoimmune disease
(rheumatoid arthritis, systemic lupus erythematodes, sclerodermia)
and sepsis of an Internal Intensive Care Unit, University hospital,
were included. The severity of the disease was assessed at the
APACHE II and SOFA-score. To determine the systemic inflamma-
tion were measured the serum concentrations of the C-reactive
protein, procalcitonin, TNF-alpha, interleucin-6 and the leukocyte
count during the septic process.
Results: There was a significant difference in TNF-alpha- and inter-
leukin-6-level and procalcitonin during the systemic bacterial
inflammation (P < 0.05). Only the marker procalcitonin was related
to the clinical signs and the severity of disease. Also compared to
the C-reactive protein and leucocyte count PCT showed a better
association to the duration of sepsis.
Conclusion: These results indicate that Procalcitonin is in autoim-
mune diseases an important marker to discriminate sepsis from
underlying disease activity. The measurement of TNF-alpha and
interleucin-6 during sepsis in these diseases described the sys-
temic inflammation but not specific the bacterial infection as com-
pared to PCT.
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P53 A new approach of endotoxic testing by using a monoclonal antibody against endotoxin (WN1-222/5) and flow cytometry
K-H Staubach*, J Nolde*, K Block*, A Woltmann*, H Brade†
*Department of Surgery, and †Forschungszentrum Borstel, Medical University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany
Serum-endotoxin was formerly measured by the limulus-amebocyte
assay. A major step forward since this test assay was available was
the introduction of chromogenic substrates which were convertible
by LAL clotting enzymes. Further improvements could not prevent
the results to be non-specific and in general unsatisfactory. An
alternative approach of our group for the detection of endotoxin
was the usage of a cross reactive monoclonal antibody against
endotoxin (WN1-222/5) in combination with flow cytometry, mea-
suring subsequent light emission of a second antibody directed
against WN1-222-5 in peripheral mononuclear cells (MØs).
In our porcine endotoxin shock model we investigated 10 pigs
under analgosedation receiving 250 ng/kg/hour endotoxin from
Salmonella friedeman.
Separation of mononuclear cells every 4 h and determination of the
concentration of endotoxin revealed the results shown in the Table.
In this preliminary study we could not find LPS at the cell surface in
vivo but in vitro (unpublished data). The current results indicate
that the process underlying LPS internalization are very complex.
During the course of our endotoxin shock with continuous endo-
toxin infusion endotoxin internalization increases gradually. Initially
the PMNs show the highest activity and a small increase thereafter.
In contrast the MØs revealed a more than 10 times higher activity
after 4 hours of the experiment.
With our new specific endotoxin test protocol it might well be pos-
sible in the future to evaluate the different responses of LPS as it
finds its way to different surface domains or intracellular compo-
nents in different cell populations, respectively.
P54 Increased concentrations of procollagen type III peptide in the evolution of septic phenomenon. An indicator of organ
damage and fibrinogenesis? (Preliminary data results)
A Mavrommatis*, S Papanicolaou*, E Kostadelou†, I Andrianakis‡, M Ikonomou*, E Zakynthinos‡, G Katsaris*, S Zakynthinos‡
*Intensive Care Unit, and ‡Hormonological Laboratory, General Hospital of Nikea-Piraeus, Piraeus, Greece; †Department of Critical Care,
Athens University, Evangelismos Hospital, Athens, Greece
The systemic response to infection is defined as septic phenome-
non. By its definition is a generalized inflammatory process and
during its progression every organ and system can potentially be
impaired. Its progression is associated with and mediated by the
activation of a number of host defense mechanisms (cytokine net-
works, activation of leukocytes, etc) and is characterized by many
organ damages mediated by this ‘whole body inflammation’. Procol-
lagen type III peptide (PIIIP), as marker of collagen type III biosyn-
thesis and turnover, directly indicates collagen synthesis and seems
to be a good marker of many fibrosing, destructive or healing
processes. However, serum concentrations of PIIIP have never
been systematically measured in patients with graded sepsis We
hypothesized that procollagen type III peptide serum levels might be
also of value in estimating the ‘whole body inflammation and
damage’ appeared in sepsis. This study was undertaken to test the
aforementioned hypothesis. We measured, by a commercially avail-
able radioimmunoassay (ELISA) technique, the serum procollagen
type III peptide levels of 51 septic patients (pts) (22 pts with sepsis
[group G1], 12 severe sepsis pts [group G2], 17 pts with septic
shock [group G3]) and we compared them with the findings of 12
healthy controls (group H). The definition of the stages of sepsis fol-
lowed the criteria established by the ACCP/SCCM consensus con-
ference (August 1992). We use one-way ANOVA to compare the
results from sepsis, severe sepsis and septic shock patients with
the ones from healthy controls. Procollagen type III peptide serum
levels was markedly increased during the septic process: group H
3.7 ± 0.2 mg/ml, group G1 10.1 ± 1 mg/ml, group G2 30 ± 6.2
mg/ml, group G3 34 ± 8.1 mg/ml (P < 0.005 — one-way ANOVA),
and was to be of statistically significant value when group H and
group G1 compared with group G3 (P < 0.05 and P < 0.005
respectively) (Sheffe test for the post hoc comparisons of means).
We conclude that PIIIP serum levels increased in parallel with the
increasing severity of septic process, probably being a good indica-
tor of tissue inflammation, damage, and fibrogenesis.
Time after LPS-infusion (h) 0 1 4
Amount of PMN endotoxin positive (%) 39.5 50.6 71.7
Amount of MØs endotoxin positive (%) 16.7 48.2 54.6
Amount of LYMPH endotoxin positive (%) 20.2 51.1 51.6
Mean fluorescence of PMN 23.7 49.8 37.9
Mean fluorescence of MØs 10.3 19.5 146.0
Mean fluorescence of LYMPH 1.9 26.1 91.1
P55 Endotoxemia induced MCP-1 expression in the intestinal muscularis causes leucocyte infiltration that mediates smooth
muscle dysfunction
A Türler, NT Schwarz, E Türler, BA Moore, JC Kalff, AJ Bauer
Department of Medicine/Gastroenterology, University of Pittsburgh, S847 Scaife Hall, 3550 Terrace Street, 15261 Pittsburgh, PA, USA
Background: Endotoxemia causes a molecular and leukocytic
inflammatory response with the intestinal muscularis, which is
associated with an inhibition of gastrointestinal motility. The
network of resident macrophages seems to play a major role as an
initiator of this cascade. We hypothesize that these resident cells
evoke the extravasation of immunocompetent leucocytes in the
intestinal muscularis through the release of chemotactic cytokines
(eg MCP-1).
Methods: Endotoxemia was induced in ACI rats by a single intraperi-
toneal injection of lipopolysaccharide (LPS: 15 mg/kg). Animals were
treated with LPS, LPS + non-specific antibody or LPS + MCP-1 anti-S27
body and sacrificed 18 hours after LPS for functional and immunohis-
tochemical studies (N = 6 each). Semi-quantitative RT-PCR was also
performed to delineate the time course of MCP-1 mRNA expression
(0, 1, 3, 6, 24, and 48 hours). MCP-1 mRNA peak expression was
confirmed and quantified by SYBR Green two-step real-time
RT-PCR. Cellular infiltration (polymorphonuclear neutrohils, mono-
cytes) and MCP-1 protein expression was determined by immunohis-
tochemistry. Spontaneous and bethanechol stimulated circular
muscle strip contractility was assessed using a standard organ bath.
Statistical analysis was performed using the unpaired Student t-test.
Data were considered statistical significant at a P < 0.05.
Results: Endotoxemia caused a significant increase in MCP-1
mRNA expression in the intestinal muscularis, peaking at 3 hours
and returned to near control levels after 48 hours. SYBR Green
real-time PCR revealed a 280-fold increase in MCP-1 mRNA
expression 3 hours after LPS compared to control tissue (relative
quantification: DDCT = –8.1 ± 0.25). MCP-1 protein was immuno-
histochemically located in resident muscularis macrophages. LPS
application caused a significant infiltration of leucocytes into the
intestinal muscularis and a 51% decrease in muscle contractility,
which was significantly blocked by MCP-1 antibody treatment (8%
decrease), but not by the non-specific antibody (38% decrease, at
bethanechol 300 mM).
Conclusions: The results suggest that locally derived MCP-1 plays
a major role in the recruitment of monocytes during endotoxemia
from which kinetically active substances contribute to ileus.
P56 Neutrophil apoptosis, phagocytosis and oxidative metabolism in septic patients
PS Martins, MA Dalboni, M Cendoroglo, S Blecher, EG Kallás, R Salomão
Laboratory of Immunology, Universidade Federal de São Paulo, São Paulo, Brazil
Objectives: To evaluate neutrophil apoptosis and to determine
neutrophil function with use of respiratory burst activity and phago-
cytosis ability during sepsis.
Setting: Laboratory of Immunology and Hospital São Paulo at Uni-
versidade Federal de São Paulo.
Patients: Ten patients with severe sepsis and septic shock, and
10 control healthy volunteers.
Interventions: Blood samples were drawn to evaluate neutrophil
apoptosis and neutrophil function by flow cytometry.
Measurements and statistical analysis: Neutrophil apoptosis
was assessed by propidium iodide (PI) DNA and annexin V stain-
ing. Neutrophil phagocytic capacity in response to Staphylococcus
aureus (S. aureus) stimulation was analyzed. Baseline reactive
oxygen species formation and in response to phorbol myristate
acetate (PMA), N-formyl-methionyl-leucyl-phenylalanine (FMLP),
lipopolysaccharide (LPS) and S. aureus stimulation, were
assessed by flow cytometry using dichlorofluorescein (DCFH). Dif-
ferences in extent of apoptosis, phagocytosis and oxidative metab-
olism in septic patients vs healthy volunteers were analyzed using a
Mann–Whitney test.
Results: Neutrophil apoptosis, neutrophil phagocytic ability and
reactive oxygen species formation were enhanced in septic
patients compared to healthy volunteers.
Conclusions: Circulating neutrophils from septic patients pre-
sented increased apoptosis and phagocytic ability. Reactive
oxygen species formation was also enhanced in these patients.
Healthy volunteers Septic patients
Median 25%ile 75%ile Median 25%ile 75%ile P value
Apoptosis (%) 5.08 3.85 6.56 8.98 6.20 12.69 0.004
Phagocytosis (GMFI) 53.21 44.01 55.26 91.93 46.98 104.64 0.04
Oxidative metabolism
Baseline (GMFI) 61.69 42.08 89.60 247.48 154.86 328.09 < 0.001
S. aureus (GMIF) 355.71 137.70 519.98 1580.59 1414.35 3069.34 < 0.001
PMA (GMIF) 146.82 76.50 432.14 949.50 314.10 2588.29 0.006
FMLP (GMIF) 147.72 96.19 194.83 792.45 359.03 880.72 < 0.001
LPS (GMIF) 117.82 86.87 203.15 544.79 479.80 768.61 < 0.001
25%ile, 25th percentile; 75%ile, 75th percentile; GMFI, geometric mean fluorescence intensity.
P57 Immunological monitoring in ICU patients: immunomodulation for compromised host
N Takeyama, S Miki, T Tanaka
Department of Emergency & Critical Care Medicine, Kansai Medical University, Fumizono-cho 10-15, Moriguchi, Osaka 570, Japan
Although the examination of system functions such as liver, kidney,
and lung is well established, monitoring of immune system is still
poorly developed. Immunosuppression or hyperinflammation are
often met in ICU patients. Thus the establishment of objective mea-
sures of immunological parameters is essential for the control of
hyperinflammatory stage and of infections as a result of immuno-
suppression. We had measured Th1/Th2 balance and monocytic
HLA-DR expression. Intracytoplasmic Th1 and Th2 cytokine pro-
duction in isolated PBMCs was assessed by flow cytometry follow-
ing in vitro activation by PMA plus ionomycin. Monocytic HLA-DR
expression was also measured. The percentage of Th1 cells in
PBMCs from severe burn injury patients, septicemia, and multiple
injuries are 4%, 9%, and 13%, respectively. The percentage of Th1
cells from healthy subjects was 22%. In the meantime, the percent-
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age of Th2 cells did not show significant change in all patients. The
significant reduction of Th1 cells and monocytic HLA-DR expres-
sion in ICU patients except for acute interstitial pneumonia (AIP)
indicates that major stress results in immunoparalysis. Two AIP
patients who revealed more than 40% of Th1 cells were tried to
immunomodulation by methylpredonisolone administration.
P58 Differential diagnosis of Th1/Th2-response by T-cell and monocyte function between sepsis and non-infectious SIRS via
flowcytometry
Y Imamura*, T Yokoyama†, E Hiyama†, Y Takesue*, T Sueda*, S Zedler‡, E Faist‡
*First Department of Surgery, and †Department of General Medicine, Hiroshima University, Japan; ‡Department of Surgery, University of
München, Germany
Objective: Under systemic inflammatory response syndrome
(SIRS), a change in Th1/Th2-response by T-cell and a defect in
monocyte function is observed, which may lead a derangement of
immunological homeostasis, associated with immunosuppression
and susceptibility to sepsis. We have recently developed an
immune-inflammatory monitoring system, that can detect a consti-
tutional change in Th1/Th2-population of T-cell subsets and
monokine production by monocyte, via multi-parameter flowcytom-
etry. The aim of this study was to investigate whether these tests
were useful in establishing the difference between septic SIRS and
non-septic SIRS.
Patients and methods: In the septic SIRS group, 11 patients with
sepsis followed by organ dysfunction were studied on admission to
ICU in our hospital. In the non-septic SIRS group, 10 patients who
underwent major elective surgery were studied on the first and
third day after operation. We investigated the cytokine expression
of T-cells after activation by ionomycin and PMA, and the expres-
sion of monokine and HLA-DR antigen by monocytes after being
stimulated with LPS and/or IFN-gamma, using whole blood culture
(6 hours). After stain for cell-surface phenotypes, the cells were
fixed and permeabilized, then fluoro-immunostained for intracellular
IFN-gamma, IL-4 in T-cells, and TNF, IL-6, and IL-12 in monocytes.
The frequencies of these cytokines-producing cells were estimated
with multicolor flowctyemetric analysis.
Results: 1) The number of IL-4 producing cells (Th2) in T-cells
increased significantly both in CD4+ and CD8+ subsets in
patients with sepsis, but not in patients with non-septic SIRS.
While the IFN-gamma producing cells (Th1) increased slightly in
patients with sepsis and non-septic SIRS. 2) The production of IL-
6, TNF, IL-12 by monocytes from patients with sepsis and non-
septic SIRS was significantly decreased, together with a reduction
of HLA-DR expression. Afterwards, the defect of TNF and IL-12
production in monocytes from non-septic SIRS patients recovered
by the third postoperative day.
Conclusion: These findings show a significant shift of Th2
response in T-cell subsets and a prolonged reduction of TNF and
IL-12 production with a reduced HLA-DR expression by monocyte
in sepsis, compared with those in non-septic SIRS. These tests
may be available for the differentiation of immunosuppression sub-
sequent to sepsis from the SIRS with a dominant pro-inflammatory
state.
Table
CD4+ CD8+ CD14+ Mo
IFN IL-4 IFN IL-4 HLA-DR IL-6 TNF IL-12
Control 9.7 ± 1.5 2.7 ± 0.6 25.4 ± 4.6 1.6 ± 0.3 96.1 ±0.4 76.7 ± 4.7 71.6 ± 3.7 18.8 ± 1.6
Sepsis 13.8 ± 1.7 8.2 ± 1.5* 37.1 ± 6.6 7.3 ± 1.2* 35.8 ± 5.6* 31.5 ± 7.4* 17.7 ± 5.6* 9.3 ± 1.4*
Non-septic  D + 1 10.9 ± 2.1 3.2 ± 0.8 36.4 ± 6.4 3.4 ± 1.0 42.9 ± 5.1* 39.2 ± 5.5* 29.5 ± 3.7* 10.0 ± 1.5*
SIRS D + 3 13.0 ± 2.6 3.5 ± 1.1 32.7 ± 6.3 4.6 ± 0.9 56.3 ± 7.5 53.1 ± 9.6 32.9 ± 7.6* 21.1 ± 3.6
* P < 0.01 vs healthy control by one-factor ANOVA.
P59 T-cell-subpopulations in septic patients
U Leonhardt*, U Wagner†, M Werner‡, L Engelmann*
*Department of Internal Intensive Care, University Leipzig, Medical Clinic I, †Medical Clinic IV, and ‡Centre of Surgery, Philipp-Rosenthal Str
27a, 04103 Leipzig, Germany
Introduction: The dysfunction of the immune system is a main
problem during the systemic inflammation. T-Lymphocytes are
responsible for the different detection of antigens and the correct
answer related to pathogens. Different T-cell function was described
in the TH1/TH2 concept in these patients with changes in the
cytokine pattern of the subpopulation of CD4+-T-cells during sepsis.
These results have shown the important part of CD4+ cells during
the development of immune dysfunction and paralysis. A second
subpopulation of T-cells are the cytotoxic (CD8+) cells. To deter-
mine the changes in CD4+/CD8+ subpopulation, the present study
investigated the relationship between these T-cells in septic patients.
Methods: Ten patients with sepsis of an Internal Intensive Care
Unit, University hospital, were included and compared to 10
healthy controls. The severity of the disease was assessed at the
APACHE II and SOFA-score. Also were measured the serum con-
centration of the C-reactive protein, procalcitonin, TNF-alpha and
interleucin-6. Levels of CD4 and CD8-expression were analysed
flow cytometrically ex vivo and after stimulation with PMA at day 1,
day 7 and day 14 in culture (proliferation index).
Results: There was a significant difference in the CD4/CD8-ratio
between septic patients and healthy controls (P < 0.05) ex vivoS29
and at day 7. Also the severity of the disease showed a linear cor-
relation to the changes in CD4/CD8-ratio after stimulation with
PMA.
Conclusion: These results indicate that changes in CD4/CD8-ratio
could be an important part of the immunologic response to pathogens
in the septic process. Therefore T-cell-subpopulations are probably
involved in the development of the dysfunction in the immune system.
P60 Mechanical ventilation affects local and systemic TNF-a a and IL-10 in normal swine lung
P Myrianthefs*, E Boutzouka*, A Papalois†, K Venetsanou*, M Kouloukousa‡, G Fildissis*, C Kittas‡, G Baltopoulos*
*Athens University School of Nursing, ICU at ‘KAT’ Hospital, Athens, Greece; †Experimental-Research Unit, ELPEN; ‡Athens University
School of Medicine Department of Histology, Athens, Greece
Introduction: Ventilatory strategies can produce or worsen lung
injury and induce a cytokine response in the lung and increase
serum cytokine levels [1]. We examined whether ventilatory strate-
gies affect local and systemic inflammatory mediators in a normal
swine lung model.
Methods: Five ventilatory strategies were employed in 25 swine
animals: group A: low-volume zero PEEP (LVZP): VT, 10 ml/kg,
group B: medium-volume zero PEEP (MVZP): VT, 20 ml/kg, group
C: high-volume zero PEEP (HVZP): VT, 40 ml/kg, group D: low-
volume PEEP (LVP): VT, 10 ml/kg, PEEP, 10 cmH2O, group E:
high-volume PEEP (HVP): VT 40 ml/kg, PEEP 10 cmH2O. TNF-a
and IL-10 were measured in BAL fluid and serum by ELISA.
Results: Mean cytokine concentration in lung fluid and serum
during the experiment are shown in the Table. One animal in LVZP
(1 h) and 3 in HVP (2, 3, 2 h) group died before the end of the
experiment.
Conclusion: Different injurious ventilatory strategies may induce
TNF-a and IL-10 response from alveolar space that may lead to an
increase in serum cytokine levels in normal swine lung.
Reference:
1. Chiumello D, Pristine G, Slutsky A: Mechanical ventilation affects
local and systemic cytokines in an animal model of ARDS. Am J
Respir Crit Care Med 1999, 160:109.
Table
Time 0 h Time 2 h Time 4 h
Serum BAL Serum BAL Serum BAL
Group A: LVZP (PIP 14 ± 2.2 cmH2O)
TNF-a (pg/ml) 7.9 ± 1.4 17.5 ± 5.6 10.2 ± 2.7 35.9 ± 11.8* 7.9 ± 1.4 61.5 ± 32.8*
IL-10 (pg/ml) 1.7 ± 0.8 6.6 ± 0.2 1.8 ± 0.6 24.8 ± 7.7* 1.6 ± 0.3 12.1 ± 4.2
Group B: MVZP(PIP 21.8 ± 0.4 cmH2O)
TNF-a (pg/ml) 4.5 ± 0.2 16.4 ± 3.2 12.7 ± 1.3* 28.8 ± 17.2 4.5 ± 0.3 29.3 ± 14.8
IL-10 (pg/ml) 6.6 ± 3.9 7.2 ± 1.3 8.6 ± 5.6 10.1 ± 2.5 7.1 ± 4.6 12.9 ± 1.8
Group C: HVZP(PIP 59.3 ± 0.8 cmH2O)
TNF-a (pg/ml) 9.4 ± 0.3 13.4 ± 2.7 43.2 ± 5.1* 12.9 ± 2.5 18.4 ± 5.6 19.9 ± 7.9
IL-10 (pg/ml) 3.3 ± 0.9 7.1 ± 2.7 12.8 ± 10.4 11.8 ± 3.2 14.3 ± 11.1 20.6 ± 8.4
Group D: LVP(PIP 26.5 ± 4.1 cmH2O)
TNF-a (pg/ml) 11.9 ± 4.5 20.5 ± 4.9 17.9 ± 4.2 46.4 ± 10.9 52.2 ± 3.4* 66.7 ± 9.5*
IL-10 (pg/ml) 7.1 ± 0.4 3.4 ± 1.1 15.9 ± 14.1 45.9 ± 14.8* 15.6 ± 12.2 66.1 ± 24.1*
Group E: HVP(PIP 65.3 ± 1.4 cmH2O)
TNF-a (pg/ml) 5.1 ± 0.9 20.9 ± 3.1 3.4 ± 1.1 35.4 ± 9.9* 16.7 ± 0.8* 33.9 ± 7.6*
IL-10 (pg/ml) 2.8 ± 0.9 2.9 ± 0.6 1.5 ± 0.7 27.2 ± 22.9* 2.8 ± 0.7* 16.2 ± 2.5*
* Statistically significant difference (P < 0.01).
The aim of this study was to show the effect of intratracheal (IT)
and intravenous (IV) lidocaine on haemodynamic and arterial blood
gas values in hydrochloric acid (HCl) induced-acute lung injury
(ALI) in rabbits.
Twenty New Zealand rabbits were randomly divided into for
groups of five. An endotracheal tube was placed through a tra-
cheostomy in all animals following ketamine hydrochloride (50
mg/kg, intramuscularly) induced anaesthesia. Maintenance of
anaesthesia was achieved by the use of ketamine hydrochloride
10 mg/kg/h and atracurium besylate 1 mg/kg/h. The animals
were ventilated with Pressure Control mod for 3 hours and the
parameters of ventilation were FiO2: 1.0, RR: 80/min, Vt: 8
ml/kg, I/E: 1/2, PEEP: 5 cmH2O. Intratracheal HCl (2 ml/kg),
was given following tracheostomy in all animals. Five minutes
after the application of HCl the group 1 received IV lidocaine (2
mg/kg),  group 2 received IT lidocaine (2 mg/kg), group 3
received IV lidocaine (4 mg/kg) and group 4 received IT lido-
caine (4 mg/kg). We recorded mean arterial blood pressures
(MAP), heart rate (HR) every 60 min. We measured arterial
blood gas values (PaO2, PaCO2, pH) at beginning of the study,
at 90th and 180th minutes. Data were compared by
Mann–Whitney  U-test. A P value of less than 0.05 was consid-
ered to indicate statistical significance.
ç
ç
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MAP levels of group 2 and group 4 were higher than group 1 and
group 3 at 120th and 180th minutes (P < 0.05). HR levels of
group 2 were lower than the other groups at 120th and 180th
minutes (P < 0.05). PaO2 levels of group 1 were higher than the
other groups at 180th minute (P < 0.001). There was no signifi-
cant difference between four groups regarding PaCO2, pH.
In conclusion, IT and IV lidocaine (2 mg/kg) given after 5 min of
HCl application had a beneficial effect on the haemodynamic
and arterial blood gas values in acute lung injury in rabbits
model.
P62 Heparin nebulization attenuates acute lung injury with sepsis after smoke inhalation in sheep
K Murakami, J Katahira, R McGuire, R Cox, H Hawkins, D Herndon, L Traber, D Traber
University of Texas Medical Branch and Shriners Burns Hospital, Galveston, TX, USA
Introduction: Fibrin formation in the airway is a common occur-
rence with acute lung injury. Mucous plugging in the airway pre-
vents alveoli expansion and may increase shunt blood flow. The
aim of this study was to investigate the effect of heparin nebuliza-
tion in acute lung injury (ALI) with sepsis or burn after smoke
inhalation in sheep.
Method: Female sheep (n = 20) were used. The animals were
divided into two groups. One is an ALI model induced by a combi-
nation injury with smoke inhalation and severe pneumonia (n = 10).
The other is an ALI model induced by a combination injury with
smoke inhalation and 3rd degree 40% body surface area flame
burn (n = 10). The preceding groups received 48 breaths of cotton
smoke (< 40°C). The sham control animals were not injured, Ps.
aeruginosa (5 × 1011 CFU) was inoculated into the airway using a
bronchoscope. All the animals were mechanically ventilated after
the injury. Burned animals were resuscitated with lactate Ringer’s
solution following the Parkland formula. Both groups were divided
into two. One was treated with heparin nebulization (n = 5;
10,000 U 1 h after the injury and every 4 hours) and the other were
treated with the same dose of 0.9% NaCl as a control. Lung histol-
ogy was scored by a pathologist who was blinded for the animal
grouping. Congestion, edema, inflammation, and hemorrhage were
scored from 0 (non) to 4 (severe) and total score was calculated
(full score = 16).
Results: In sepsis study, the drop in PaO2/FiO2 was significantly
attenuated by a heparin while it was not in burn study. The lung histol-
ogy score was also attenuated by heparin in sepsis but not in burn.
Discussion and conclusion: Heparin nebulization was effective in
reducing acute lung injury induced by severe pneumonia and
smoke inhalation but not in burn and smoke inhalation. Since
heparin does not inhibit thrombin without antithrombin, the result
suggests that antithrombin level in the alveolar space, which is
exuded from a bronchial blood flow, may be different.
Histology score
Treatment Burn & smoke Smoke & pneumonia
Sham control 2.60 ± 0.60 2.70 ± 0.49
Saline nebulization 6.62 ± 1.00 9.46 ± 2.33*
Heparin nebulization 6.95 ± 1.67 5.82 ± 0.90†
* P <0.05 vs sham. † P < 0.05 vs Saline-treated.
P63 Reduced release of superoxide from isolated human neutrophils in response to high extracellular glucose
A Perner, SE Nielsen, J Rask-Madsen
Department of Gastroenterology, Herlev Hospital, DK-2730 Herlev, University of Copenhagen, Denmark
Background: Superoxide (O2
–) — a key anti-microbial agent in
phagocytes — is produced by the activity of NADPH oxidase. High
concentrations of glucose may reduce O2
– production through
inhibition of glucose-6-phosphate dehydrogenase (G6PD) [1],
which catalyzes the formation of NADPH.
Aims: To measure the acute effects of high glucose or the G6PD
inhibitor, dehydroepiandrosterone (DHEA), on release of O2
– from
isolated human neutrophils.
Methods: Neutrophils were isolated from peripheral blood of
healthy subjects by gradient centrifugation and incubated for
1 hour in Krebs–Ringer buffer containing 5, 10 or 25 mM
glucose, 5 mM glucose with 0, 5 or 20 mM mannitol or 5 mM
glucose with 1, 10 or 100 mM DHEA at 37°C. N-Formyl-
methionyl-leucyl-phenylalanine (fMLP)-induced O2
– release was
measured by superoxide dismutase-inhibitable reduction of
cytochrome  c or luminol-enhanced luminescence. Scavenging of
O2
– by glucose or DHEA was assessed by the pyrogallol assay
[2].
Results: Incubation with glucose or DHEA, but not glucose/manni-
tol, dose-dependently reduced fMLP-induced release of O2
– as
detected by either method. In a cell free system, neither glucose
nor DHEA scavenged O2
–.
Conclusions: Inhibition of G6PD may be the cause of acutely
reduced O2
– release from activated neutrophils in response to high
Figure 1
Superoxide release from fMLP-activated neutrophils — effect of high
glucose or DHEA. Note: Mean (± SEM; n = 6) O2
– release. * P < 0.01
compared with 5 mM glucose or absence of DHEA (paired t-test).S31
extracellular glucose concentrations. If this occurs in vivo, micro-
bial killing by neutrophils may be impaired in patients with acute
hyperglycemia.
References:
1. Zhang et al: J Biol Chem (in press). http://jbc.org/
2. Marklund et al: Eur J Biochem 1974, 47:469.
P64 Mobilization of leukocytes in patients with severe sepsis and septic shock is associated with increased apoptosis, as
detected by Annexin V binding
M Weiss*, E Barth*, G Fischer*, M Elsharkawi*, LL Moldawer†, M Georgieff*, EM Schneider*
*Department of Anesthesiology, University Hospital, Steinhoevelstr 9, D-89070 Ulm, Germany; †Department of Surgery, University of Florida
College of Medicine, Gainesville, FL 32610, USA
Objectives: To clarify whether mobilization of leukocytes during
human severe sepsis and septic shock occurs independently of
apoptosis.
Methods: Over a 6 month period, 33 patients with severe sepsis
or septic shock were studied in the intensive care unit. Annexin V
binding by leukocytes was determined daily using flow cytometry
and FITC-labeled Annexin V. Transient leukocytosis, or peaks in
leukocyte counts, were defined as individual increase of at least
30% within 2 days, followed by a decrease of at least 30% within
the following 2 days.
Results: Nine, 14 and 10 peaks in neutrophil, monocyte and lym-
phocyte counts, respectively, were observed in 6, 9 and 10
patients; in all of these patients, increased Annexin V binding by
neutrophils, monocytes and lymphocytes, respectively, by 69% up
to 809% (median 215%), by 32% up to 973% (median 330%),
and by 32% up to 4713% (median 224%), respectively, paralleled
the neutrophil, monocyte and lymphocyte (in 13/14 episodes)
peaks, respectively. During periods in which neutrophil, monocyte
and lymphocyte numbers were stable, Annexin V binding was con-
stant as well.
Conclusions: In conclusion, mobilization of leukocytes during
severe sepsis and septic shock in critically ill patients is associated
with increased apoptosis, as determined by Annexin V.
P65 C5a receptor expression on leukocytes from patients with severe sepsis or septic shock
M Furebring*, L Håkansson*, P Venge*, A Siegbahn*, B Nilsson†, J Sjölin*
*Department of Medical Sciences, and †Department of Oncology, Radiology and Clinical Immunology, University Hospital, 751 85 Uppsala,
Sweden
Background: Recently animal studies have been presented sug-
gesting that complement factor C5a blockade might be of benefit
in patients with severe sepsis/septic shock. In one study the
expression of the C5a receptor (CD88) on the granulocytes from
septic animals was increased. The aim of the present investigation
was to study the CD 88 expression on leukocytes in human sepsis.
Methods: Twelve ICU patients fulfilling the ACCP/SCCM criteria
for severe sepsis/septic shock were prospectively included into the
study as early as possible in their septic course. Blood samples for
analyses of leukocyte receptor expression and complement factors
were taken on day 1, 3 and 15. The leukocytes were isolated from
heparinised whole blood and labelled with CD88 antibodies. As
controls leukocytes from 20 healthy individuals were used. The
samples were analysed by the use of flow cytometry and results
presented as mean fluorescence intensity (MFI). The complement
proteins C3a and terminal complement complex (TCC) were
analysed in EDTA plasma by capture ELISA techniques. Levels of
TNF-a, IL-6, IL-8, IL-10, IL-1ra, and MCP-1 were analysed in EDTA
plasma with ELISA technique.
Results: On day 1 10/11 patients had increased levels of C3a,
1144 ± 138 ng/ml, (mean ± SE) (normal range: 92–268) and
11/11 of TCC 146 ± 46 AU/ml (normal range: 12–56). CD88
expression on the granulocytes in the control group was 63 ± 4. In
comparison with the controls, the patients with severe
sepsis/septic shock had significantly lowered values: on day 1
37 ± 5 (P < 0.001), on day 3 45 ± 8 (P < 0.05), and on day 15
5 1±8  ( P  < 0.05). The granulocyte expression of CD88 on day 1
correlated negatively to APACHE-II score at inclusion (r = –0.59,
P < 0.05). Besides a weak correlation to IL-1ra, there were no sig-
nificant correlations to the other cytokines. In the patient group, the
CD88 expression on the monocytes did not change during the
observation time and did not differ from that in the control group.
Conclusion: Although a transient increase at an earlier stage of
the septic course cannot be excluded, our results demonstrate that
the expression of the C5a receptor on granulocytes — at the time
when diagnosis can clinically be made — is low, despite an activa-
tion of the complement system. Our result suggest that C5a block-
ade in human sepsis might be of a more limited value than that
found in animal experiments.
P66 Terminal complement complex in porcine septic shock with substantial capillary leak syndrome
M Cobas-Meyer*, G Marx†, F Kube*, B Vangerow*, T Schuerholz*, J Schmidtko‡, M Winkler‡, KF Gratz§, M Leuwer†, H Rueckoldt*
*Department of Anaesthesiology, ‡Department of Viceral- and Transplantsurgery, and §Department of Diagnostic Radiology, Hannover
Medical School, Carl-Neuberg-Str 1, D-30625 Hannover, Germany; †Department of Anaesthesia, Royal Liverpool University Hospitals,
Liverpool L69 3GA, UK
Introduction: In septic shock with capillary leak syndrome (CLS), it
has been suggested that hemodilution, and capillary leakage of
protein may account in part for reduced levels of complement pro-
teins observed in sepsis . Aim of this study was to determine com-
plement activation by terminal complement complex (TCC) in
septic shock under the conditions of substantial CLS.
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Methods: Ten anaesthetised, and multi-catheterised pigs (20.6 ±
1.3 kg) were investigated over a period of 8 h. Sepsis was induced
by fecal peritonitis. Animals were infused using 6% hydroxyethyl
starch 200/0.5 to maintain a CVP of 12 mmHg. In kidneys biopsies
TCC deposition was detected immunohistologically. Plasma levels
of TCC were measured in a double antibody EIA using the neoepi-
tope-specific MoAb aE11 as catching antibody. Albumin escape
rate (AER; tc 99m-labeled albumin), serum protein (S-Protein), and
hematocrit (Hct) were determined. After verifying normal data dis-
tribution (skewness < 1.5) Student’s t-test was performed by rank-
ordered stepwise testing. Data are mean ± SD.
Results: Septic animals showed marked renal deposition of TCC.
Other results, see Table.
Conclusion: Although plasma levels of TCC declined over study
period, in septic animals marked renal depositions of TCC indi-
cated complement activation. Since AER increased and serum
protein levels decreased, capillary loss of TCC into organ tissue
may explain our findings in part. We conclude that in septic shock
with substantial CLS plasma levels of TCC may not reflect degree
of complement activation.
Reference:
1. Nuijens JH et al: Blood 1988, 72:1841–1848.
Table
Baseline 4 h 8 h
Sepsis Control Sepsis Control Sepsis Control
TCC (%) 104 ± 40 118 ± 37 22 ± 29* 58 ± 11* 16 ± 31* 20 ± 22*
S-Protein (g/l) 43 ± 4 42 ± 2 13 ± 2*† 26 ± 9* 9 ± 1*† 22 ± 4
AER (%) 39 ± 16* 5 ± 5 52 ± 26* 3 ± 10
Hct (%) 29 ± 1 29 ± 2 30 ± 5 25 ± 3* 29 ± 3* 26 ± 1
* P < 0.05 compared with baseline. † P < 0.05 compared with control group.
P67 Peaks in G-CSF serum concentrations are accompanied by an increase in phagocytotic activity in most patients with
severe sepsis or septic shock
G Fischer*, E Barth*, H Wiedeck*, LL Moldawer†, EM Schneider*, M Georgieff*, M Weiss*
*Department of Anesthesiology, University of Ulm, Germany; †Department of Surgery, University of Florida, Gainesville, FL, USA
Objectives: To investigate the relationship between endogenous
serum concentrations of granulocyte colony stimulating factor (G-
CSF) and phagocytotic activity of granulocytes during septic shock
in postoperative/post-traumatic patients.
Methods: Over a 6 month period 35 patients with proven infec-
tion and severe sepsis or septic shock for at least 3 days’ dura-
tion were monitored on a daily basis during their stay in the
intensive care unit (ICU) until discharge from the ICU or death.
In 19 out of these 35 patients one or more peaks in G-CSF
serum concentrations occurred. Eleven of these 19 patients sur-
vived, eight patients died. A longitudinal analysis of G-CSF
serum concentrations, phagocytotic activity of granulocytes and
surface expression of monomeric Fc receptor type I (CD64,
FcgRI) on granulocytes was performed by ELISA technique
(R&D Systems, Minneapolis, MN, USA) and flow cytometry
(Phagotest™; Orpegen, Heidelberg, Germany) and CD64 (clone
22; Immunotech, Krefeld, Germany), respectively on a daily
basis.
Results: A G-CSF peak was defined as an increase of at least
30% from one day to the other, followed by a decrease of at least
15% on the next day. The following results are expressed as
median (min – max) values. In seven episodes there was a parallel
course of the G-CSF peak and phagocytosis with an increase in
phagocytosis by 37% (6–50%). In 11 episodes, phagocytosis
continuously increased and remained on a higher level after the
increase of 10% (1–164%) from day 1 up to day 2. In 10
episodes, there was a decrease by 40% (17–76%) at the day of
the G-CSF peak, followed by an increase by 58% (6–322%) on
the next day. In 12 episodes, there was no increase (n = 4) or even
a decrease (n = 8) by 24% (3–46%) over all days.
Conclusions: A peak in G-CSF serum concentration was followed
by a continuous increase in phagocytosis at the same day in 7, and
a delayed increase in 21 out of 40 episodes, but no increase or
even an decrease in 12 out of 40 episodes. Thus, phagocytotic
activity is increased when G-CSF peaks endogenously, in most
patients with severe sepsis or septic shock.
P68 Influence of GM-CSF supplementation on PaO2/FiO2 index in septic patients
P Myrianthefs, E Karabatsos, E Boutzouka, P Evagelopoulou, G Georgiadis, G Fildissis, G Baltopoulos
Athens University, School of Nursing, ICU, KAT Hospital, Athens, Greece
Introduction: Granulocyte-Macrophage Colony-Stimulating Factor
(rHuGM-CSF) is used in leucopenic febrile patients to enhance
leukocyte production. It can prime resting monocytes and augment
their inflammatory response [1]. It strongly up-regulates HLA-DR
expression, LPS induced TNF-a monocyte secretion and down-
regulates anti-inflammatory cytokines release [1].S33
Methods: Twenty septic patients, mean age 64.8 ± 3.7 (14 males)
and illness severity scoring, SAPS II, 43.5 ± 4.5 were given subcu-
taneous molgramostin 200 mg q12 h for 3 consecutive days. We
observed white blood count increase and PaO2/FiO2 index course
having the same FiO2.
Results:
WBC count and PaO2/FiO2 index
Days WBC (x 103/mm3) P (t-test) PaO2/FiO2 index P (t-test)
1st 9.72 ± 1.43 172.8 ± 20.2
2nd 15.92 ± 1.83 < 0.01 199.3 ± 21.8 0.251
3rd 30.81 ± 419 < 0.01 167.6 ± 23.8 0.478
4th 19.20 ± 1.44 < 0.01 193.6 ± 20.9 0.392
There was a statistically significant increase in WBC count
between the 1st and 2nd, 3rd and 4th days (P < 0.01). There was
no statistically significant PaO2/FiO2 index improvement between
the 1st, 2nd and 4th days (P < 0.251 and 0.392) and index deteri-
oration between the 1st and 3rd day (P < 0.478).
Conclusions: Despite significant WBC count increase after rHu
GM-CSF supplementation, the PaO2/FiO2 index was not signifi-
cantly altered. Molgramostin, when given in septic patients may
improve the PaO2/FiO2 index except during the 3rd day of the
major WBC count increase during which there is a nonstatistically
significant decrease in this index by 3.1%. GM-CSF supplementa-
tion can be safely used without deteriorating pulmonary gas
exchange function.
Reference:
1. Heumann D, Glauser M, Caladra T: Monocyte deactivation in septic
shock. Curr Opin Infect Dis 1998, 11:279–283.
P69 Superoxide output and expression of NADPH oxidase 1 in human colonic epithelial cells
A Perner, L Andresen, G Pedersen, J Brynskov, J Rask-Madsen
Department of Gastroenterology, Herlev Hospital, 2730 Herlev, Denmark
Background: Translocation of microorganisms from the gut lumen
may contribute to morbidity in sepsis. Conservation of normal
barrier function should, therefore, be a goal in critical illness, but its
components is only partly defined. Beyond mechanical contribu-
tion, the colonic epithelium may possess antimicrobial activity via
yet undefined mediators [1]. Superoxide (O2
–), generated by mem-
brane-bound NADPH oxidase (Nox), is a key antimicrobial agent of
phagocytes, but output from human colonic epithelial cells has not
been demonstrated.
Aims: To measure O2
– output and expression of the non-phago-
cytic NADPH oxidase, Nox1, in short term cultures of primary
epithelial cells from normal human colon and in Caco-2 colonic
epithelial cell line.
Methods: Colonic epithelial cells were isolated from biopsies of sub-
jects with uninflamed bowel and Caco-2 cells were grown in 24-well
plates [2]. Output of O2
– was measured by the cytochrome c assay
or luminol-enhanced luminescence and localised by the nitroblue-
tetrazolium (NBT) assay [3]. Effects of 1 mM NADPH, oxidoreduc-
tase inhibition by 10 mM diphenylene iodonium (DPI) and protein
kinase C-activation by 0.5 mg/ml phorbol myristate ester (PMA) were
assessed. mRNA expression of Nox1 was analysed by RT-PCR.
Results: Identical results were obtained in primary epithelial cells
(see Figs) and Caco-2 cells. NBT-reduction was observed at the
outer cell membrane and Nox1 mRNA was detected in all cell cul-
tures. NADPH increased output of O2
– within seconds although
cell membranes are impermeable to NADPH.
Conclusions: These results show that cultures of human colonic
epithelial cells produce extracellular O2
– possibly through mem-
brane-bound Nox1, which appears to independent of protein
kinase C activation. O2
– from epithelial cells may possess antimi-
crobial activity and contribute to colonic barrier function.
References:
1. Shock 1995, 4:345.
2. Scand J Gastroenterol 2000, 35:772.
3. Gastroenterology 1998, 115:1186.
Figure
Superoxide output in cultures of primary colonic epithelial cells. O2
–
output (mean ± SEM, n = 5) was adjusted to mg protein. * P < 0.05
compared with basal (t-test). SOD, O2
– dismutase.
P70 Heat shock paradox: subsequent heat shock increases lethality of polymicrobial sepsis in vivo
JJ Wizorek, JP Cobb, Y Qui, J Laramie, RS Hotchkiss, IE Karl, TG Buchman
Cellular Injury and Adaptation Laboratory, Department of Surgery, Washington University School of Medicine, Campus Box 8109, 660
South Euclid Ave, St. Louis, MO, USA
Previous  in vitro studies have shown that induction of the heat
shock response (HSR) prior to an inflammatory stimulus is cytopro-
tective, whereas induction of HSR after an inflammatory stimulus
can cause apoptosis (the heat shock paradox). We sought to
determine whether induction of HSR in an animal model of sepsis
caused similar, order-dependent effects on survival.
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In pilot studies to calibrate the murine HSR, 20–25 g ND4 mice
were anesthetized and immersed in a water bath for a total of
20 min to raise core body temperature to 37, 40 or 41.5°C (n = 3
per group). Livers were harvested 24 hours later. Western blot
analyses for Heat Shock Protein-72 (HSP-72, a widely-accepted
marker of HSR) showed the expression of HSP-72 at 41.5°C for
20 min but not at or below 40°C. This pattern is strain independent.
Next, the effect of HSR prior to or subsequent to cecal ligation and
puncture via halothane anesthetic (CLP) upon survival was tested.
20–25 g male inbred C57-BL6 mice were randomized to one of six
groups (n = 15–20 per group) and heated for 20 min to either 37
or 41.5°C alone or in combination with CLP. Survival was 70%
and 15% for HSR induction prior, or subsequent, to CLP respec-
tively (P = 0.001). To exclude the possibility that the order-depen-
dent response was strain specific, the study was repeated with
outbred ND4 mice (n = 11–13 per group). In the ND4 mice, sur-
vival for HSR induction prior to CLP was 25% but following CLP
was nil (P = 0.0001, Fig. 1).
Though beneficial and somehow protective when induced prior to
insult, the heat shock response paradoxically increases mortality
when activated after severe stress. This paradoxical potentiation of
injury also appears independent of the specific strain. The suscep-
tibility of infected animals to devastating HSR at 41.5 degrees may
explain, at least in part, why human fevers are generally self-limited
to 40 degrees or less.
Figure 1
P71 The influence of endotoxin on the expression of the ORL-1 receptor
UM Stamer, Q Shu, A Hoeft, F Stüber
Department of Anesthesiology and Intensive Care Medicine, University of Bonn, Sigmund-Freud Str 25, 53105 Bonn, Germany
Objective: The ORL-1 receptor (Orphan opioid receptor) has been
discovered recently and is involved in pain perception and immune
function [1–3]. The regulation of the ORL-1 receptor in patients
with systemic inflammation has not been elucidated yet. This study
investigates the influence of different doses of LPS on ORL-1
expression in peripheral blood cells ex vivo.
Methods: Human whole blood from healthy volunteers was cul-
tured at 37°C and 5% CO2 without LPS or LPS 0.1 ng, 10 ng and
100 ng/ml for 3, 6, 12 and 24 hours. Reverse transcriptase poly-
merase chain reaction (rt-PCR) using specific primers was per-
formed and RNA contents was estimated by semiquantitative
analysis employing a housekeeping gene as internal standard.
Southern blot analysis and hybridisation to a specific DIG-labeled
probe confirmed the identity of the ORL-1 transcripts.
Statistics: Mean ± SEM, repeated measures ANOVA.
Results: ORL-1 receptor was expressed constitutively in human
peripheral blood cells. Mean baseline expression resulted in a ratio
of ORL/GAPDH of 1.0 ± 0.07. Semiquantitative rt-PCR revealed a
dose and time dependent down regulation of ORL-1 expression
(P < 0.05). Incubation with LPS 0.1 ng/ml decreased the ratio
ORL/GAPDH from 0.95 ± 0.06 at 3 hours to 0.19 ± 0.02 at
24 hours. In contrast, incubation with LPS 100 ng/ml already sup-
pressed the ORL-1 message after 3 hours of incubation. Southern
blot analysis and hybridisation proved the specificity of the ampli-
fied PCR products for ORL-1 transcripts.
Conclusions: Endotoxin decreased ORL-1 expression in human
peripheral blood cells. The results suggest that the ORL-1 receptor
is involved in immune response to infection.
References:
1. J Neuroimmunol 1998, 81:184.
2. BJA 1998, 80:577.
3. Mol Brain Res 1995, 32:342.
P72 Influence of endotoxin adsorption to immunity
S Kanesaka, S Uda, M Kuzume, Y Takahashi
Department of Emergency & Critical Care Medicine, Showa University Fujigaoka Hospital, 1-30 Fujigaoka Aobaku, Yokohama, Japan
The influence of direct hemoperfusion using polymyxin B immobi-
lized fiber (PMX) to immunity was studied in severe septic patients
with organ dysfunction. Thirty-four cases whose mean age and
APACHE II were 59 years and 23 were treated by the PMX in 50
times. They were divided into the detectable (³10 pg/ml, n = 27)
and non-detectable (n = 23) endotoxin group, analyzed before PMX
by colorimetric limulus test with chromogenic substrate (Toxicolor).
After PMX, mean arterial pressure and systemic vascular resistance
index were significantly increased in both groups. Endotoxin, neu-
trophils and monocytes were significantly decreased from 76.4 ±
19.5 to 64.8 ± 17.8 pg/ml (P = 0.0158), from 14810 ± 2020 to
9990 ± 1660/mm3 (P = 0.0002), and from 688 ± 103 to 512 ±
99/mm3 (P = 0.0087) respectively in the D group, while lympho-
cytes were decreased not significantly in both groups. Furthermore
IL-6 was significantly decreased from 958 ± 437 to 722 ± 296
pg/ml (n = 37, P = 0.0495), IL-8 and CD4 were significantly
increased from 162 ± 80 to 195 ± 114 pg/ml (n = 31, P = 0.0456)
and from 31 ± 4 to 34 ± 3% (n = 14, P = 0.0091) respectively, but
TNFa and IL-1b did not change significantly. These results indi-
cated that the therapy with PMX in severe sepsis could be going to
end the response of innate immunity and induce the adaptive immu-
nity, so that it would be helpful for hemodynamic stability.S35
P73 Influence of mast cells on leukocyte-independent plasma extravasation during endotoxemia
A Walther*, M Jäger*, A Secchi*, W Schmidt*, MM Gebhard†, E Martin*, H Schmidt*
*Department of Anesthesiology, and †Department of Experimental Surgery, Ruprecht-Karls-University, Im Neuenheimer Feld 110, 69120
Heidelberg, Germany
Introduction: Endotoxemia is characterized by increased
microvascular permeability. Endothelial factors and mast cell acti-
vation seems to promote microvascular permeability independently
from leukocyte adherence [1]. The aim of our study was to investi-
gate the influence of mast cells on leukocyte-independent
microvascular permeability changes. Therefore, microvascular per-
meability was determined during endotoxemia after inhibition of the
L-selectin mediated leukocyte-endothelium interaction by fucoidin.
Mast cells were either degranulated with compound 48/80
(CMP48/80) prior to the experiment or pre-treated with the mast
cell stabilizing agent cromolyn.
Methods: In male Wistar rats, microvascular permeability (MP),
leukocyte adherence (LA) and mast cell activation (MCA) were
determined in mesenteric postcapillary venules using intravital
microscopy at baseline, and at 60, and 120 min after start of a con-
tinuous infusion of endotoxin (groups A–C, n = 8 each). Animals
underwent laparotomy and the mesentery was exposed beneath an
in vivo videomicroscope. MCA was determined in vivo by superfu-
sion of the mesentery with ruthenium red. MP was measured using
fluorescein isothiocyanate (FITC) labeled albumin. Leukocyte–
endothelial interaction was blocked by fucoidin 10 min before
laparotomy in groups A, B, and C. Animals in group B additionally
received CMP48/80 (1 mg/kg b.w. i.p.) 48 h before the start of the
experiment. Animals in group received cromolyn (20 mg/kg b.w.
i.v.) prior to baseline measurement followed by a continuous super-
fusion of the mesentery with cromolyn. Group D (control, n =8 )
only received equivalent volumes of NaCl 0.9%. Statistical analysis
was performed using student’s t-test. A P value < 0.05 was con-
sidered significant.
Results: In the endotoxin and fucoidin treated groups (A–C), LA
was attenuated to levels similar to control group (D). Endotoxin-
induced MCA was prevented in both the CMP48/80- and the cro-
molyn-treated animals (groups B + C) (P < 0.05 vs group A).
However, in the CMP48/80- and the cromolyn-treated groups the
endotoxin-induced increase in microvascular permeability tended
to be reduced too, but without being significant (P > 0.05 vs group
A). Differences in MP between group A and the control group were
significant at 120 min.
Conclusions: The results of this study demonstrate that mast cells
are only less involved in the pathophysiology of leukocyte-indepen-
dent plasma extravasation during endotoxemia. Further patho-
mechanisms must be discussed.
References:
1. Kubes P: Am J Physiol 1996, 271:H2438–H2446.
P74 Reactive haemophagocytic lymphohistiocytosis: a frequent finding in immunosuppressed patients with multiple organ failure
G Auzinger*, J Devlin*, PG O’Callaghan*, ND Heaton†, GJ Mufti‡, JA Wendon*
*Institute of Liver Studies, †Department of Transplant Surgery, and ‡Department of Haematological Medicine, King’s College Hospital,
Denmark Hill, London SE5 9RJ, UK
Reactice haemophagocytic lymphohistiocytosis (HLH) is a highly
underdiagnosed condition in Adult Intensive Care. It is character-
ized by a non-malignant proliferation of histiocytes with phagocyto-
sis of haematopoietic cells, resulting in cytopenia of at least two cell
lines. The acquired form of HLH has been associated with infec-
tions, neoplasms, autoimmune diseases and immunosuppression.
Methods: Retrospective review of 15 patients who developed
reactive HLH during their stay in the Liver Intensive Care Unit
between January and November 2000. Predictors for survival were
calculated using a non-parametric Mann–Whitney U-test.
Results: Admission diagnosis was fulminant hepatic failure in six
patients, two patients presented with sepsis and chronic liver
disease and seven patients following liver transplantation. All
patients were in multiple organ failure (MOF) and severely throm-
bocytopenic (median 32 × 105), despite platelet support in 13
patients, at the time of diagnosis. Twelve patients received
immunosuppressive medication. Among the post transplant
patients, six tested positive for CMV DNA and were treated with
Ganciclovir. Ten patients died, two are still requiring intensive care
treatment and three have been discharged from ITU (two from hos-
pital). Survivors had significant lower SOFA scores at the time of
HLH diagnosis, a significant higher, unsupported platelet count 7
days after diagnosis and high dose gamma-globulin therapy and a
trend towards a shorter stay on mechanical ventilation (Table — all
parameters median and range).
Table
All patients Non-survivors Survivors P value
Apache II 17 (8–32) 21 (10–32) 16 (8–17) 0.07
SOFA 16 (7–21) 16 (11–21) 9 (7–12) 0.009
Platelets day 0 32 (4–59) 30.5 (4–59) 35 (34–38) 0.3
Platelets day 7 45 (11–256) 36 (11–63) 130 (85–256) 0.004
Duration MV 13 (6–61) 24 (7–61) 10 (6–10) 0.07
Conclusion: Reactive HLH should be suspected and excluded in
all thrombocytopenic patients with MOF. This is especially true for
the immunosuppressed post transplant population. The diagnosis
of HLH in these patients is associated with a poor prognosis.
Reference:
Stephan F et al: Role of hemophagocytic histiocytosis in the etiology of
thrombocytopenia in patients with sepsis syndrome or septic shock.
Clin Infect Dis 1997, 25:1159–1164.
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P75 Dexamethasone effect on sFas/sFas ligand following cardiopulmonary bypass
U Joashi, SM Tibby, A Mayer, A Durward, C Turner, IA Murdoch
Department of Paediatric Intensive Care, Guy’s Hospital, London SE1 9RT, UK
Introduction: Steroids decrease systemic inflammation following
cardiopulmonary bypass (CPB). Membrane bound Fas is a recep-
tor found on many cells, which stimulates apoptosis when cleaved
by Fas ligand (FasL). FasL also has a proinflammatory role and is
released following ischaemia-reperfusion. We wished to investi-
gate the time course of release of the soluble forms of Fas and
FasL (sFas, sFasL) post CPB, and whether steroid pre-treatment
altered the response.
Method: Twenty-seven children with congenital heart disease were
studied, median (IQ) age 7 (0.4–10) months. Patients were given
0.25 mg/kg dexamethasone (DEX) (n = 13) or no DEX (n = 14) at
induction of anaesthesia. Groups were well matched in terms of
age, type of operation, length of CPB, cross clamp, and circulatory
arrest (all P > 0.15). sFas, sFasL and interleukin (IL) 6 (a marker of
cytokine response) were measured over 24 hours by double sand-
wich ELISA.
Results: DEX significantly blunted the release of IL6 and sFas, but
not sFasL. The DEX group exhibited a decreased clinical inflamma-
tory response post CPB as evidenced by a lower temperature, less
colloid requirement, chest drain loss, acidosis, hyperlactataemia
and coagulopathy (all P < 0.05).
Conclusion: DEX blunts IL6 and sFas but not sFasL release fol-
lowing CPB, attenuating clinical inflammatory response. The signifi-
cance of the sFas response is unclear; this may be a passive
marker of a decreased inflammatory response but decreased levels
may also negatively influence apoptosis/inflammation by being less
able to ‘mop-up’ excess membrane and soluble FasL.
Figure
P76 Moderate hypothermia during cardiac surgery provides hepatic protection by modifying the balance between gene
expression of TNFa a and IL10
M Qing*, JF Vazquez-Jimenez†, B Klosterhalfen‡, K Schumacher*, BJ Messmer†, G von Bernuth*, M-C Seghaye*
*Department of Pediatric Cardiology, †Department of Cardiovascular Surgery, and ‡Department of and Pathology, Aachen University
Hospital, Pauwelsstrasse 30, D-52075 Aachen, Germany
Aims: To investigate the effect of moderate hypothermia during
CPB on intrahepatic gene expression of TNFa, IL10, apoptosis
regulatory proteins (Fas, Bak and Bcl-xL) and hepatic cell death
during and after cardiac surgery.
Methods: Pigs were assigned to a temperature (T°) group during
standardized cardiopulmonary bypass (CPB): normothermia (T°,
37°C; n = 8) and moderate hypothermia (T°, 28°C; n = 8). Liver
probes were taken before and 6 hours after CPB for standard-
and immunohistological examinations. Apoptotic cells were
detected by TUNEL-staining. Intrahepatic gene expression of
TNFa, IL10 and of apoptosis regulating proteins were examined
by competitive RT-PCR.
Results: Gene expression of cytokine and apoptosis regulating
proteins was not detected before but 6 hours after CPB. Pigs
operated on under 28°C showed lower TNFa-mRNA and higher
IL10-mRNA than those operated on under 37°C (P < 0.05). While
expression of apoptosis regulatory proteins and percentage of
apoptotic hepatocytes were similar in both groups, percentage of
necrotic hepatocytes was lower in 28°C than in 37°C group
(P < 0.05). TNFa-mRNA after CPB was correlated with the per-
centage of necrotic hepatocytes (P < 0.05).
Conclusions: Moderate hypothermia during CPB provides hepatic
protection by increasing IL10- and decreasing intrahepatic TNFa-
gene expression without affecting gene expression of apptosis reg-
ulatory proteins.S37
P77 Influence of cardiac surgery on immune competence in children
D Kunz*, K Schumacher†, J Germar†, I Franke†, AM Gressner*, G von Bernuth†, M-C Seghaye†
*Department of Clinical Chemistry, and †Department of Pediatric Cardiology, University Hospital, University of Technology, Pauwelsstr 30,
D-52074 Aachen, Germany
Aim: To study whether immune competence as assessed by HLA-
DR expression on monocytes and by ex vivo production of TNFa
allows prediction of complications after cardiac surgery, and to
analyze the influence of cardiac surgery on immune competence.
Methods: Forty patients aged 1 to 188 months undergoing
cardiac surgery were enrolled. Whole blood was collected before,
1, 3, and 5 days after surgery. HLA-DR expression (expressed as
antiboby binding capacity, Abc) was determined using a flow cyto-
metric assay. TNFa production was assessed in the supernatant
after whole blood stimulation with LPS (500 pg/ml; incubation: 4
h) with the Immulite (DPC Biermann GmbH). Severity of the opera-
tion and postop clinical condition were assessed by score.
Results: Ten patients developed postop complications (group 1)
and 30 not (group 2). Preop HLA-DR (32,000 Abc) was not signif-
icantly different between groups. In contrast, preop ex vivo produc-
tion tended to be lower in group 1 than in group 2 (TNFa: 363 vs
628 pg/ml, P = 0.06). In both groups, HLA-DR significantly
decreased on postop day 1 (10,000 Abc, P < 0.002 vs preop) and
remained significantly lower than preop value up to postop day 5.
Group 1 had significantly higher and persistent decrease of HLA-
DR over the postop period than group 2. Severity of operation and
clinical score 4 and 24 h postop negatively correlated with postop
HLA-DR but not with ex vivo TNFa production.
Conclusion: Cardiac operations in children are associated with
impairment of immune competence, which is more severe and
persistent in patients with postop complications. Our results
suggest that preop ex vivo TNFa production but not HLA-DR
expression could be predictive for the development of postop
complications. With this regard, additional study of TNFa gene
polymorphism (locus 308) is expected to allow further preopera-
tive risks stratification.
P78 Earlier extubation using axillary temperature as the endpoint for rewarming following hypothermic cardiopulmonary
bypass
MA Kai, MJ Herbertson, RS Gill
Department of Cardiothoracic Anaesthesia, Southampton General Hospital, Tremona Road, Southampton, Hants SO16 6YD, UK
Patients having uncomplicated coronary artery bypass surgery
(CABG) are extubated within 2–3 hours of surgery. Despite
warming to core temperatures of 37°C post bypass, extubation is
often limited by postoperative hypothermia caused by redistribution
of thermal energy from core to periphery (afterdrop). We hypothe-
sised that rewarming using axillary temperature as an endpoint may
eliminate post bypass afterdrop, thus potentially allowing earlier
extubation.
Methods: Following ethics committee approval, 39 patients for
CABG or aortic valve replacement were randomised to be
rewarmed to either a nasopharyngeal temperature (NPT) of 37°C
(Group A) or an axillary temperature of 35.5°C (Group B) following
hypothermic cardiopulmonary bypass (CPB). Nasopharyngeal and
axillary temperatures were recorded at 1 min intervals in all patients
until extubation. Extubation occurred when a patient achieved car-
diorespiratory stability, blood loss < 1.5 ml/kg/hour and a NPT
³ 36.5°C. The data was statistically analysed using the Mann–
Whitney  U-test.
Results: From the end of surgery, time to a NPT of 36.5°C (and
thus eligibility to extubation on temperature criteria alone) was 84
(± 50) min in Group A and 32 (± 44) min in Group B (P = 0.003).
55% (11/20) of Group B maintained a NPT ³ 36.5°C post bypass
compared with 15% (3/19) of Group A. Lowest postoperative NPT
in Group B was 36.5 (± 0.3)°C compared with 36.1 (± 0.5)°C in
Group A. Values are mean (SD) above and mean (range) below.
Conclusions: Warming to an axillary temperature of 35.5°C
reduces the time taken to achieve core temperatures adequate for
extubation following hypothermic cardiopulmonary bypass.
Group A Group B P value
Rewarm time (min) 18 (7–33) 30 (13–45) 0.0002
Temp end rewarm  37.5 (34.6–38.5) 38.3 (37.4–38.9) 0.006
(°C) (NP)
Temp end rewarm  34.4 (30.1–37.7) 36.2 (35.0–38.6) 0.007
(°C) (AX)
Coldest postop  36.1 (35.3–37.2) 36.5 (35.5–37.1) 0.008
temp (°C) (NP)
End surgery to  84 (0–158) 32 (0–131) 0.003
NP 36.5°C (min)
Total CPB times and lowest temperature on CPB were similar in both
groups.
P79 An effective aspiration method of purulent abdominal fluid for preventing abdominal sepsis
Y Moriwaki, K Yoshida, YT Kosuge, K Uchida, T Yamamoto, M Sugiyama
Department of Critical Care and Emergency Medicine, Yokohama City University, Japan
Uncontrolled abdominal abscess after major trauma or surgery
easily makes a patient septic condition. It is important but difficult to
aspirate mucinous purulent abdominal fluid effectively and to keep
the abscess cavity dry for prevention of abdominal sepsis. Formerly,
we use double luminal tube, which we use usually as nasogastric
tube with low negative pressure. However we could not keep the
condition of the infectious space dry by this technique.
Materials and methods: Patients with abdominal infection or
abscess after major trauma or major surgery were examined. We
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used an overcoated double luminal drain. The tube consisted of an
outer big with many side pores containing an inner small drain and
the tip of the inner drain was kept its site never extended the tip of
the outer drain. We aspirate this overcoated drain with maximum
negative high pressure of central aspirating system. Mucinous
infectious fluid was aspirated with air. We evaluate the clinical
course of the patients, condition of the infectious space, volume of
aspirate, the number of dressing change.
Results and discussion: Fourteen patients were examined. We
could (1) keep infectious spaces, (2) keep the skin around infec-
tious space intact resulting in good and rapid healing, (3) exactly
evaluate the volume of aspirated fluid, that made it easy to evaluate
the healing course, (4) save the number of dressing change result-
ing in saving the cost.
Conclusions: Overcoated double luminal drainage is useful for
aspirating mucinous infectious fluid effectively, for keeping the
infectious space dry, for reducing the infectious space, and conse-
quently for preventing abdominal sepsis.
P80 Catheter-related infections (CRI) after guidewire exchange of subclavian catheters compared to CRI after direct placement
of the catheter
H Bardouniotou, M Vidali, F Tsidemiadou, H Trika-Grafakou, PhM Clouva-Molyvdas
Thriassio Hospital of Eleusis, Attica, Greece
Objective: To compare CRI rate after guidewire exchange of sub-
clavian catheters for suspected CRI with the rate observed after
direct placement.
Study design: Prospective controlled study.
Patients and methods: All subclavian catheters placed consecu-
tively in 202 adult ICU patients, from Oct 1999 to Nov 2000, were
included. Maximum barrier precautions were used during insertion.
Catheter placement, and catheter site care were made according
to the recommendations for the prevention of nosocomial intravas-
cular device-related infections. All catheters were left in place until
no longer needed or until there was evidence of phlebitis, malfunc-
tion or if CRI was suspected. If a new central catheter was still
needed, the catheter was exchanged over a guidewire (GWE
catheter), unless there was evidence of phlebitis, inflammation at
the catheter insertion point or if the previous catheter changed
over a guidewire was colonized, in which case a new anatomical
site was used (NSI catheter). After removal of the catheter, the tips
were processed according to the Maki semiquantitative method.
Catheter colonization, exit-site infection, catheter related blood
stream infection (CR-BSI) were defined according to the guide-
lines for prevention of intravascular device-related infections.
Results: We analysed 423 subclavian catheters (258 NSI and
165 GWE) from a total of 530 inserted (333 NSI and 197GWE).
Hundred and seven catheters (74 NSI and 33 GWE), were not
included in the study. They were lost to further analysis because
either the patient left the ICU with the catheter in place (90), or
there were missing data (accidents at the time of removal 10, other
7). Duration of catheterisation was 7.5 ± 4 days for NSI vs 6 ± 4.4
days for GWE catheters (P < 0.05). There were 17 CR-BSI in the
NSI catheters (8.8/1000 catheter-days) vs 14 in the GWE
(14.1/1000 catheter days) (P > 0.1). Thirty-one NSI catheters
were colonized vs 36 GWE (P < 0.05).
Conclusions: Exchange of the subclavian catheters over guidewire
was not associated with higher CR-BSI compared to catheters
placed directly. A higher rate of colonisation was however
observed in the GWE catheters.
P81 Low dose pentoxifylline (PTX) reduces mortality in an animal model of acute hepatic and multi-organ failure
TM Rahman*, HJF Hodgson†
*Department of Intensive Care Medicine, St Thomas’ Hospital, London SE1, UK; †Centre for Hepatology, Royal Free & University College
Hospital, Royal Free Campus, Rowland Hill St, London NW3 2PF, UK
Introduction: Pentoxifylline inhibits, release of TNF-a, platelet
aggregation and adherence of leukocytes to endothelium. Previ-
ous studies report increased mortality following its use.
Methods: AHF is induced by two intraperitoneal (i.p.) injections
(500 mg/kg 8 hours apart) of TAA. Four groups were studied (n =
5). Group 1 received TAA only. Groups 2, 3, & 4 followed the pro-
tocol for Group 1, however, Groups 2 and 3 were pre-treated for 5
days with once daily high dose PTX (300 mg/kg i.p.) and low dose
PTX (25 mg/kg i.p.), respectively. Whereas, Group 4, commenced
PTX (25 mg/kg i.p.) post-TAA for 5 days. Mortality was determined
at 96 hours in separate groups (n = 5).
Results: See Table.
Conclusion: Pre-treatment with low dose PTX reduces hepatic
injury, multi-organ failure and mortality.
Mortality
AST (iu/l) PT (s) Ammonia (mg/ml) Lactate (mmol/l) (%)
Hours 24 72 24 72 24 72 24 72 96
G1-TAA 1553 ± 343 4512 ± 501 26 ± 3 121 ± 12 58 ± 8 134 ± 12 2.6 ± 1.2 6.3 ± 0.4 75
G2-PTX 300 mg/kg 2065 ± 330 5221 ± 528 >121* >121 117 ± 34* 153 ± 13 3.9 ± 0.5 7.8 ± 0.6 100*
G3-PTX 25 mg/kg 1177 ± 177 2021 ± 43* 23 ± 4 101 ± 13 71.4 ± 9 70.2 ± 10* 3.5 ± 0.1 4.6 ± 0.2* 40*
G4-Post PTX 25 mg/kg 2161 ± 166 5014 ± 299 >121 >121 121 ± 8* 156 ± 12 4.7 ± 0.6* 7.4 ± 0.8 100*
* P < 0.05, mean ± SD.S39
P82 Differences in iNOS inhibition in an animal model of acute hepatic and multi-organ failure
TM Rahman*, HJF Hodgson†
*Department of Intensive Care Medicine, St Thomas’ Hospital, London SE1, UK; †Centre for Hepatology, Royal Free & University College
Hospital, Royal Free Campus, Rowland Hill St, London NW3 2PF, UK
Introduction: iNOS inhibition in AHF is controversial, fuelled by
conflicting results from studies using varieties of pharmacological
agents, animal models and temporal protocols.
Methods: We have previously described a robust model of acute
hepatic and multi-organ failure in the Wistar rat. AHF was induced
by two i.p. injections (500 mg/kg, 8 hours apart) of thioacetamide
(TAA). Six groups were studied (n = 5). Group 1 received TAA
alone. Groups 2, 3 & 4 followed protocol for Group 1, however,
Groups 2 & 3 were pre-treated and Groups 4 & 5 post-TAA
treated with iNOS inhibitors AMG (100 mg/kg s.c.) and L-NAME
(100 mg/kg s.c.) for 5 days.
Results: See Table
Conclusion: AMG is a more selective iNOS inhibitor, significantly
reducing parameters of AHF compared L-NAME. Beneficial effects
are, however, negated if iNOS inhibitors are administered after
TAA, exacerbating hepatic injury, increasing mortality, and thus
demonstrating temporal constraints.
Mortality
AST (iu/l) PT (s) Ammonia (mg/ml) Lactate (mmol/l) (%)
Hours 24 72 24 72 24 72 24 72 96
G1, TAA 1653 ± 338 3166 ± 612 18 ± 3 121 ± 12 54 ± 12 169 ± 34 2.6 ± 0.8 5.26 ± 1 75
G2, Pre-AMG 346 ± 102 1486 ± 341* 32 ± 3* 43 ± 7* 47 ± 10* 75 ± 14* 1.9 ± 0.2* 3.5 ± 0.4* 10*
G3, Pre-L-Name 1780 ± 441 5179 ± 606* >121* >121 90 ± 10 151 ± 11 4.3 ± 0.3 6.5 ± 0.3 80
G4, Post-AMG 2188 ± 450 5069 ± 512* >121* >121 132 ± 12 167 ± 8 3.3 ± 0.3 7.8 ± 0.6 100
G5, Post-L-Name 1897 ± 327 5468 ± 268* >121* >121 139 ± 5 168 ± 9 4.2 ± 0.5 7.9 ± 0.5 100
* P < 0.05, mean ± SD.
P83 Effects of a dual inhibitor of TNF-a a and IL-1 on lipopolysaccharide-induced lung injury in rats
D Yoshinari*, I Takeyoshi*, Y Koibuchi*, S Ohwada*, T Yokoe†, Y Iino†, K Matsumoto‡, Y Morishita*
*Second Department of Surgery, and †Emergency and Critical Care Medicine, Gunma University School of Medicine, 3-39-15 Showa-
machi, Maebashi, Gunma 371-8511, Japan; ‡Division of Pathology, Nippon Medical School Second Hospital, Kawasaki, Japan
Purpose: In this study, we evaluated the effect of FR167653,
which is a potent suppressant of TNF-a and IL-1 production, on
lipopolysaccharide (LPS)-induced lung injury and lethality in rats.
Methods: Male Sprague–Dawley rats weighing from 200 to 270 g
were used. Subject animals in the LPS only and LPS/FR groups
received 6 mg/kg of LPS intravenously. The animals in the LPS/FR
group also received an infusion of FR167653 at 0.2 mg/kg/hour,
commencing 30 min prior to the LPS injection and continuing for
5.5 hours.
Measurements and results: The LPS significantly induced the
accumulation of pulmonary neutrophils and lung edema, both of
which were significantly attenuated by the treatment with
FR167653. FR167653 also significantly decreased the LPS-
induced lethality. Histologically, tissue damage was milder in the
LPS/FR group than in the LPS only group. Serum levels of TNF-a
and IL-1b were suppressed in the LPS/FR group compared with the
LPS only group. Western blot analysis revealed that FR167653
inhibited the phosphorylation of p38 MAP kinase in lung tissues.
Conclusions: FR167653 administration resulted in a decrease in
the serum TNF-a and IL-1b levels that was associated with
decreased lung injury and lethality. The mechanism responsible for
the decreased TNF-a and IL-1 may be related to the inhibitory
effect of FR167653 on p38 MAP kinase activation.
P84 Agreement between Multiple Organ Dysfunction (MOD) and interleukin (IL)-6 levels at baseline in septic patients: a post
hoc analysis from the MONARCS trial
J Marshall, for the MONARCS Study Group
University of Toronto, Toronto, Ontario, Canada
Dedicated organ dysfunction scores such as the Multiple Organ
Dysfunction (MOD) score [1] objectively measure morbidity in criti-
cally ill patients. The MOD score is constructed using simple physi-
ologic measures of dysfunction in six organ systems and correlates
in a graded fashion with the ICU mortality rate. Serum interleukin
(IL)-6 levels have been proposed as a biochemical marker of the
severity of the multiple organ dysfunction syndrome.
Purpose: To assess the agreement of the MOD score with IL-6
levels as baseline prognostic indicators in patients enrolled in the
MONARCS trial.
Methods: The MONARCS trial was a double-blind, placebo-con-
trolled trial designed to evaluate the safety and efficacy of afe-
limomab, an anti-tumor necrosis factor (TNF)a antibody. Before
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randomization, patients were stratified by the results of a rapid
semiqualitative test (Septest) measuring serum IL-6 levels. A posi-
tive (+) Septest indicates elevated IL-6 levels. An aggregate MOD
score  ³ 9 defines significant multiorgan dysfunction syndrome.
Mean baseline score, percent patients with score ³ 9, and the
strength of the agreement of each component of the aggregate
MOD score were compared in the groups of patients Septest (+)
and (–) at baseline. The difference (delta) between the percent of
Septest (+) and (–) patients with the highest scores for each com-
ponent of the MOD score was used to test the strength of agree
between IL-6 levels and each organ system component of the
aggregate MOD score.
Results: A total of 2634 patients were enrolled. 998 (37.9%) had
elevated IL-6 levels and 1636 (62.1%) did not. Baseline mean
MOD score was higher in Septest (+) patients compared to
Septest (–) patients, 8.77 vs 6.64 (P < 0.001), respectively. Base-
line aggregate MOD score ³ 9 was found in 52% of Septest (+)
versus 28% test (–) patients. The cardiovascular, neurologic and
respiratory components of the MOD score appeared to show the
best agreement with baseline IL-6 levels.
Conclusion: Despite lack of strong agreement between certain
organ system components of the MOD score, the aggregate MOD
score and Septest strongly agree at baseline. By inference, there-
fore, the results suggest that the Septest might also be a useful
marker for ICU mortality. 
Reference:
1. Crit Care Med 1995, 23:1638.
Organ systems  Septest (+)  Septest (–) 
components of  percent pts with  percent pts with 
MOD score highest score highest score Delta
Cardiovascular 14.8 4.6 10.2
Neurologic 27.4 18.5 8.9
Respiratory 9.8 3.1 6.7
Renal 6.2 4.3 1.9
Hematologic 2.4 1.1 1.3
Hepatic 1.6 1.5 0.1
P85 Baseline characteristics of patients with and without hypercoaguable sepsis and the effect of afelimomab on mortality: a
post hoc analysis from the MONARCS trial
E Panacek*, S Johnson†, D Johnson‡, T Albertson*, J Marshall§, B Barchuk¶, L Teoh¶
*UC Davis, Sacramento, CA, USA; †University of Arizona, Tucson, AZ, USA; ‡Royal University Hospital, Saaskatoon, Alberta, Canada;
§University of Toronto, Toronto, Ontario, Canada; ¶Knoll Pharmaceutical Co, Mt Olive, NJ, USA
Tumor necrosis factor (TNF)a may modulate clot-promoting and
inhibiting pathways, and have potentially important roles in dissemi-
nated intravascular coagulation (DIC).
Purpose: 1) To determine if differences in baseline characteristics
exist between patients with and without hypercoaguable sepsis,
and 2) to explore the effect of afelimomab (an anti-TNFa antibody)
on mortality of hypercoaguable and non-hypercoaguable septic
patients.
Methods: A post hoc analysis identified patients with a hyperco-
aguable state in the overall population enrolled in a large placebo-
controlled sepsis trial investigating the safety and efficacy of
afelimomab. A hypercoaguable state was defined by (1) platelet
count below 140,000 per ml plus (2) D-dimer > 250 ng/ml.
Patients were randomized to receive placebo or afelimomab.
Results: A total of 2634 patients were enrolled, and 1313
(49.8%) had baseline determinations of both platelets and D-
dimer. The table describes the baseline characteristics of the two
patient groups. Compared to those without laboratory evidence of
consumption coagulopathy, patients with a hypercoagulable state
had higher organ dysfunction scores, higher interleukin-6 levels
and higher frequencies of positive blood cultures. Among the
patients with evidence of consumption coagulopathy, 283 were
treated with placebo and 311 with afelimomab. Mortality at 28
days was 43.8% vs 38.6% in placebo and afelimomab patients,
respectively. In patients not meeting the definition of hypercoagua-
bility, 376 and 343 received placebo and afelimomab; mortality
was 35.9% and 26.5%, respectively.
Conclusions: Septic patients with evidence of consumption coag-
ulopathy had more organ dysfunction and a higher rate of positive
blood cultures. Afelimomab appears to be beneficial in reducing
the mortality of septic patients with a hypercoaguable state.
Table
Absence of
Hypercoaguable hypercoaguable 
state state 
(n = 594) (n = 719)
Mean age (SD) 57.9 (17.0) 60.1 (17.0)
Gender (M/F) 58.6% / 41.4% 61.6% / 38.4%
Shock 399 (67.2%) 504 (70.1%)
MOD score 9.1 6.3
Median interleukin-6 (pg/ml) 1360 908
Mean platelet count × 1000 (SD) 81.7 (35.6) 231.4 (141.7)
Positive blood culture (%) 278 (46.8%) 226 (31.4%)
G (+) bacteria only (%) 185 (31.1%) 207 (28.8%)
G (–) bacteria only (%) 169 (28.5%) 177 (24.6%)
Mixed G (+) and G (–) (%) 65 (10.9%) 102 (14.2%)
Other or unknown (%) 175 (29.5%) 233 (32.4%)S41
P86 Effect of PMX-DHP according to differences in infection site
T Ikeda*, K Ikeda*, T Onizuka*, H Suzuki*, K Suzuki*, H Ohashi*, J Sakurai*, N Matsuno†
*Division of Critical Care and Emergency Medicine, and †5th Department of Surgery, Hachioji Medical Center, Tokyo Medical University, Japan
PMX-DHP (Endotoxin adsorption method) is used for treatment of
patients with sepsis and septic shock primarily caused by Gram
negative infections, and its effectiveness has been evaluated in
Japan. In this study, patients with septic shock caused by intra-
peritoneal infections were classified as a group in which septic
shock was caused by biliary tract infections (Group C) or a group
in which septic shock was caused by perforation of the lower
digestive tract (Group P). Both groups of patients were assessed
for the clinical effect of PMX-DHP, inflammatory mediators and
markers related to vascular endothelial cell function.
Subjects: Cases in which PMX-DHP was performed consisted of
seven in Group C (age: 69 ± 11 years; mean no of treatments: 1.6)
and 18 in Group P (age: 73 ± 24 years; mean no of treatments: 1.5).
Results: There were no significant differences observed in
APACHE-II scores with Group C having a score of 28.9 ± 8.5 and
Group P having a score of 27.1 ± 8.2.
However, Goris MOF scores were obviously higher in Group C,
with a score of 8.5 ± 1.5 for Group C and a score of 4.9 ± 2.0 for
group P. The number of days from the onset of shock until PMX-
DHP was performed was also greater in Group C (1.6 ± 0.8 days
versus 0.9 ± 0.8 days). Although blood pressure elevating effects
were observed in both groups, the magnitude of those effects was
higher in Group P. The amount of catecholamine use was also
obviously greater in Group C than in Group P. Although Group C
exhibited higher endotoxin (ET) values than Group P, there were no
significant differences observed. The values of vascular endothe-
lium markers (ICAM-1, ELAM-1, thrombomodulin, PAI-1 and NOx)
before the start of PMX-DHP were higher in Group C. Although IL-
6 tended to decrease before and after PMX-DHP in both groups,
there were no significant differences observed. However, IL-6 in
Group P demonstrated a significant decrease at 24 hours after
PMX-DHP. IL-1ra tended to decrease before and after PMX-DHP
in both groups, and values before and after PMX-DHP in Group P
were roughly twice that of those in Group C.
Conclusion: Vascular endothelial cell activation and the degree of
its impairment were considered to be greater in Group C than in
Group P.
P87 Early respiratory infection in patients admitted in ICU: microbiological profile and effectiveness of initial therapy
T Cardoso, LM Lopes, AH Carneiro
Intensive Care Unit, Hospital Geral de Santo António, Largo Abel Salazar, 4050 Porto, Portugal
Background: First intention treatment for early acquired respira-
tory infections diagnosed in an ICU is usually made without micro-
biological identification. Microbiological profile is important in
supporting therapeutic options.
Objectives: Study of the microbiological profile and effectiveness
of first intention antibiotic therapy in early respiratory infections.
Methods: Retrospective clinical study of 385 patients admitted to
our ICU, from January to September 2000; selection of those with
respiratory infection diagnosed in the first 72 hours of admission.
Tracheobronchitis was defined by ‘new’ purulent bronchial secre-
tions, with fever (> 38.5°C, axilar) and leucocytosis (> 10,000),
and pneumonia by the three mentioned criteria plus ‘new’ pul-
monary infiltrate. For these patients we reviewed the microbiologi-
cal profile of specimens collected in the first 72 hours and the
antimicrobial therapy.
Results: In 105 (27.3%) of the patients admitted it was diag-
nosed an early respiratory infection: 47 (44.8%) had pneumonia
and 58 had (55.2%) traqueobronquitis. A total of 56 organisms
were isolated, in 43 patients (41%). 98.2% of the isolations were
obtained from tracheobronchial aspiration. Agents involved were:
Haemophilus influenzae (39.3%), Staphylococcus aureus MS
(23.2%), Streptoccus pneumoniae (19.6%), Klebsiella pneumo-
niae (1.8%), Moraxella catarrhalis (1.8%), E. coli (3.6%), Proteus
mirabilis (1.8%),  Enterobactereacea (1.8%),  Pseudomonas
aeruginosa (3.6%), Serratia marcenses (1.8%) and Staphylococ-
cus aureus MR (1.8%). The patients in whom we isolate the
Pseudomonas aeruginosa, Serratia marcenses and Staphylococ-
cus aureus MR were already hospitalised and had comorbidities.
First intention treatment was in the vast majority amoxicilin +
clavulanate (72 patients — 68.6%). Initial therapy was changed
according to antibiogram in 5 patients and in 18 patients (17.1%)
it was necessary to change the therapy without microbiological
guidance.
Conclusions: Early respiratory infection is a frequent diagnosis in
our ICU (27.3%). The microbiological profile in our patients shows,
in 93% of the cases, organisms usually acquired in the community.
Amoxicilin and clavulanate as first intention therapy appeared to be
a good option (it failed only in 7% of the patients in whom it was
used), and according to our microbiological profile it seems to be a
good choice.
P88 Cost/benefit analysis of initial cultures in the management of acute burns
PL Miller, F Matthey
University of California, Davis Medical Center, 2315 Stockton Blvd, Sacramento, CA 95817, USA
The use of burn clinical pathways has helped to improve quality of care
and decrease costs in the Burn Center. However, despite implementa-
tion of these pathways, certain ‘ritual care’ persists as part of the ‘burn
culture’. Specifically, the collection of wound cultures of acute burns at
admission and the collection urine, blood, sputum, and wound cultures
(‘pan-culturing’) on patients with temperatures greater than 38.5°C in
the first 24 hours of admission are considered standard of care
despite the lack of scientific data supporting these practices.
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Purpose: The objectives of this study are to (1) establish the pro-
portion and cost of cultures obtained in the first 24 hours after
acute burn injury that yield positive microbiological cultures and (2)
determine the utility of pan-culturing for temperatures greater than
38.5°C in the first 24 hours following burn injury.
Design: Retrospective, computer-assisted chart review.
Setting: University-based burn center.
Methods: The records all burn injuries evaluated at the Burn
Center or in the Emergency Department between 1/1997 and
1/1998 were retrospectively identified by ICD-9 release codes.
Patients presenting with evidence of infection and pediatric burn
patients were excluded. Data evaluated included: extent of burn
injury, length of stay (LOS), documentation of initial cultures,
culture results, and intervention/treatment.
Results: A total of 713 patients were identified. 598 charts met
the inclusion criteria. 447 patients had LOS < 1 day and were pri-
marily treated in the ED and discharged home. Wound cultures
were obtained for 42 (10%) of these patients. Thirty cultures
(71%) had no significant growth. Twelve cultures (29%) grew
mixed, common skin flora. No patients in this group were pan-cul-
tured. No patients in this group required antibiotic treatment on the
basis of culture results. A total of 151 patients were admitted to
the Burn Center with an average LOS of 3.9 days (range 2–125
days). In this group, 45 patients (30%) had wound cultures and 24
patients (16%) were pan-cultured in the first 24 hours of admis-
sion. One patient with a deep, open abdominal burn grew entero-
coccus species from the initial wound culture and was treated with
antibiotics. No other patients had antibiotics ordered on the basis
of cultures.
Conclusion: Clinical management of the acute burn is not altered
by the results of routine wound cultures and pan-cultures obtained
in the first 24 hours of admission. Management of patients with
deep, abdominal wounds with potential contamination from bowel
flora may prove an exception. The cost for a wound culture and
gram stain at this hospital is $58.00 (US). Omitting initial cultures
would result in potential savings of $16,686.00 (US) and would
not compromise the quality of patient care.
P89 The utility of routine wound surveillance cultures in the management of burn injury
PL Miller, F Matthey
University of California, Davis Medical Center, 2315 Stockton Blvd, Sacramento, CA 95817, USA
Purpose: The objectives of this study are to establish the propor-
tion and cost of surveillance cultures that yield a positive microbio-
logical culture and to determine the influence of surveillance
cultures in the ordering of antimicrobials.
Design: Retrospective, computer-assisted chart review.
Setting: University-based burn center.
Methods: The records of all burn injuries admitted to the Burn
Service between Jan 1997 and Jan 1998 were retrospectively
identified by ICD-9 release codes. Patients with length of stay less
than 1 day, or who had a bed assignment other than in the burn
center were excluded. Patients with at least one surveillance
culture were included. Surveillance cultures were defined as cul-
tures obtained on Wednesdays and Saturdays per Burn Center
protocol. Data collected included: length of stay, extent of burn
injury, documentation of surveillance culture results, documentation
of signs and/or symptoms of cellulitis and intervention and treat-
ment. A P value < 0.05 was considered statistically significant.
Results: 151 patients were identified. Eighty patients met the
inclusion criteria. A total of 179 surveillance cultures were col-
lected. 89% (71/80) of study patients received antimicrobials
during their hospital course and 82% (58/71) had clinical signs
of cellulitis. 91% (53/58) of patients with clinical signs of celluli-
tis were treated with antimicrobials. Most of these patients
(86%) received empirical antimicrobials for cellulitis, based
solely on clinical judgment not on culture results. In only three
cases (1.6%) were orders for antimicrobials initiated or changed
on the basis of wound surveillance cultures. Patients with sur-
veillance culture were significantly more likely to receive antimi-
crobials than those who were not cultured (39.6% vs 1.7%
P = 0.001). However, among those patients with surveillance
cultures (n = 179), there were significantly more patients who
did not receive any antimicrobials (60.3% vs 39.7% P = 0.001)
There was no significant relationship between a positive or neg-
ative surveillance culture and orders for antimicrobials
(P=0.097).
Conclusion: The clinical management of burn wounds is not signif-
icantly altered by the results of routine surveillance wound cultures.
The diagnosis of cellulitis is based on clinical judgment and treat-
ment is initiated empirically. Omitting twice-weekly routine surveil-
lance cultures would result in potential savings of $25,550.00
(US) and would not compromise the quality of patient care.
P90 Attributable mortality in critically ill patients with bacteremia involving methicillin susceptible (MSSA) and methicillin
resistant Staphylococcus aureus (MRSA)
S Blot, K Vandewoude, E Hoste, F Colardyn
Intensive Care Department, Ghent University Hospital, De Pintelaan 185, B-9000 Gent, Belgium
Background: Staphylococcus aureus bacteremia carry high fatal-
ity rates. Outcome comparisons between MRSA and MSSA bac-
teremic patients are difficult to perform because of important
differences in severity of illness.
Methods: In a retrospective study (01/1992–12/1998), attribut-
able mortality for MSSA and MRSA bacteremia was investigated
and compared in critically ill patients. Two independent case–
control studies were performed. Matching (1:2-ratio) was based
upon APACHE II-score and admission diagnosis. As expected
mortality can be derived from these two variables, this matching
procedure resulted in an equal expected mortality rate for cases
and controls. Attributable mortality is determined by subtracting
the in-hospital mortality rate of the controls from the in-hospital
mortality rate of the cases.S43
Results: During the study period 22,431 patients were admitted
to the ICU. In 85 patients a microbiologically documented S.
aureus bacteremia was diagnosed. In the MSSA case–control
study, an attributable mortality of 1.3% was found: mortality in
cases (n = 38) and controls (n = 76) was respectively 23.7%
and 22.4% (P = 0.937). In the MRSA case–control study an
attributable mortality of 23.4% was found: mortality rates for
cases (n = 47) and controls (n = 94) were respectively 63.7%
and 40.4% (P = 0.017). The difference between both attributable
mortality rates (22.1%) was statistically significant (95% CI:
8.8–35.3%).
Conclusion: In critically ill patients, MRSA bacteremia have a sig-
nificantly higher attributable mortality than MSSA bacteremia.
P91 Prescription of antibiotics in a neonatal intensive care unit
L Maury, S Cantagrel, S Thionois, C Chamboux, S Cloarec, J Laugier
Paediatric Intensive Care Unit, Hôpital Clocheville, 49 Bd Béranger, 37000 Tours, France
Two in three neonates in intensive care units are treated with
antibiotics. However, the extensive use of wide spectrum antibi-
otics increases the emergence of multiresistant bacteria.
Aim: To study the use of antibiotics in a neonatal intensive care unit.
Methods: All neonates receiving antibiotic treatment over a 6
month period were included in this prospective study. The informa-
tion gathered included the indications and criteria for initiating
antibiotic therapy (clinical, biological and bacteriological), duration
of treatment and the reasons for withdrawal of treatment. The pre-
scription/written procedures correlation was judged a posteriori by
a non-prescribing physician.
Results: One hundred and thirty-five infants were included, of
whom eight received several courses (2–5 courses) at different
times. Mean gestational age was 33.5 weeks (24.5–41.5 weeks).
In 82% of cases admission was for respiratory distress. The main
indications for antibiotic treatment were 1) primary infection (78%,
of which 92.4% were for suspected feto-maternal infection), 2)
nosocomial infection (17% of which occurred in neonates born at
less than 28 weeks’ GA and hospitalized in the unit for more than
21 days) and 3) post-operative prophylaxis (5%). Clinical criteria
predominated in the primary infections but in 62% of cases feto-
maternal infection was not confirmed, justifying withdrawal of treat-
ment after 3 days. Bacteriological criteria played a part in the
treatment decision only in nosocomial infections (14/23 new-
borns). Infringement of treatment guidelines represented 9% of
infants treated and mainly involved length of treatment.
Conclusion: These results show that 1) the majority of antibiotic
treatments for suspected feto-maternal infection were uncon-
firmed, demonstrating the need to refine the criteria for diagnosis,
2) the level of nosocomial infection was low and mainly occurred
in very premature infants (7–30% in the literature) and 3) the
fewer than 10% infringements of guidelines emphasized the value
of continuous surveillance of use of antibiotics in neonatal inten-
sive care units.
P92 ICU-acquired infections on a patient-to-patient antibiotic rotation policy in ICU
L Lorente Ramos*, J Málaga Gil*, M Lecuona Fernández†, C Revert Gironés†, T Delgado Melián†, ML Mora Quintero*
*Department of Intensive Care, and †Department of Microbiology, Hospital Universitario de Canarias, La Laguna, Tenerife, Spain
Objective: To determine ICU-acquired infections and sensibility to
antibiotics by an antibiotic therapy policy with a patient-to-patient
rotation. We have compared our dates with EPIC study [1].
Design: Prospective observational study.
Setting: A 20-bed medical-surgical Intensive Care Unit (ICU).
Patients: All patients admitted in ICU from 1-1-1999 to 30-7-1999
and from 16-6-2000 to 16-10-2000, with a length of stay in ICU
longer than 24 hours. The infections were diagnosed according to
the criteria of the CDC.
Results: 371 patients (66.85% males) and 163 patients (63.19%
males) fulfilled all criteria in respectives periods. Mean age was
57.71 ± 16.85 years and 57.58 ± 16.56 years. APACHE-II was
14.4 ± 6.2 and 12.5 ± 5.2. Mortality was 12.18% and 12.19%.
Patients distribution was: 43% and 46% cardiac surgery, 14% and
15% cardiologic, 9% and 13% neurologic, 9% and 7% traumath-
ology, 10% and 5% pulmonary, 5% and 6% digestive, 10% and
8% others. Mechanical ventilation was need in 74% and 91%,
central venous line in 79% and 97%, vesical catheter in 92% and
97%. We diagnosed 145 UCI-acquired infections in 90 patients
and 105 UCI-acquired infections in 52 patients. Distribution infec-
tions was: respiratory 40% and 39%, urinary tract 28% and 22%,
bloodstream 14% and 12%, others 18% and 27%; 152 and 106
Table
EPIC HUC- HUC-
1999 2000
Rate infections
For pseudomonas aeruginosa 28% 6% 9%
For acinetobacter 9% 0.6% 0%
For fungi 17% 7% 10%
Rate resistance of pseudomonas
To gentamicin 46% 37% 25%
To ureidopenicillin 37% 37% 0%
To ceftazidime 27% 25% 0%
To ciprofloxacin 26% 4% 10%
To imipenem 21% 17% 10%
Rate resistance
Of staphylococci aureus to  60% 4% 30%
methicillin
Of coagulase-negative  70% 91% 88%
staphylococci to methicillin
Of coagulase-negative  3% 0% 0%
staphylococci to vancomycin
Of coagulase-negative  66% 69% 42%
staphylococci to gentamicin
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germs were isolated: 48% and 45% gram negative, 45% and 45%
gram positive, 7% and 10% fungi. Most frequently germs reported
in first period were: 15% S. Aureus, 12% Enterococci and 11% E.
Coli; and second period were: 19% Epidermidis Staphylococci,
9% S. Aureus and 9% E. coli. The differences we found with EPIC
are shown in the Table.
Conclusions: The antibiotic therapy policy with a patient-to-patient
rotation can be useful for the control of infectious mape in ICU.
Reference:
1. Vincent JL et al: Results of the European Prevalence of infection in
Intensive Care (EPIC) Study. JAMA 1995, 274:639–644.
P93 Cefepime in critically ill patients: continuous infusion versus intermittent regimen
B Georges, S Saivin, P Cougot, JF Decun, P Andrieu, M Archambaud, Ch Roche, B Chaminade, R Fuzier, M Mazerolles, Ch Suc, 
G Houin, I Lavrard, K Samii, Ch Virenque
Service de Réanimation Polyvalente, CHU Rangueil, 31403 Toulouse, France
Background: Beta-lactams have a time-dependent bactericidal
activity and the time above MIC (T > MIC) is the best predictive
factor of efficacy. The aim of this study was to compare the phar-
macokinetic and pharmacodynamic parameters and the clinical effi-
cacy of a continuous infusion of cefepime versus an intermittent
regimen in critically ill adults patients with gram negative bacilli
infection.
Methods: The prospective cross-over study was carried out in 34
patients with severe pneumonia (n = 26) or bacteriemia (n = 8).
There were randomized to receive Cefepim 4 g per day either as a
continuous infusion (Group 1, n = 17) or intermittent administration
2 g x 2 (Group 2, n = 17) in combination with amikacin 15
mg/kg/day in the two groups. Patients were significantly compara-
ble in terms of age, sex, initial infection disease, IGS II score and
MIC of gram negative bacilli isolated. Clinical outcomes: mechani-
cal ventilation, ICU stay durations and clinical recovery were
assessed along with pharmacokinetic (24-hour AUIC, 12-hour
AUIC) and pharmacodynamic (T > MIC and T > 5 MICs) in both
groups and compared (chi-squared and Mann–Whitney U-tests).
Results with P < 0.05 were considered significant.
Results: Mechanical ventilation, clinical recovery (13 vs 11), bacte-
riologic eradication (12 vs 10) and duration of stay in ICU (35 vs
38 days) were better in Group 1 but did not significantly differ
between the two group. Neither did 24-hour AUIC (569 vs 414)
nor 12-hour AUIC (218 vs 202). However, T > MIC in Group 1
(23.8 ± 0.2) was significantly higher (P < 0.05) than in Group 2
(20.4 ± 3). T > 5 MICs in Group 1 (23.6 ± 0.6) was also very sig-
nificantly higher (P < 0.01) than in Group 2 (16.7 ± 6).
Conclusion: Clinical outcome was similar but our results indicate
that continuous infusion likely provides a better steady bactericidal
effect with concentration above MIC than intermittent administra-
tion, especially if there is a high risk of cephalosporinase as with
Enterobacter spp. Further studies including more patients are nec-
essary to confirm the interest of continuous infusion and to assess
the possibility of reducing the daily dosage.
P94 Leptospirosis and acute respiratory failure: report of 34 cases
SRR Vieira, JS Brauner
ICU from Hospital Clínicas de Porto Alegre (UFRGS)/Hospital NS Conceição, São Luis 1127, 501, CEP 90620-170, Porto Alegre, RS,
Brazil
Introduction: Leptospirosis is generally found in tropical regions
but it can occur in temperate regions. It is caused by all kinds of
leptospiras and it is, in general, a self limited disease. However,
reports of important complications as acute respiratory failure
(ARF), associated or not with other organic dysfunction had
increased in the last years and had been associated with a high
mortality rate [1].
Objective: The goal from this paper is to evaluate the clinical char-
acteristics and the morbimortality of severe leptospirosis associ-
ated with ARF in two general ICU from two general hospitals.
Methods: All cases with the diagnosis of leptospirosis, confirmed
by blood macroagglutination test, associated with ARF and admit-
ted from January 1990 to October 2000, in two general ICU from
two general hospitals, were studied. There were analyzed the clini-
cal and laboratory characteristics, the associated organic dysfunc-
tion and the mortality rate. Survivors were compared with
non-survivors. The quantitative variables have been compared by
unpaired t-test and the qualitative variables by a chi-squared test.
The level of significance was P < 0.05.
Results: We described 34 adults patients, 39 ± 16 years, 28 men
and 6 women. The most frequent clinical manifestation were
dyspnea (n = 32), fever (n = 31), myalgias (n = 29), jaundice
(n = 28), hemoptysis (n = 25) and cough (n = 25). All patients
showed ARF needing for mechanical ventilation (PaO2/FIO2 =
169 ± 73, with diffuse pulmonary infiltrates in all cases) as well as
some level of other organic dysfunction as hepatic (n = 26), renal
(n = 25), cardiovascular (n = 22), hematological (n = 20) and neu-
rological (n = 11). The mortality rate was 53% (n = 18). The com-
parison between non-survivors and survivors showed they were
older (P < 0.05) and had: 1) higher number of organic dysfunction,
principally higher incidence of renal, cardiovascular and neurologi-
cal failures (P < 0.05); 2) higher levels of acidosis (P < 0.05); 3)
higher use of invasive mechanical ventilation and positive end-expi-
ratory pressure (P < 0.05).
Conclusions: In endemic regions leptospirosis has to be consid-
ered as a cause of ARF as well as a cause of other associated
organic dysfunction. Leptospirosis associated with ARF has a high
mortality rate mainly when associated with other organic failures.
Reference:
1. Ko AI, Reis MG, Dourado CMR, Johnson Jr WD, Riley LW, and the
Salvador Leptospirosis Study Group: Urban epidemic of severe
leptospirosis in Brazil. Lancet 1999, 354:820–825.S45
P95 Comparison of two cohort of patients with severe tetanus in ICU
JS Brauner, SRR Vieira, SS Affonso
ICU, Hospital NS Conceição and Hospital Clínicas Porto Alegre, UFRGS, São Luis 1127, 501, CEP 90620/170, Porto Alegre, RS, Brazil
Introduction: Tetanus is a toxic disease produced by Clostridium
tetani mostly prevented by immunization, but it is still prevalent in
the Third World, has a high mortality rate and uses a high number
of ICU resources. Our objective is to show our experience in two
different periods managing this disease.
Methods: We compared a historical cohort of 126 patients
(1981–1993) — group 1 — with a prospective cohort of 101
patients (1994–2000) — group 2, with severe tetanus. The differ-
ences between groups were: the use of lower dose of human
tetanus immunoglobulin (HTIG) in group 2 (500 UI in group 2
versus 5000–7500 UI in group 1); the use of more advanced venti-
lators in group 2 and early physiotherapy in group 2. Both groups
were compared considering: age, sex, incubation period (IP), onset
period (OP), symptomatic period (SP), autonomic instability (AI),
period of use of benzodiazepine (Pbenzo), curare (Pcur), mechani-
cal ventilation (PMV), ICU stay (PICU), complications and mortality.
Analysis were done with t-test for independent samples for contin-
uous variables and chi-squared test for categorical variables. The
level of significance was considered P < 0.05.
Results: Group 2 was older (49 × 39 years — P < 0.001), with
less women (14/101 in group 2 × 32/126 in group 1 — P < 0.005)
and presented more chronic pulmonary obstructive disease
(P < 0.05) and alcoholism (P < 0.05) than group 1. There was no
significant difference between groups considering other concomi-
tant diseases (ischemic cardiopathy, diabetes mellitus, systemic
arterial hypertension). Group 2 presented longer PI (P = 0.04), OP
(P  = 0.02), SP (P < 0.001), PICU (P < 0.001), Pbenzo
(P < 0.001), Pcur (P < 0.001), and PMV (P < 0.001) than group 1.
During clinical evolution, group 2 presented higher incidence of
arrythmias, respiratory and urinary infections than group 1
(P<0.001). Group 1 presented more pneumothorax and car-
diopulmonary arrest (P < 0.001) than group 2, probably secondary
to problems with mechanical ventilators. There were no differences
between both groups regarding hypertension, hypotension and
renal failure. The mortality rate was 36.5% in group 1 and 16.8% in
group 2 (P < 0.005).
Conclusions: 1) The reduced mortality in group 2 (P < 0.005) is
probably related to advances in ICU resources (advanced ventila-
tors and early physiotherapy). 2) The higher incidence of infections
in group 2 is probably related to longer ICU stay, mechanical venti-
lation period and use of invasive procedures. 3) Smaller doses of
HTIG (500 UI) can be safely used.
P96 Multiorgan failure in malaria: what we have learned over the past 10 years
B Zeippen, I Joubert, C O’Reilly
Intensive Care Unit, Chris Hani Baragwanath Hospital, University of the Witwatersrand, PO Bertsham 2013 Soweto, RSA
Objectives: Incidence and outcome of multiorgan failure in Severe
Malaria. Usefulness of severity of disease scoring systems.
Design and methods: This is a retrospective analysis of data from
152 patients admitted to the Intensive Care Unit at the Chris Hani
Baragwanath Hospital between 1990 and 1999 with a confirmed
diagnosis of Severe Malaria.
Results: Of the 152 patients, 81 (53.3%) were male and 71
(46.7%) female. The overall mortality was 31.6% (48/152).
Demographics
All (n = 152) Alive (n = 104) Dead (n = 48)
Median Range Median Range Median Range P value
Age (years) 32.5 14–71 32 14–67 34 17–71 NS
Apache II 17 1–43 15 1–30 22 9–43 < 0.005
WHO 5 0–12 4.5 0–10 8 3–12 < 0.005
Parasitaemia (%) 11 < 1–71 11 < 1–56 12 < 1–71 NS
SOFA 10 0–18 9 0–17 12 6–18 < 0.005
ICU stay (days) 4 < 1–80 4 1–37 4 < 1–80 NS
Hemoglobin (g/dl) 9.2 3.2–16 9.6 4.3–16 8.5 3.2–15 NS
Platelet count (x 103/dl) 41 4–300 42.5 4–300 36 7–96 < 0.005
Organ failure: incidence and outcome
ARDS ARF with CVVHD ARDS & ARF
Mortality Y N Y N Both None
Number 31 121 (20.4%) 75 77 (49%) 24 70 (16/46%)
Mortality (%) 80.6 19.4 P < 0.000 52 11.7 P < 0.000 87.5 7.1 P < 0.000
Available online http://ccforum.com/supplements/5/S1S46
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Conclusions: The occurrence of acute renal failure in malaria is an
ominous event even when it occurs on its own. ARDS is however a
serious complication which carries a high mortality. The combination
of ARF together with ARDS has an almost universally fatal outcome.
APACHE II score, SOFA score and WHO criteria correlate closely
with outcome.
P97 Malaria and the HIV virus: is there any interaction?
I Joubert, B Zeippen, C O’Reilly
Intensive Care Unit, Chris Hani Baragwanath Hospital, University of the Witwatersrand, PO Bertsham 2013 Soweto, RSA
Objectives: The aim of the study is to see if HIV influences the
severity and outcome of Plasmodium Falciparum Malaria.
Design and methods: This is a retrospective analysis of ICU
records of patients admitted to the ICU at the Chris Hani Barag-
wanath Hospital between 1990 and 1999 with a confirmed diag-
nosis of malaria. 70 of the 152 patients had their HIV status
defined, those were reviewed.
Results: See Tables.
Conclusions: There is no interaction between HIV seropositivity
and severe Plasmodium Falciparum Malaria. HIV status does not
impact on severity of malaria. The incidence and outcome of Multi-
ple Organ Failure related to Malaria is not significantly different in
HIV infected patients.
Table 1
Characteristics
HIV positive (n = 20) HIV negative (n = 50) P value
Male/female ratio 12 M 8 F 26 M  24 F 0.454
ICU stay (median/range) 4.5 days 1–16 5 days 0.5–37 > 0.10
Parasitaemia (median/range) 14.5% 1–50% 1% < 1–71% > 0.10
WHO criteria (median/range) 5.5 0–11 5 1–12 > 0.10
APACHE II (median/range) 16 10–29 17.5 6–38 > 0.10
Incidence of ARDS  3/20 15% 14/50 28% 0.278
Incidence of ARF 12/20 60% 26/50 52% 0.454
Incidence of ARDS & ARF 3/20 15% 12/50 12% 0.372
Table 2
Outcome
HIV positive  HIV negative P value
Overall mortality 8/20 40% 15/50 30% 0.375
Mortality of ARDS  3/3 100% 11/14 78% 0.571
Mortality of ARF 8/12 66% 13/26 50% 0.410
Mortality of ARDS & ARF 3/3 100% 10/12 83% 0.600
P98 Undiagnosed tuberculosis as the reason of failure in treatment of critical care patients
IY Shpaner
Kazan Medical University, p/b No 12, Kazan-29, 420029, Russia
Intensive treatment sometimes becomes unsuccessful due to
diagnostics mistakes. Tuberculosis — one of the most serious dis-
eases in Russia — also leads to critical status of patients. But in
some of such patients tuberculosis remains undiagnosed.
Purpose of present study was to analyse why not recognition of
pulmonary tuberculosis became the reason of failure in treatment
of critical care patients. Thirty-eight cases of patients (28 men
and 10 women) treated in emergency departments of general
practice hospitals of Tatarstan Republic, Russia, were investi-
gated. Age of patients was from 42 to 77 years. Clinical diagno-
sis of pneumonia was in 86.8% of them, pleuritis of obscure
etiology in 10.5% and one patient had clottage of mesenteric
blood vessels. Patients status at entering the hospitals was esti-
mated as serious. Complaints to tussis with a sputum were in
89.5% cases. Average value of ESR was 17.3 mm/h, leukocyto-
sis —16.2 × 109/l. All patients received a complex intensive care.
Patient with the surgical pathology was operated. But despite
treatment there were not improvement in patients status, and
1–5 days after entering hospitals all patients died. Postmortem
examination found out that the reason of failure in complex treat-
ment of patients was undiagnosed pulmonary tuberculosis. Infil-
tration tuberculosis was in 14 patients, fibro-cavernous in 13
patients and disseminated tuberculosis in 11 patients. Analysis
of that cases showed that radiography was done only to 36.8%S47
of patients on the average 2.3 days after entering the hospitals.
Sputum microscopy was done only in two cases and also with an
appreciable delay. In both cases BK were found out. Radiogra-
phy and smear microscopy results became accessible to doctors
only after patients morses. Investigation showed the necessity of
urgent fulfillment of radiography and sputum microscopy in criti-
cal patients with suspicion of pulmonary tuberculosis just after
entering the hospitals.
P99 Risk factors for Candida colonization/infection in non-neutropenic medical critically ill patients
J Nolla*, C León†, R Jordá‡, MA León§, MJ Pontes¶, M Casado†, and EPCAN Group Study
*Hospital del Mar, Barcelona, Spain; †Hospital University de Valme, Seville, Spain; ‡Hospital de Son Dureta, Palma de Mallorca, Spain;
§Hospital General de Catalunya, Barcelona, Spain; ¶Gilead Farmaceútica, SA, Madrid, Spain
Background: To evaluate the risk factors of Candida
colonization/infection in the non-neutropenic medical critically ill
patients (pts) who were admitted to ICUs.
Methods: Prospective observational multicenter study from May
1998–January 1999 in pts staying ³ 7 days in 73 Spanish inten-
sive care units (ICU). Surveillance cultures were performed weekly
from: tracheal aspirates, urine, and gut (oropharynx ± gastric aspi-
rates). The pts were catalogued in two groups: colonized (appear-
ance or persistence of Candida in surveillance cultures) and
invasive candidiasis (IC) (defined as any one or more of the condi-
tions following: candidemia, endophtalmitis, other infections: peri-
tonitis, organ biopsy). Multisite colonization (MC) was defined as
³ 2 sites positive from surveillance cultures, and persistent MC as
positive cultures in ³ 1 week. The pts were clasified in two groups,
medical, and surgical-traumatic. Demographic variables, APACHE
II, comorbidity, associated risk factors and outcome were analized
and compared between the two groups.
Results: We analyzed 1765 consecutive pts: 961 were consid-
ered colonized or infected by Candida species: 468 were medical,
309 surgical and 184 traumatic pts. In the medical group 438
were colonized (persistent MC, 78 pts; non-persistent MC, 183
pts; and in a single site, 202 pts, and 30 (6.4%) were in IC group.
C. albicans was the most prevalent (82.4%). Univariate analysis
identified factors to be associated with Candida colonization/infec-
tion in the medical pts: age, APACHE II, diabetes, COPD, hemato-
logic malignancies, renal insufficiency, immunosupression, steroid
therapy time, and mortality rate (intra-ICU and hospital). By step-
wise logistic regression, hematologic malignancies (OR 6.0 [95%
CI, 1.1–31.4]), diabetes (OR 2.4 [95% CI, 1.4–4.2]), and enteral
nutrition (OR 2.2 [95% CI, 1.4–3.6]), proved to predict the devel-
opment of Candida presence in medical pts independently.
Conclusions: Hematologic malignancies, diabetes and enteral
nutrition are independently significant risk factors for Candida colo-
nization/infection in medical critically ill patients.
P100 Therapeutic variability in the treatment of Candida colonization/infection in non-neutropenic critically ill patients
C León*, J Nolla†, R Jordá‡, MA León§, MJ Pontes¶, A Loza*, and EPCAN Group Study
*Hospital University de Valme, Seville, Spain; †Hospital del Mar, Barcelona, Spain; ‡Hospital de Son Dureta, Palma de Mallorca, Spain;
§Hospital General de Catalunya, Barcelona, Spain; ¶Gilead Farmaceútica, SA, Madrid, Spain
Background: To determine the therapeutic variability in the treat-
ment of Candida colonization or invasive candidiasis (IC) among
critically ill patients (pts).
Methods: Prospective observational multicenter study from May
1998–January 1999 in pts staying ³ 7 days in 73 Spanish inten-
sive care units (ICU). Surveillance cultures were performed
weekly from: tracheal aspirates, urine, and gut (oropharynx ±
gastric aspirates). The pts were catalogued in two groups: colo-
nized (appearance or persistence of Candida in surveillance cul-
tures) and IC (defined as any one or more of the following:
candidemia, endophtalmitis, other infections [OI]: peritonitis,
organ biopsy). Multisite colonization (MC) was defined as ³ 2
sites positive from surveillance cultures, and persistent MC as
positive cultures in ³ 1 week.
Results: We analyzed 1765 consecutive pts: 961 were consid-
ered colonized or infected by Candida species, of them, 55 pre-
sented candidemia, 35 OI, 7 endophtalmitis, and 864 pts were
considered colonized. Were treated with antifungal drugs 48/55
(87.2%), 27/35 (77.1%) and 267/864 (20.9%) of the pts with
candidemia, OI and colonized groups, respectively. All pts with
endophtalmitis were treated. 57 pts received a second antifungal
drug. Fluconazole was the antifungal drugs most used, as the first
intention, especially in the colonized groups (86.4%) and less
(57.1%) in the endophtalmitis group. The liposomal amphotericin B
18/58 (31.0%) was the most used as the alternative therapeutic.
The time of treatment in the ICU was of the 7.7, 10.6, and 5.5.days
in the candidemia, OI and endophtalmitis, respectively.
Conclusion: The kind and time of the antifungal treatment was dif-
ferent between the groups analized.
P101 Lipopolysaccharides-induced interleukin-8 production is inhibited by antithrombin
E Gray*, R Iampietro*, P Souter*, J Römisch†, S Poole*
*NIBSC, Potters Bar, UK; †Aventis Behring, 35002 Marburg, Germany
Sepsis is one of the main causes of death in developed countries. It
is commonly associated with disseminated intravascular coagula-
tion (DIC), caused by consumption of coagulation factors and
inhibitors such as antithrombin (AT) and the production of inter-
leukin 6 (IL-6) and interleukin 8 (IL-8) have been shown to correlate
positively with the severity of disease. Large doses of antithrombin
(AT) reduce mortality and morbidity in septic patients and there is
increasing evidence to suggest that AT has anti-inflammatory prop-
erties in addition to its anticoagulant properties. In our previous in
vitro study, we have found that AT inhibits tissue factor and inter-
leukin-6 production induced by lipopolysaccharides (LPS). In the
present investigation, we have studied the effects of AT on LPS
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induced IL-8 production in three in vitro cellular systems. Citrated
whole blood, human umbilical vein endothelial cells (HUVECs) and
mononuclear cells (MNCs) were stimulated with LPS for 4–6 hours
in the presence and absence of 0–40 IU/ml AT. IL-8 was measured
by ELISA. In all three systems, AT dose-dependently inhibited IL-8
production, with greatest inhibition (98.7 ± 5.2% at 40 IU/ml)
observed for the whole blood system and the least inhibition seen
with MNCs (8.7 ± 21.7% at 40 IU/ml). RNA extraction of time
course whole blood experiment followed by the detection of mRNA
specific for IL-8 showed that in the absence of AT, mRNA for IL-8
was apparent after 30 min incubation with LPS. However, the level
of IL-8 mRNA was found to decrease with increasing concentra-
tions of AT. These results imply the inhibition of IL-8 antigen produc-
tion by AT is due to the suppression of mRNA and indicated that
the anti-inflammatory activity of AT also extends to the inhibition of
IL-8, an important cytokine implicated in neutrophil migration.
P102 Distinct antithrombin III preparations deactivate IL-8-induced neutrophil chemotaxis with different potency
N Kaneider, S Dunzendorfer, CJ Wiedermann
Department of Internal Medicine, University of Innsbruck, Anichstr 35, A-6020 Innsbruck, Austria
Background: Neutrophil activation is a crucial step in the pathogene-
sis of sepsis and subsequent development of multiple organ failure.
Antithrombin III (ATIII) exerts direct effects on neutrophils by inhibiting
chemokine-induced migration. The positive outcome of animals in
models of severe sepsis treated with ATIII may be due to this neu-
trophil-dependent action. The aim of the present study was to deter-
mine the potency of different ATIII preparations in inhibiting neutrophil
chemotaxis compared to monoclonal antibody-purified ATIII.
Methods: Human neutrophils were isolated using standard prepa-
ration methods. Cell migration was tested in modified Boyden
microchemotaxis chambers bearing nitrocellulose filters in the
leading front assay. Human neutrophils were incubated with seven
different ATIII preparations at various concentrations (1 mIU/ml to 5
IU/ml) for 20 min. Immuno-purified ATIII served as positive control.
After washing twice, neutrophils migrated toward interleukin-8 (1
nM) for 30 min in humidified atmosphere at 37°C. After staining of
the cells, migration depth was measured microscopically.
Results: At concentrations below 10 mIU, neutrophil chemotaxis
toward interleukin-8 was decreased by the ATIII preparations with
different potencies, whereas at higher concentrations (1 IU and 5
IU) no significant differences could be observed. Deactivation of
neutrophil chemotaxis was most pronounced by Kybernin®P
(Aventis Behring, Marburg, Germany) at 100 mIU and was compa-
rable in potency to homologous deactivation with IL-8. The purified
ATIII inhibited interleukin-8-induced chemotaxis at all concentra-
tions tested (1 mIU to 5 IU).
Conclusion: We suggest that antiinflammatory activity of ATIII may
be due to deactivation of chemokine-induced leukocyte migration.
Commercially available ATIII-preparations at distinct concentrations
show significant differences in their ability to deactivate neutrophil
chemotaxis toward interleukin-8. This may suggest also different
activities in vivo depending on the various preparation procedures.
P103 Specific deactivation of monocyte and lymphocyte migration by antithrombin III
C Reinisch*, N Kaneider*, A Rabensteiner*, S Dunzendorfer*, J Römisch†, CJ Wiedermann*
*Department of General Internal Medicine, University of Innsbruck, Anichstr 35, A-6020 Austria; †Aventis Behring GmbH, Research, 
D-35002 Marburg, Germany
Background: Antithrombin III exerts direct effects on neutrophils
by inhibiting chemokine-induced migration [1]. Whether ATIII
directly affects the migratory behaviour of other types of leukocytes
is unknown.
Methods: We investigated the effect of ATIII on spontaneous and
chemokine-triggered migration using RANTES and interleukin-8 as
attractants of lymphocytes, and RANTES and monocyte chemotac-
tic peptide-3 as attractants of monocytes, in modified Boyden
chamber micropore filter assays. Lymphocyte and monocyte popu-
lations from human peripheral blood were pure. Signaling of ATIII in
migration of the leukocytes was studied by blocking signaling
enzymes with staurosporine, GFX, wortmannin and rolipram. As AT
III, the concentrate Kybernin®P and antibody purified AT III thereof
were used.
Results: Pretreatment of lymphocytes with ATIII slightly augmented
random locomotion, chemotaxis toward optimal concentrations of
RANTES or IL-8 was significantly inhibited by pretreatment of the
cells with ATIII followed by washing. Significant inhibition of chemo-
taxis was seen at ATIII concentrations as low as 10 nU/ml. Exposure
of lymphocytes to gradients of ATIII stimulated migration in the
absence of additional chemokines. Pretreatment of monocytes with
ATIII before triggering of directed migration revealed similar find-
ings, with ATIII again being active at low concentrations. In the
absence of chemokines, ATIII again activated monocytes’ directed
migration. This ATIII-induced augmentation of migration was used
for investigating signaling events induced in the cells by preincuba-
tion with various enzyme blockers: in contrast to neutrophils, where
ATIII effects are mediated by protein kinase C and cAMP,
responses of monocytes were wortmannin- and rolipram-sensitive;
lymphocytes were additionally affected by GFX.
Conclusion: ATIII directly affects monocyte and lymphocyte func-
tions in vitro. ATIII inhibits chemokine-stimulated migration of the
two peripheral blood mononuclear cell populations. Thus, cellular
effects of ATIII may occur not only in neutrophils but also in other
immune cell populations. Signal transduction may be cell type-
dependent, as it differs between neutrophils, lymphocytes and
monocytes. A specific pathway for direct cellular activation by ATIII
is postulated.
Reference:
1. Dunzendorfer  et al:  Cell-surface heparan sulfate proteoglycan
mediated regulation of human neutrophil migration by the serpin
antithrombin III. Blood (in press).S49
P104 Control of DIC after administration of ATIII in ICU septic patients
S Vasiliagou*, E Andoniadou*, A Bekridelis*, K Kyparissi*, I Galatianos*, X Lagoudaki†, O Ioannou†, T Varvataki†, CH Boboti‡, 
D Andoniadou‡
*ICU, †Hematological Laboratory, and ‡Biochemistry Laboratory, General Hospital ‘G Gennimatas’, 41 Ethnikis Aminis str, 54635,
Thessaloniki, Greece
Objective: To study the effectiveness of ATIII in critically ill septic
patients with DIC.
Design: Prospective observational study.
Settings: An 8 bed medical-surgical ICU of a general hospital.
Patients: Septic adult patients with findings of DIC during a 1 year
period.
Methods: A total of 45 patients (age 21–72) fulfilling the classical
criteria of sepsis and DIC having similar APACHE II and MODS
scores at admission were studied. These patients divided in two
groups A and B including 23 and 22 patients respectively. Group
A: All patients received ATIII in a loading dose (BW × [100 –
Laboratory Value ATIII% × 2/3]) when ATIII levels in blood measured
< 60%. Blood derivatives were used when PTL < 20,000 mm3, PT
> 20 s, fibrinogen < 1 g/l and D-Dimers > 500 mg/l. Group B:
Patients were treated according to the classical treatment. Hema-
tological parameters Ht, Hb, PTL, WBC, PT, PTT, ATIII, Fibrinogen,
D-Dimers, were measured every 8 h until their improvement and
restoration.
Results: A significant differences in improvement of hematological
parameters were observed between the two groups. In group A
after a single dose of ATIII the values of PT (19.7 ± 2.5 vs 26.6 ±
4.1), PTT (49.4 ± 5.2 vs 54.9 ± 8.9), ATIII (70 ± 6 vs 37.6 ± 4.7),
Fibrinogen (161 ± 18 vs 104 ± 14) and D-Dimers (177 ± 21 vs
264 ± 31) improved significantly after 12 h (P < 0.05 for all com-
parisons). In 16/23 (Group A) patients received a single dose of
ATIII, hematological disorders restored in first 32 h. The rest 7/23
patients needed a second dose in 48 h. In group B the hematolog-
ical disorders remained for at least 5 days and restored beyond the
10th day.
Conclusions: The use of ATIII seems to be critical for the rapid
improvement and stabilization in septic patients with hematological
disorders.
P105 Incidence and implications of coagulopathy in medical intensive care patients
R Strauss*, M Wehler*, D Kreutzer*, K Mehler*, A Mueller*, C Koebnick†, EG Hahn*
*Department of Medicine I, and †Department of Medical Informatics, Biometrics and Epidemiology, University Erlangen–Nuremberg,
Krankenhausstr 12, D-91054 Erlangen, Germany
Introduction: Coagulopathy is frequently seen in ICU patients.
These patients may increase ICU costs considerable by their
higher need of blood products. Detailed information about inci-
dence and consequences of coagulopathy would be useful in pre-
dicting prognosis and resource consumption in this cohort.
Objective: To determine incidence, severity, prognosis and thera-
peutic implications of coagulopathy in a 12-bed medical (non-coro-
nary) ICU.
Methods: We evaluated in a prospective observational study over
13 months (1.11.1997–30.11.1998) all patients (pts), who stayed
longer than 48 h in the ICU. Coagulopathy was defined as an
abnormal prothrombin time (PT < 70%, Quick’s method, corre-
sponding to an INR > 1.26). Pts with thrombolytic therapy or pre-
existing therapeutic anticoagulation were excluded.
Results: Defined by PT (INR) coagulopathy was diagnosed in 187
of 231 cases (81%). Of these pts 55 had ICU acquired coagu-
lopathy (24%). Coagulopathy was classified as mild in 78 (34%),
moderate in 72 (31%), severe in 37 (16%) (Table). PT values nor-
malized until ICU discharge or death in 77 (41%) pts with coagu-
lopathy. In patients with a relative drop in PT of ten or more percent
between day 1 and 3 mortality was significantly higher than in
patients with a lower or no decrease irrespective of absolute PT
values (mortality: 28 of 66 vs 33 of 165, P < 0.001, OR 3.0, 95%
CI 1.6–5.5; c2 test).
Conclusion: The incidence of coagulopathy in our pts is high
(81%). Moderate and severe but not mild coagulopathy are associ-
ated with increased mortality. Even a slight decrease in PT during
the first 3 days is associated with higher mortality and may be
regarded as an early warning sign.
Table
Coagulopathy PT (%) INR n PRBCa units FFPa units SDAPa units Mortalityb (%)
None ³ 70 £ 1.26 44 0 (0–2) 0 (0–0) 0 (0–0) 7
Mild 50–69 1.27–1.62 78 0 (0–4)* 0 (0–0) 0 (0–0) 17
Moderate 30–49 1.63–2.46 72 4 (0–8)** 0 (0–2)** 0 (0–1)** 33**
Severe < 30 > 2.46 37 4 (0–8)** 6 (2–21)** 0 (0–3)** 57**
a vs none, median (interquartile range 25–75) (U-test); b vs none (Fischer’s exact test); * P < 0.05; ** P £ 0.001.
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Introduction: Substitution of clotting factors is one of the most
costly therapies in ICU treatment. However, efficacy of such treat-
ment in clinical practice is poorly investigated. In a multi-centre trial
we evaluated if substitution of PPSB-concentrate is able to raise
clotting parameters.
Methods: In a multi-centre observational trial in 27 Austrian Hospi-
tals and following ethics committee approval 280 patients (median
age 58 [6–93]) were included in the study. During the observation
period all patients requiring substitution with PPSB concentrate
were included. No trigger-levels and no prescribed dosage was
defined but patients received a PPSB-concentrate containing the
vitamine K dependent factors II, VII, IX, X and the vitamin-depen-
dent inhibitors C and S (Prothromplex® Total S-TIM 4, Baxter) as
regarded clinically necessary by the physician concerned. Change
in coagulation parameters, dosage applied, and adverse side-
effects were registered. Statistical analysis based on the intention-
to-treat principle while using the last value technique.
Results: Median dose applied was 21.4 IU/kg and lead to a
median rise in Quick test from 38 to 62%. No side effects were
reported. The increase was clinically sufficient in all cases and no
further substitution was required.
Conclusion: For the first time in a representative number of patients
we showed that the substitution of 1 IU/kg bodyweight PPSB con-
centrate raised Quick test by about 1%. Use of PPSB concentrate
is save and no side effects, especially thrombosis were reported.
P106 Efficacy of substitution therapy with PPSB concentrate in intensive care patients
RD Fitzgerald, A Zalewski, W Oczenski, H Haumer, H Krenn, S Schwarz
L Boltzmann Institute for Economics of Medicine in Anesthesia & Intensive Care, and Department Anesthesia & Intensive Care, Lainz
Hospital, Vienna, Austria
P107 Assessment of rVIIa as a universal haemostatic agent in a model of haemodilution
S Chillala, PA Evans, KJ Pasi
Accident and Emergency Department, Leicester Royal Infirmary and Division of Haematology, University of Leicester, Leicester, UK
Haemostatic failure, secondary to large volume fluid replacement,
is a major component to the mortality and morbidity associated
with blunt trauma. Progressive bleeding in multiply injured patients
is due to both dilution effects and specific inhibitory effects on
platelet function of the colloids used. Recombinant factor VIIa
(rVIIa) is seen increasingly as a possible universal haemostatic
agent that could act to reverse or prevent haemostatic failure asso-
ciated with dilution and the direct effects of the colloids within the
‘Golden’ hour of haemorrhagic shock.
We have conducted a pilot preclincal study to evaluate the poten-
tial role of rVIIa as a universal haemostatic agent in a model of large
volume fluid replacement using thrombelastography (TEG). TEG is
a method of global haemostasis assessment, providing information
on the rate of clot formation, clot strength and durability.
Whole blood samples from normal donors were tested undiluted
(100%) or diluted (50% and 80%) with standard colloid replace-
ment solutions (Haemacel, Albumin, Gelofusine, Hydroxyethyl starch)
and N/Saline. Global haemostasis was assessed in the TEG, ± 90
mg/kg rVIIa added. In undiluted blood (100%) there were no statisti-
cally significant changes in any TEG parameter when rVIIa was
added. At dilutions of > 50% addition of rVIIa significantly improved
the kinetics of clot formation and rate of platelet reactivity, P < 0.05,
although time to the start of coagulation and final clot strength were
not significantly different. The beneficial effects of addition of rVIIa
did not differ between different fluid replacement solutions.
Addition of rVIIa therefore appears to improve markers of global
haemostasis in this model of large volume fluid replacement.
Further work is required to assess its potential value as a universal
haemostatic agent in the setting of blunt trauma and large volume
fluid replacement.
P108 Measurement of serum transferrin receptor (sTfR) in critically ill patients
S Kolias*, H Nikolaou*, P Eleftheriadi†, N Sakarelou†, A Fortis*, M Laskou*, N Maguina*
*ICU, Konstantopouleion General Hospital, ‘Ag Olga’, Nea Ionia 14233, Athens, Greece; †Haematology Department, ‘Elpis’ General
Hospital, Athens, Greece
Introduction: Measurement of sTfR is an important new hemato-
logical parameter. Laboratory studies have indicated that sTfR
values are elevated in anemias associated with enhanced erythro-
poiesis and tissue iron deficiency only. The aim of this study was to
demonstrate whether iron deficiency, expressed through elevations
of sTfR, constitutes an important etiologic component of ICU
patients’ anemia.
Methods: Twenty-seven patients were studied (10 male, 17
female), mean age 65.4 ± 4.0 years and mean APACHE II score of
16.5 ± 1.0. Five patients had sepsis syndrome, 12 severe sepsis,
8 had septic shock and 2 patients suffered from multiple organ
failure. Patients who presented with a bleeding episode were
excluded from the study. We measured sTfR, hemoglobin, hemat-
ocrit, serum iron concentration and ferritin and calculated APACHE
II and sepsis score on day 1, 4 and 8 of ICU stay. For the measure-
ment of sTfR, monoclonal antibodies were used.
Results: All critically ill patients had sTfR values at the lower level
of the normal range (0.93 ± 0.5 mg/l, with normal values ranging
between 0.94 and 1.28 mg/l). Though all sTfR values were found
in the normal range, variations of transferrin receptors were corre-
lated to sepsis score, hemoglobin and hematocrit on correspond-
ing days. Statistical analysis revealed no significant difference.
Conclusion: Investigation of anemia in critically ill patients
includes bone marrow examination for iron status determination.
This invasive procedure can now be substituted by transferrin
receptors’ measurement, since ferritin levels are not reliable in
septic patients, as it is the case with all acute phase proteins.S51
Based on the above data, normal transferrin receptors in septic
ICU anemic patients, indicate the minor role of iron deficiency in
the aetiology of anemia in these patients, usually provides informa-
tion on the etiology of anemia. Given that definitive distinction
between iron deficiency anemia and the anemia of chronic
disease requires a bone marrow examination to determine the iron
status. To avoid the cost and discomfort of this method, measure-
ment of sTfR can be used as a reliable index. In this study we
observed that the iron deficiency anemia has low incidence in the
critically ill patients.
P109 How we reduce allogenic blood transfusions in the patients undergoing surgery of ascending aorta
D Radojevic, Z Jankovic, B Calija, M Jovic, B Djukanovic
Cardiovascular Institute ‘Dedinje’, Milana Tepica 1, 11000 Belgrade, Yugoslavia
Background: Allogenic blood transfusion is associated with many
risks. For the reduction of its usage acute normovolemic haemodi-
lution (ANH) and intraoperative blood salvage were recommended.
Aim: The reduction of allogenic blood transfusion during the oper-
ations on ascending aorta by the usage of ANH, intraoperative
salvage of blood and antifibrinolitic drug — aprotinin.
Materials and methods: During the observation period (Jan
1997–Oct 1999) there were 83 patients (13 female and 70 male)
of age 56.2 ± 9.8 who underwent ascending aorta surgery. Exclu-
sion criteria for ANH were haemoglobin concentration < 11 g/dl
and haemodynamic instability. All patients were premedicated with
midazolam 5 mg and meperidine 50 mg i.m. Anaesthesia: midazo-
lam 0.1 mg/kg, fentanyl 5 mg/kg, and pancuronium 0.1 mg/kg; main-
tenance: the same drugs plus isoflurane 0.5–1 vol%. ANH was
started after induction of anaesthesia and completed before the
beginning of operation. Autologous blood 15 ml/kg was withdrawn
from a. radialis into standard autologous blood collection sets con-
taining CPDA-1. Gelatin and Hartman’s solutions were infused to
maintain baseline central venous pressure (CVP). 106 iu of aprotinin
were given i.v. and 2 x 106 iu were added into the solution for extra-
corporal circulation. Autologous blood was processed into packed
red blood cells (PRBC), plasma and platelet. Arterial pressure, heart
rate and CVP were continuously measured. Cell saver was installed
in all patients. Arterial blood samples were obtained for analysis of
blood gases, haemoglobin concentration, platelet count, elec-
trolytes, acid–base status and activated coagulation time. PRBC
were given toward the end of operation and in postoperative period
when haemoglobin concentration was < 8.0 g/dl.
Statistical analysis: All data are expressed as mean values (SD).
Results: ANH procedure lasted for 20 ± 5 min and 1350 ± 150
ml of autologous blood was withdrawn. Three units of PRBC of
allogenic blood were given to 59 (71.1%) out of 83 patients during
their stay in hospital, while no allogenic blood had to be given to
the rest of them (24 patients or 28.9%).
Discussion: The efficacy of ANH in the reduction of allogenic blood
transfusion is still a debated issue [1]. Our data confirm that ANH has
a beneficial effect on the reduction of allogenic blood transfusion.
Conclusion: ANH is the useful method for saving allogenic blood
in major surgery.
References:
1. Gillon J: Transfusion 1994, 34:269–271.
P110 Hyperdynamic circulation following cardiopulmonary bypass predisposes to postoperative bleeding
R Taneja*, JP Yared*, J Hammel†, MS O’Connor*, S Insler*, NJ Starr*
*Department of Cardiothoracic Anesthesia, and †Department of Biostatistics and Epidemiology, Cleveland Clinic Foundation, Cleveland, OH, USA
Cardiac surgery and cardiopulmonary bypass (CPB) may initiate a
clinical state of hyperdynamic circulation that is presumed to be
due to activation of inflammatory mediators. This state of high
cardiac indices/low SVR is considered analogous to the systemic
inflammatory response syndrome (SIRS); however its epidemiology
and clinical significance have not yet been elucidated. We hypoth-
esized that a persistent inflammatory response to CPB leads to
systemic vasodilatation and accompanying high cardiac indices
requiring vasopressor therapy.
Methods: Data was collected prospectively for 8492 patients
undergoing CPB from 1995–1999. Patients were included if they
required vasopressor infusions (norepinephrine, phenylephrine,
vasopressin) to maintain clinically acceptable mean arterial blood
pressure on admission to the Intensive care unit. We analyzed pre-
operative factors, perioperative events and outcome in isolated
valve and coronary artery bypass surgery (CABG). Groups were
compared by ANOVA for continuous and logistic regression for
dichotomous variables.
Results: 1075 patients (12.6%) manifested with vasodilatory
shock following CPB. Although preoperative demographics and
ICU admission scores were similar amongst groups for CABG
patients, hyperdynamic patients following valvular surgery more
frequently had a history of previous MI or poor LV function (9.4
vs 3.9% and 10 vs 4.8%, P < 0.001). Intubation time, CPB and
aortic cross clamp times as well as ICU and hospital stay were
statistically increased in the hyperdynamic group (P < 0.001).
The hyperdynamic patients had statistically significant reduc-
tions in hematocrit (P < 0.001) and platelets (P < 0.001); this
was associated with an increased incidence of return to the OR
for bleeding/tamponade (9.4 vs 2%, P < 0.001). Although
overall morbidity was increased (5.7 vs 2.5%, P < 0.001), this
was not accompanied by significant increases in mediastinitis or
blood stream infections (P = 0.09), ARDS (P = 0.25) or MODS
(P = 0.09).
Conclusions: Hyperdynamic circulation, presumably secondary to
a CPB induced inflammatory response, is associated with
increased postoperative hemorrhage and morbidity but not with
increased susceptibility to MODS. Elucidation of unique mecha-
nisms regulating systemic vasodilatation following CPB may point
to novel strategies that attenuate CPB mediated inflammation.
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P111 Regional release of tissue-type plasminogen activator in sepsis: effects of volume resuscitation
H Seeman-Lodding, A Fagerberg, A Nyberg, M Ahlqvist, A Åneman
Department of Anesthesiology and Intensive Care, Sahlgrens University Hospital, SE-413 45 Göteborg, Sweden
Background: Septic shock is characterised by increased systemic
fibrinolytic activity. This study in endotoxemic pigs was designed
to: 1) describe regional tPA (tissue-type plasminogen activator)
activity; 2) assess changes in tPA activity following aggressive
volume resuscitation.
Materials and methods: Anesthetised, mechanically ventilated
pigs (24–29 kg) were instrumented to monitor cardiac output (CO),
portal- (QMES), hepatic- (QHEP), and renal (QREN) blood flow. Aortic
arterial and renal, portal and hepatic venous blood samples were
collected. Total tPA (ng/ml) in plasma was analysed by ELISA and
together with blood flow data enabled the calculation of net flux of
tPA across the pulmonary (PULM), mesenteric (MES), hepatic
(HEP) and renal (REN) circulation. Following baseline sampling,
endotoxin (E. Coli 0111:B4) was infused for 2 hours. Animals were
then volume resuscitated with albumin and saline and observed
another 3 hours. Statistical analyses were made by ANOVA and
Fisher’s PLSD. * P < 0.05. Values are mean ± SEM, n = 8.
Results: CO decreased from 4.1 ± 0.3 l/min to 2.7 ± 0.1* during
sepsis and was restored to 4.7 ± 0.1 by volume resuscitation. Par-
allel changes were observed in QMES (from 0.9 ± 0.1 l/min to
0.5 ± 0.1*, and back to 1.1 ± 0.2) and QREN (from
135 ± 15 ml/min, to 62 ± 20*, and back to 124 ± 25). QHEP was
maintained at 1.1 ± 0.1 to 1.3 ± 0.1 l/min by an effective hepatic
arterial buffer response. Net regional plasma fluxes of tPA are
shown in the Table.
Conclusions: Fibrinolytic activity increases early in sepsis
shown by a net pulmonary and mesenteric release of tPA.
Increased net hepatic uptake would mask the pre-hepatic
changes in tPA. Early volume resuscitation in sepsis is able to
completely reverse all these changes. The findings demonstrate
the dynamics of hemostasis during sepsis. Early interventions to
restore hemodynamic stability are important to maintain normal
fibrinolytic activity.
Table
Baseline 2 hours 3 hours 4 hours 5 hours
Net PULM (mg/min) 2.2 ± 1.3 33 ± 12 * –1 ± 6 1 ± 1 0.1 ± 1.6
Net MES (mg/min) 1.3 ± 0.4 8.3 ± 2.8 * 2.7 ± 0.5 0.8 ± 0.4 0.7 ± 0.4
Net HEP (mg/min) –1.9 ± 0.4 –21 ± 5 * –6.9 ± 0.8 –2.2 ± 1.4 -2.4 ± 1.1
Net REN (mg/min) 0.1 ± 0.1 0.4 ± 0.4 –0.07 ± 0.2 –0.1 ± 0.1 0.04 ± 0.04
P112 The effect of the combined administration of colloids and Ringer’s Lactate on the coagulation system — an in vitro study
using thrombelastography (roTEG®)
D Fries, P Innerhofer, A Klingler, U Berresheim, A Calatzis, W Schobersberger
Department of Anaesthesia and Intensive Care Medicine, University Hospital Innsbruck, Austria
Introduction: Gelatine and hydroxyethylstarch (HES) based col-
loids are given in clinical practice normally in combination with
Ringer’s Lactate (RL), but also dose dependent combinations of
HES and gelatine are administered. Colloids impair the coagula-
tion system in different ways: gelatine disturbs fibrin polymerisa-
tion and HES reduces F VIII and vWF in plasma in the first line.
There are no data available, to which extent the combined admin-
istration of colloids and RL affects the coagulation system. Aim of
our study was to investigate, if the combined administration
handicaps the coagulation system differently than the use of
single substances.
Methods: We diluted citrated blood from 10 healthy male volun-
teers to 20%, 40% and 60% with gelatine (Gelofusin®), 6% HES
130:0,4 (Voluven®), 6% HES 200:0.5 (Iso-Hes®) and RL, as well
as with the combinations of these solutions in a ratio of 1:1 (gela-
tine/RL, 6% HES 130:0.4/RL, 6% HES 130:0.4/gelatine, 6% HES
200:0.5/RL, 6% HES 200:0.5/gelatine). Thereafter, blood was
recalcified, the samples were activated with InTec® (thromboplas-
tin, Nobis®) and analysed by modified thrombelastography
(roTEG®). A repeated measures ANOVA as applied for the analy-
sis of the influence of dilution on thromboelastographic parame-
ters, different colloid combinations were compared using an
ANOVA after subtracting the 0% dilution value and Tukey’s post
hoc tests for individual intergroup comparisons.
Results: We could not detect any significant differences between
the combination gelatine/RL and 6% HES 130:0.4/RL. The clot
formation time (CFT) of 6% HES 200:0.5/RL was significant
longer than gelatine/RL at 40% and 60% dilution. At 40% dilution,
the CFT of 6% HES 130:0.4/RL and gelatine/RL was significant
shorter and the maximal clot formation (MCF) significant higher
than 6% HES 130:0.4 and 6% HES 200:0.5 alone.
Conclusion: Concerning to our data, 6% HES 200:0.5 and the
combination of 6% HES 200:0.5/RL impair the coagulation system
more than the combination of gelatien/RL or 6% HES 130:0.4/RL.
Regarding its influence on the coagulation system, 6% HES
130:0.4 may be as safe as gelatine in patients with blood loss and
huge volume substitution.S53
P113 Large volume resuscitation with hydroxyethyl starch (HES) in lactated Ringer’s (LR) solution restores perfusion, minimally
induces hyperchloremia or impairs coagulation
LJ Kaplan, H Bailey
MCP-Hahnemann University, 3300 Henry Avenue, Philadelphia, PA 19129, USA
Objective: To evaluate the impact of large volume (> 25 cc/kg bw)
Hextend (HES in LR) resuscitation on perfusion, hyperchloremic
metabolic acidosis and coagulation.
Methods: A convenience sample of ICU patients resuscitated by a
single Intensivist at a University hospital using > 25 cc/kg bw of
Hextend as part a resuscitation strategy was retrospectively exam-
ined. Patients were divided into three groups: trauma, sepsis, and
post-op. IRB approved data included: age, sex, principal diagnosis,
laboratory data, and fluid volumes. Successful resuscitation was
defined as resolution of lactic acidemia. Data were divided into
admission and 24 hour values and compared using a two-tailed,
paired t-test. Data were compared using a t-test or chi-square; sig-
nificance assumed for P < 0.05 (*).
Results: Patient mix was 54% trauma, 34% sepsis, and 12% post-
op. Of the trauma patients, 17% had traumatic brain injury, and
23% were receiving blood components on a massive transfusion
protocol. All patients were mechanically ventilated and 26% were
admitted with a coagulopathy. 36% of patients were admitted with
a hyperchloremic metabolic acidosis. 78% of patients also had evi-
dence of lactic acidosis on admission. 82% of trauma, 64% of
sepsis, and 92% of post-op patients cleared their lactic acidemia
by 24 hours. Mean HEX volumes were 38 ± 4 cc/kg bw (trauma),
31 ± 4 cc/kg bw (sepsis) and 27 ± 5 cc/kg bw (post-op). Chloride
concentration remained unchanged no patients; decreased in
94%* (trauma), 100% sepsis, and 100% post-op patients; and
increased in 6%* (trauma), 0% sepsis, and 0% post-op patients.
PT/PTT remained unchanged in 0%* (trauma), 90% sepsis, and
95% post-op patients; decreased in 97%* (trauma), 7% sepsis,
and 3% post-op patients; and increased in 3% (trauma), 3%
sepsis, and 2% post-op patients. The mean pre-resuscitation pH
was 7.24 ± 0.12 (trauma), 7.32 ± 0.09 (sepsis) and 7.35 ± 0.8
(post-op) while the mean pH at 24 hours was 7.36 ± 0.09*
(trauma), 7.37 ± 0.05 (sepsis), and 7.39 ± 0.08 (post-op).
Conclusions: Hextend may be used as part of a large volume
resuscitation strategy in diverse patient populations including
those with traumatic brain injury. Hextend helps minimize the
hyperchloremia associated with massive volume resuscitation
without significantly perturbing the serine protease dependent
coagulation profile.
P114 Advantages of 6% hydroxyethyl starch 130/0.4 (Voluven®) at repetitive high dose levels in patients with severe cranio-
cerebral trauma
ThA Neff*, C Jungheinrich†, M Doelberg†, A Sauerland‡, DR Spahn*, R Stocker‡
*Institute of Anesthesiology, and ‡Division of Surgical Intensive Care, University Hospital Zurich, Switzerland; †Clinical Research, Fresenius
Kabi, 61346 Bad Homburg, Germany
Introduction: Regarding the use of high dose hydroxyethyl starch
(HES) in patients with cranio-cerebral trauma (CCT), potential side
effects on blood coagulation are primarily due to the decrease in
Factor VIII activity (F VIII:C) and von Willebrand factor (vWF:Ag).
These effects are correlated with average molecular weight and
molar substitution of the specific HES, which were optimized in a
new HES solution, HES 130/0.4 (6%, Voluven®).
Patients and methods: Thirty-one patients with severe CCT were
randomized after ICU admission to receive one of two different 6%
HES solutions for up to 28 days. Group A: HES 130/0.4
(Voluven®) up to 70 ml/kg BW/day (n = 16). Group B: HES
200/0.5 (HAES-steril®) up to 33 ml/kg/day, followed by human
albumin 5% up to a total dose (HES 200/0.5 + albumin) of 70
ml/kg/day (n = 15). Additionally FFP was allowed if required. Blood
coagulation was monitored using standard coagulation tests,
F VIII:C, vWF:Ag, and thrombelastography.
Results: The two study groups did not differ regarding demo-
graphic data, initial GCS (A vs B; mean 7.7 vs 8.0), other baseline
scores (Apache II, SAPS II, ISS, Marshall Trauma Score, modif.
MOF), ICU and hospital days, and mortality rate (4/16 vs 3/15). A
mean total of 19 l HES 130/0.4 (range 6–66 l) vs 22 l HES
200/0.5 (6–47 l) + 7 l albumin (1–15 l) were infused. Usage of
RBC, platelets, FFP, and fibrinogen was not different between
groups. Intracranial bleeding complications (5/16 vs 5/15 patients)
were not accompanied by any coagulation disorder but related to
the underlying cerebral trauma. In the HES 130/0.4 group ventila-
tion days (mean 9.6 vs 15.7, P < 0.01), colloid treatment days (6.3
vs 11.3, P < 0.01), and number of patients with ICP increase > 35
mmHg (3/16 vs 12/15, P < 0.01) were significantly reduced
(Wilcoxon-2-sample test).
Conclusions: Up to 70 ml/kg/day HES 130/0.4 (6%) can be used
over several days without compromising blood coagulation or
causing bleeding complications in CCT. Possible benefits are
reduced ventilation days, lower frequency of ICP peaks, and the
avoidance of human albumin.
P115 Effects on general safety and coagulation after long-term, high-dose volume therapy with 6% hydroxyethyl starch 130/0.4
in patients with acute ischemic stroke. Results of a randomized, placebo-controlled, double-blind study
MT Grauer*, D Baus†, R Woessner*, F Bepperling†, T Kahles‡, S Georgi‡, O Bianchi‡, J Treib*
*Department of Neurology, Academic Teaching Hospital, 67655 Kaiserslautern, Germany; †Department of Clinical Research, Fresenius
Kabi, 61352 Bad Homburg, Germany; ‡Department of Neurology, Medical University, 66424 Homburg/Saar, Germany
Introduction: In the past, high-molecular weight, highly substituted
hydroxyethyl starch (HES) 450/0.7, which is mostly used in the
United States, has been implicated in bleeding complications,
some of them lethal. In Europe, medium-molecular weight HES
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with a low degree of substitution (0.5) has been preferred. The
present study investigated, whether a long-term, high-dose volume
therapy with a newly developed 6% HES 130/0.4 (Voluven®) is
safe in patients suffering from acute ischemic stroke. In particular,
the effects on hemostaseology were examined.
Patients and methods In a randomized, double-blind, placebo-
controlled study carried out in accordance with GCP and ICH
guidelines, 40 patients suffering from acute ischemic stroke
received either 6% HES 130/0.4 or crystalloid solution, after giving
their informed consent. There were no differences between the
treatment groups regarding demography and baseline characteris-
tics. Each patient received a loading dose of 500 ml HES or crys-
talloid solution over 1 hour and subsequently 1500 ml HES or
crystalloid solution per day over a period of 4 days for a total dose
of 6500 ml. Hemostaseological parameters (platelets, prothrombin
time, aPTT, fibronectin, Factor VIII:C, von Willebrand factor
antigen, von Willebrand Ristocetin cofactor) were measured daily.
Patients were followed-up until 90 days post treatment.
Results: A total of 390 g HES per patient was administered and
well tolerated by all patients in the study group. Only one serious
adverse event was noted in the crystalloid group, whereby a rela-
tion with the study medication was unlikely. The most frequent
adverse event was itching, reported by two patients in the crystal-
loid group and three patients in the HES group.
At baseline all hemostatic parameters were within the normal range
and no clinically relevant changes were observed with respect to
any parameter between the two treatment groups.
Conclusions: Medium molecular weight HES 130 with a low
degree of substitution (0.4) was well tolerated and can be adminis-
tered in larger doses over longer periods of time without relevant
effects on hemostaseology compared to a crystalloid group. In par-
ticular, there is no increased risk of bleeding in this clinical setting.
P116 No evidence of excess mortality in patients receiving human albumin: a meta-analysis of randomized controlled trials
MM Wilkes, RJ Navickis
Hygeia Associates, 17988 Brewer Road, Grass Valley, CA 95949, USA
A meta-analysis of randomized controlled trials was conducted to
test the hypothesis that albumin administration is not associated
with excess mortality. Candidate trials must have compared
albumin administration with crystalloid, no albumin or a lower
dosage of albumin. No restrictions were placed on clinical indica-
tion. Trials were identified by computer searches of bibliographic
databases, the Cochrane Controlled Trials Register, the Cochrane
Medical Editors Trial Amnesty and other Internet-resident
resources; hand-searching of general medical journals; contacts
with albumin suppliers; and consulting the reference lists of prior
meta-analyses, review articles and other publications. A total of 55
trials with 525 deaths among 3504 randomized patients were
included in the meta-analysis. Included trials involved six categories
of clinical indications: surgery or trauma (n = 27), burns (n = 4),
hypoalbuminemia (n = 5), high-risk neonates (n = 6), ascites
(n = 5) and other (n = 8). The pooled relative risk of death and mor-
tality risk difference were 1.11 (95% CI, 0.95–1.28) and 1.5%
(95% CI, –0.7 to 3.8%), respectively, under a fixed-effects model
(P = 0.66 and P = 0.65 for heterogeneity, respectively). Thus,
without the application of any exclusion criteria that might have
biased the results, there was no evidence of significant excess
mortality risk in albumin recipients. In addition, there was no signifi-
cant excess risk within any of the six categories of clinical indica-
tions. For the seven trials incorporating some form of blinding the
pooled relative risk was 0.73 (95% CI, 0.48–1.12). The pooled rel-
ative risk among the 17 trials with mortality as an endpoint was
1.00 (95% CI, 0.84–1.18). In the 35 trials without crossover of
control group patients to the albumin group the pooled relative risk
was 1.04 (95% CI, 0.89–1.22). For all trials there was evidence of
significant small-trial bias (ie publication or other bias) favoring
control (P = 0.03 by Egger’s test). The adjusted relative mortality
risk taking into account small-trial bias was 0.83 (95% CI,
0.65–1.08) based on regression analysis. Thus, lack of blinding,
absence of mortality as a study endpoint, crossover and small-trial
bias all consistently biased pooled relative risk in favor of control.
This meta-analysis furnished no evidence of excess albumin-asso-
ciated mortality and strongly suggested that albumin may reduce
mortality. These findings support the safety of albumin.
P117 Evaluation of early and late histamine release by three standard volume substitutes
I Celik*, D Duda†, B Stinner‡, H Gajek§, W Lorenz*
*Institute of Theoretical Surgery, and ‡Department of General Surgery, Philipps-University Marburg, Baldingerstraße, 35043 Marburg,
Germany; †Department of Anaesthesiology, St Hildegardis-Acadamic Hospital of the Johannes Gutenberg-University, Mainz, Germany;
§Aventis Behring GmbH, Marburg, Germany
Introduction: Following meta-analysis [1], the use of colloidal solu-
tions in intensive care medicine is under discussion. Although
polygeline [2] and human albumin are known to cause histamine
release, other substances eg hydroxyethyl starch were thought to
be without effect. Histamine release depends on the clinical sce-
nario, concomitant drugs, infusion speed, duration and amount of
infusion. However, there is no information about their effect regard-
ing time periods longer than immediate reactions. This study inves-
tigated the histamine releasing effects of three plasma substitutes
administered and observed over a longer period of time, simulating
many of the clinical scenarios.
Methods: In a prospective, randomised, controlled clinical study 21
healthy, male volunteers were randomly allocated to three groups
receiving i.v. 3.5% polygeline (Haemaccel, n = 9), 5% human
albumin (n = 6) and 3% hydroxyethyl starch 200/0.5 (HAES-steril, n
= 6) for normovolaemic haemodilution over a period of 90 min, after
calculated and adjusted blood withdrawal before infusion. H1-antag-
onist (dimetinden) and H2-antagonist (cimetidine) i.v. premedication
was given to prevent histamine-related clinical signs. Blood samples
for plasma histamine determination were drawn at defined time
points and systemic (cardiovascular, skin reactions, etc) parameters
documented over 240 min after start of infusion.S55
Results: There was a high overall incidence of histamine release in
all groups (Haemaccel 100% [9/9], Albumin 100% [6/6], HAES
100% [6/6]). In the first 30 min, histamine release was observed in
all groups (Haemaccel 77.8% [7/9], Albumin 50% [3/6], HAES
50% [3/6]; P > 0.05 between groups). Peak values were 4.59
ng/ml (Haemaccel), 3.42 ng/ml (Albumin) and 4.98 ng/ml (HAES).
H1 + H2 prophylaxis prevented systemic histamine related symp-
toms, although one HAES subject had a histamine associated
reaction (headache).
Conclusion: This study demonstrated that infusion of all colloidal
plasma substitutes tested is associated with early and late hista-
mine release. This reaction is a known phenomenon for polygeline
and albumin, but a novel finding for HAES and should be consid-
ered in further routine clinical use.
References:
1. Shierhout G et al: Br Med J 1998, 316:961.
2. Lorenz W et al: Lancet 1994, 343:933.
P118 Pharmacokinetics and tolerability of intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%) in 19 subjects with
mild to severe renal impairment: terminal half life and peak concentration (Cmax)remain unaffected
C Jungheinrich*, R Scharpf*, M Wargenau†, F Bepperling*
*Clinical Research, Fluid Therapy Division, Fresenius Kabi, 61346 Bad Homburg, Germany; †MARCO Institute for Biomedical Statistics,
40227 Düsseldorf, Germany
Introduction: Hydroxyethyl starches are almost exclusively excreted
renally, for the larger molecules only after hydrolysis by amylase to
smaller fragments which can be filtered glomerularly. A new specifi-
cation, HES 130/0.4 (Voluven®), was developed in order to improve
pharmacokinetics by more rapid metabolism while preserving effi-
cacy of volume effect compared to HES 200/0.5 (6%). In this study,
the dependency of pharmacokinetics of HES 130/0.4 on renal func-
tion was studied according to GCP after fully informed consent.
Patients and methods: Prospectively 19 volunteers (m, f) with dif-
ferent degrees of stable, non-anuric renal dysfunction, ranging from
almost normal creatinine clearance CLcr (80 to < 120), mild (50 to
< 80), moderate (30 to < 50), to severe (15 to < 30) renal impair-
ment (mean: 50.6 ml/min/1.73 m2), were given a single infusion of
500 ml 6% HES 130/0.4 over 30 min. HES serum levels were
measured at 0, 5, 10, 30, 60, 120, 240, 360, 480 min, 24 h, 48 h,
and 72 h after start of infusion as well as urinary excretion until
72–96 h. CLcr using urine collections had been obtained at least
twice before and twice after dosing. Standard pharmacokinetic cal-
culations and regression analysis were performed (primary parame-
ters: area under the curve AUC0–inf, Cmax).
Results: AUC0–inf clearly depended on renal function comparing
subjects with CLcr below to ³ 50 (ratio 1.73; 95% confidence
interval: 1.44, 2.07). This means that a more than doubled AUC
could be excluded. Half-life for drug elimination from the central
(= blood) compartment in a two-compartment model increased
from 2.6 h at CLcr ³ 50 to 4.9 h in subjects with CLcr < 50. Cmax
(mean: 4.34 mg/ml) as well as terminal half-life from the model
independent approach (mean: 16.1, range 14.1–18.9 h) were
not affected by renal impairment. At CLcr ³ 30, 59% of the drug
could be retreived in urine, vs 51% at CLcr 15 to < 30. The mean
molecular weight of HES in serum was 62,704 D at 30 min, with
a tendency to lower values with increased renal impairment. Also,
higher pre-dose amylase levels correlated with lower baseline
CLcr. No serious AE or deterioration in CLcr occurred.
Conclusions: 500 ml of HES 130/0.4 (6%) can be safely adminis-
tered to patients even with severe renal impairment as long as
urine flow is preserved. Pharmacokinetics of HES 130/0.4 (6%) in
subjects with moderate to severe renal impairment (CLcr 15 to
< 50 ml/min/1.73 m2) resembles that of HES 200/0.5 (6%) in
healthy volunteers.
P119 Comparison of ultrasound muscle thickness measurements in ICU patients in muscle groups known to undergo atrophy
vs muscle groups that do not undergo atrophy
M Moukas*, F Takis†, K Mandragos*, E Palli*, I Dimitrakaki*, E Panou*, M Vassiliou‡
*Intensive Care Unit, and †Radiology Department, Korgialeneion-Benakeion Hellenic Red Cross Hospital, Athens, Greece; ‡Pulmonology
Department, Hellenic Oncologic Institute ‘Agios Savas’, Athens, Greece
Purpose: To determine if ultrasound can detect muscle atrophy in
muscles that are known to undergo muscle atrophy in ICU patients,
measured as decrease in muscle thickness.
Materials and methods: Twelve women, mean age 55 ± 14 years
old, who entered the ICU for diverse reasons, and were not under
mechanical ventilation, did not received corticosteroids and/or
muscle relaxants, and received either total parenteral nutrition or
enteral nutrition at 30 kcal/kg/day with 1 g prot/kg/day were
chosen. All patients had 1 hour of bedside passive physicotherapy.
Ultrasound measurements were taken at the moment of admission
and at the moment of disclosure from the unit. The intercostal
muscle group thickness was measured at the 6th intercostals
space, and the biceps brachialis muscle thickness, at is point of
maximum width. Both sets of measurements were recorded and
analyzed with the unpaired t-test.
Results: The mean ICU stay was 14.2 ± 3.3 days. In the following
table are summarized the recordings.
Admission Disclosure
Intercostal muscle group 0.396 cm 0.379 cm 
(SD 0.026) (SD 0.026)
Biceps beachialis 2.696 cm  1.977 cm 
(SD 0.545) (SD 0.513)
The P value for the intercostal muscle group did not show any sta-
tistical significant difference, while the P value for the biceps
brachialis showed a statistical significant difference.
Conclusion: Ultrasound can detect a decrease in muscle thick-
ness in muscle groups known to show muscle atrophy in patients
that enter the ICU. This decrease in thickness is not seen in muscle
groups that do not undergo muscle atrophy.
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P120 Some metabolic and hormonal aspects of enteral nutrition
E Havel, L Sobotka, V Bláha, D Solichová, R Hyšpler, Z Zadák
Department of Intensive Metabolic Care, Facultas Medica, Charles University, Sokolská 581, 500 05 Hradec Králové, Czech Republic
Enteral nutrition is popular in intensive care. Keeping the intestine
in function by feeding stimulation helps to treat intensive care
patients. We aimed to find metabolic and hormonal differences
between enteral and parenteral feeding.
Design: Twenty cardiopulmonary stable patients hospitalised at
the Metabolic Department of Teaching Hospital in Hradec Králové
were monitored in a prospective study.
Interventions: The patients, who were fed more than 2 weeks par-
enterally without enteral feeding due to their disease (mostly
uncomplicated intestinal fistula after surgical intervention with pos-
sibility to start enteral feeding), where studied after obtaining
informed consent. The parenteral nutrition was fortified by 4200 kJ
parenterally in days 0–2 and next enterally in the same contents
(Nutrison 1000 ml) in days 7–14. The local Ethics committee
approved this research project.
Measurement and methods: Comparisons between parenteral +
parenteral period and parenteral + enteral period in several sero-
logic and urine parameters were calculated. Wilcoxon’s pair t-test
was used for statistical analysis.
Results: HDL cholesterol (0.61 vs 0.72 mmol/l), apoprotein A
(0.63 vs 0.71 g/l) and insulin like growth factor (IGF-1) (291.7 vs
321.4 ng/ml) were significantly higher in enteral period (P < 0.05).
The urinary output of urea (551 vs 489 mmol/day), P (31 vs 24
mmol/day), Na (418 vs 220 mmol/day) were significantly lower
during enteral period (P < 0,05).
Conclusion: Enteral nutrition application is associated also with
some anabolic effects in comparison to application of parenteral
nutrition alone. The higher level of IGF-1 is main anabolic marker of
enteral nutrition in our study. The decline of urea output means an
enhanced proteosynthesis (probably most in intestine mass).
Higher level of HDL cholesterol and apo A during enteral feeding
we explain by the enhanced synthesis of cholesterol in the intes-
tine. The metabolic function of intestine may be important for inten-
sive care patients. Because tolerance of enteral feeding is
changing quickly during the critical situation, we prefer combina-
tion of parenteral and enteral nutrition in unstable intensive care
patients.
Supported by Grant IGA-MZ-CR-4788-3/98.
P121 Endoscopically placed naso-jejunal feeding tubes in ICU patients: a retrospective review
AL Jukes, M Smithies
Critical Care Directorate, University Hospital of Wales, Cardiff, UK
Introduction: The preferred method of nutritional support in inten-
sive care patients is via the enteral feeding route due to its
favourable trophic effects on the intestinal mucosa, reduced rate of
complications and lower costs when compared with parenteral
nutrition. Impaired gastric emptying can be a limiting factor in pro-
viding enteral nutrition, commonly affected by critical illness, and
naso-jejunal tube feeding can be useful in patients who fail to toler-
ate naso-gastric tube feeding. Endoscopic placement of naso-
jejunal tubes can be performed at the bedside, is highly successful,
85–90% success rate can be expected and enteral feeding can
start immediately following the procedure.
Method: This retrospective review evaluated the use of feeding
tubes (8 fr, 240 cm: Wilson-Cook Medical Inc.) endoscopically
placed in ICU patients over a 15 month period.
Results: A total of 27 patients had 36 naso-jejunal feeding tubes
placed endoscopically (five patients had more than one place-
ment). The patients were typically male admitted to the ICU follow-
ing an emergency procedure. All were placed successfully and
used for a mean 5.7 days/tube (range 1–27 days). Avoidable com-
plications such as blockages or accidental misplacement of the
tube occured in 28% of the tubes.
A review of these results suggests that the majority of patients would
have benefited from placement of an enteral feeding tube during
theatre, and that the success of naso-jejunal feeding could be
improved by attention to the care of the feeding tubes once placed.
Conclusion: Following this review, new standards and guidelines
have been produced within the Critical Care Directorate for the
multidisciplinary team members caring for patients who have naso-
jejunal feeding tubes.
P122 A novel technique for nasoduodenal feeding tube placement in critically ill patients
RJ Young, MJ Chapman, R Fraser, D Chorley, S Creed
Intensive Care Unit & Department of Medicine, Royal Adelaide Hospital, North Terrace, Adelaide, SA, Australia
Introduction: Although enteral nutrition is considered superior to
parenteral nutrition in critically ill patients, it is frequently delayed or
prevented by gastroparesis. A variety of approaches have been
developed to bypass the stomach, but none has proved entirely
satisfactory. The Cathlocator™ is a novel device that permits real
time localization of the end of feeding tubes by detection of a mag-
netic field generated by a small electric current in a coil in the tip of
the tube. It is portable, can be used at the bedside and uses no
ionizing radiation.
Study objective: To evaluate placement of tubes for (i) nasoduo-
denal feeding, and (ii) nasogastric drainage in critically ill patients
using the Cathlocator™.
Methods: Ten nasoduodenal tube placements were attempted in
nine critically ill patients. The Cathlocator™ was used to guide posi-
tioning of the tube beyond the pylorus and also to determine whether
a separate nasogastric tube was placed correctly. Tube tip position
was confirmed by plain abdominal X-ray. Data are median and range.S57
Results: Nasoduodenal tube placement was successful in 9 of 10
attempts (insertion time 14.5 min [5.0–34.4]). All nasogastric tube
placements were successful (insertion time 4.4 min [0.8–9.5]). The
Cathlocator™ accurately determined the position of both tubes in
all cases. There were no complications.
Conclusion: The Cathlocator™ accurately gives the location of an
enteral tube in real time. It thus provides an effective bedside tech-
nique for nasoduodenal tube placement to facilitate enteral feeding
in critically ill patients.
This study was partially funded by Micronix Pty Ltd.
Reference:
Williams AJK, Fraser R, Chorley DP, Dent J. The Cathlocator: a novel non-
radiological method for the localisation of enteral tubes. J Gastroenterol
Hepatol 1996, II:500–505.
P123 Enteral glutamine feeding and some aspects of immune function in intensive care patients
AM Venhuizen*, L Bell*, CS Garrard†, LM Castell*
*University Department of Biochemistry, Oxford OX1 3QU, UK; †Intensive Care Unit, John Radcliffe Hospital, Oxford OX3 9DU, UK
Glutamine-enriched total parenteral nutrition (TPN) is beneficial in
reducing both infective complications and mortality of critically ill
patients. Similar results were observed in bone marrow transplant
patients, as well as increased circulating numbers of lymphocytes,
in particular T-cell subsets. An increase was observed in T-cell DNA
synthesis in colorectal cancer patients receiving glutamine-enriched
TPN. However, TPN is associated with complications such as
intestinal atrophy, and enteral nutrition is now the preferred route.
The present study assessed the effects of feeding glutamine enter-
ally in 14 intensive care patients who were not immunosuppressed.
Blood samples were analysed for plasma glutamine concentration
(enzymatically), lymphocyte proliferation via 3H thymidine incorpo-
ration into DNA (counts per minute — CPM) with and without mito-
genic stimulation (Concanavalin-A), neutrophil activity (using an
oxidative burst technique) and cytokine production in culture
medium (IL-2 and IL-8). Patients were randomly divided into two
groups and fed 15-g bolus doses in water of either glutamine
(n = 7; 60 ± 8 years) or placebo (n = 7; 60 ± 6 years) for 5 days.
Nasogastric nutrition was discontinued daily at midday and a blood
sample was taken; 1 hour later, a bolus dose of glutamine/placebo
was administered via the tube; 2 hours later total nutrition was
started again.
Lymphocyte proliferation increased in the glutamine group
(P < 0.04) compared with the placebo, as measured by CPM and
the stimulation index. IL-2 production increased in culture medium
from Day 0 to Day 5 for patients receiving glutamine (P < 0.02)
compared with the placebo group. IL-8 production, neutrophil
numbers or activity, and plasma glutamine did not change. Our
results suggest that glutamine is able to induce an IL-2 mediated
increase in the proliferative ability of T-cells, and we hypothesise
that these changes may underlie previously observed clinical bene-
fits from glutamine administration in critically ill patients.
P124 A glutamine containing dipeptide in high concentration may be given safely via the peripheral route in ICU-patients
A Berg, E Forsberg, J Wernerman
Department of Anaesthesia and Intensive Care, Huddinge University Hospital, Karolinska Institutet, SE-141 86 Stockholm, Sweden
The need for glutamine supplementation in catabolic states is well
established. In ICU-patients the majority is fed by the enteral route.
However, the documentation and control of glutamine administra-
tion enterally is still insufficient, while parenterally provided gluta-
mine is well documented. Concentrated dipeptide solution may be
given in a central venous line as a nutritional adjunct, but as central
venous lines are associated with complications and risks, adminis-
tration via a peripheral vein would be preferable. The osmolarity of
a 20% glutamine dipeptide solution is 920 mosmol/l, which
exceeds the recommended limit of 800 mosmol/l. Therefore we
systematically evaluated local tolerance in a group of ICU-patients.
Patients and methods: ICU-patients (n = 20) on ventilator, but with
limited liver and kidney insufficiency and with available peripheral vein
were randomised to receive a 20% alanyl-glutamine (Dipeptiven, Fre-
senius-Kabi) infusion of 0.5 g/kg or the same volume of saline during
4 h in a peripheral vein on 3 consecutive days. The venous lines (BD
Venflon® i.v.; 1.0 mm diameter) were inserted especially for this
purpose, and removed after each infusion. Different veins in the same
arm were used. Local tolerance was evaluated clinically by Maddox
score, and ultrasonically (Aspen™ Ultrasound System equipped with
L10 transducer with frequency 11–6 MHz) before the infusion and
on days 1, 4 and 8 after the infusion.
Results: In the study 56 out of 60 (93%) planned infusions were
administered and 157 out of 168 (93%) clinical evaluations were
successfully performed. The ultrasonic evaluation revealed that the
utilized veins had a diameter of 2.15 ± 0.8 mm (mean ± SD; range
1.0–4.4 mm; n = 56) 3 cm proximal of the insertion site. Using the
protocol described above, there were no signs of thrombophlebitis
in any single patients by either Maddox score or ultrasound.
Conclusion: Administration of glutamine-containing dipeptide con-
centrate (20%) by peripheral veins is safe in terms of local toler-
ance, if a strict protocol is adapted for this purpose involving a
separate line for the infusion removed immediately afterwards.
P125 Serum amylin correlates with delayed gastric emptying in critically ill children
A Mayer, S Skellett, A Durward, SM Tibby, C Turner, N Dalton, IA Murdoch
Department Paediatric Intensive Care, Guy’s Hospital, London SE1 9RT, UK
Introduction: 
Delayed gastric emptying is common in critically ill patients. Amylin
is a novel 37 amino acid polypeptide, which is co-localised and co-
secreted with insulin by pancreatic beta cells [1]. In conjunction
with its role in glucose homeostasis it is a potent inhibitor of gastric
motility [2]. Thus we hypothesised that high circulating levels of
amylin may be associated with delayed gastric emptying in critically
ill children.
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Method: Nineteen children were enrolled within 48 hours of ICU
admission. Exclusion criteria included: liver disease, gastrointesti-
nal abnormalities and use of prokinetic agents. All patients were
N.P.O., and maintained on a ivi glucose (5–8 mg/kg/min). Gastric
emptying (GE) was assessed clinically by feed intolerance and
using a paracetamol absorption technique (PTA). Feed intolerance
was defined as a residual gastric volume > 0.25 ml/kg after
4 hours of a bolus 2 ml/kg test milk feed. At this point (T0), a single
15 mg/kg dose of paracetamol was administered nasogastrically,
and serial blood samples taken for paracetamol assay at 0, 15, 30,
60, 120, 240 and 360 min.
GE was calculated using the gastric emptying ratio (GER) which is
the time to reach peak paracetamol level divided by its peak con-
centration, with high values reflecting delayed gastric emptying [3].
Blood amylin and insulin sample were taken at T0 and T360 with
the mean of these two values used to reflect the average level over
the study period. Amylin was measured by radioimmunoassay.
Data were assumed non-parametric, thus Spearman’s correlation
coefficient and Mann–Whitney tests were used. Data are shown as
median (interquartile range).
Results: Nineteen patients were enrolled with a median age
6 years (1.7–8.5), and weight 20 kg (11.5–31.5). Diagnoses
included sepsis (n = 8), respiratory (n = 5), head injury (n = 2),
neurology (n = 2) and other (n = 2). Four patients did not tolerate
enteral feeds (median residual volume 4.4 ml/kg). Factors associ-
ated with impaired gastric emptying were not different between the
two groups, in particular opiate infusions (4/4 vs 14/15 P = 0.6)
and dopamine use (0/4 vs 2/15 P = 0.4). Amylin levels (pmol/l)
were higher in patients (n = 4) with feed intolerance 44.1
(37.0–50.8) vs 22.7 (13.6–26.7), P = 0.009. This coincided with
higher GER values 4.29 (2.75–5.25) vs 1.54 (0.69–2.25),
P = 0.08. Overall, amylin levels correlated with GER r = 0.49 (95%
CI 0.03–0.78), P = 0.03, and with insulin r = 0.51, (95% CI
0.08–0.78),  P = 0.02, which is consistent with co-secretion.
Conclusion: Failure to establish enteral feeds in critically ill chil-
dren may be due to raised amylin levels.
References:
1. Clarke A: Lancet 1987, ii:231–234.
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P126 The effect of lactulose on tolerance of gastric feeding in long term ICU patients
V Zvonicek, P Sevcik, M Votava, P Ondrovcik, I Sas, R Kraus, V Sramek
Department of Anaesthesia and Intensive Care, St Ann’s University Hospital, Pekarska 53, Brno, CZ-65691, Czech Republic
Introduction: Lactulose was reported to inhibit gastric tone and
motility in healthy volunteers [1]. Double blind placebo controlled
study using lactulose four times 15 ml daily (ie 40 g) or saline for
prevention of ventilator associated pneumonia was performed in
our ICU during 1999–2000. In this report the impact on gastric
feeding tolerance of lactulose given into stomach is evaluated.
Materials and methods: Forty-eight patients without pneumonia
and mechanically ventilated for < 24 hours entered the study. From
day 2 EN was given by a standardised protocol into the stomach.
Daily amount of enteral nutrition (EN) was recorded. Failure was
defined as EN interruption > 24 hours because of large residuals.
Metoclopramide was used in all patients.
Statistics: Chi-square and Mann–Whitney U-tests when appropri-
ate. Data presented as means ± SD. P < 0.05 was considered sig-
nificant.
Results: Thirty-eight patients in whom EN was not contraindicated
and stayed in the ICU > 3 days were analysed. Fifteen patients
received lactulose (L) and 23 were given placebo (P). L and P
groups did not differ in age (50.3 ± 18.2 and 52.7 ± 16.3; NS),
APACHE II on admission (24.7 ± 8.7 and 26.0 ± 7.3; NS). There
also was no difference in L and P groups in mortality (6 ICU sur-
vivors and 9 non-survivors in lactulose group and 13 non-survivors
and 10 survivors in placebo group; NS), length of ICU stay (LOS)
(13.5 ± 7.4 and 15.2 ± 11.0; NS) and ventilatory days (12.5 ± 6.8
and 12.0 ± 7.8; NS). Patients receiving L did not differ from P in
daily tolerance of gastric feeding (604 ± 438 and 425 ± 264 ml/day;
P = 0.16) and number of EN intolerances per hospitalisation
(0.51 ± 0.26 and 0.50 ± 0.35 intolerances/LOS; NS). This was
also true when ICU survivors were analysed separately.
Conclusions: Lactulose administered into the stomach has no
impact on poor tolerance of gastric feeding in mechanically venti-
lated long term ICU patients.
Supported by IGA grant of Ministry of Health of the Czech Repub-
lic No. 4702-3
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P127 Investigation of insulin clearance in septic patients with glucose intolerance: analysis under strict blood glucose control by
means of artificial pancreas
M Hoshino*, Y Haraguchi†, M Sakai*, K Hayashi*, N Miyayama*, H Saegusa*, H Ohsawa*
*Department of Intensive and Critical Care Medicine, Tokyo Police Hospital, Fujimi 2-10-41, Chiyoda-ku, 102-8161 Tokyo, Japan; †Tokyo
Disaster Medical Center, Tokyo, Japan
Purpose: Analysis of insulin metabolism in severely ill patients with
glucose intolerance is important for appropriate nutritional support.
Significance of the measurement of insulin clearance (IC) and the
factors which influence IC in septic patients were investigated.
Method: Twenty septic patients in whom blood glucose (BG)
levels were strictly controlled by means of bedside-type artificial
pancreas (AP) (STG-22: manufactured by NIKKISO corporation
in Japan) were studied. IC was calculated from the data obtained
by euglycemic hyperinsulinemic glucose clamp method per-
formed by means of AP twice for each patient (first measurement
was done in acute condition or within 3 days after admission,
second measurement was done 1 week after the first measure-
ment basically. Clamped BG level: 80 mg/dl. Insulin infusion rate
[IIR]: 1.12 and 3.36 mU/kg min. I1/I3 and C1/C3, the blood
insulin levels, and the C-peptide reactivity levels, when IIR is
1.12/3.36 mU/kg min respectively. Glucose disposal rate:
M value [mg/kg min]). IC was calculated from the followingS59
formula: IC = (3.36 – 1.12) × 1000/(I3 – I1), normal value of IC:
10–15 ml/kg min. Relationships between IC and the following
factors were investigated: (1) M value, (2) daily mean BG (BGm),
(3) diabetes mellitus (DM), (4) degree of organ dysfunction/
failure (MOF score: calculated from the MOF criteria of Japanese
Association for Critical Care Medicine), (5) cardiac output/body
weight (C/B), (6) serum fat (triglyceride, free fatty acid, total cho-
lesterol) levels (SF), and (7) blood stress hormone levels (SH).
Results: The results are as follows (shown in mean ± SD): 1)
C1–C3: 0.52 ± 0.88 ng/ml (n = 40), 2) I1: 53 ± 26, I3:
1 9 1±7 5mU/ml, IC: 20 ± 10 ml/kg min (n = 40), 3) IC in compari-
son between the patients (1) with liver dysfunction (–)/(+):
23 ± 11 ml/kg min (n = 25)/15 ± 5 ml/kg min (n = 15) (P < 0.025),
(2) with the MOF score 0 or 1/more than 5: 24 ± 14 ml/kg min
(n = 15)/16 ± 4 ml/kg min (n = 14) (P < 0.05), 4) There was posi-
tive correlation between IC and C/B (Y = 0.11 X + 5.0, n = 23,
r = 0.59, P < 0.003), 5)There was no definite relationship between
IC and organ dysfunction except liver dysfunction, M value, BGm,
DM, SF, and SH.
Interpretation and conclusions: (1) IC calculated from our
method seemed to be reliable because there seemed no signifi-
cant influence of the intrinsic insulin which was apparent from the
small amount of (C1–C3) value. (2) Insulin clearance was elevated
in most patients with hyperdynamic state, although the degree of
the elevation was suppressed in patients with liver dysfunction and
multiple organ dysfunction. (3) The results suggest the justification
of sufficient insulin therapy.
P128 Comparative analysis of two different total parenteral nutrition delivery systems
S Milanov, M Milanov
Emergency Institute ‘Pirogov’, General ICU, Totleben 21, Sofia, Bulgaria
Background: The importance of parenteral nutritional therapy for
patients in whom gut feeding is not feasible has been well docu-
mented. The main goal in such cases is to correct, maintain and
improve patients’ nutritional status by choosing an optimal TPN
regimen [1].
Objective: In this prospective randomized trial we compared the
average cost of two different TPN delivery systems — Three Bottle
System (TBS) and All In One (AIO) (3) using three compartment
NuTRIflex®Lipid bags provided by B|Braun Ltd. We also studied
the average time spent for prescription, transcription, preparation
and handling of the two regimens.
Patients and methods: Twenty-four patients admitted to our
general ICU at the ‘PIROGOV’ Emergency Institute (1050 beds)
and requiring TPN were enrolled in this prospective randomized
study. The patients were randomized into two groups. Group 1
(n = 12) received TPN with the standard three bottle system with
fat, glucose and aminoacids. Group 2 (n = 12) received TPN with
the NuTRIflex®Lipid three compartment bags system. A record of
all solutions and disposables was kept and a stopwatch was kept
at each bed and each time the TPN needed attention. In addition
we interviewed the nurses about their impression working with the
two systems.
Result and discussion: The results suggest a big difference in
average nursing time (10 min), and cost (1.0–1.17 units) favouring
the NuTRIflex®Lipid system. The possibility of less working errors
and the reduction of risk from infection also makes it worthwhile.
We concluded that the cost/day difference, ergonomic and time
saving advantages and well known better tolerance and lower
complications risk of three compartment bags system makes it an
acceptable and safer TPN regimen.
Reference:
1. ASPEN Board of Directors. Guidelines for the use of parenteral and
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P129 Influence of an intravenous fish oil emulsion on monocyte–endothelial interactions
B Nohé, H Ruoff, T Johannes, C Zanke, HJ Dieterich, K Unertl
Department of Anesthesiology and Critical Care, University of Tübingen, Hoppe-Seyler-Str 3, 72076 Tübingen, Germany
Introduction: Monocyte adhesion contributes to perfusion abnor-
malities, tissue damage and activation of the coagulation system
during overwhelming inflammation. This study was performed to
determine whether an intravenous fish oil emulsion for parenteral
nutrition may attenuate monocyte–endothelial interactions under
flow and reduce procoagulant activity, measured as tissue factor
(TF) expression on adherent monocytes.
Methods: Human vascular endothelial cells were incubated with
either a 10% intravenous fish oil emulsion (Omegaven™, Frese-
nius Kabi) or a conventional w-6 lipid emulsion (Intralipid™, Phar-
macia Upjohn) at 0.05–1 mg/ml for 24 h. Six hours following
activation with TNFa (25 ng/ml), expression of endothelial cell
adhesion molecules was measured by flow cytometry. Adhesion
of isolated monocytes to pretreated endothelium was examined in
a parallel plate flow chamber at postcapillary shear forces of 1.5
dyn/cm2. Following perfusion, the cells were cocultured for addi-
tional 4 h and TF-expression on monocytes was determined by
flow cytometry.
Results: In contrast to w-6 lipids, fish oil downregulated CD62E,
ICAM-1 and VCAM-1 in a dose-dependent manner. CD62P,
however, remained unchanged. The changes in adhesion molecule
expression were accompanied by a significant reduction of firm
adhesion to 54%, whereas rolling interactions remained
unchanged. In contrast to monocyte adhesion, fish oil had no effect
on TF expression of cocultured monocytes.
Conclusion: Intravenous fish oil emulsions reduce both, endothe-
lial cell adhesion molecule expression and monocyte adhesion.
However, under flow conditions, rolling interactions via P-selectin
remain unaltered. The functional importance of this effect is illus-
trated by the corresponding upregulation of TF in response to
residual monocyte–endothelial interactions.
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P130 Sepsis progression is associated with a gradual depletion of both insulin-like growth factor I (IGF-I) and insulin-like
growth factor binding protein-3 (IGFBP3) and a progressive elevation of growth hormone (GH) serum levels
A Mavrommatis*, S Papanicolaou*, E Kostadelou†, A Kotanidou‡, A Malefaki‡, G Katsaris*, S Zakynthinos‡
*Intensive Care Unit, and ‡Hormonological Laboratory, General Hospital of Nikea Piraeus, Piraeus, Greece; †Department of Critical Care,
Athens University, Evanagelismos Hospital, Athens, Greece
Critical illness is associated with increased protein catabolism that
is resistant to nutritional support. There is some evidence that an
acquired resistance to GH anabolic action appeared in these situa-
tions, may be partly responsible. Moreover, in the same conditions,
IGF-I and IGFBP-3 serum levels concentrations are low, despite
high circulating concentrations of GH. Among several critical ill-
nesses, sepsis is one that GH/IGF-I axis has never systematically
studied, and mainly in regard to its progression from uncompli-
cated sepsis to severe sepsis and/or septic shock. Thus, the aim of
this study was to investigate the GH/IGF-I axis in septic phenome-
non, especially with regard to its evolution. We measured, by com-
mercially available radioimmunoassays (ELISA), the serum GH,
IGF-I and IGFBP-3 levels of 59 septic patients (pts) (24 pts with
sepsis [group G1], 12 severe sepsis pts [group G2], 23 pts with
septic shock [group G3]) and we compared them with the findings
of 15 healthy controls (group H). The definition of the stages of
sepsis followed the criteria established by the ACCP/SCCM con-
sensus conference (August 1992). We use one-way ANOVA to
compare the results from sepsis, severe sepsis and septic shock
patients with the ones from healthy controls. Results were as in the
Table.
We conclude that GH/IGF-1 axis impairment increases in parallel
with the increasing severity of septic process.
Table
Normal Sepsis Severe sepsis Septic shock P
GH (ng/Ml) 1.12 ± 0.56 5.58 ± 0.27 2.3 ± 1.1 6.3 ± 1.9b 0.013884
IGF-I (ng/mL) 170.9 ± 18.3 124.3 ± 18.6 91.7 ± 24.2 62.1 ± 7.6a,b 0.000163
IGHBP-3 (mg/Ml) 2.98 ± 0.14 1.98 ± 0.19a 1.73 ± 0.46a 1.38 ± 0.15a 0.000002
Data are mean±standard error of mean, a statistically different from normal, b statistically different from sepsis.
P131 The effect of enteral and perenteral nutrition on blood and respiratory tract immunoglobulins in intensive care unit patients
M Moukas, K Mandragos, K Schulpis, E Palli, I Alamanos, A Karavas, I Giannopoulou, A Dimitrakaki, M Vassiliou
Intensive Care Unit, Hellenic Red Cross Hospital, 1 Erythrou STR, 11526, Athens, Greece
Aims: The immunoglobulin production is influenced by the func-
tional integrity of the intestinal mucosa, as long as 50% of the
secretory IgA originates from it. Therefore, the type of nutritional
schedule could interfere with immune response of the respiratory
tract. The aim of our study was to compare the changes of the
immunoglobulins (IgA, IgG and IgM) in the blood and the bronchial
secretions in intensive care unit (ICU) patients under enteral (EN)
and total parenteral (TPN) nutrition.
Methods: Twenty ICU patients were included in the study. Ten of
them received EN and the other 10 TPN. Immunoglobulins (IgA,
IgG and IgM) were measured in the blood and the bronchial secre-
tions (samples obtained during bronchoscopy), at the 1st and 5th
hospitalization day. White blood cells were also measured and cul-
tures of bronchial secretions were received.
Results: Our results concerning immunoglobulins levels on the 1st
and 5th day (mean values ± SD) are presented in the following
table (mg/dl).
During the 1st day of the study immunoglobulins did not differ sig-
nificantly either in blood or in bronchial secretions in both groups.
During the 5th day of the study we did not detect significantly dif-
ferences (P > 0.05) for immunoglobulins in the blood in both
Table
IgG IgA IgM
Enteral Parenteral Enteral Parenteral Enteral Parenteral
1st day — blood
973.2 ± 433.66 794.1 ± 262.69 214.0 ± 137.4 206.6 ± 128.40 131.1 ± 77.47 112.6 ± 51.67
1st day — bronchial secretions
32.2 ± 55.81 20.3 ± 10.73 13.6 ± 18.47 9.99 ± 9.41 15.9 ± 43.62 0.96 ± 1.3
5th day — blood
925.5 ± 468.98 880.2 ± 441.96 230.8 ± 149.62 230.7 ± 160.17 146.3 ± 99.69 116.0 ± 61.68
5th day — bronchial secretions
43.7 ± 42.69 13.3 ± 9.50 16.0 ± 15.90 2.25 ± 4.17 2.6 ± 2.70 0.7 ± 1.15S61
groups. We detected significantly differences (P > 0.05) of
immunoglobulins in bronchial secretions between EN and TPN.
Between 1st and 5th day in EN group, there are not significantly
differences for immunoglobulins either in blood or in bronchial
secretions.
Between 1st and 5th day in TPN group, there are not significantly
differences for immunoglobulins in blood, but there are significantly
differences for IgA and IgG in bronchial secretions.
Conclusions: The TPN results in atrophy of intestine mucosa and,
therefore in deficiency of the gut associated lymphoid tissue, which
would explain the decrease of respiratory tract immunoglobulins.
P132 Noninvasive monitoring capnometry for continuous monitoring of metabolic status in pediatric diabetic ketoacidosis (DKA)
TJ Abramo, RA Wiebe, E Garcia, A Bracken, S Scott
The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75235-9063, USA
Purpose: Patients with diabetic ketoacidosis (DKA) have complex
metabolic abnormalities and manifest a low pCO2 as result of res-
piratory compensation. During treatment, as venous pH improves,
respiratory rate (RR) decreases causing an increase in pCO2. To
determine the reliability and clinical value of continous ETCO2 by
oral/nasal capnometry for monitoring the metabolic status of the
pediatric DKA patient.
Design/setting: Prospective observational study, university affili-
ated children’s hospital E/R.
Materials and methods: Patients with pH of 7.33 or less with evi-
dence of hyperglycemia, ketosis and between the age of 1 year to
18 years of age were enrolled. ETCO2 measurements was
obtained by continuous oral/nasal side stream capnometry and
vital signs were recorded every 15 min. Venous blood gases analy-
ses were obtained every 1–2 hours with simultaneous recorded
ETCO2, (RR). ETCO2 measurements were compared with venous
pCO2 and changes in respiratory rates.
Results: A total of 121 patients were monitored for a mean of
5.9 hours. Age ranged from 1.8 to 18 years, mean of 10.9 ± 5.2
years. Patient disposition were admitted to PICU or Wards or dis-
charged to home.
ETCO2 correlated with pCO2 R = 0.92 P = 0.0001, pH R = 0.88
P = 0.0001 and inversely correlated with respiratory rate
R = –0.79  P = 0.0001. The concordance correlation for first
(R = 0.93  P = 0.0001), last (R = 0.60 P = 0.0001) and all
(R = 0.92 P = 0.0001) observation between ETCO2 and pCO2
were significant.
Conculsion: Dependable noninvasive continuous ETCO2 monitor-
ing can be obtained using oral/nasal capnometry circuits and
reflect metabolic changes in the pediatric DKA patient. We have
demonstrated that continous end-tidalCO2 monitoring can be used
as a nonivasive assessment of the metabolic status of the pediatric
patient in DKA.
Mean values Initial Disposition
PH 7.08 ± 0.18 7.29 ± 0.05
RR (bpm) 35.14 ± 9.13 22.39 ± 3.69
ETCO2 (mmHg) 18.55 ± 10.75 35.29 ± 5.81
pCO2 (mmHg) 20.45 ± 10.55 36.84 ± 5.27
Correlation coefficient P
ETCO2/pCO2 0.94 0.62 < 0.0001
ETCO2/pH 0.89 0.53 < 0.0001
ETCO2/RR –0.84 –0.18 0.045
P133 Serial measurements of energy expenditure in critically ill children: optimizing nutritional therapy?
G de Klerk, WCJ Hop, M de Hoog, KFM Joosten
Department of Pediatrics, Sophia Children’s Hospital, Dr Molewaterplein 60, 3015 GJ Rotterdam, the Netherlands
Objectives: First, to determine the variation of total daily energy
expenditure (TDEE) and respiratory quotient (RQ) in serial mea-
surements of mechanically ventilated critically ill children. Second,
to relate TDEE and RQ with daily and cumulative energy intake.
Methods: Patients requiring mechanical ventilation for more than
24 hours were enrolled if; FiO2 < 0.60, tubeleakage < 10%, venti-
lated with Servo 300 (Siemens) and haemodynamically stable.
Daily measurements to determine TDEE and RQ were performed
(Deltatrac™ II MBM-200, Datex), until the 7th day of admission.
TDEE and RQ values were compared with daily and cumulative
energy intake.
Results: The study consisted of 17 patients (11 male, 6 female),
with different clinical diagnoses (8 meningococcal septic shock,
5 post-surgical, 4 other). Median (range) for; age 14 months
(1/4–53), admission period 7 days (3–15), length of ventilatory
support 5 days (2–12), PRISM 20 (4–27) and temperature
37.4°C (36.1–38.5). All patients were sedated, 4 received
muscle paralysis and 11 inotropic therapy. A total of 66 measure-
ments were performed (4/patient). There was no significant dif-
ference in TDEE between the first and last day of measurement
(Table). The mean coefficient of variation (CV) among daily mea-
surements of TDEE was in 14 out of 17 patients (82%) < 10%,
in the other 3 patients the CV was 10, 11 and 14%. Including all
measurements there was a strong positive correlation between
the ratio energy intake/TDEE and RQ (rs = 0.65, P < 0.01). There
was a significant difference in RQ between patients with a ratio
energy intake/TDEE < 1 or ³ 1 (resp. 0.82 and 0.90, P < 0.01).
At the last day of measurement, nine patients with a positive
cumulative energy balance (PCEB) (89 kcal/kg, range: 3–446)
had a significant higher RQ than eight patients with a negative
cumulative energy balance (NCEB) (–21 kcal/kg range: –53 to
–4), (resp. 0.89 vs 0.83, P < 0.01), whereas there was no signifi-
cant difference in RQ between these groups at the first day of
measurement.
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Table
Day of measurement 1st 2nd 3rd 4th Last
TDEE (kcal/kg) 52.5 48.6 51.4 48.3 51.4
Energy intake/TDEE 0.8 1.3 1.5 1.6 1.3
RQ (All patients) 0.82 0.88 0.9 0.87 0.88
RQ (PCEB) 0.85 0.88 0.92 0.92 0.89
RQ (NCEB) 0.81 0.86 0.84 0.83 0.83
All values expressed as median,day 5–7 are not shown because of
limited data.
Conclusion: During mechanical ventilation of critically ill children,
TDEE can be predicted in 82% of the patients by performing only
one measurement, despite individual differences. RQ is strongly
influenced by the ratio energy intake/TDEE and by the cumulative
energy balance. We advocate to feed critically ill mechanically ven-
tilated children according to or in excess of their TDEE as soon as
possible during admission, in order to optimize nutritional therapy.
P134 Oxygen consumption in critically ill patients: the relation between calculation by Fick’s principle and measurement by gas-
mixing chamber indirect calorimetry
F Ragab, YL Sakr, H Khaled, S Mokhtar
Department of Critical Care Medicine, Faculty of Medicine, Cairo University, Egypt
Background: The accurate calculation of Oxygen consumption
(VO2) using the Fick equation require accurate measurement of
cardiac output (Q), usually by thermodilutuion, Oxygen content in
arterial blood (CaO2) and Oxygen content in venous blood (CvO2).
Each of these measurements can carry random errors and propor-
tional errors and this well result in a significant final error in the cal-
culated VO2 (cVO2). Gas mixing chamber indirect calorimeter has
been an extremely valuable tool in measuring VO2 in critically ill
patients (mVO2).
Objectives: To compare cVO2 and mVO2 in different groups of
critically ill patients.
Subjects and methods: The study was conducted on 31 critically
ill patients admitted to the department of critical care medicine,
Cairo University, 25 males and 6 females, mean age 56.2 ± 10.4
(range: 37–75), 11 patients with congestive heart failure (CHF)
(class III & IV according to NYHA), 10 males and 1 female, mean
age 53.4 ± 5.9 (range: 45–63), 10 patients with acute respiratory
failure, 8 males and 2 females mean age 63.7 ± 7.97 (range:
50–75), 10 patients with sepsis or septic shock, 7 males & 3
females, mean age 52.2 ± 12.9 (range: 37–69). Each was sub-
jected to VO2 measurement utilizing Fick’s equation; cVO2 = Q
(CaO2 – CvO2), the average of three double checked readings
over 1 hour is determined. Concomitant measurements utilizing
gas mixing chamber indirect calorimeter is carried out, the average
of sixty readings over the same hour is recorded (mVO2).
Results: Oxygen consumption measured by Fick’s method was
comparable with that measured utilizing gas mixing chamber indi-
rect calorimetry with no significant difference between means in
the whole population (162.3 ± 44.7 vs 165.0 ± 33.4 ml/min/m2,
respectively,  n = 61), in CHF (176.4 ± 57.4 vs 177.4 ± 22.1
ml/min/m2, respectively, n = 20), in RF (143.8 ± 40 vs
147.2 ± 30.7 ml/min/m2, respectively, n = 17) and in sepsis and
septic shock (161.9 ± 35.3 vs 170.0 ± 39.9 ml/min/m2, respec-
tively, n = 24). However, correlation was present only in the whole
population (r = 0.3, P < 0.05) and in patients with congestive heart
failure (r = 0.4, P < 0.05).
Conclusion: Gas mixing chamber indirect calorimetery is a non-
invasive, safe method for measuring Oxygen consumption in criti-
cally ill patients. Oxygen consumption measured by Fick’s method
is comparable with that measured utilizing gas mixing chamber
indirect calorimetry, however correlation was absent in patients
with respiratory failure, sepsis and septic shock.
P135 Calculation of unmeasured anions fails to assist outcome prediction in patients in an adult intensive care unit
RJ Cusack, P Lochhead, B Jordan, S Perry, JAS Ball, A Rhodes, ED Bennett
Intensive Care Unit, St George’s Hospital, Blackshaw Road, London, SW17 0QT, UK
Introduction: The anion gap (AG) and base excess (BE) are used to
identify the presence of a metabolic acidosis. A method of analysis
using physico-chemical principals has been developed by Stewart
and refined by Fencl. This technique has recently been demonstrated
to detect unmeasured anions, due to metabolic derangement, more
readily than the traditional markers of AG and BE. This method may
be a more sensitive indicator of patients with circulatory inadequacy
or organ dysfunction. The Fencl–Stewart method of assessing
unmeasured anions, resulting in the strong ion gap (SIG), has been
shown to be more strongly associated with mortality in paediatric
patients than BE or AG [1]. This study examines the predictive value
of these measurements in an adult population of critically ill patients.
Methods: 100 consecutive patients admitted to an adult intensive
care unit had electrolyte and blood gas analysis performed on
admission. The AG, SIG were calculated on admission and the
base excess measured (BE) by blood gas analyser. APACHE II
data and 28 day mortality were recorded.
Results: 100 mixed medical and surgical patients (48 and 52
respectively) with a mean age 60.5 years (range 18–97) and mean
APACHE II score of 20.4 (range 5–40) were enrolled into the study.
Twenty-eight day mortality was 31%. Logistic regression analysis
showed that the APACHE II score was the best predictor of
outcome (OR 1.17 95% CI 1.07–1.26 P < 0.001). Predictions did
not significantly improve when either BE, AG, SIG or lactate were
included. From ROC analysis, the best of the acid base variables for
prediction of mortality was the BE (area under curve 0.70) followed
by AG (AUC 0.66), lactate (AUC 0.66) and then SIG (AUC 0.57).
Conclusion: These data indicate that SIG does not have a useful
predictive value in the adult patients in our ICU practice. Further
studies are required to determine whether the application of SIG
differs between adult and paediatric ICU patients.
References:
1. Balasubramanyan et al: Crit Care Med 1999, 27:1577–1581.S63
P136 Elevated blood lactate concentration in psychogenic hyperventilation
S Desplenter, DC Knockaert
UZ Gasthuisberg, Algemene Interne Geneeskunde, Herestraat 49, 3000 Leuven, Belgium
Background: An elevated blood lactate concentration is a classic
marker of hemodynamic instability and tissue hypoperfusion. It is
considered by most physicians as the hallmark and even signature
of a life threatening underlying condition. After the sporadic obser-
vation of an elevated lactate value in patients with typical hyperven-
tilation we decided to study systematically blood lactate
concentration in these patients.
Methods: We included consecutive patients admitted to the emer-
gency department with a history and clinical findings suggesting
hyperventilation, either primary (psychogenic, panic attack) or sec-
ondary to a renal colic. In addition to a standard history taking,
complete physical examination, laboratory screening, ECG and
chest radiograph, arterial blood gases and venous lactate were
measured by standard clinical laboratory methods.
Results: Twenty patients, 10 females and 10 males, mean age 36
years, were studied. Sixteen had psychogenic hyperventilation and
four hyperventilated as a reaction to a typical renal colic. Lactate
concentration was increased in 12 cases (> 2 mmol/l); in 3 of
them a value of more than 4 mmol/l was found. The lactate value
did not correlate with pH nor paCO2.
Conclusion: An increased blood lactate concentration may be
caused by hyperventilation, either primary pscyhogenic or sec-
ondary to intense pain. This latter finding is of particular importance
for the clinical assessment of the patient presenting with acute
abdominal pain in whom most physicians consider an increased
lactate concentration as a sign of mesenteric ischemia.
P137 Need for cardiac output monitoring in elderly trauma patients determined by base deficit
D Ziegler, K Blackburn, C Eisenstein, D McReynold, F Garcia, C Webber, T Connors, G Tellez
Department of Surgery, John Peter Smith Hospital, Fort Worth, TX, USA
Introduction: Elderly patients tolerate trauma less well than
younger patients. Early monitoring of the cardiac output to improve
peripheral perfusion can diminish mortality and complications in
elderly patients. Base deficit can be used as a marker of significant
injury and to predict resource utilization and mortality. The purpose
of this study is to determine which patients will require intervention.
Method: Our Trauma Service has established a trauma in the
elderly protocol. Criteria for activation includes patients 60 years or
older, multisystem injuries or single system injuries with significant
co-morbid factors. Patients meeting criteria are transferred to the
intensive care unit and placed on cardiac output monitoring. Inter-
vention consisting of packed red blood cells, vasopressors and/or
inotropes is indicated if the cardiac index is less than 3 l/min/m2 or
the patient has an abnormal base deficit.
Results: From April 1995 to July 2000, 76 patients met criteria.
The patients were divided into three Groups according to their
initial base deficit: Group I normal base deficit, 3 to –2, Group II
moderate base deficit –2.1 to –6, Group III severe base deficit
–6.1 or greater. The results are summarized in the Table.
Group I patients required significantly less intervention to improve
cardiac output than Group II and Group III, 15% versus 42% and
94% respectively, P < 0.05. Overall, 22 patients (29%) expired, 31
(41%) were discharged home and 23 (30%) to an extended care
facility.
Conclusions: Base deficit can be used to determine which
patients are most likely to require intervention. Elderly trauma
patients with normal base deficit on admission seldom require
cardiac output monitoring. Elderly patients with severe base deficit
have a high mortality.
Table
Group I II III
Number of patients 33 26 17
Age (years) 71 ± 10 74 ± 7 72 ± 7
Injury severity score 8.6 ± 7* 20.2 ± 14 22.8 ± 9 *P < 0.01
SAPS II score 25.6 ± 10 34.4 ± 14 63.1 ± 10* *P < 0.01
Mortality (%) 6 23 82* *P < 0.01
P138 Pulmonary lactate production in septic patients with and without ARDS
E Silva, A Garrido, CSV Barbas, C Hoelz, E Knobel
ICU, Hospital Israelita Albert Einstein, São Paulo, Brazil
Introduction: The lungs may be a source of lactate in septic
patients, specially when severe respiratory failure is present. Fur-
thermore, first-days lactate levels have been related to outcome in
those patients.
Objectives: To describe the relationship between pulmonary
lactate flux and PaO2/FiO2 ratio in septic patients; to verify the rela-
tionship between lactate flux and outcome.
Setting: A large general ICU.
Design: Prospective, observational study.
Patients: Thirty-two adult septic patients.
Method: All patients were monitored with pulmonary artery
catheter and gastric tonometer. Systemic hemodynamic and
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oxygen variables, arterial and mixed-venous lactate levels, and
gastric mucosal pCO2 (PgCO2) were measured every 8 hours for
5 days. PCO2gap (PCO2gap = PgCO2 – PaCO2) and pulmonary
lactate flux [(arterial lactate – mixed venous lactate) × cardiac
output] were calculated. Results were expressed as median and
inter-quartile 25–75%. The median values at the first day were
used to statistical analyzes. Mann–Whitney U-test was used to
evaluate of differences between the groups.
Results: Mean age was 57 ± 17 years, being higher among
patients with ARDS than the ones without ARDS. Mean APACHE
II and SOFA scores were 21.5 ± 6.6 and 9.9 ± 2.5, respectively.
The lactate flux showed a trend to be greater in non-survivors than
survivors septic patients (P = 0.06).
Conclusion: Despite of respiratory failure severity, all septic
patients presented pulmonary lactate production, which was signif-
icantly greater in patients with ARDS.
Table 1
The first day data for hemodynamic and oxygenation parameters
ARDS (n = 9) Non-ARDS (n = 23) P value
PWP (pulmonary wedge pressure) (mmHg) 14 (12–15) 16 (15–19) < 0.05
Cardiac output (l/min) 7.3 (6.0–7.6) 8.0 (7.3–9.4) NS
PCO2 gap (mmHg) 9.4 (6.6–12.3) 11.7 (7.1–17.1) NS
PaO2/FiO2 129.4 (117.5–212.5) 239.7 (197.1–342.2) < 0.05
Arterial lactate (mmol/l) 2.2 (1.6–2.4) 1.93 (1.31–3.33) NS
Arteriovenous lactate gradient (mmol/l) 0.11 (0.07–0.15) 0.06 (0.03–0.08) < 0.05
Lactate flux (mmol/h) 44.37 (33.7–62.7) 31.7 (11.2–40.3) NS
Mortality (%) 44.4 43.4 NS
P139 Relationship among sigmoid pHi, blood lactate and outcome in surgical patients of abdominal aortic aneurysm
A Donati, O Cornacchini, S Loggi, R Giretti, G Conti, C Grilli Cicilioni, G Pagliericcio, P Pelaia, P Pietropaoli
Università degli Studi di Ancona, Via Conca, 60020 Torrette, Ancona, Italy
Introduction: Many works have shown the relationship between the
outcome of surgical critically ill patient and oxygen availability of the
body. Many factors cause an insufficient oxygen availability: tissutal
traumatism with the consequent beginning of the inflammatory
cascade, anemia, hypotension due to the blood losses, anesthesia.
Shoemaker has called this alteration as ‘oxygen debt’ and has
demonstrated that patient outcome is directed correlated to it and
that this oxygen debt must be extinguished as soon as possible. The
higher is the oxygen debt, higher is the risk of multiple organ failure
and death. The gut has certainly a prominent role to determine these
two last events and previous studies have shown the importance of a
low gastric perfusion to cause death, measuring intramucosal pH
with a gastric tonometer. A previous study has shown a correlation
between Il-6 levels and outcome in major abdominal surgery. Now
we have done a work to investigate the correlation between gut
hypossia, measured with sigmoid tonometry, during aortic clamping
for abdominal aortic aneurysm operation, and patient outcome.
Materials and methods: It was a prospective study on a series of
13 patients operated for abdominal aortic aneurysm. These patients
were monitored with a sigmoid tonometer and pHi was detected at
some times, together with arterial blood lactate and blood lactate of
portal vein. These parameters have been detected at these times: at
the beginning of anesthesia (t0), before aortic clamping (t1), 30 min
after aortic clamping (t2), just after the operation (t4). The portal
blood have been taken only in the first two times by the surgeon.
Results: Data have been divided in two groups following the devel-
oping or not of organ failures (OF) in the postoperative period.
Seven patients had not organ failure, while among the other six
patients, one died for MOF and the other five developed organ fail-
ures: three patients had acute renal and two cardiac failure. Arterial
blood lactate trend was not significatly different between the two
groups. Tables 1 and 2 show portal blood lactates and pHi trend.
Patients with organ failure had a drop of sigmoid pHi with an
increase of portal blood lactate after aorta declamping. At T4 pHi
was still significatly lower in patients with OF. Fisher exact test has
shown a significative relationship between pHi < 7.15 at 30 min
after declamping and outcome (P < 0.05).
Conclusions: Patients operated for abdominal aortic aneurysm
often have organ failures in the postoperative period. The develop-
ing of organ failure is correlated with the gut ischemia which
happens in the intraoperative period. In fact from these preliminary
data patients with a persistent drop of pHi < 7.15 had organ failure
in the postoperative period.
Table 1
T0 T1 T2 T4
Without 8.38 ± 1.9 11.26 ± 2.2 P = ns
With OF 9.78 ± 2.52 16.97 ± 4.02 P = 0.0172
Table 2
T0 T1 T2 T4
Without 7.374 ± 0.14 7.3 ± 0.18 7,216 ± 0.15 7.25 ± 0.15
With OF 7.23 ± 0.167 7.092 ± 0.16 6.995 ± 0.24 7.00 ± 0.16
P = ns P = ns P = 0.035 P = 0.014S65
P140 Correlation of stress ulceration in the critically ill patients to APACHE score and role of Helicobacter pylori
M Youssef, A Abd El-Fattah, S El-Attar, H Mowafi, S Mokhtar
Cairo University, Egypt
Objective: Prevalence of Helicobacter pylori in critically ill patients,
its relation to bleeding, the grade of stress ulcers and the APACHE
score.
The study included 40 critically ill patients admitted to critical care
department with different medical emergencies (21 males with
mean age of 49 ± 17 years). Thirty patients had stress ulceration
of different grades and 10 patients did not have stress ulcers
(control group).
On admission all patients were subjected to full clinical assess-
ment, routine laboratory investigations, occult blood in stool and
upper GIT endoscopy (done in the 1st 24 hours) taking multiple
biopsies from gastro-duodenal mucosa for culture of Helicobacter
pylori (HP).
The APACHE II score for each patient was calculated. Endoscopi-
cal grading of stress ulceration was done using the grading system
of Martin.
The patient group was classified into bleeders (73%) and non-
bleeders (27%).
Results:  Helicobacter pylori was +ve in 9 out of 40 patients
(22.5%), 8 in the patient group (26%) and 1 in the control group
(10%) P = NS. HP +ve cultures were uncountered in 7 bleeders,
(32%) and 1 non-bleeders (12.5%).
The mean grade of stress ulcer in the HP +ve group was 3.3 ± 0.7
vs 2.5 ± 0.6 in HP –ve group (P = 0.026).
The stress ulcer grade was higher in bleeders than in non-bleeders
(mean 2.9 ± 0.7, 2.3 ± 0.5, respectively P = 0.01) and higher in
overt bleeders than in occult bleeders (mean 3.4 ± 0.5, 2.4 ± 0.5,
respectively P = 0.000).
APACHE II score was higher in patient with grades 3 and 4 of stress
ulceration than with grades 1 and 2 (mean 17.8 ± 5.6, 12.6 ± 4.8,
respectively, P = 0.004), higher in bleeders than in non-bleeders
(mean 17.0 ± 5.4, 12.9 ± 2.2, respectively P = 0.006).
Conclusions: The presence of HP was correlated with higher
grades of stress ulceration and incidence of bleeding. As the
APAPCE score was directly propertioned to the ulcer grading and
to the incidence of bleeding, it can predict the occurrence of
bleeding from stress ulceration and also its severity.
P141 Peptic ulcer bleeding in intensive care unit (ICU): a prospective, controlled, randomized study
P Skok*, A Sinkovic†, D Ceranic*, M Pocvajt*
*Department for Gastroenterology and Endoscopy, and †ICU, General Hospital, Maribor, Ljubljanska 5, 2000 Maribor, Slovenia
Background: In Slovenia the annual incidence of peptic ulcer hem-
orrhage is 118/100,000 inhabitants, with mortality up to 14%.
Interventional endoscopy has largely reduced mortality in these
patients.
Study aims: To compare the efficacy of argon plasma coagulation
(APC) and injection sclerotherapy (IS) in endoscopic hemostasis
and evaluate mortality in this potentially lethal medical emergency.
Study design: A prospective, controlled, randomized study.
Patients and methods: 100 patients with bleeding peptic ulcer
(m 63, f 37, av age 57.1 years, SD ± 16, span 26–80; gastric
ulcer 50 pts, duodenal ulcer 50 pts;) were treated between
1.01.1999 and 15.05.2000 in ICU. Fifty patients were randomized
to receive APC (ARCO 2000 ES unit, group A) and 50 patients IS
(sclerosing with diluted adrenalin 1:10,000 plus polidocanol 1%;
group B). The groups did not differ with respect to age, sex, site
and severity of bleeding, additional diseases and NSAIDs intake. In
ICU blood pressure and heart rate were continously monitored.
Patients were receiving proton pump inhibitors, conventional sup-
portive therapy, including i.v. fluids and transfusions as required.
Results: Clinically and endoscopically diagnosed rebleeding
occured in 7/50 patients (14 %) in group A and in 9/50 patients
(18%) in group B; OR 1.34, 95% CI 0.45–3.95. The majority of
reebleding occured within 48 hours, group A 4/7 (57.1%), group
B 7/9 (77.7%); P = 0.74. Repeated endoscopic hemostasis
failed in 8 patients (8/100, 8%, group A 3, group B 5), OR 1.74,
95% CI 0.39–7.71. Seven patients were treated operatively. The
total mortality rate was 9% (group A 4/50, 8%, group B 5/50,
10%), OR 1.27, 95% CI 0.32–5.06; only two patients died from
gastrointestinal bleeding, other 7 patients died due to concomi-
tant diseases.
Conclusions: APC seems to be an effective treatment modality in
peptic ulcer bleeding. It is likely that improved endoscopic thera-
pies, increased sophistication of ICU and better trained personnel
are responsible for the decline in mortality from bleeding peptic
ulcer in the last decade.
P142 Molecular proinflammatory mechanism in the intestinal muscularis following intestinal manipulation
JC Kalff, NT Schwarz, C Hierholzer, A Türler, A Hirner, AJ Bauer
Departments of Surgery, University of Bonn, Germany and University of Pittsburgh, PA, USA
Background: We have previously demonstrated that manipulation
of the rat intestine leads to a local inflammatory response within the
intestinal muscularis followed by a decrease in gastrointestinal
motility. Furthermore, locally produced mediators play a major role
in systemic inflammatory syndromes. The aim of this study was to
delineate the initial steps of the local inflammatory cascade within
the gut wall in respect to the known prototypic inflammatory
cytokine interleukin-6.
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Methods: ACI rats, IL-6–/– and IL-6+/+ mice underwent a standard-
ized intestinal manipulation (IM) and were sacrificed at various time
points postoperatively. One group of rats received repeated i.v.
doses of blocking antibodies against the adhesion molecules
(1A29 + WT.3) pre- and postoperatively. The small bowel was
separated in mucosal and muscularis layers and specimens were
used for RNA and protein extraction. STAT protein was quantified
using EMSA. IL-6 protein was measured by ELISA in tissue culture
and by immunohistochemistry in muscularis whole-mounts.
Results: Muscularis extracts demonstrated an early upregulation
(12.3 fold at 3 hours) in IL-6 mRNA by RT-PCR. This was in con-
trast to mucosal extracts that did not show significant changes.
Adhesion molecule blockade resulted in a significant decrease in
infiltrating cells, but did not change mRNA expression. IL-6 immuno-
histochemistry stained resident muscularis macrophages, smooth
muscle cells and infiltrated leukocytes. Muscularis tissue culture
after IM demonstrated a significant increase in IL-6 protein com-
pared to untreated control cultures (420 vs 230 pg/100 mg tissue).
Postoperatively STAT proteins showed a significant increase in acti-
vation (32 fold at 30 min) with a prototypic IL-6 supershift profile
(Stat3a). IL-6–/– mice demonstrated a significantly lower STAT acti-
vation following IM compared to IL-6+/+ mice.
Conclusion: These results demonstrate for the first time that oper-
ative trauma leads to an early and signifcant production of IL-6
within the intestinal muscularis. IL-6 is mainly produced by resident
cells within the muscularis and has functional activity. Therefore,
the intestinal muscularis plays a role in the postoperative produc-
tion of the proinflammatory mediator IL-6.
P143 Continuous multi-parameter tissue monitoring during shock and resuscitation
CA Sims, M Menconi, I Shim, C Ochoa, J Monarca, J Clavjio, JC Puyana
Brigham and Womens Hospital, Department of Surgery, 75 Francis Street, Boston, MA 02114, USA
Introduction: Continuous assessment of tissue perfusion may
allow for early detection and correction of hemorrhagic shock. We
investigated continuously monitoring pH, pO2 and pCO2 of skele-
tal muscle (SM), subcutaneous tissue (SQ) and bladder wall (BW)
as possible sites for following the course of hemorrhagic shock
and resuscitation.
Methods: Seven anesthetized pigs (25–35 kg) underwent laparo-
tomy, femoral vessel cannulation, cystostomy, and ureteral cannu-
lation. Multi-parameter sensors (Diametrics Medical, MN, USA)
were placed in the deltoid (SM), chest wall (SQ), femoral artery,
and adjacent to the bladder mucosa (BW). Ventilation was
adjusted to keep the PaCO2 at 40–45 mmHg. Animals were
rapidly bled and maintained at a MAP = 40 mmHg by withdrawing
and infusing blood as needed. When a constant infusion was
required to maintain a MAP = 40 mmHg (decompensation),
animals were resuscitated with shed blood + 2x shed volume in
LR (20 min) and observed for 2 hours. The time dependence of
pH, pO2 and pCO2 in each tissue was analyzed using ANOVA
with repeated measures and a post hoc Tukey’s test for signifi-
cance (* P < 0.05, † P < 0.01).
Results: Average blood loss was 48 ± 11%. All tissue sites were
found to respond significantly to shock and resuscitation. Both
SMpH and SQpH remained significantly lower than baseline until
90 min of recovery, whereas BW returned to normal by 30 min.
PCO2 was significantly elevated at decompensation in all tissues,
but returned to baseline by the end of resuscitation. Only SM and
BW were found to decrease significantly at the end of decompen-
sation, but returned to normal with resuscitation. Overall, SM
afforded the greatest measurable change with the smallest relative
variance at each time point.
Conclusions: Continuous multi-parameter monitoring of SM, SQ
and BW potentially provide a minimally invasive method of assess-
ing shock and resuscitation. Of the tissue sites investigated, SM
provides the most sensitive means of monitoring hemorrhagic
shock with the least amount of inter-subject variance.
Baseline Decompensation Resuscitation 30 Recovery 60 Recovery 90 Recovery 120 Recovery
MAP 90 ± 35 37 ± 3† 74 ± 27† 79 ± 26 85 ± 14 78 ± 5 82 ± 4
SM pH 7.35 ± 0.09 7.02 ± 0.09† 7.04 ± 0.07† 7.10 ± 0.13† 7.14 ± 0.17† 7.23 ± 0.06 7.22 ± 0.07
CO2 53.7 ± 8.2 85.7 ± 23.3† 71.3 ± 19.8 66 ± 13.8 64.9 ± 16.3 55.9 ± 5.2 56.8 ± 4.1
O2 65.7 ± 43.6 7.8 ± 13.5† 44.6 ± 29.3 55.1 ± 29.7 56 ± 29.6 56 ± 12 57.3 ± 12
SQ pH 7.38 ± 0.08 7.11 ± 0.12† 7.10 ± 0.07† 7.16 ± 0.08† 7.19 ± 0.12† 7.24 ± 0.08 7.24 ± 0.08
CO2 53.5 ± 10.6 84.3 ± 23.6† 66.6 ± 15.1 58.5 ± 15.1 55.4 ± 18.1 48.8 ± 9.5 50.1 ± 8.6
O2 92 ± 75 41.6 ± 63.5 63 ± 53 74.5 ± 58.5 81.4 ± 77.3 110 ± 85.6 96.8 ± 46.2
BW pH 7.33 ± 0.08 7.01 ± 0.2† 6.99 ± 0.36† 7.09 ± 0.2 7.09 ± 0.21 7.11 ± 0.19 7.11 ± 0.18
CO2 49.3 ± 5.6 71.4 ± 18.7† 60 ± 12.1 53.3 ± 12.9 56.7 ± 21.9 51.7 ± 9.9 53.8 ± 9.8
O2 114.5 ± 81 27.1 ± 20† 75.3 ± 53.4 75.7 ± 47.1 46.1 ± 36.7 37.1 ± 28.9 38.7 ± 26.1S67
P144 Relationship between superior (PSVC), inferior (PIVC) vena cava and bladder (PCYST) pressure
N Markou*, P Myrianthefs†, E Boutzouka†, M Rizos*, C Apostolakos*, G Baltopoulos†
†Athens University School of Nursing, ICU, and *B¢ ICU, KAT Hospital, Nikis 2, 14561, Athens, Greece
Introduction: Measurements of PIVC have been reported to allow a
fairly reliable assessment of CVP. On the other hand, in patients
with abdominal hypertension, PIVC has been reported to reflect
PCYST. We studied the relationship between Pivc and a) Psvc, b)
intra-abdominal pressure measured in the urinary bladder (Pcyst).
Methods: We obtained simultaneous measurements of Psvc, Pivc
and Pcyst in 27 critically ill hemodynamically stable patients under
mechanical ventilation (81 sets of measurements). Phlebostatic
zero and pubic symphysis were at the same level. Measurements
were divided in two groups: Group A (Pcyst ³ Psvc,  n = 39).
Group B (Pcyst < Psvc, n = 42). Statistics were performed with
paired t-test and Pearson correlation.
Results: a) Pivc was significantly higher than Psvc (15.7 ± 0.5 vs
14.9 ± 0.6, P = 0.008), with r = 0.87. Pivc was significantly higher
than Pcyst (15.7 ± 0.5 vs 13.6 ± 0.7, P= 0.000), with r = 0.61. 
b) In Group A, Pivc was significantly higher than Psvc (15.8 ± 0.9
vs 13.4 ± 0.9, P= 0.000), with r = 0,89. There was a significant
difference between Pivc and Pcyst (15.8 ± 0.9 vs 17.3 ± 0.8,
P = 0.030), with r = 0.85. c) In Group B there was no significant
difference between Pivc and Psvc (15.7 ± 0.7 vs 15.8 ± 0.8,
P = 0.877)  r = 0.91. Pivc was significantly higher than Pcyst
(15.7 ± 0.7 vs 10.2 ± 0.7, P= 0.000), with r = 0.62.
Conclusions: When Pcyst < Psvc, Pivc reflects Psvc and not
Pcyst. When Pcyst > Psvc, Pivc does not allow an accurate
assessment either of Pcyst or of Psvc but becomes highly corre-
lated with Pcyst.
References:
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P145 Effects of epinephrine, norepinephrine and phenylephrine on regional and microcirculatory blood flow during sepsis
VKrejci, LB Hiltebrand, GH Sigurdsson
Department of Anaesthesiology and Intensive Care, University Hospital, Inselspital, 3010 Bern, Switzerland
Backgrounnd and goal of study: The use of alpha-adrenergic
substances for treatment of hypotension in sepsis might deterio-
rate splanchnic regional and microcirculatory blood flow. The aim
of this study was to measure microcirculatory blood flow (MBF)
continuously and simultaneously in multiple abdominal organs
during administration of epinephrine, norepinephrine and phenyle-
phrine in peritonitis induced sepsis.
Materials and methods: Pigs (20–25 kg, n = 9) were anaes-
thetised and ventilated. Cardiac index (CI) was measured with ther-
modilution. Superior mesenteric artery (SMA) flow was measured
using ultrasound transit time flowmetry. MBF was measured in
gastric, colon and jejunal mucosa, jejunal muscularis, the pancreas,
the liver and the kidney using a multi-channel Laser Doppler
flowmeter. Peritonitis was induced by instillation of autologous
feces in the peritoneal cavity. After 240 min of peritonitis, intra-
venous colloids were given to transform hypodynamic shock into
normodynamic shock. Each animal received a continuous infusion
of epinephrine (Epi), norepinephrine (Nor) and phenylephrine (Phe)
in a random order. A separate baseline was taken before adminis-
tration of each drug. The infusion rate was adjusted to obtain MAP
between 20% and 30% above baseline for at least 10 min. After
stopping the infusion MAP and CI were allowed to return within
10% of baseline. Additional intravenous fluids were given when
needed.
Results: MAP was 66 ± 5 mmHg before epinephrine, 70 ± 4 mmHg
before norepinephrine and 69 ± 5 mmHg before phenylephrine.
Conclusions: Epinephrine and norepinephrine appeared to divert
blood flow away from the splanchnic circulation, in particular from
the small intestine. In contrast, SMA flow and MBF of the intestine
remained unchanged during administraton of phenylephrine. As
phenylephrine is a pure alpha-adrenergic agonist, the beta-adrener-
gic properties of epinephrine and norepinephrine might play a role
in the redistribution of blood flow when administered in sepsis.
Epinephrine Norepinephrine Phenylephrine
0.75 mg/kg/min 0.5 mg/kg/min 2.0 mg/kg/min
MAP 126 ± 3%** 125 ± 2%** 125 ± 3%**
CI 143 ± 9%** 141 ± 8%** 90 ± 6%
SMA flow 89 ± 4%* 74 ± 6%* 100 ± 6%
MBF gastric  112 ± 4% 104 ± 6% 104 ± 3%
mucosa
MBF jejunal  73 ± 7%* 79 ± 4% 102 ± 6%
mucosa
MBFjejunal  91 ± 10% 68 ± 8%** 124 ± 7%
muscularis (ns)
MBF colon mucosa 101 ± 7% 93 ± 5% 102 ± 4%
MBF pancreas 84 ± 3%* 93 ± 8% 88 ± 4%
MBF liver 114 ± 10% 102 ± 8% 106 ± 6%
MBF kidney 105 ± 3% 92 ± 4% 105 ± 3%
Values are percent of baseline ± SEM. * P < 0.05, ** P < 0.01 vs
baseline.
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P146 Dose–response of arginine-vasopressin (AVP) on blood pressure (MAP), renal macro and micro cortical and medullary
flows in anesthetized rabbits
M Albert, M-R Losser, D Payen
RVH, MHUC, McGill University, 687 Pine Avenue W, H3A 1A1 Montreal, Canada
AVP is a vasopressor used in various clinical vasoplegic situations.
Little is known about AVP effect on intact animal for MAP and renal
circulation. Anesthetized (pentobarbital) ventilated New Zealand
rabbits (2.5–3.3 kg) were studied.
Measured parameters: MAP, systolic (SVRen) and diastolic
(DVRen) renal blood flow velocities (20 MHz pulsed Doppler);
laser Doppler cortical Flcort and medullary Fl med flows.
Baseline values:
MAP (mmHg) SVren (cm/s) DVren (cm/s) Flcort (TPU) Flmed (TPU)
78.5 ± 14.5 51.6 ± 16.8 20.4 ± 11.8 37.3 ± 6.0 16.8 ± 4.7
Incremental boluses of AVP (1, 2.5, 5, 10, 25, 50, 100, 250, 500
and 1000 ng, 1 ng = 0.4 mU) were i.v. injected. Recording
maximal effect, data were expressed in absolute difference from
baseline (D related to AVP dose).
Data processing: Best statistical curve fit (Fig. 1).
Results: Two linear curves for MAP, SVRen variations were observed
(Fig. 1) with two different slopes (slope1 [doses from 1 to 25 ng AVP]
= 0.17 & –0.12 and slope 2 [doses from 50 to 1000 ng AVP] = 0.01
& –0.02 respectively). EC50 (AVP dose inducing half of the
response) was calculated from both curves: EC1MAP = 9 ng; EC2MAP
= 662 ng; EC1SVRen. = 13 ng; EC2SVRen = 349 ng. The shift from
curve 1 to curve 2 occurred at 40 ng for MAP and 68 ng for SVRen
of AVP. For DVRen, Flcort, Flmed no linear relation was observed at low
AVP doses. For higher AVP doses, similar negative slopes have been
calculated: DVRen –0.01; Flcort –0.01; Flmed –0.003.
Conclusion: MAP and SVRen react strongly to low AVP doses
whereas DVRen Flcort Flmed did not. At higher dose, Flmed is better
preserved than DVRen and Flcor.
Figure 1
P147 Corticosteroids reduce inotrope requirements in hypotensive liver failure
R Harry, J Wendon
Liver Intensive Care Unit, King’s College Hospital, London SE5 9RS, UK
Introduction: Corticosteroids improve haemodynamic profile in
patients with septic shock [1,2]. Adrenal dysfunction is common in
patients with acute hepatic necrosis (AHN) and haemodynamic
instability [3].
Methods: We studied 13 patients aged between 19 and 63 years
with liver failure defined by the presence of encephalopathy and
hypotension requiring noradrenaline (NA) support despite ade-
quate fluid resuscitation. Eleven patients had AHN and two decom-
pensated alcoholic cirrhosis. Treatment with 300 mg
hydrocortisone daily by infusion was started when BP required NA
support. Baseline, incremental rise and peak cortisols following
250  mg intravenous synacthen were recorded, as were NA require-
ments and mean arterial BP for 24 hours before and 24 and 48
hours after the start of corticosteroids.
Results: NA was given for a median of 2 days prior to steroid
therapy. Three patients survived, eight died and one underwent
liver transplantation (OLT).
Of those who came off NA (seven), three required further NA and
all died; four required no further inotropes of which three survived
and one underwent OLT.
There were no differences between baseline, increment and peak
cortisols between those who became inotrope independent and
those who did not using the Mann–Whitney test.
Conclusion: Low dose corticosteroids improve the haemodynamic
profile in patients with hypotensive liver failure and may improve
survival. This may not be dependent upon endogenous adrenal
function.
References:
1. Bollaert et al: Crit Care Med 1998, 26:645–650.
2. Breigel et al: Crit Care Med 1999, 27:723–732.
3. Harry et al: Int Care Med 2000, 26:S275.
After 24 hours  After 48 hours 
steroids steroids
Withdrawal of noradrenaline 1/13 8% 7/12 58%
Reduced dose of noradrenaline 7/12 58% 9/11 82%S69
P148 Do beta-adrenergic drugs increase microcirculatory blood flow in the gut in sepsis?
LB Hiltebrand, VKrejci, GH Sigurdsson
Department of Anesthesiology, University Hospital Inselspital, CH 3010 Bern, Switzerland
Introduction: Splanchnic blood flow is impaired in sepsis [1].
Therefore, beta-adrenergic agents are frequently administered in
sepsis to increase global oxygen delivery in an attempt to increase
splanchnic blood flow as well. However, changes in microcircula-
tion can not be predicted by changes in systemic blood flow [2]
and the effects of beta-adrenergic drugs on the splanchnic and gut
mucosal circulation in sepsis is still not well understood. The aim of
this study was to measure the effects of dopexamine and dobuta-
mine, on systemic flow, regional flow and microcirculatory blood
flow in the intestinal mucosa in septic shock.
Materials and methods: Systemic flow (CI), regional flow (superior
mesenteric artery) and microcirculatory blood flow (MBF) were
measured in nine sedated (midazolam & fentanyl) and ventilated
pigs (20–24 kg). MBF in the mucosa of the stomach, jejunum and
colon was measured with multichannel laser Doppler flowmetry.
Septic shock was induced by fecal peritonitis at 0 min. After
240 min, i.v. fluids were administered to alter hypodynamic shock to
hyperdynamic septic shock. At 360 min each animal received either
i.v. infusion of dopexamine (1.0 mg/kg/min, increased after 30 min to
2.0  mg/kg/min for another 30 min) or dobutamine (5 mg/kg/min,
increased after 30 min to 10 mg/kg/min for another 30 min) in a
random order. After 30–60 min recovery period a new baseline was
taken before infusion with the other test drug was started.
Results and discussion: Results are presented in the Table as
percent of baseline ± SEM. Changes within each parameter were
tested with ANOVA for repeated measurements. *P < 0.05;
†P < 0.01;  ‡P < 0.001. Both the tested beta-adrenergic drugs
increased cardiac index significantly. However, regional blood flow
was only increased with dopexamine, but not with dobutamine.
Microcirculatory blood flow in the gastric mucosa was also signifi-
cantly increased with dopexamine, but not with dobutamine.
Neither drug appeared to influence microcirculatory flow in the
intestinal mucosa.
Conclusion: Although the beta-adrenergic agents significantly
increased cardiac output the mucosa of the gastrointestinal
tract appeared to profit very little from increased systemic flow.
Dobutamine did neither influence regional flow or microcircula-
tory flow. Dopexamine improved both regional and gastric
mucosal flows, but had no effects on mucosal flow in the small
and large bowel.
References:
1. Rasmussen I et al: Circ Shock 1992, 38:22–28.
2. Hiltebrand LB et al: Crit Care Med 2000, 28:3323–3331.
Table
Dopexamine Dopexamine Dobutamine Dobutamine 
Drug dosage 1 mg/kg/min 2 mg/kg/min 5 mg/kg/min 10 mg/kg/min
Mean arterial pressure (mmHg) 70 ± 4.6 71 ± 4.3 70 ± 4.3 66 ± 3.6
Cardiac index (% of baseline) 119 ± 4.3† 135 ± 5.7‡ 124 ± 4.7† 148 ± 6.4‡
Superior mesenteric artery flow (%) 115 ± 5.7* 119 ± 6.0† 104 ± 3.0 103 ± 4.8
MBF in the gastric mucosa (%) 105 ± 1.7 111 ± 3.3† 103 ± 2.0 101 ± 4.2
MBF in the jejunal mucosa (%) 92 ± 5.4 98 ± 5.7 105 ± 4.3 97 ± 3.2
MBF in the colonic mucosa (%) 103 ± 2.1 102 ± 2.7 101 ± 2.2 99 ± 3.9
P149 Clinical evaluation of a noninvasive method to measure cardiac output
J Reutershan, T Kapp, R Fretschner
Klinik für Anaesthesiologie, Hoppe-Seyler-Str 3, 72076 Tübingen, Germany
Introduction: In the presence of severe complications associated
with invasive measurement of cardiac output a noninvasive tech-
nique is desirable. This study was to evaluate a rebreathing method
to determine cardiac output in mechanically ventilated patients.
Methods: The noninvasive method is based on a lung model con-
sisting of a ventilated and a non-ventilated compartment, the first
leading to effective pulmonary blood flow (PBF), the latter to shunt
perfusion (QVA/Qt). In this model QVA/Qt can be calculated as
QVA/Qt = (CcO2 – CaO2) x PBF/VO2. Using a gas mixture of
soluble nitrous oxide and insoluble sulfur hexafluoride in oxygen,
PBF was calculated from the uptake of N2O (PBF,rb) and oxygen
uptake (VO2) from the disappearence of oxygen (VO2,rb) (AMIS
2001 Intensive Care Monitoring System, INNOVISION, Odense
Denmark). CcO2 was calculated from the alveolar gas equation and
CaO2 measured by gas analysis. Thus, QVA/Qt and cardiac output
(CO) could be determined by means of the rebreathing data
(QVA/Qt,rb) (CO,rb = PBF,rb / [1 – QVA/Qt]). Simultaneously,
CO, VO2 and QVA/Qt were determined by thermodilution (CO,thd),
indirect calorimetry (VO2,ic) (Deltatrac II, Datex-Engström, Finland)
and by calculation from arterial and mixed venous blood gas analy-
ses (QVA/Qt,bga), respectively. After approval by the local ethics
committee of the medical faculty the investigations were performed
in 40 patients on mechanical ventilation.
Results: CO,rb varied from 3 to 12 l/min, QVA/Qt,rb from 0.06 to
0.33 and VO2,rb from 200 to 600 ml/min. Mean values of CO,thd
and CO,rb, QVA/Qt,bga and QVA/Qt,rb and VO2,ic and VO2,rb
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were taken as reference values. Bias and precision were calcu-
lated as mean difference and standard deviation between the
rebreathing and reference values in relation to the reference values.
The mean difference between Co,rb and reference value was
–3.6% (bias), with a standard deviation of ± 10.9% (precision).
The mean difference between QVA/Qt,rb and reference value was
17.5%, with a standard deviation of 14.0% respectively; VO2 was
determined with a bias of 3.4% and a precision of ± 15.4%. The
mean difference between duplicate measurments related to their
mean value accounted for 3.5%.
Conclusion: The present results suggest, that cardiac output,
venous admixture and oxygen consumption may be reliably esti-
mated by the proposed rebreathing technique.
Supported by INNOVISION, Denmark, providing the gasanalyser
and the computer software for the calculation of pulmonary blood
flow and oxygen consumption (AMIS 2001 system).
P150 Pulmonary embolism detected by transesophageal echocardiography during cemented total hip surgery: the effects on
hemodynamic, hemogasanalytic, and pulmonary shunt values
MJ Koessler*, R Fabiani†, H Hamer†, RP Pitto‡
*Department of Anesthesiology and Intensive Care, and †Department of Cardiology, Waldkrankenhaus, Erlangen, Germany; ‡Department of
Orthopaedic Surgery, University of Erlangen-Nuremberg, Germany
Introduction: During insertion of a cemented total hip arthroplasty,
the rise of the intramedullary pressure in the femur, causes emboli-
sation of fat and bone marrow into the pulmonary circulation. The
goal of this study was to relate the embolic events observed by
transesophageal echocardiography to the changes in hemody-
namic, hemogasanalytic, and calculated pulmonary shunt values.
Material and methods: In this clinical trial entered 65 patients
(> 65 years). During the surgical period continually monitoring
included ECG, measurement of invasive arterial pressure, pulsoxi-
metric oxigen saturation, endtidal carbondioxid concentration as
well as transesophageal echo-cardiography. A blinded observer
graded embolic events from videotapes off-line after published crite-
ria [1]. Hemogasanalysis was performed at defined points of the
perioperative period. Preoperative clinical status of the patients was
assessed according to the classification of the ASA. Pulmonary
shunt-values were calculated with the formula of Ries et al [2].
Results: Cementation of the stem caused a cascade of fine emboli
of less than 5 mm with an opacification of the right atrium and ven-
tricle. In the same set of patients, after reduction of the hip joint, it
was followed by macroemboli up to 3 cm (49 patients, 75%). No
important embolic phenomena were observed during other surgical
steps. Both embolic events were followed by changes in hemody-
namics (increase in heart rate in 18%, P < 0.05; hypotension more
than 20 mmHg in 62%) and blood gas parameters (paO2
decreased for 7.7%, 41.4 mmHg; P < 0.05). PetCO2 decreased
for a mean of 2.9 mmHg (P < 0.05). Pulmonary shunt values
increased after embolisation for a mean of 30.5% (P < 0.05). They
did not turn back to baseline values in the postoperative period in
patients classified ASA III and IV. A significant correlation
(P < 0.05) was found between the clinical state before surgery and
the duration and intensity of hemogasanalytic changes after inser-
tion of the stem.
Conclusion: There is a correlation between embolic events quanti-
fied by transesophageal echo-cardiography and the grade of
hemodynamic and haemogasanalytic changes of patients during
cemented total hip arthroplasty. Patients with high anasthesiologi-
cal risk can suffer severe cardiopulmonary complications from fat
and bone marrow embolisation, that last even into the postopera-
tive period and may cause intesive care treatment.
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marrow embolism in cemented total hip arthroplasty. Clin Orthop
1998, 355:23–34.
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P151 Continous right ventricular monitoring under lysis with rt-PA in acute pulmonary embolia
SM Christoph, JC Lewejohann, E Muhl, HP Bruch
Medical University of Lübeck, Department of Surgery, Ratzeburger Allee 160, 23538 Lübeck, Germany
Introduction: During postsurgical treatment on our ICU by six
patients occurred an acute lung embolia Grade III/IV. Right after
resuscitation we placed prior to angiography a Swan–Ganz-
Catheter with SVO2 in a pulmonary arteria. Typical signs of a lung
embolia like increased PAP, PCWP and decreased SVO2 and CO
were obtained. We used the right-ventricular monitoring during
lysis with rt-PA.
Methods and patients: Six patients with average age of 68.3 were
monitored. Prior to embolia none of the patients had insufficient
heart function or irregular heart rhythms. After resuscitation all
patients showed increased PAPsys higher than 50 mmHg, CI lower
than 2.5 and SVO2 lower than 75%. All patients were treated with
administration of rt-PA in fraction of 5 mg each 90 s. Success of
lysis was shown by angiography and right-ventricular monitoring.
Results: By four patients there was a rapid normalisation after
administration of highest 15 mg rt-PA. The result was to be seen
first at angiography than on SVO2. Cardiac parameters took 5–8
min to normalize. One patient needs administration of 40 mg rt-PA
for normalization. One patient died during lysis without any remark-
able normalization and after unsuccessful resuscitation.
Discussion: It was shown that continous right-ventricular monitor-
ing is a capable feature for monitoring during lysis at thecritically ill
patient. Even angiography is more sensitive the SVO2-monitoring
provides usefull information. If there is no way to have an angiogra-
phy, right-ventricular monitoring is a valuable system. Placement of
catheters can easily be performed and is even in unstable patients
practicable.S71
P152 Pulse oximeter waveform analysis as a measure of circulatory status
PM Middleton, A Retter, JA Henry
Department of Academic Accident & Emergency Medicine, Imperial College School of Medicine, St Mary’s Hospital, Praed Street, London
W2 1NY, UK
The pulse oximeter waveform (POW) is derived from variation in
intensity of transmitted light through tissues. It may be used to
provide a non-invasive surrogate for the intra-arterial waveform, and
represents an accessible measure of cardiovascular status. We
examined the effects of age, blood pressure and smoking on the
waveform patterns. These factors are known to decrease arterial
compliance, increase peripheral wave reflection and alter the
contour of the pulse pressure waveform.
Supine and standing POW recordings were taken from 200
healthy volunteers. The resting waveform patterns were cate-
gorised into four distinct classes as described by Murgo and
Nichols for intra-arterial pressure waveforms, and compared to age
and systolic blood pressure.
Post hoc ANOVA revealed a significant relationship between
waveform class and age (P < 0.001), blood pressure (P < 0.001),
and smoking status (P = 0.021. These effects appear to represent
changes in the peripheral arterial system resulting from altered
wave reflection.
We also analysed the POW in both time and frequency domains.
On standing, time domain analysis showed a decrease in total vari-
ability, as measured by standard deviation and variance. Frequency
domain analysis demonstrated an increase in power at a frequency
(0.1 Hz) associated with sympathetic nervous system output. These
results are consistent with changes in the microcirculation related to
autonomic control mechanisms. These patterns of change,
however, were only apparent in a proportion of the subjects. We
believe that the responses elicited are dependent on factors affect-
ing the long-term compliance of the arterial tree, and are thus
related to the pulse oximeter waveform classification described. We
have shown that POW analysis yields consistent and reproducible
patterns. Further research may lead to the use of these techniques
as a measure of peripheral vascular responsiveness, with potential
utility in the evaluation of cardiovascular disease.
P153 Positive correlation between daily changes of initial distribution volume of glucose and cardiac output following subtotal
esophagectomy
H Okawa, H Ishihara, T Iwakawa, T Tsubo, A Matsuki
Intensive Care Unit and Department of Anesthesiology, University of Hirosaki School of Medicine, 5 Zaifu-cho, Hirosaki, Aomori, Japan
Introduction: We have reported that the initial distribution volume
of glucose (IDVG) reflects the central extracellular fluid volume
status and correlated with cardiac output following major surgery.
In clinical practice we are using IDVG as an indicator of cardiac
preload to predict hypovolemia or fluid refilling phase following
major surgery. IDVG is an intermittent measurement parameter and
its rather time consuming procedure limits frequent measurements
of IDVG. In this study, to investigate whether or not continuous
cardiac output (CO) monitoring could be used as a clinical alterna-
tive of IDVG to estimate the changes in cardiac preload, we exam-
ined a correlation between changes in CO and IDVG in sedated,
mechanically ventilated postoperative patients.
Methods: Thirty-one patients with written informed consent
managed in our ICU following subtotal esophagectomy ware
included. IDVG was measured once a day from the day of admission
in our ICU until 3rd postoperative day by injecting 5 g of glucose and
calculated using a one-compartment model. CO was measured
using a pulmonary artery catheter equipped with a continuous CO
calculation computer. Regression analysis was used to detremine
the relationship between daily differences in IDVG and CO.
Results: Trends of mean absolute values of IDVG and CO indicate
parallel changes of the curves. Daily differences in IDVG and CO had
a statistically significant correlation (r = 0.59, n = 93, P < 0.0001).
Conclusion: In sedated, mechanically ventilated patients following
subtotal esophagectomy, changes of IDVG and CO had a good
correlation. In this limited clinical setting, continuous CO monitor-
ing could be used as an alternative of IDVG as a preload indicator
although false positive error of changes in CO during the period of
each IDVG measurement cannot be ruled out in our study design.
P154 Hemodynamics changes induced by volume expansion measured by PiCCO® system: the post-expansion effect
P Cougot*, O Puyoo†, O Anglès†, B Georges*, JF Decun*, Ch Roche*, Ch Virenque*, B Cathala†, M Génestal†, K Samii*†
*Réanimation Polyvalente, Hôpital Purpan, Toulouse, France; †Réanimation Polyvalente, Hôpital Rangueil Toulouse, France
Aim: Volume expansion is usually guided by central venous pressure
(CVP) [1]. PiCCO® system which evaluates intra thoracic blood
volume (ITBV) may be a useful guide for volume expansion The aim
of this study was, using a PiCCO® system, to measure the changes
induced by a volume expansion in cardiac index (CI), systolic index
(SI), mean systemic arterial pressure (MSAP), CPV and ITBV.
Materials and methods: Eighteen patients with acute circulatory
ditress syndrome were prospectively studied. All the patients were
sedated and mechanically ventilated and received 50 or 100 ml
(group 1: CVP > 14 and 14 £ CVP ³ 8 respectively) or 200 ml
(group 2: CVP < 8 cmH2O) of HEAfusine 6%® over a 10 min
period. Hemodynamics measurements were performed using a
transpulmonary indicator dilution technique (PiCCO® Pulsion,
Munich) before (T0), after fluid administration (T10) and 10 min
later (T20).
Results: The acute circulatory distress syndrome was due to
septic shock (n = 15), cardiogenic shock (n = 2) and hypovolemic
shock (n = 1). The Table shows the changes observed from the
baseline values at T10 (T0–T10) and from the end of volume
expansion to 10 min later (T10–T20) in each group.
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Discussion: In the 200 ml group, 10 min after the end of volume
expansion, the increase in MSAP and CVP disappears, whereas
ITBV, CI and SI increases remain unchanged and even shows for
ITBV a trend toward increase. This suggest a post-expansion effect
which is not observed on CVP values. In group 2 who had a higher
baseline CVP and a lower volume expansion, the increases in MSAP,
CVP, ITBV and SI observed at the end of volume expansion disap-
pear 10 min later, suggesting the absence of a post-expansion effect
when the baseline CVP is high and/or the volume infused is low.
Conclusion: ITBV measurement may be a useful guide for the eval-
uation of volume expansion and post-volume expansion effect
when baseline CVP is low and/or volume expansion is 200 ml.
Reference:
1. Weil MH, Henning RJ: New concepts in the diagnosis and fluid
treatment of circulatory shock. Anaesth Analg 1979, 58:2.
Table
200 ml group 2 (n = 26) 50 or 100 ml group 1 (n = 42)
Changes T0 T0–T10 T10–T20 T0 T0–T10 T10–T20
CI (l/min/m2) 3.86 ± 0.9 0.3 ± 0.09 0.11 ± 0.07 3.9 ± 0.9 0.12 ± 0.06 –0.36 ± 0.04*
SI (ml/m2) 42.3 ± 12.2 3.5 ± 0.8 1.9 ± 0.1 42.5 ± 10.4 1.74 ± 0.7 0.09 ± 0.56 *
ITBV (ml/m2) 867 ± 245 12 ± 11 40 ± 15 862 ± 124 61.3 ± 10.7 –18.6 ± 10.8*
MSAP (mmHg) 77.3 ± 11.6 4.9 ± 1 1.6 ± 0,5 * 73.3 ± 8.5 3.6 ± 0.5 –0.3 ± 0.1 *
CVP (cmH2O) 5.8 ± 2.8 1.9 ± 0.2 –0.07 ± 0.2 * 9.95 ± 1.75 1.2 ± 0.2 –0.05 ± 0.13 *
* P < 0.05 changes from T10 to T20 vs changes from T0 to T10.
P155 Usefulness of an expert software for hemodynamic evaluation: results of the HEMODYN™ Survey
P Squara
Réanimation Polyvalente, Hôpital Victor Dupouy, 69 rue du Lieutenant Colonel Prudhon, 95100 Argenteuil, France
In an earlier study, we clinically validated an expert computer
program (Hemodyn™) designed to assist in interpreting pulmonary
artery catheterization data [1]. The present study in seven Euro-
pean centers assessed the influence of Hemodyn™ on the thera-
peutic strategies of experienced residents.
Patients with a pulmonary artery catheter inserted were included in
the study if they had hemodynamic disorders unresponsive to stan-
dard therapy and/or if their condition raised a therapeutic problem
that PAC was expected to solve. Each resident examined and col-
lected PAC data from the study patients in their center, under the
supervision of the local study coordinator. Then, the resident com-
pleted a data form and made one or more choices among the diag-
nostic possibilities listed on the form. The same PAC data were
then entered into the software. Based on the software’s diagnostic
evaluation, the resident could either maintain or change his or her
diagnosis and treatment. Finally, a senior intensivist accepted or
rejected the resident’s final diagnosis and treatment plan. Agree-
ment between the residents’ initial evaluation and the software’s
evaluation was poor (kappa < 0.6).
Sixty-four hemodynamic profiles from 44 patients were used for the
study covering a broad spectrum of critical situations. Before com-
puter assistance, the residents suggested at least one treatment
change (to improve hemodynamics) in 83% of patients and a mean
of 2.2 treatment changes per patient. After computer assistance
and evaluation by the local study coordinator, the residents
changed their treatment suggestions in 94% of patients, making a
mean of 1.9 changes per patient. Therapeutic agreements before
and after computer assistance are shown in the Table (* P < 0.05
vs other comparisons).
After computer assistance, agreement was very good between res-
idents and seniors and between seniors and the software. Com-
puter assistance led the residents to change at least one sug-
gested treatment in 63% of cases; in 55% of cases, the change
was not minor. Analysis of the points of disagreement showed that
the residents often underused fluids and vasodilators: these two
points contributed 42% of changes after computer assistance. In
only 20% of the cases in which the patient received a vasodilator
was this treatment suggested initially by the resident. For the other
treatments, the proportions of inappropriate use and inappropriate
absence of use were similar.
Expert software capable of helping residents to interpret PAC data
properly may improve the quality of care given to critically ill
patients.
Reference:
1. Squara P, Dhainaut J, Lamy M, Perret C, Larbuisson R, Poli S, Arma-
ganidis A, de Gournay J, Bleichner G: Computer assistance for
hemodynamic evaluation. J Crit Care 1989, 4:273–282.
Table
Number of 
disagreements Kappa coefficient
Before computer assistance
Resident-computer 5.7 ± 2.2 0.64 ± 0.14*
After computer assistance
Resident-computer 1.9 ± 2.0 0.88 ± 0.12
Resident-senior 1.2 ± 1.7 0.92 ± 0.10
Senior-computer 0.9 ± 1.2 0.95 ± 0.07S73
P156 Measured and calculated SvO2: do they alter clinical decisions?
P Myrianthefs, C Ladakis, G Fildissis, S Pactitis, A Damianos, V Lappas, G Baltopoulos
Athens University, School of Nursing, ICU, KAT Hospital, Nikis 2, Kifissia, Athens, Greece
Introduction: Blood gas analysis (BGA) and PA oximetry catheters
(PAOC) used to determine mixed venous oxygen saturation (SvO2)
are based on fundamentally different technologies and thus they
often produce discrepant values [1]. Directly measured SvO2 by
the PAOC is the criterion standard against which calculation of
SvO2 from PvO2 by BGA is judged.
Methods: We investigated the accuracy of SvO2 determination
between BGA (AVL 995-Hb) and PAOC (Opticath, PA Catheter P
7110, Abbot) in 61 critically ill ICU patients. We had 244 couples’
of SvO2 values simultaneously determined by the two different
technologies.
Results: Results, descriptive statistics and correlation coefficients
are shown the Table. The difference between measured and calcu-
lated SvO2 was statistically significant (P < 0.000).
Conclusions: Calculation of SvO2 using BGA technology is
always higher than PAOC SvO2 direct measurement by 1.6%.
Although this difference is statistically significant (P < 0.00) the
correlation between the two methods is quite high (r = 0.828,
P < 0.01). BGA significantly overestimates SvO2 in comparison to
PAOC. These results suggest that calculated SvO2 may affect
therapeutic decisions in comparison to directly measured SvO2
because the slope of the oxyhemoglobin dissociation curve is very
steep in the usual SvO2 range and thus small changes in the deter-
mination of PvO2 will result in relatively large changes in calculated
saturation [1]. Also, minor calculated hemoglobin saturation differ-
ences in this steep part of the curve represent major differences in
hemoglobin O2 carrying capacity.
Reference:
1. Bowton D, Scuderi P: Monitoring of mixed venous oxygenation. In
Principles and Practice of Intensive Care Monitoring, Chapter 19.
Edited by T Martin. McGraw-Hill, Inc, 1998:303–315.
Table
Method  X ± SEM P (t-test) r* R2
Blood gas analysis 70.3 ± 0.65% 0.000 0.828 0.685
Oximetric PA catheter 68.7 ± 0.61%
*Correlation is significant at the 0.01 level (2-tailed).
P157 Comparison of two thermodilution devices for postoperative care in patients with aneurysmal subarachnoid hemorrhage
S Wolf, L Schürer, R Dietl, H Gumprecht, HA Trost, ChB Lumenta
Department of Neurosurgery, Academic Hospital Munich-Bogenhausen, Technical University of Munich, Munich, Germany
Objective: In the postoperative care of patients with severe
aneurysmal subarachnoid hemorrhage, a pulmonary artery (PA)
catheter is highly recommended for guiding the appropriate hyper-
dynamic volume management. We prospectively evaluated the
accuracy of cardiac output (CO) measurements of a new device
for continuous CO monitoring based on transpulmonary thermodi-
lution detected in a femoral artery line against the known gold stan-
dard of a PA catheter.
Methods: Ten patients presenting with high-grade aneurysmal sub-
arachnoid hemorrhage were monitored in their postoperative course.
CO measurements were obtaken simultaneously via a PA catheter
and the transpulmonary thermodilution CO device. After calculating
the accuracy of the new device, the obtained data of CO and
cardiac preload values, wedge pressure and intrathoracic blood
volume index (ITBI), were related to the patients final outcome.
Results: In 183 parallel measurements of CO, the correlation coef-
ficient R2 of both devices for CO and systemic vessel resistance
was 0.88. Mean difference between the two devices was
0.02 ± 0.78 l/min. Absolute values of CO ranged from 3.1 to
15.6 l/min. Comparing the ITBI obtained from the new device
(mean 912 ± 136 ml/m2, within normal range) with known pul-
monary capillary wedge pressure values (mean 14.4 ± 5.2 mmHg,
above normal range) resembled that preload was overestimated
when solely regarding wedge pressure. There was no correlation
of both preload parameters (R2 = 0.001). Albeit a small sample
size, both mean CO and wedge pressure correlated significantly
with the patients final outcome. However, best differentiation of
final outcome states was obtained with mean ITBI.
Conclusions: The reliability for CO measurements of the new
transpulmonary thermodilution device is high when compared with
the gold standard of a PA catheter. The measuring device is far
less invasive than a PA catheter and simple in handling. Although
still to be validated by a larger database, guiding hyperdynamic
volume therapy with filling volumes rather than filling pressures
seems promising.
P158 Correlation of the monitorization with continuous esophageal echo-Doppler in critically ill patients
L Natera-Ramírez, JE Colomé-Ruiz, D Rubio Payán, JC Lescas-Vásquez, E Rivero-Sigarroa, M Méndez-Bettrán, G Domínguez-Cherit
División de Medicina Crítica, Instituto Nacional de Ciencias Médicas y Nutrición ‘Salvador Zubirán’, Vasco de Quiroga 15, Col Secc XVI,
Tlalpan, CP 14000 México, D.F., Mexico
Introduction: The cardiac output (CO) for thermodilution can have
a great variability. The esophageal echo-Doppler estimates the CO
for the measurement of blood in the aorta. In spite of these poten-
cial advantage, the clinical use is limited for the lack of experience.
The objective is to describe the correlation that exists between the
obtaing of CO by Swan-Ganz catheter and by esophageal echo-
Doppler continuous aortic blood flow and CO estimated. The
placing of the Doppler probe was considered a minimal invasive
procedure, and it doesn´t have major complications.
Material and methods: We included the prostective form, no
random, all patients older than 18 years that required invasive mon-
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itorization for their treatmeant. A Swan-Ganz catheter (Baxter
Healtcare 131F7) was placed on all by the usually form. The
esophageal echo-Doppler (Hemosonic 100, Arrow International)
was placed via oral/nasal passages and simultaneous measu-
ments of CO were given, with interval of 3 min between each.
The investigator was blinded by the CO by Swan-Ganz. The ther-
apeutic decision were guided by the value of the SG catheter.
For the statistical analysis we will the paired samples for patients
and time of measurement. We used sofware SPSS 8.0. We
made a analysis correlation for Pearson and a comparison
between group with ‘U’ Mann–Whitney for a significant statistic
between populations of P < 0.05. We obtained difference of the
medications by descriptive statistic, the inferencial analysis was
made with IC 95%.
Results: We studied 12 patients; 3 of them it was imposible insert
the probe, in 4 patients it was difficult to get a well measument
because the lack of vision of diameter aorta and correct flow
curves. And in 5 patients we made a total of 38 measurements
with each of the described methods, for a total of 76 measuments.
With the SG catheter the mean CO were 6.94 ± 2.1 l/min (IC
95% 6.2–7.2, range 3.1–11.2). The measurements of aortic blood
flow with the esophageal echo-Doppler were 5.14 ± 1.9 l/min (IC
95% 4.5–5.7, range 1.8–8.5). The measurements of CO with
esophageal echo-Doppler were 6.90 ± 2.2 l/min (IC 95%
6.17–7.63, range 2.9–10.5). The comparison between groups
was NS. The Pearson correlation between SG and echo-Doppler
ABF was 0.838 (r2 = 0.70), between SG and CO by echo-Doppler
was 0.819 (r2 = 0.67).
Conclusion: The preliminary report showed that the correlation
between the measurements of ABF with esophageal echo-Doppler
is good. This new method offers advantage that are minimally inva-
sive and quickness in obtaning results; however it requires replac-
ing the esophagus transductor every time the patient is mobilized
and not in all patients could be used.
P159 Accuracy of blood volume measurement using an integrated fiberoptic monitoring system in septic shock
G Marx*, M Cobas Meyer†, T Schuerholz†, B Vangerow†, T Simon†, KF Gratz‡, M Leuwer*
*University Department of Anaesthesia, University of Liverpool, L69 3GA, UK; †Department of Anaesthesia, and ‡Department of Nuclear
Medicine, Hannover Medical School, Germany
Objectives: To compare the accuracy of an integrated fiberoptic
monitoring system in measuring blood volume (BV) with standard
method using chromium-51-tagged erythrocytes in septic shock.
Design: Prospective animal laboratory study.
Measurement and main results: Twenty anaesthetised, and
mechanically ventilated pigs (20.9 ± 1.9 kg) were investigated over
a period of 8 h. Septic shock was induced with faecal peritonitis
(1 g/kg body weight autologous faeces). A central venous catheter
was used for the injection of the indicator dyes. BV was measured
by detecting indocyanin green by reflection densitrometry using a
fiberoptic thermistor tipped catheter inserted into right carotid
artery (4F PV 2024, Pulsion Medical Systems). Haemodynamic
treatment scheme was aimed at maintenance of a central venous
pressure of 12 mmHg. Data were analysed using Bland–Altman
analyses, linear regression and correlation. Forty data pairs of
simultaneous BV-measurements were yielded during haemody-
namic consistency with a mean BV measured by integrated
fiberoptic monitoring system of 66.6 ± 20.3 ml/kg (range:
24.5–122.6 ml/kg). Mean BV measured by chromium-51-tagged
erythrocytes was 76.1 ± 17.9 ml/kg (range: 49.7–121.6 ml/kg).
Linear regression equation was: BV by integrated fiberoptic moni-
toring system = 0.65 x BV: chromium-51-tagged erythrocytes +
17.6; r = 0.57, P < 0.01. The mean bias was 9.6 ml/kg (95% con-
fidence interval: 3.7–15.4 ml/kg), with limits of agreement of –26.5
to 45.6 ml/kg and a precision of 16.8 ml/kg.
Conclusion: In this model of porcine septic shock we could show a
significant correlation in blood volume measurement between
fiberoptic monitoring system and chromium-51-tagged erythrocytes.
The relatively wide limits of agreement might be due to pronounced
circulatory alterations including slow mixing compartments, pro-
longed equilibration and sequestration in septic shock.
P160 Patterns and kinetics of cardiac troponin I and T after coronary artery bypass grafting
AA Peivandi*, M Dahm*, FM Doerr*, U Hake*, D Peetz†, G Hafner†, UT Opfermann*, H Oelert*
*Department of Cardiothoracic and Vascular Surgery, and †Institute of Clinical Chemistry, University Hospiral Mainz, Langenbeck Str 1,
55131 Mainz, Germany
Objective: Cardiac troponins have shown to be specific markers of
myocardial injury. Aim of this prospective study was to compare
patterns and kinetics of troponin I and T after Coronary Artery
Bypass Grafting (CABG) with or without perioperative myocardial
infarction (PMI).
Methods: 119 patients (male/female: 96/23, age 64 ± 10 years)
underwent first-time elective CABG. Preoperative mean ejection frac-
tion was 55.8% ± 15.6%. The mean number of grafts was 3.1 ± 1.1/
patients, in 85.7% the internal mammary artery was used. Cardiac tro-
ponin I and T levels, total creatine kinase and creatine kinase isoen-
zyme MB activities in the serum were measured before operation, at
arrival on the ICU and 6, 12, 24, 48 and 120 hours after declamping.
Twelve-lead electrocardiograms were recorded preoperatively and at
day 1, 2 and 5. The relationship between perioperative data and post-
operative cTnI and cTnT levels were statistically identified.
Results: Two patients died due to refractory myocardial failure
early postoprative. For further evaluation patients were grouped
according to their postoperative ECG (group I: Patients without
PMI, n = 107; group II: Patients with PMI, n = 10: six of them
with Q-wave and four of them with non-Q-wave PMI). Best cutoff
values were calculated with ROC analysis for cTnI (8.35 mg/l)
and for cTnT (0.768 mg/l). Serum concentrations of cTnI, and
cTnT were preoperatively normal and significantly increased after
surgery in both groups. In both groups cTnI reached its medium
peak level after 24 h: (group I: cTnImedian peak = 2.7 mg/l, 95% CI:
[2.1, 3.2]); group II: 70.5 mg/l). CTnT reched its medium peak
level in group I without PMI after 48 h (cTnTmedian peak = 0.298
mg/l, 95% CI: [0.254, 0.354]) in group II with PMI not until 120 h
(3.0 mg/l). In Group II serum level of both troponins remained
considerably high at 120 h (cTnImedian = 10.75 mg/l, cTnTmedian =
3 mg/l).S75
Conclusions: Patterns of release of cTnI and cTnT after CABG are
different: cTnI reaches its postoperative peak value earlier and
declines more quickly than cTnT. After uncomplicated CABG
surgery both cardiac troponins remain continuously low. Elevated
concentrations reflect perioperative myocardial injury.
P161 Apoptosis and oxygen free radicals after interventional reperfusion in acute myocardial infarction: diagnostic value and
prognostic implications
K Mashhour, S Abd El-Shafy, H El-Ghawaby, A El-Naggar, A Abd El-Aziz, A El-Sherif, M Mokhtar
Critical Care Department, Cairo University, Egypt
Reperfusion of the infarct related artery is mandatory to salvage the
myocardium, and the best way nowadays to achieve this goal is
percutaneous transluminal coronary angioplasty (PTCA). Although
important to preserve the myocardium, reperfusion leads to what is
called reperfusion injury which decreases the benefits of reperfu-
sion. The process of reperfusion is known to generate oxygen free
radicals and activation of apoptosis (programmed cell death)
through different mechanisms, both may participate in the patho-
physiology of reperfusion injury.
Methodology: This study was intended to evaluate the effects of
reperfusion done by PTCA of the infarct related artery, on both the
generation of oxygen free radicals (assessed indirectly by measur-
ing  oxygen free radicals scavenger Glutathione Peroxidase
‘GPx’) as well as the induction of apoptosis (assessed by measur-
ing Soluble Fas using APO-1/Fas), in correlation with the clinical
outcome. This study comprised 32 pts admitted with acute MI,
including 28 males and 4 females (mean age 52.09 ± 9.6 years) to
Critical Care Department of Cairo University from December 98 to
June 2000. Peripheral & coronary arterial samples were withdrawn
before and after inteventional restoration of coronary arterial
patency as well as 24 hours later.
Results: Our study, has shown that following interventional
restoration of coronary arterial patency, there was significantly
decreased GPx levels in the coronary vessels (expressed as mean
rank 16.1 vs 15.8, P < 0.05), possibly due to the liberation of
excessive amounts of oxygen free radicals after reperfusion, con-
suming the GPx scavengers. There was a further significant
decrease in the GPx scavenger levels after 24 hours following
reperfusion (expressed as mean rank 16.44 vs 15.1, P < 0.05),
probably due to a reactionary increase in oxygen free radicals
levels. A 15% increase in sFas levels in coronary arteries and
peripheral circulation after reperfusion (4.83–5.58 ng/ ml) points to
increased apoptosis after reperfusion. Stratified into 27 survivors
and 5 non-survivors, non-survivors exhibited a significant decrease
in GPx levels in coronary samples after reperfusion (66%) com-
pared to an insignificant increase in survivors (7%). Suggesting
that the high levels of oxygen free radicals produced after reperfu-
sion may directly affect patients mortality, together with a signifi-
cant increase in coronary arterial sFas levels after reperfusion
(44%) in non-survivors versus an insignificant increase in survivors
(12%)
Conclusion: Increased levels of oxygen free radicals ‘indirectly
assesed by peripheral and coronary arterrial levels of GPx scav-
enger’ and increased apoptosis ‘indirectly assesed by the apop-
totic marker sFas’ charecterise the reperfusion phase of ischemic
myocardium following interventional PTCA. Non-survivors were
found to have higher levels of oxygen free radicals and higher inci-
dence of apoptosis, than survivors, indicating a direct relationship
between their levels and the ultimate pts prognosis. Modern tech-
nology of molecular markers thus permits elucidation of the poten-
tial mechanisms of reperfusion injury.
P162 Effects of glycoprotein IIb/IIIa receptor blocker (tirofiban) in acute coronary syndromes angiographic, scintigraphic and
molecular biology studies
A Rizk, AA El-Fattah, O Tayeh, A El-Naggar, AA El-Aziz, M Ashraf, H El-Ghawaby, M Sayed, S Mokhtar
Background: Platelet activation and aggregation are central
mechanisms in the pathogenesis of coronary thrombus formation
in acute coronary syndromes ACS. One final obligatory step for
platelet aggregation is binding to GP IIb/IIIa receptor. In this study
an attempt has been made to assess the effects of the glycopro-
tein IIb/IIIa receptors antagonist (tirofiban) on angiographic
patency, scintigraphic perfusion and GP IIb/IIIa receptors activity
in ACS.
Methods: A total of 20 pt comprising 11 M and 9 F (mean age
43.8 ± 14.3 years) were included in this study. Sixteen pts had
unstable angina and 4 pts had non Q MI. All pts were randomly
assigned in a blind manner to receive either Heparin and Aspirin
only (Gp1) or heparin and aspirin combined with Tirofiban (Gp2)
(in a dose of 0.4 mg/kg/min for 30 min then 0.1 mg/kg/min for 48
hours). Following clinical evaluation, all pts were subjected to
acute perfusion imaging both on admission as well as prior to dis-
charge — by injecting 10 mCi Tc-sesta MIBI I.V. — with coronary
angiography within 1 week following admission. Four blood
samples were collected from all pts to measure Gp II ± b/IIIa
receptor activity: On admission, after 30 min, 48 hours and before
discharge respectively.
Results: Compared to Gp1, Gp2 exhibited significantly greater
decline in GP IIb/IIIa receptor activity (91.4% vs 71.8%,
P < 0.002 for IIb & 87.1% vs 65.2%, P < 0.002 for IIIa in the
second sample and 88.6% vs 60.7%, P < 0.0007 for IIb &
84.4% vs 54%, P < 0.001 for IIIa in the 3rd sample). Subse-
quent return to baseline values were significantly higher in both
groups compared to control group (89.6%, 89.3% vs 74.3,
P < 0.001 for IIb & 86.6%, 84.8% vs 68.4%, P < 0.0006 for IIIa).
This dramatic effect on platelet function was not paralleled by
coronary angiographic patency (TIMI flow ³ 2 is 70% in both
groups, P > 0.05) but was expressed in significantly better
myocardial perfusion as evidenced by regression of myocardium
at risk from a mean of 20.3 ± 5.7% to a mean of 8.1 ± 4.9% in
Gp2 vs a mean of 20.4 ± 8.59% to a mean of 14.4 ± 7.05% in
Gp1, P < 0.03 and improved perfusion scoring from a mean of
12.3 ± 3.5 to a mean of 4.6 ± 3 in Gp2 vs a mean of 12.4+5.1 to
a mean of 8.7 ± 4.2 in Gp1, P < 0.03 with salvage index exceed-
ing 30% in 80% of pts in Gp2 vs 50% in Gp1, P < 0.05.
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Conclusion: In acute coronary syndromes, the use of platelet gly-
coprotein IIb/IIIa blocker tirofiban could effectively reduce GP
IIb/IIIa receptor activity, enhance myocardial perfusion, improve
salvage of myocardium, reduce residual ischemia and improve
short term outcome.
P163 Early stenting vs conservative treatment after thrombolysis in acute myocardial infarction: results of a randomized trial
B Hammer, B Scheller, M Böhm, B Hennen, for the SIAM-III-Study Group
Internal Medicine III (Cardiology/Angiology), University of Saarland, D-66421 Homburg/Saar, Germany
Thrombolysis (T) in acute myocardial infarction (AMI) is limited by
TIMI III-flow rates of 60% and reocclusion of the infarct related
artery in 5 to 10%. Prior studies showed no benefit of PTCA fol-
lowing T in AMI. Recent studies have demonstrated superiority of
primary stenting versus PTCA alone in AMI.
We are conducting a multicenter, randomized, prospective, con-
trolled trial to compare the strategy of early coronary stenting
(group A) with conservative treatment (group B) following T within
12 hours after onset of AMI. Patients of group A are transferred to
the interventional center within 6 hours after T for coronary angiog-
raphy including stenting of the infarct related artery. Group B has
elective coronary angiography after 2 weeks. Primary endpoint is a
combined endpoint of death, reinfarction, and target lesion revas-
cularization.
So far (November 2000) 176 pts have been randomized. There are
no significant differences regarding sex, age, infarct localization,
risk factors, ck-elevation and cardiogenic shock. Mean follow-up
time is 158 ± 97 days.
Results:
Group A Group B 
(n = 71) (n = 75) P value
Combined end point 22.5% 37.3% 0.038
Death 5.6% 10.7% ns
Reinfarction 2.8% 2.7% ns
Target lesion revascularization 16.9% 25.3% ns
Bleeding complications occurred in 11% of pts in group I vs 8% in
group II (ns).
Conclusion: Early stenting after T in AMI is safe. This preliminary
data indicate a clinical benefit by this approach compared to con-
servative treatment after T in AMI.
P164 Myocardial infarction on elder 80 years old patients: women handicap
L Lorente Ramos, M Martín Velasco, R Medina Sánchez, JJ Valencia Vera
Intensive Care Unit, Clínica La Colina, Santa Cruz de Tenerife, Spain
Objective: To analyze epidemiology and evolution differences
between sex on elder 80 years old patients with myocardial infarction.
Methods: It is a retrospective analysis. Were included all patients
elder 80 years admitted from 1-1-1990 to 31-10-1998 with a
myocardial infarction. We used c2 test and P < 0.05 to establish a
statistically significant association.
Results: Were included 211 patients, 50.71% males. Myocardial
infarction was anterior 71.09% cases and 81.04% patients devel-
oped Q wave. Pathological antecedents were: arterial hypertension
38.38%, coronary disease 33.17% and diabetes mellitus 26.54%.
Patients developed next complications: 13.74% supraventricular
tachycardia, 6.16% complete atrioventricular block, 58.76% left
ventricular failure, 35.07% cardiogenic shock and dead 40.28%.
Women had more antecedents of diabetes mellitus (32.69% vs
20.56%, P < 0.05), and developed more complete atrioventricular
block (9.61% vs 2.80%, P < 0.05) and exitus (47.11% vs 33.64%,
P < 0.05).
There was no statistically significance to compare pathological
antecedents of arterial hypertension (38.46% vs 38.31%) and
coronary disease (34.61% vs 31.77%), localization anterior
(70.19% vs 71.96%), development of Q wave (80.76% vs
81.30%) and the development of left ventricular failure (59.61% vs
57.94%), cardiogenic shock (36.53% vs 33.64%) and supraven-
tricular tachycardia (16.34% vs 11.21%).
Conclusions: Women have a higher mortality rate and more com-
plete atrioventricular block.
P165 Epidemiology of gender-related differences of arrhythmias in the ICU
U Priglinger, P Reinelt, M Koreny, G Delle Karth, A Geppert, R Berger, G Heinz
Department of Cardiology, University Hospital of Vienna, Austria
Background: Studies have revealed sex-specific differences in the
electrophysiology with respect to rate, sinus node function, refrac-
tory periods, conduction time of accessory pathways and the type
and duration of arrhythmias. However, data on sex-specific differ-
ences of arrhythmias are lacking in critically ill patients.
Aim of the study: From November 1996 until July 1999 a
prospective study was conducted in the ICU of a university hospi-
tal to assess sex-specific differences in all consecutive tachy-
arrhythmias.
Results: 278 episodes of tachy-arrhythmia (wide QRS complex
n = 168, narrow QRS complex n = 108, ventricular fibrillation
n = 2) were recorded in 119 patients (83 m, 36 f, age 65 ± 12,
APACHE II 19.6 ±18). There was no significant sex-specific differ-
ence (P = 0.49) in the incidence of wide QRS complex tachycar-S77
dia (100/168 vs 68/110) and narrow QRS complex tachycardia
(66/168 vs 42/110). A significant gender-related difference,
however, was detected in the etiology of narrow complex tachycar-
dia: male patients exhibited a higher incidence in atrial fibrillation
(AFIB) and atrial flutter (AFLU) while female patients suffered more
frequently from supraventricular tachycardia (SVT; ie atrial, juc-
tional or AV nodal reentry tachycardia) (P = 0.003). The incidence
of mononomorphic ventricular tachycardias (VT) was comparable
in both groups. Similarly, there was no significant difference in the
rate of the tachy-arrhythmias (204.5 ± 77/min vs 202 ± 74/min).
Conclusion: Data from this study show that there are gender-related
differences in the type of tachyarrhythmia in critically ill patients.
Whereas men were prone to AFIB and AFLU, female critically ill
patients had a preponderance for regular SVT in this analysis. The
distribution of VT was relatively homogeneous among sexes.
Ectopic Torsades 
junctional des  Ventricular 
AFIB AFLU SVT tachycardia Undetermined VT pointes fibrillation
M 57 (68.7%) 8 (80%)  5 (23.8%) – 9 (75%) 79 (58.5%) 8 (61.5%) 2 (100%)
F 26 (31.3%) 2 (20%) 16 (76.2%) 2 (100%) 3 (25%) 56 (41.5%) 5 (38.5%) –
P166 A circadian pattern of occurrence of ventricular tachycardia and atrial fibrillation is present during periods of
analgosedation
G Heinz, P Reinelt, M Koreny, G Delle Karth, R Berger, A Geppert
Department of Cardiology, University of Vienna, Austria
Aim: Ventricular tachycardia (VT) and atrial fibrillation (AF) are the
single most frequent arrhythmias (ARRHY) in our ICU. The present
study investigated whether there is a circadian variation in the
onset of these ARRHY in critically ill patients in a medical cardio-
logic ICU which also admits cardiac surgery patients.
Results: Between 11/96 and 7/99 there were 98 consecutive
patients with VT (43 pts) or AF (55 pts). There were a total of 218
ARRHY episodes (AF, n = 83; VT, n = 135). The time of onset of
these ARRHY was not evenly distributed across the 24 hours day.
Both, VT and AF showed a nadir during the night. The circadian
variation in the occurrence of VT, but not AF, could well be modeled
by a sine wave function. For VT, but not AF, there was a significant
correlation between the observed frequency distribution and a sine
wave function (VT r = 0.71, P < 0.001; AF r = 0.29, P > 0.05). The
circadian variation with/without analgosedation was not significantly
different for VT episodes (n = 86 and n = 49; c2 = 20.3, P = 0.56).
For the distribution of VT episodes, there was a significant correla-
tion to a sine wave function irrespective of the presence of anal-
gosedation (no analgosedation, r = 0.59, P < 0.05; analgosedation,
r = 0.9, P < 0.001; Fig.). VT occurrence showed a peak in the early
afternoon between 1 and 2 PM. As for VT, the distribution of AF
episodes was not different during periods with (n = 47) or without
analgosedation (n = 36; c2 = 19.6, P = 0.6).
Conclusion: The distribution of VT and AF episodes across the
day in critically ill patients is nonuniform. The distribution of VT
episodes follows a sine wave function showing a peak in the early
afternoon between 1 and 2 pm. The circadian variation and its rep-
resentation by a sine wave function is less clear for the onset of AF
episodes. Most striking, the circadian variation is present even
during periods of analgosedation.
Figure
P167 Intra-hospital response to cardiac arrest in Rome area
F Cavallaro, C Sandroni, P Fenici, G Ferro, A Valente
Department of Anaesthesiology and Intensive Care, Catholic University School of Medicine, Largo Gemelli, 8-00168 Rome, Italy
Introduction: The survival from cardiac arrest is strongly influenced
by the delay and appropriateness of interventions as CPR and
defibrillation. For intra-hospital cardiac arrests which occur in
general wards, the ALS rescuers are usually non-readily available at
bedside and rescue depends on an emergency team moving inside
the hospital. We investigated how the response to cardiorespiratory
emergency is organised inside the hospitals in Rome.
Materials and methods: Twenty-five secondary and tertiary level
hospitals of the Rome area (2,840,000 inhabitants) have been con-
sidered. Among them 22 included an ITU. Data were collected by
means of interviews with ALS team members and direct overview
on site. The time interval to reach the farthest ward from the start-
ing point of the crash team was also measured.
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Results: Only 8% of hospitals have a dedicated telephone number
for the emergency team. In 44% of cases a beeper is used, in 40%
of cases the personnel call directly the ICU. In the remaining 8% of
cases the Anaesthesiologist on duty is called. Only in 27% of
cases the beeper allows bi-directional communication. In 42% of
cases the number corresponding to the beeper is always the same,
while in the remaining cases it may change even daily or from day
to night.
The ALS team includes one Anaesthesiologist and one nurse in
20% of cases, one Anaesthesiologist and one optional nurse in
40% of cases and only one Anaesthesiologist in 40% of cases.
The ALS equipment carried by the crash team includes a monitor-
defibrillator, intubation equipment and drugs in 12% of cases, intu-
bation equipment with drugs in 52% of cases and no equipment at
all in 36% of hospitals. In these last cases, the crash team relies on
the equipment available in the wards, but only 75% of them have
protocols to check it regularly. In 20% of hospitals there is a defib-
rillator in every ward, in 24% there is one defibrillator per floor and
in 56% less than one per floor. In 79% of these last cases, the
crash team does not carry the defibrillator, which has to be found
by the personnel in other ward of the same floor or in other floors
of the hospital, and has to be carried by hand or by elevator. In two
hospitals a transthoracic emergency pacemaker is not available; in
only one hospital the pacemaker is included in the crash cart
carried by the emergency team; in the remaining cases, it is avail-
able, but it has to be found in CCU, ITU or OR.
Fifty-six percent of hospitals do not have standard ALS protocols;
28% have them, while in 16% of hospitals some providers use
them, others do not. Only in two hospitals the Utstein style for
reporting cardiac arrest is used.
Despite the fact that the majority of hospitals have a regular BLS
training programme for the personnel, in 88% of hospitals the
emergency team members complained of insufficient CPR training
of general ward personnel, on which they rely to perform ALS on
arrival.
The time for arrival in the farthest ward of the hospitals ranges from
30 s to more than 15 min (average 3 min 30 s ± 4 min 27 s SD). The
majority of hospitals are on a single building with less than six floors,
but seven of them have separate buildings, and two have 11 floors.
Conclusions: The majority of hospitals in Rome do not have a ded-
icated telephone number for emergencies and do not use interna-
tional ALS protocols for cardiac arrest treatment. Only in 12% of
cases the crash team carries a complete ALS equipment on the
scene, while the majority of ALS teams prefer to move with a
limited equipment, relying on materials available on the wards.
However, only in 20% of hospitals there is a defibrillator in every
ward. In the majority of hospitals there is regular training on CPR
for general ward personnel, but the majority of emergency team
members complaint of insufficient CPR training of general ward
personnel.
P168 Sudden death resuscitation announcing acute myocardial infarction: early outcome and mortality factors
Y Gottwalles*, O Katz*, J-M Boulenc*, J-P Monassier†, P Couppié‡, M Hanssen‡
*Réanimation Clinique Saint Joseph Colmar; †Centre Hospitalier Général Mulhouse; ‡Centre Hospitalier Général Haguenau, France
Between January 1999 and June 2000, we analysed in a prospec-
tive study patients admitted for sudden death with positive resusci-
tation (SD) after acute myocardial infarction (AMI). All patients
were assigned to undergo immediate PTCA.
About 588 AMI were recruted during this period, and 38 patients
(6.46%) have presented a SD. Mean age of patients of this group
is 65.3 years ± 12.3 (37–88). Sex-ratio is 3/1. Patients with Killip
grade over III represent 44.7%, and cardiogenic shock is present
in 47.3%. Myocardial localisation of infarction is anterior in 60.5%,
and inferior in 34.2%. The culpit lesion interests left main coronary
artery in 7.9%, LCA in 39.4%, circomflex in 5.3%, and right coro-
nary in 42.1%. An angiographic occluded vessel is present in
94.7%, and we have one-vessel disease in 50.0%, two-vessels
disease in 15.8% and three-vessels disease in 34.2%. Successful
procedure after PTCA is obtained in 93.5%, with stent implanta-
tion in 71.0% of the cases. 53.6% patients are under mechanical
ventilation (MV), 31.6% have a cardiac pump assitance by IABP,
and 50.0% have b-mimetic medication. In-hospital mortality rate is
31.6%, among which 13.2% in the first day. If we analyse the two
groups with or without cardiogenic shock, we obtain:
Cardiogenic shock Without cardiogenic 
(n = 18) shock (n = 20) P
Successful procedure 92.8% 94.1% ns
MV 83.3% 25.0% < 0.01
IABP 44.4% 20.0% < 0.01
b-Mimetic medication 83.3% 20.0% < 0.01
In-hospital mortality 66.7% 0.0% < 0.01
First day mortality 27.8% 0.0% < 0.01
Conclusion: Mortality rate after successful resuscitation for sudden
death during acute myocardial infarction is depending on the haemo-
dynamic status at admission. In presence of cardiogenic shock, two
thirds of patients will die. Without shock, no death is observed.
P169 Quality of life after cardiac arrest — evaluation with EQ-5D
C Granja, G Cabral, L Guerreiro, A Vieira, AT Pinto
Intensive Care Unit, Resuscitation Committee, Hospital Pedro Hispano, 4450 Matosinhos, Portugal; Department of Biostatistics and
Medical Informatics, Oporto Medical School, Oporto, Portugal
Background: Evaluation of outcome after cardiac arrest focuses
mainly on survival. Survivors of cardiac arrest end up in different
states of health and survival alone may not be a sensitive measure
for successful cardiopulmonary resuscitation (CPR).
Objectives: To evaluate health-related quality of life (HR-QOL) of
cardiac arrest survivors with EQ-5D, a generic instrument devel-
oped by the EuroQol group.S79
Patients and methods: From April 1997 to December 1999, all
cardiac arrest adult patients admitted in a six-bed medical/surgical
(ICU) of a tertiary care hospital were enrolled. At six months after
ICU discharge survivors attended a follow-up interview and
answered EQ-5D questionnaire. A match-control group was
created choosing for each survivor of cardiac arrest two controls,
with similar age range (± 3 years) and similar Apache II (± 2 Apache
units), that were randomly selected among other ICU patients.
Results: From a total of 834 patients, 67 patients were admitted
after cardiac arrest. Of these, 33 (49%) were discharged from
ICU. From these, five patients died in the ward. Twenty-eight
(42%) patients were discharged from hospital. Ten patients died
after hospital discharge but before 6-month evaluation. Seven
patients were not evaluated, five because they were living in distant
locations, one because was in prison and another one for unknown
reasons. Eleven patients attended the follow-up consultation. Two
patients presented with anoxic encefalopathy with severe neuro-
logical dysfunction. A third one presented less severe anoxic neu-
rological sequelae. Cardiac arrest survivors exhibit significantly
worst quality of life only in the self-care dimension.
Conclusions: When evaluated with EQ-5D at 6 months after ICU
discharge, survivors of cardiac arrest exhibit a HR-QOL similar to
other ICU survivors presenting only more difficulties in the self-care
dimension. These results agree with previous reports stating that
CPR is frequently unsuccessful but if survival is achieved a fair
good quality of life can be expected.
P170 Epidemiological study of burns in Kurdistan province, Iran
B Groohi, R Alaghehbandan
Department of Research, Kurdistan University of Medical Sciences, PO Box 66135-756, Sanandaj, Kurdistan, Iran
Introduction: Burn injuries still produce a significant morbidity and
mortality in Iran. This study was carried out to analyze the epidemiology,
mortality, and current etiological factors of burn injuries in Kurdistan
province in order to develop effective burn prevention programs.
Methods: During 6 years (1994–2000), 874 patients were admit-
ted to the burn unit of Tohid hospital affiliated to the Kurdistan Uni-
versity of Medical Sciences. Data were obtained by analysis of the
medical records of hospitalized patients included age, sex, per-
centage of burn in terms of body surface, etiology, and the
outcome of treatment.
Results: The overall incidence rates of hospitalization and death
were 10.8 and 3.6 per 100,000 person-years. The mean age was
20.6 years, and 58% of patients were children under 20-years-old.
The highest rates of hospitalization were observed in the age
groups 16–20 years (19.3/105 person-years) and £ 5 years
(17.8/105 person-years). Thus, 53% of the patients had BBS less
than 40%. Burn injuries were more frequent and larger with higher
mortality in females than in males (P < 0.00001). There was also
statistically significant correlation between age groups, gender,
and BBS with mortality rate (P < 0.00001). Flame was the most
common etiology of burns (63.7%). There was also significant cor-
relation between age groups and type of burns (P < 0.00001).
Suicide attempts for all patients ³ 13 years were the cause of 12%
(59/468) of the burns involving women and of 4% (7/151) of the
burns involving men. The overall case fatality rate was 33.4%
(292/874). The mortality rate was significantly higher for self-
inflicted burns (72%, 48/66) than for accidental burns (30%,
244/808). Most of the lesion requiring hospital admission occurred
during the winter months.
Conclusions: A large number of burn injuries, which affect children
and females, occur in the domestic setting and could have been
prevented. Therefore, it is necessary to implement programs for
health education relating to prevention of burn injuries focusing on
the domestic setting. Most of the burn injuries were caused by
domestic accidents and were therefore preventable.
P171 Pre-hospital emergency care in the remote areas in Jordan
SM Abbadi
Royal Medical Services, PO Box 960940, Amman 11196, Jordan
In Jordan, pre-hospital care is provided by the civil defense depart-
ment in general but there is a wide underpopulated area in the
eastern and southern parts of the coutry plus many remote small vil-
lages and communities, which are underserved by clinics, hospitals
and civil defense units and the evacuation routes are very long, so
emergency care which is needed is provided by general physicians
and family practitioners with little if any training in emergency care.
Ten years ago we started to train all physicians who would practice
in such areas, in providing emergency care.
All 220 physicians graduated from the family medicine residency
programs in Jordan had to rotate through the emergency depart-
ments as basic 3-month rotation in their family medicine training
program and were required to master all life saving skills before
they finish this rotation.
Also all of them were tested to make sure that they are competent
to provide emergency care.
A questionnaire was designed for both the receiving hospitals and
the providers in the field physicians to assess the outcome of this
training scheme.
Feedback from the hospitals on the quality of care given to patients
by those physicians in pre-hospital setting indicated great improve-
ment in evaluating, stabilizing, and providing the necessary care
mainly to trauma and cardiac patients.
All providers feel more satisfied with their practice and less
stressed when they face an emergency, and that pre-hospital care
had improved dramatically in those remote areas.
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P172 A report on emergency service by ambulance with doctor on board of the Emergency Department of Prato, Italy
PM Olia, TV Mollica, E Vanni
Department of Emergency and Urgency, Azienda Unita’ Sanitaria Locale n 4, Pzza dell’Ospedale 5, 59100 Prato, Italy
In the urban area of Prato (population 172,473 01.01.2000), the
Emergency Department runs three ambulances with doctor on
board coordinated by the emergency number 118. Here we
analysed the typology of 798 consecutive services carried out by
our ambulance from 01.08.1998 to 31.01.1999. Twenty-eight ser-
vices (3.5%), canceled for various reasons, were excluded by the
statistical analysis. 770 patients were visited; 402 (52.2%) were
males and 368 females (47.8%); males were significantly younger
than females (53.8 ± 24.2 vs 59.9 ± 17 years, P = 0.001). 75.5%
of services concerned non-traumatic cases, 17.9% traumatic
cases and 6.6% transfers between hospitals. The services for non-
trauma group, concerned dyspnoic symptoms (15.7%), cases of
lipothimia (15.2%), chest pain (11.1%), mental disorders (7.9%),
cerebrovascular pathology (6.8%), abdominal pain (4.4%), use of
psychotropic substances (4.3%), epileptic and not epileptic con-
vulsions (3.5%). Metabolic disorders (diabetes, hypoglycemic
crises, hyperthyroidism) accounted for 2.4% of cases, hypertensive
crises 2.4%, tachycardia 2.2%, support to patients with terminal
cancer 2.2%, vertigo 2%, allergies 1.1% and obstetric pathology
0.9%. 1.9% of cases required cardiopulmonary resuscitation.
15.9% was a miscellany of services including poisonings,
migraines, haemorrhages, flu syndromes. Trauma cases were road
accidents (64.7%), falls (27.2%), work-related accidents (4.4%)
and aggression (3.7%). 75.8% of patients were admitted to hospi-
tal; the others (24.2%) were not urgent or refused hospitalisation.
According to Sonsin et al [1], the most frequent services were
related with cardiorespiratory pathologies, cases of lipothimia and
trauma so as the % of non-hospitalised patients (24.2% vs 23%).
The % of our traumatic cases is like that found by Brismar et al [2]
in Sweden urban areas (17.9% vs 20%). Cases of cardiopul-
monary resuscitation were 1.9%, similar to 1.8% found by Hu et al
[3]. Further studies are in progress.
References:
1. Sonsin et al: Aust Fam Physician 1989, 18: 233–234.
2. Brismar et al: Ann Emerg Med 1984, 13: 1037–1039.
3. Hu et al: J Formos Med Assoc 1995, 95: 2s 87–93.
P173 Impact of interhospital intensive care unit transfers
NW Knudsen, WJ Fulkerson, SN Vaslef, MW Sebastian
Duke University Medical Center, Box 3094, Durham, NC 27710 USA, USA
Duke University Medical Center is a tertiary referral level one
trauma hospital with a 16 bed surgical intensive care unit (SICU)
averaging 1100 admissions per year. SICU patients include
trauma, gastrointestinal, vascular, transplant, urology, orthopedics,
otolaryngology and gynecology services. SICU admissions consist
of postoperative, trauma via emergency room, intrahospital floor
transfer and interhospital direct transfer. Transfers from outside
institutions are often critically ill patients who have a significantly
prolonged length of stay (LOS) and use vast amounts of
resources.
All SICU admissions were compared with interhospital transfers for
the last 3 fiscal years.
Interhospital transfers account for 5% of ICU admissions but 10%
of total costs. These patients generate increased cost per case of
over $11,000. The ICU LOS is significantly increased from 3.3
days for all patients to 7.5 for transfers. Likewise, the SICU mortal-
ity of these cases is significantly increased from 7.3% to 28.6%
and hospital mortality from 9.6% to 33.5%
We continually review our practices to dedicate our resources
where they do the most good. We must continue to take salvage-
able, critically ill patients in transfer early in the course of their
illness when appropriate SICU management can favorably influ-
ence outcome. In our experience, interhospital transfer of critically
ill patients identifies a group with overall poor prognosis. There is a
need for a means to evaluate and appropriately triage outside refer-
rals in order to maximize clinical outcomes. Analysis of these trans-
fers is underway to identify prospective predictors of potentially
futile care to allow better utilization of available resources.
ICU 
average ICU  Hospital 
Fiscal Total LOS  mortality  mortality 
year admits (days) (%) (%)
97 1175 3.4 8 10
98 1044 3.5 7 9
99 1039 3.1 7 10
Transfers ICU Hospital 
ICU average  mortality for mortality 
Fiscal Total  LOS  transfers  for  transfers
year transfers (days) (%) (%)
97 40 7.5 32.5 37.5
98 52 8.2 23.1 32.7
99 69 6.7 30.4 30.4
P174 Hypothermia is a marker for adequacy of resuscitation in severe truncal injury
SG Frangos, N Atweh, MJ Pineau, SM Kavic, ME Ivy, PP Possenti, D Bandanza, SJ Dudrick
Department of Surgery, Bridgeport Hospital, Yale University School of Medicine, 267 Grant Street, Bridgeport, CT 06610, USA
Introduction: Hypothermia after massive resuscitation is known to
lead to coagulopathy, myocardial depression, and a depressed
immune response. Attempts at prevention or correction of
hypothermia in the perioperative period frequently fail in spite of uti-
lizing aggressive rewarming modalities. We hypothesized that the
response to rewarming is directly correlated to control of bleeding
and adequacy of resuscitation.S81
Methods: Retrospective review of injured patients admitted to a
level 1 trauma center who: 1. underwent emergent celiotomy
and/or thoracotomy, 2. received six or more units of blood within
12 hours of operation, 3. arrived at the ED normothermic (tempera-
ture > 96°F), and 4. developed perioperative hypothermia. Hypo-
thermia was defined as mild (temperature 92–94°F), moderate
(temperature 90–92°F), or severe (temperature < 90°F). pH and
base excess were measured sporadically. All patients were
managed in one institution, and temperature control procedures
were standardized.
Results: Thirty-eight patients met inclusion criteria. 28 patients
sustained penetrating injury of which 24 survived. Ten patients sus-
tained blunt injury of which six survived. All deaths occurred within
24 hours of injury. The Table represents degree of hypothermia in
survivors and non-survivors. Two non-survivors had initial control of
surgical bleeding and a transient partial correction of temperature,
but had progressive hypothermia and death related to bleeding
recurrence.
Discussion: Failure of correction of hypothermia indicates inade-
quate resuscitation or failure to control bleeding. In survivors and
non-survivors, the pH response tended to lag behind temperature
fluctuations, implying hypothermia may be superior to pH in reflect-
ing correction of hypovolemia. At 8 hours, survivors achieved tem-
peratures over 96°F, while non-survivors averaged < 90°F.
Non-survivors failed to correct hypothermia, probably due to inade-
quacy of resuscitation.
Conclusion: Hypothermia is a marker for the adequacy of resusci-
tation in patients with severe truncal injury. Failure to correct a
hypothermic trend should prompt a search for ongoing bleeding.
Table
Degree of  Survival  Survival  Death  Death 
hypothermia penetrating blunt penetrating blunt
Mild 11 2 1 1
Moderate 4 2 3 2
Severe 9 2 0 1
P175 Survival and recovery after pediatric hypothermic immersion injury achieved through coordinated multidisciplinary approach
B Simon, P Letourneau, AB Schwartz, S Lieberman, R Courtney, KF Lee
Baystate Medical Center Children’s Hospital, 759 Chestnut Street, Springfield, MA, USA
Our purpose is to illustrate how this Level 1 Trauma Center coordi-
nated multiple disciplines to facilitate the care of two pediatric
hypothermic immersions. The clinical services involved in the stabi-
lization and care of these children included Prehospital EMS,
Emergency Services, Operating Room, Cardiac Surgery, Trauma,
Pediatric Surgery, and Pediatric Critical Care
Three children ages 5, 7 and 12, fell through the ice on a pond
December 23, 1998. The oldest child was able to pull himself to
safety and call for help. The water temperature was 32°F. The first
responders were city police followed by EMS. A call was placed to
the Trauma Team by prehospital personnel shortly after their arrival
at the scene. The Trauma Attending notified the Operating Room
and the Cardiac Surgery Attending to prepare for cardiopulmonary
bypass. The 7-year-old was finally rescued 45 min after initial
immersion and was intubated at the scene. He arrived in the
Trauma Room at 12 noon, asystolic with a temperature of 81°F. He
was taken directly to the OR for rewarming via cardiopulmonary
bypass. He was on bypass for approximately 4 hours and was suc-
cessfully resuscitated. He was admitted to the Pediatric Intensive
Care Unit for 34 days and then discharged to inpatient rehabilita-
tion. He has made a full functional and neurological recovery. A
similar treatment was pursued for the 5 year old child when recov-
ered but resuscitation of vital signs could not be achieved.
This institution experienced many ‘firsts’ with these cases. We had
not previously used cardiopulmonary bypass in children. For future
cases of hypothermic immersion injury, we needed a method to
assure adequate communication and a systematic way of mobiliz-
ing appropriate personnel in a timely manner. Pediatric cardiopul-
monary bypass equipment needed to be available and ready.
When literature search did not yield specific guidelines for
hypothermia, a multi-departmental task force was formed and a
new hypothermia management protocol was created. This protocol
insured maintenance of necessary equipment, availability of spe-
cialty personnel and rapid sequential mobilization and coordination
of staff from many disciplines.
Development of a multi-departmental protocol is the key to suc-
cessful coordination of multiple departments toward a favorable
outcome in such time-critical cases as hypothermic immersion
injury. Institutional education and the publicizing of favorable out-
comes will help to motivate staff in maintaining preparedness for
these cases.
P176 Diagnosis: heart contusion?
R Šplechtna*, L Pokorný*, E Hušková*, D Nalos*, P Obruba†
*Department of Anesthesiology and Critical Care, and †Trauma Center, Masaryk Hospital, Pasteurova 9, 401 13 Ústí nad Labem, Czech Republic
Introduction: Myocardial contusion can result from blunt thoracic
trauma and is commonly suspected in deceleration injuries. Unfor-
tunately, traumatic heart disease is frequently overlook and the
diagnosis of myocardial contusion is often unrecognized. Also the
frequency and prognostic influence of cardiac injury in patient with
blunt trauma is contraversial. Myocardial contusion is reported to
be present in as few as 0% of patients and as many as 76% with
blunt chest trauma depending on the criteria used for establishing
the diagnosis.
Diagnosing myocardial damage as a result of trauma may be a
problem because there is a lack of a gold standard for establishing
the diagnosis.
More articles brought no clear results about specifity and significa-
tion of these methods. The conventional CKMB activity and
CKMB/CK-total ratio are still used in our country even if low speci-
fity of these markers has been demonstrated, especially in Ameri-
can literature. On the contrary echocardiography (and particularly
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transesophageal echocardiography) is still not fully used and in
many hospitals is not accessible at all.
Methods: The group of 101 patients hospitalized in traumatology
and general ICUs (1998–2000) with diagnosis: multiple trauma
(including trauma of chest) or isolated thoracic trauma. The only
including criterion — admission to our ICU within 24 hours from the
injury. We have tried to determine the incidence of heart contusion
and to compare all accessible methods of diagnosis and its impor-
tance. The aim of this study was to assess the validity of diagnostic
procedures and possibility of its simplification.
Results: The incidence of heart contusion in our group was
11.8%. See the Figure.
Conclusion: The Figure demonstrates that validity of CK-MB/CK-
total ratio is very low. Also changes of ECGs are not specific.
Values of troponin I and results of TTE are mostly correlating and
are the most conclusive for diagnosis. For these patients assess-
ment of CK-MB/CK is useless and brings higher economic charges.
Figure
P177 Long-term follow up of traumatic multiple rib fractures
K Kawamae, Y Ikegami, C Tase
Department of Emergency Medicine, Fukushima Medical University, Hikarigaoka-1, Fukushima city, Fukushima 960-1295, Japan
We investigated the prognosis of patients with multiple rib frac-
tures for 2 years after discharge from the hospital, and whether the
pain control management during the initial respiratory care influ-
ence the respiratory function or neurological findings. The ethical
committee in Fukushima Medical University approved this study.
221 patients with chest blunt trauma were admitted in our hospital
from 1990 to 1996. We found 61 cases that had more than 4 rib
fractures with or without pulmonary contusion. The subjects that
were 51 patients who had traffic or some other accidents can be
followed by phone and investigated. Forty-one cases were
received mechanical ventilation for from 5 to 18 days. All of 51
cases were administrated oxygen and drugs that controlled the
chest pain. Nineteen of 51 patients (EPI group) were undergone
the epidural anesthesia with xylocain for the first 7 days (5–9 days).
The other patients (non-EPI group) were administrated narcotics or
non-steroid anti-inflammatory agents.
Measurements were arterial blood gasses, respiratory functions,
chest X-ray, physical and neurological findings. The subjects were
48 patients who had traffic or some other accidents. Respiratory
care was required in 20 cases for 5 ± 18 days. PaO2, PEFR (peak
expiratory flow rate) were gradually increased after discharge. The
improvement was not associated between both of pain controls.
Chest deformities were seen in 12 of 51 cases. Râle sound was
audible in three cases. Neurological findings (spontaneous pain, ten-
derness, hypersthesia, sensory disturbance) were found less fre-
quent in patients who were treated under epidural anesthesia. The
epidural anesthesia sometimes induced hypotension, however, fluid
resuscitation improved. The epidural anesthesia was better than the
other narcotics or anti-inflammatory drugs from the points of neuro-
logical prognosis. Sensory disturbance is not associated with chest
deformities but pain control.
Epidural anesthesia was one of the useful pain management to
avoid neurological complications after long-term of multiple rib
fractures of chest trauma.
P178 Decompressive craniectomy as an ultimate therapy for post-traumatic brain swelling
R-D Stenger*, S Mukodzi*, W Kleist-Welch Guerra†, J Piek†, J-U Müller†, H Wiersbitzky‡, R-M Gaab†
*Department of Paediatrics, †Department of Neurosurgery, and ‡Department of Radiology, Ernst–Moritz–Arndt-University Greifswald,
Soldmannstr 15, D-17487 Greifswald, Germany
Introduction: Decompressive craniectomy can be the ultimate
therapeutic possibility of severe traumatic brain edema. Indications,
surgical techniques and results are presented.
Patients and methods: Seven patients with severe head injuries,
5 girls (8–18 years), 2 boys (11–16 years) and incresead intracra-
nial pressure not responding to conventional treatment wereS83
observed between 1993 and 2000. Due to their bad Glasgow
Coma Scale (< 9 pts), all these patients received an epidural moni-
toring of the intracranial pressure (ICP). Increased ICP (> 30 mmHg),
decreased cerebral perfusion pressure (< 45 mmHg), clinical deto-
riation, and signs of raised ICP in CT scans were the indications
for the decompressive craniectomy. Fronto-temporoparietal
decompressive craniectomy (5 × unilateral, 2 × bilateral) was per-
formed 1–7 days after the trauma. The bone flap was preserved in
the abdominal wall or stored under sterile conditions at –80°C. Re-
implantation was carried out 6 weeks to 3 months later.
Results: After acute decompression 6/7 patients (4 girls, 2 boys)
survived and had a good outcome (Glasgow Outcome Scale: 4–5
pts.). Two patients had bone flap infections.
Conclusions: Increased traumatic brain edema requires intensive
care, a good monitoring and a well-timed decompression for pre-
vention of irreversible brain damages.
P179 Cerebral blood flow and oxidative metabolism during human endotoxaemia
K Møller*, GI Strauss†, J Qvist‡, L Fonsmark‡, BK Pedersen*
*Department of Infectious Diseases, †Department of Hepatology, and ‡Department of Anaesthesiology, University Hospital Rigshospitalet,
Blegdamsvej 9, DK-2100 Copenhagen Ø, Denmark
Background and purpose: In a model of human endotoxaemia,
we have previously shown that the blood concentration of tumour
necrosis factor alpha (TNF-a) peaks at 90 min after an intravenous
bolus of endotoxin (ETX) [1]. At this time (peak TNF-a), subjective
symptoms are marked. We measured cerebral blood flow (CBF)
and cerebral metabolic rates (CMR) of oxygen (O2), glucose (glu),
and lactate (lac), at peak TNF-a after ETX.
Subjects and methods: Eight healthy young volunteers (median
age, 25 [range, 21–28] years) were studied. Informed consent was
obtained after approval by subjects and the Scientific-Ethics Com-
mittee of Copenhagen. After an overnight fast, catheters were
placed in the left radial artery, the right internal jugular bulb, and
bilaterally in the antecubital veins. Isotonic glucose was infused at
100 ml/hour. Mean arterial pressure (MAP), heart rate, peripheral
saturation, and rectal temperature (Tprect) were continuously moni-
tored. CBF and CMR were measured by the Kety–Schmidt tech-
nique [2] at baseline, during normoventilation and voluntary
hyperventilation (to measure subject-specific CO2 reactivity), and
90 min after an intravenous bolus (2 ng/kg) of a standard E. coli
endotoxin (ETX).
Results: At 90 min, Tprect was slightly, but significantly increased
from baseline (median 37.0 [range, 36.6–37.3] vs 37.6
[37.0–38.5]°C); MAP was unchanged (96 [74–107] vs 99
[72–126] mmHg). Subjective symptoms were headache, nausea,
chills, and shivering but not overt encephalopathy. Compared to
baseline, CBF was significantly decreased; however, PaCO2 also
decreased, and the CBF decrease was sufficiently explained by
hyperventilation, as calculated from individual CO2 reactivities. A
trend occurred towards decreased CMRlac, ie increased lactate
efflux, similarly explained by hyperventilation. CMRO2 remained
unchanged after ETX, whereas we observed a trend towards
decreased CMRglu associated with decreasing blood glucose
levels. All subjects were alert without signs of cerebral dysfunction
throughout the study.
Conclusion: In this human model of early sepsis, the high levels of
TNF-a were associated with spontaneous hyperventilation, which
decreased CBF and increased cerebral lactate efflux, but did not
affect the cerebral metabolic rate of oxygen. Thus, high circulating
levels of TNF-a during endotoxaemia and sepsis appear not to be
responsible for the development of encephalopathy by a direct
reduction in global cerebral oxidative metabolism.
References:
1. Krabbe K et al: Clin Diagn Lab Immunol 2001 (in press).
2. Kety SS, Schmidt CF: J Clin Invest 1948, 27:476–483.
P180 The role of the adrenergic system in septic encephalopathy
DC Davies*, NK Parmar*, R Moss†, D Tighe‡, ED Bennett‡
*Department of Anatomy and Developmental Biology, †Department of Electron Microscopy, and ‡Department of Anaesthetics and Intensive
Care Medicine, St George’s Hospital Medical School, Cranmer Terrace, Tooting, London SW17 0RE, UK
Encephalopathy is a common complication of systemic sepsis, but
its pathogenesis has received little attention. The adrenergic
system has been implicated in the inflammatory response to sepsis
and therefore the effects of adrenergic agents on the brain were
investigated in an animal model of systemic sepsis.
Thirty-two pigs (25–30 kg) were anaesthetised, intubated and a
thermodilution catheter placed in the pulmonary artery. Peritonitis
was induced by spreading caecal contents around the peritoneum.
Non-septic pigs underwent laparotomy without caecotomy. The
effects of the predominantly b2 adrenoceptor agonist dopexamine
(0.6 mg/kg/h; i.v.), the a1-agonist methoxamine (80 mg/h; i.v.) and
the b2-blocker ICI 118,551 (a 20 mg/kg bolus given hourly; i.v.)
were investigated. Samples of frontal cortex were obtained 8 h
after induction of sepsis, processed for electron microscopy and
subjected to quantitative morphometry.
Septic pigs showed significantly more (P < 0.0004) peri-microves-
sel (PMV) oedema than non-septic pigs. However, there was no
difference between the amount of PMV oedema in septic pigs that
received dopexamine and in non-septic pigs. Neither was there any
significant difference between the amount of PMV oedema in
septic pigs treated with dopexamine + methoxamine and in non-
septic pigs. However, non-septic pigs treated with methoxamine
showed significantly more PMV oedema than non-septic pigs (P =
0.0044). There was significantly more PMV oedema in septic pigs
treated with ICI 118,551 than in non-septic pigs (P = 0.0028). The
mean cross-sectional area of cerebral microvessel endothelial cells
in methoxamine-treated septic pigs was significantly greater than
that in pigs with sepsis (P = 0.0036) and in non-septic pigs (P =
0.0004). The mean endothelial cell area was also significantly
greater in methoxamine-treated non-septic pigs (P = 0.0036) and
in dopexamine + methoxamine septic pigs (P = 0.0036) than in
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non-septic pigs. The mean cerebral microvessel lumen area was
significantly larger in septic than in non-septic pigs (P = 0.012).
None of the drug treatments used resulted in a mean lumen area
significantly different from that of non-septic pigs.
Therefore, sepsis resulted in PMV oedema, which was protected
against by dopexamine treatment. Conjoint methoxamine treatment
did not impair this protective effect of dopexamine in septic pigs,
but methoxamine alone caused PMV oedema formation in non-
septic pigs. b2 adrenoceptor blockade did not affect the formation
of PMV oedema in sepsis. Methoxamine treatment resulted in the
swelling of microvessel endothelial cells in both septic and non-
septic pigs, but conjoint dopexamine treatment did not prevent this
swelling. These results suggest that b2 adrenoceptor stimulation is
beneficial and a1 adrenoceptor stimulation is detrimental to the
treatment of septic encephalopathy.
Treatment group (n) PMV oedema (mm2) Endothelial area (mm2) Luminal area (mm2)
Septic (5) 80.20 ± 5.347 16.27 ± 2.139 30.49 ± 2.197
Non-septic (5) 26.20 ± 2.666 12.34 ± 1.258 20.56 ± 1.063
Dopexamine/septic (5) 39.80 ± 5.546 16.11 ± 1.294 26.53 ± 1.163
ICI 118,551/septic (4) 62.20 ± 6.339 17.75 ± 1.844 24.99 ± 0.709
Methoxamine/septic (5) 58.26 ± 5.944 26.28 ± 2.581 23.54 ± 1.952
Methox/non-septic (4) 60.80 ± 11.785 23.00 ± 1.080 20.83 ± 0.994
Dopex/methox/septic (4) 43.23 ± 7.655 23.00 ± 2.836 26.75 ± 4.473
P181 Prognostic features and outcome of surgically treated aneurysmal subarachnoid haemorrhage
G Tsaousi*, A Efthimiou*, P Selviaridis†, D Vasilakos*, M Yannakou*
*Department of Anaesthesiology & ICU, and †Department of Neurosurgery, AHEPA University Hospital, Delfon 146A Street, GR 54645,
Thessaloniki, Greece
Introduction: Aneurysmal subarachnoid haemorrage (SAH) is a
challenging pathology which remains a cause of considerable mor-
bidity and mortality. We attempted to classify patients with
aneurysmal SAH according to prognostic estimates, identifying
cases with a certain risk profile.
Method: Retrospective chart review of 80 SAH patients admitted
in our ICU following surgical ligation of cerebral aneurysm. The fol-
lowing clinical details were recorded: age, sex, ASA physical
status (ASA-PS), timing of angiography and surgical treatment,
pre-operative Glasgow Coma Scale, Hunt–Hess grade, admission
angiographic features, length of sedation and ICU stay. Functional
outcome was assessed by Glasgow Outcome Scale (GOS) upon
ICU discharge. For statistical purpose two subgroups according to
outcome were identified: a) GOS 1–3 (unfavorable outcome) and
B) GOS 4–5 (good recovery). Statistical analysis was performed
using Students’ t-test and c2 analysis.
Results: History of longstanding hypertension was recorded in
45% (n = 36) of the cases, while cigarette smoking in 48.7% (n =
39). Male to female ratio was 1.3:1. Early operation (within the first
3 days after the bleed) was performed 8.7% (n = 7) of the cases
with a mortality rate of 43% (n = 3). Calcium antagonists (nimodip-
ine) were administered to 90% of the patients in the study group.
In addition early hints for poor neurological outcome were also
acquired from ASA-PS, pre-operative Hunt–Hess, evidence of
angiographic spasm and presence of severe brain swelling intra-
operatively (c2-test, P < 0.001). Overall mortality rate was 5%
(n = 4).
Conclusion: Our results indicate that age, neurological status
upon admission, pre-existing medical condition, evidence of
vasospasm and cerebral oedema are the most important determi-
nants of outcome for patients with aneurysmal SAH, regardless of
treatment utilized.
Table
GOS 1–3 GOS 4–5 
(n = 20) (n = 60) P
Age (years)* 55.8 ± 9.9 50.2 ± 10.8 < 0.05
Time to angiography (days)* 11.8 ± 9.4 12.3 ± 8.2 ns
Time to surgery (days)* 24.1 ± 17.6 25.8 ± 14.4 ns
GCS* 11.1 ± 3.8 14.2 ± 0.7 < 0.001
Sedation in ICU (days)* 4.5 ± 4 0.8 ± 0.4 < 0.001
ICU stay (days)* 15.2 ± 21.9 2.3 ± 5.6 < 0.001
* Mean ± SD.
P182 Intracranial pressure monitoring in patients with subarachnoid haemorrhage
M Cormio, G Citerio, M Cortinovis, S Celotti, A Conti, L Mazza, A Pesenti
Rianimazione-Osp S Gerardo Monza, Via Donizzetti, 106-20052 Monza (MI), Italy
Introduction: ICP monitoring is part of intensive care management
of subarachnoid hemorrhage patients (SAH). However, patterns of
ICP and their relationship with cerebral ischemia or quality of
outcome have not yet been clearly defined.S85
Objective: This study describes the occurrence of intracranial
hypertension; its correlation with clinical presentation; its rela-
tionship with cerebral ischemia and its association with
outcome.
Methods: This prospective study was performed in patients who
suffered aneurismal SAH, admitted into our Intensive Care Unit
(ICU) from 1998 to 2000. Hemodynamic parameters, ICP, cere-
bral perfusion pressure (CPP) and jugular bulb O2 saturation
(SjO2) were monitored and collected up to 7 days after admission.
Continuous ICP and CPP were summarised by 24-h mean values.
In addition, patients were classified by their ‘worst mean data’, ie
worst data of the daily means; this allowed us to identify three
groups based on their ‘worst mean ICP’ (wmICP): < 20, 20–29
and ³ 30 mmHg. Hypodense lesions were detected on serial CT
scans. Outcome at ICU discharge was classified as: obeying
orders, alive but not obeying, died.
Results: Fifty-four patients (64% female, mean age 54 ± 12 years)
were studied. Patients were classified according to the Hunt–Hess
(HH) scale: I 25%, II 30%, III 20%, IV 14% and V 11% respectively.
Thirty-two (60%) of patients had ICP monitoring and was performed
in HH classes as follow: HH1 9%, HH2 35%, HH3 28%, HH4
19%, HH5 9% (P = 0.02). Elevated ICP (ICP ³ 20 mmHg — HICP)
was recorded in 27 patients (84.3% of monitored patients). Worst
mean ICP was 21.7 ± 17.8 (range 3–85). HICP was detected in
HH1–2 (28.6%), in HH3 (11.1%) and HH4–5 (55.6%) (P = 0.12).
Ischemia was more frequent in wmICP ³ 20 than in wmICP < 20
group (62% vs 11% — P = 0.003). Patients with higher wmICP suf-
fered a poorest outcome: 4.5% patients with wmICP < 20; 33.3%
with wmICP 20–29 and 75% with wmICP ³ 30 died (P = 0.006).
Conclusion: In our sample of selected patients, HICP occurred
frequently, in all HH grade, and an association with low-density
changes on CT scans was observed. Persistently HICP was asso-
ciated with poor clinical outcome even in good HH classes.
P183 A novel signaling pathway to facilitate synaptic transmission in the cerebral cortex
SM Smith*, JB Bergsman†, RH Scheller*, RW Tsien‡
*Howard Hughes Medical Institute, †Neurosciences Program, and ‡Department of Molecular and Cellular Physiology, Beckman Center,
Stanford University School of Medicine, Stanford, CA 94305, USA
Excessive and uncontrolled synaptic transmission resulting in
increased glutamate release has been highlighted as responsible
for neuronal death in a variety of neurological conditions including
head trauma, stroke and status epilepticus. We are interested in
synaptic transmission and how this can be regulated at times of
critical illness. Ca2+ entry is a critical signal at the synapse where it
triggers exocytosis, plasticity, and gene expression. The small
volume and limited accessibility of the synaptic cleft has led to the
prediction that pre-and postsynaptic Ca2+ influx during neurotrans-
mission will reduce extracellular [Ca2+] ([Ca2+]o), significantly
attenuating the release probability of the synapse. Recordings in
intact cortex and single synapses have demonstrated falls of one
third in [Ca2+]o following moderate activity. It has been proposed
that mechanisms to reduce the effect of the fall of [Ca2+]o at the
synaptic cleft have a key role in sustaining neurotransmission
during periods of high activity. Here we report direct electrophysio-
logical recordings from rat cortical nerve terminals made to identify
mechanisms which compensate for reductions of [Ca2+]o. We
show that a novel voltage-sensitive, non-specific cation channel
(NSCC) was a major contributor to the membrane current of the
presynaptic terminal and that this channel was activated by
decreases in [Ca2+]o. The [Ca2+]o sensor was also modulated by
Mg2+, Gd3+, and spermidine, consistent with properties of identi-
fied extracellular Ca2+ receptors (CaRs), and regulated the NSCC
via a diffusible second messenger. We predict that the NSCC may
act to counter the fall in release probability produced by physiolog-
ical decreases in [Ca2+]o at the synaptic cleft, by favoring Ca2+
delivery via broadening of presynaptic action potentials. If this
novel signaling pathway acts to ensure synaptic efficacy at times of
excessive synaptic activity, inactivation of the pathway may provide
a new route through which we can reduce glutamate excitotoxicity
and so reduce neuronal death.
P184 Feasibility and advantages of normothermia in patients with acute cerebral damage: preliminary results of a prospective
randomised study
M Cormio, L Barile, G Citerio, G Portella, E Colombo, A Pesenti
Rianimazione, Ospedale S Gerardo Monza, Via Donizzetti, 106-20056 Monza (MI), Italy
Introduction: Even moderate fever soon after head trauma or cere-
bral ischemia may markedly worsen brain injury. These effects may
justify aggressive antipyretic treatment.
Objectives: In this study we compared two modalities to treat
fever and to maintain normothermia and examined their influence
on: ICP, CPP, SjvO2, length of ICU stay (LOS) and clinical course
of existing infections.
Material and methods: We prospectively randomised patients with
severe head injury (TBI) and subarachnoidal hemorrhage (SAH) in two
groups: low doses Diclofenac sodium infusion (0.01–0.08 mg/kg/h)
[DCF] and extemporaneous antipyretic bolus by unrestricted physi-
cian prescription [NSAIDs]. Randomisation was designated when
internal temperature was ³ 38°C lasting longer than 30 min. Drugs
were used till clinically necessary. Internal temperature (T°), cere-
bral and systemic hemodynamic data were continuously recorded.
Results: Eight TBI and three SAH (mean age 40 ± 17 — 64%
male) were studied. Median TBI GCS motor score was 5 and all
SAH patients were Hunt Hess IV. Five patients were enrolled in
NSAIDs group and six in DCF group. Age, admission GCS, cere-
bral damage, max temperature before randomisation and outcome
were not significantly different in the two groups. During treat-
ment, normothermia was easier maintained by DCF than by
NSAIDs: mean T°, max T°, % minutes T° ³ 38°C, and febrile
episodes incidence were lower in DCF than in NSAIDs with minor
antipyretics use (P < 0.05). During treatment, mean ICP and
minutes of ICP > 20 were not while, mean CPP, minutes of CPP
< 70 and mean SjvO2 were significantly different (P < 0.05)
between groups. Incidence of infections and LOS were not differ-
ent between the two groups.
Conclusions: During the infusion period, a better stability of hemo-
dynamic and cerebral parameters demonstrated the superior
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antipyretic effect of DCF. NSAIDs were associated with deeper
CPP reductions and not all febrile episodes were completely
managed. We, preliminary, concluded that DCF at low dosage was
advantageous and effective.
P185 Plasma sodium and sodium balance following sub-arachnoid haemorrhage (SAH)
MP Margarson, V Sazhin, M Magnaye, S Finfer
Intensive Care Unit, Royal North Shore Hospital, St Leonards 2065, Australia
Introduction: Following SAH a massive diuresis, natriuresis and
hyponatraemia may occur, termed ‘cerebral salt wasting’. The aeti-
ology of this condition is unclear and its existence has been ques-
tioned [1,2]. This study aimed to document sodium balance in a
patient cohort treated by the same protocol following SAH, hoping
to further elucidate the mechanism of this condition.
Patients and methods: Prospectively entered data from a com-
puterised database of SAH patients admitted to an eight-bedded
neurosurgical ICU were analysed to assess the correlation of
sodium flux with the course of the disease. For up to 18 consecu-
tive days plasma sodium was measured, 24-hour urinary collec-
tions were analysed for sodium loss and the daily intravenous
sodium intake was calculated from the charted intravenous fluids.
Patients underwent check cerebral angiography on day 5–7 follow-
ing admission or earlier if there was clinical evidence of vasospasm.
Papaverine was administered to patients with vasospasm who then
underwent further angiography and hypertensive therapy with nora-
drenaline. The total doses of papaverine and noradrenaline adminis-
tered were used as markers of the severity of spasm.
Results: Data from 39 patients was analysed. In 15 patients
urinary sodium excretion and hence sodium balance could be cal-
culated for 8 or more days. The median sodium input was 360
mmols/day (range 15–4868), see Figures for daily plasma sodium
and sodium balances.
Measured sodium balance was consistently negative in this popu-
lation. There were no significant differences between high and low
papaverine and noradrenaline groups.
Conclusions: In this limited dataset, following SAH and saline
loading, plasma sodium increased in these patients but there was
no obvious natriuretic phase. Cerebral salt wasting was not clearly
demonstrated by these data.
References:
1. Maeseka JK et al: Cerebral salt-wasting syndrome: does it exist?
Nephron 1999, 82:100–109.
2. Harrigan MR: Cerebral salt-wasting syndrome. Neurosurgery 1996,
38:152–160.
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P186 Secretion pattern of melatonin after head injury
T Pararrigopoulos*, A Melissaki†, G Kribeni†, A Efthymiou†, M Sartzi†, X Geronicola‡, A Zissimopoulos‡, N Baziotis‡
*Athens University Medical School, Department of Psychiatry, Eginition Hospital, 74 Vas Sophias Avenue, GR-11528 Athens, Greece;
†ICU, and ‡Nuclear Medicine Department, Agios Savvas General Hospital, Greece
Introduction: The circadian rhythm of melatonin secretion is a most
reliable biochemical marker of the endogenous biological rhythm of
the organism. Plasma melatonin levels are low during the day (1–5
pg/ml) and normally increase to about 50–100 pg/ml at night. The
objective of the present study was to investigate any potential dis-
turbances of melatonin’s secretion pattern after head injury.
Materials and methods: The sample consisted of eight subjects
(seven males and one female) admitted at the Intensive Care Unit
after head injury. Mean age ± SD of subjects was 41 ± 17.91
years, mean APACHE II Score was 15.5 ± 3.75, mean Glasgow
Coma Score was 7.11 ± 3.14, mean duration of stay in the ICU
was 23.44 ± 12.23 days, and mortality rate was 11.1%. AllS87
patients were under sedation (Fentanyl and Propofol) and mechan-
ical ventilation. Various medications were administered as appro-
priate. Blood samples for melatonin determination were collected
via an arterial line at 08.00, 12.00, 16.00, 18.00, 21.00, 24.00,
03.00 and 06.00 for the first 2 days after admission. Core body
temperature was also recorded through an esophageal thermome-
ter at hourly intervals. All patients were under constant ambient
light (< 600 lux) and none of them received b-adrenergic blockers.
Plasma melatonin was assayed using a RIA method.
Results: The peak mean melatonin concentrations were recorded
during the dark photoperiod and the lowest mean concentrations
were recorded during daylight hours (Table 1).
In overall a clear circadian secretion pattern of melatonin was
observed during the first two post-admission days, with higher
melatonin levels during the dark period (24.00–06.00) and lower
levels during daylight hours (08.00–18.00). However, only four
patients exhibited a typical diurnal variation of plasma melatonin,
whereas the other four did not.
No consistent core body temperature pattern was observed during
the study period and individual temperature fluctuations were not
related to the corresponding melatonin changes.
Conclusions: Melatonin secretion appeared reduced in subjects
treated in the ICU after head injury. However, its circadian secre-
tion pattern was not disturbed in half of them during the first two
post-admission days, indicating an intact endogenous circadian
generating system. Furthermore, the diurnal secretion pattern of
melatonin appeared to be desynchronized with the rhythm of core
body temperature.
Table 1
Peak mean  Lowest mean 
concentrations concentrations
First day  14.22 ± 4.49 pg/ml  8.49 ± 3.4 pg/ml 
at 03.00 at 08.00
Second day 13.56 ± 8.66 pg/ml  8.67 ± 2.98 pg/ml 
at 06.00 at 12.00
P187 Influences of different bypass modalities and body core temperatures during extracorporal circulation (ECC) on
pathomorphological and immunohistochemical changes in the pig brain
HH Hövels-Gürich*, B Hermanns†, S Lücking*,MQing*, D Kunz‡, JF Vazquez-Jimenez§, BJ Messmer§, G von Bernuth*, M-C Seghaye*
*Department of Paediatric Cardiology, and §Department of Thoracic- and Cardiovascular Surgery, †Institute of Pathology,and ‡Institute of
Clinical Chemistry,Aachen University of Technology, Pauwelsstrasse 30, D-52057 Aachen, Germany
Aim: To assess influences of different bypass modalities and core
temperatures during ECC on brain pathomorphology and immuno-
histochemistry in an animal model of cardiac surgery.
Methods: Twenty-one pigs, aged 4 months, were assigned to the
following temperature- and flow groups: I: 37°C–2.7 l/min/m2–(7),
II: 28°C–1.6 l/min/m2–(9), III: 20°C–1.3 l/min/m2–(5). Duration of
ECC was 120 min, including cooling and rewarming 30 min each.
Six hours after ECC, brains were harvested for histology and
immunohistochemistry. Coronal sections from different brain
regions were stained with hematoxylin/eosin and antibodies
against glial fibrillary acid protein (GFAP), astroglial cell protein S-
100 (PS-100) and neuron-specific enolase (NSE) for standard
light microscopy. Ischemic lesions were evaluated by a quantitative
histological score with respect to tissue stratification and vac-
uolization, ganglion and glial cell densitiy and glial fiber reaction.
Apoptosis was identified by in situ DNA fragmentation (TUNEL). In
addition, perioperative PS-100 serum kinetic from jugular venous
bulb blood was evaluated.
Results: In frontal lobe, the most severe ischemic lesions were
observed in group III showing frequent and distended loss of histo-
logic stratification between outer molecular and pyramidal cell
layers, caused by necrosis of pyramidal cells and vacuolization
within the outer molecular cell layer. In group II, these lesions were
less and only focal, in group I hardly present. In all groups, apopto-
sis was not apparent in the neocortex. In hippocampus, pyramidal
cell damage was severe in III, moderate in II, whereas slight in I. In
cerebellum, Purkinje’s cells were found markedly reduced in III,
moderately reduced in II, and slightly reduced in I. Striate body and
medulla oblongata were free from ischemic lesions in all groups.
Signs of inflammation or edema were not observed. In addition,
marked expression of PS-100 in perivascular glial cells as well as
significant elevation of serum PS-100 values at the end of ECC
and return to preoperative values 6 h after ECC were assessed in
all groups.
Conclusions: Ischemic lesions with loss of ganglion cells in sensi-
tive brain regions as cortex, hippocampus and cerebellum are most
marked after deep-hypothermic low-flow bypass, lowest-graded
after normothermic full-flow bypass, and intermediate after moder-
ate hypothermic low-flow bypass. Reduction of flow-rate and
hypoxia during ECC rather than inflammation are assumed to con-
tribute to the histopathological findings. Serum PS-100 elevation
after ECC is, independent of the bypass modalities, supposed as
the result of a temporary disturbance of the blood–brain barrier
with respect to tight relations between astroglial and vascular
endothelial cells.
P188 Clinical utility and reliability of transcranial Doppler ultrasonography for the confirmation of brain death
L Dosemeci, B Dora, F Gurpinar, M Yilmaz, S Balkan, A Ramazanoglu
Department of Anaesthesiology and Intensive Care, University Hospital of Akdeniz, Antalua, Turkey
Introduction: Clinical examination criteria have been established to
determine brain death and subsidiary investigations such as elec-
troencephalogram (EEG), arteriography and radionuclide scans
have been used to determine the arrest of the cerebral circulation
and to confirm the diagnosis of brain death. We examined in this
study the clinical utility and reliability of transcranial doppler ultra-
sonography (TCD) as a confirmatory test for brain death.
Patients and methods: A total of 30 (20 male, 10 female and
ranged in age from 2 to 80) consecutive comatose patients were
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studied by TCD and at the same time EEG recording was per-
formed. Twenty-five of 30 patients clinically presented with brain
death. Undetectable flow despite accurate bone window or the
demonstration of isolated systolic spikes or diastolic reverse flow
without forward flow in TCD examination and isoelectricity in EEG
recording were accepted as confirmation of brain death. TCD
examination was repeated in clinically brain death patients in whom
TCD demonstrated initially systolodiastolic forward flow or diastolic
forward flow and reverse flow in middle cerebral artery (MCA).
Results: Five of 25 patients who were brain death excluded from the
study because of the lack of accurate bone window in TCD examina-
tion. In only 9 (45 %) of 20 patients who were clinically brain dead,
three wave-form patterns that confirmed brain death were seen at
the initial of TCD examination. Various wave-form patterns were
detected in 11 patients in the first examination. Repeated TCD exam-
ination of 9 of these 11 patients who initially had forward flow pat-
terns later demonstrated flow patterns which confirmed brain death.
In 2 of 11 patients TCD examination could not be reperformed
because of sudden cardiopulmonary arrest. In one of 5 patients who
were not clinically brain death, TCD showed systolic spikes and no
diastolic flow. The sensitivity and specificity of TCD for brain death
were found to be 45% and 80%, respectively.
Discussion: TCD is a simple and noninvasive imaging modality
that is easily performed at the patient’s bedside in order to evaluate
cerebral perfusion. A number of authors have presented very
similar results concerning the specificity (100%) and sensitivity
(91–100%) of this method [1,2]. However, we found 11 (55%)
false negative and one false positive (20%) results which are
higher rates than the results of previous studies [1,2]. Finally, in our
study we interestingly found that the specificity and sensitivity of
TCD examination in confirming brain death were lower than in pre-
vious studies.
References:
1. Hadani M et al: Application of TCD for brain death. Intensive Care
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2. Feri M et al: TCD and brain death diagnosis. Crit Care Med 1994,
22:1120.
P189 A prospective multicenter study of ICU acquired paralysis
T Sharshar, JP Lefaucheur, S Bastuji-Garin, B De Jonghe, for the Groupe de Réflexion et d’Etude des Neuromyopathies En
Réanimation (GRENER)
Réanimation Médicale, Hôpital Raymond Poincaré, 104 bd Raymond Poincaré, 92380 Garches, France
Objectives: Although the incidence of electrophysiological and
muscle histological abnormalities in ICU patients has been
largely described, the clinical incidence of ICU acquired paraly-
sis (ICUAP) remains poorly explored. The objective of this study
was to assess clinical incidence, risk factors and outcome of
ICUAP.
Method: All consecutive patients without pre-existent neuromus-
cular disease were daily screened for awakeness in the 5 partici-
pating ICUs after 7 days of mechanical ventilation (MV). The first
day patient was considered awake (based on a specific awake-
ness scale) was Day 1. Patients with a neuromuscular score
(NMS) < 48 (on a scale ranging from 0, totally paralyzed to 60,
normal muscle strength) on Day 7 were considered as having
ICUAP. These patients underwent an electrophysiologic (EP)
examination within the next 72 hours. Patients with persistent
paralysis (NMS < 48) on Day 14 underwent a muscle biopsy.
Potential risk factors (including demographic, metabolic, drug-
related and organ failure-related variables) were recorded
between ICU admission and Day 1. Odd ratios (OR) with 95% CI
were separately computed for each potential risk factor. Then, sig-
nificant factors were simultaneously included in a multivariate
logistic regression model (BMDP software).
Results: Among the 95 patients who satisfactorily woke up, the
incidence rate of ICUAP was 25.3% (95% CI 16.9–35.2). EP
examination showed a sensory-motor axonopathy in all cases. A
specific muscle involvement, not exclusively related to the nerve
involvement, was observed in all the patients who underwent a
muscle biopsy. The median duration of ICUAP was 21 days. ICUAP
patients had a significantly longer duration of MV after Day 1 (18.2
± 36.3 vs 7.6 ± 19.2 days, P = 0.03) and longer ICU length of stay
after Day 1 (27.6 ± 31.4 vs 14.6 ± 19.6 days, P = 0.02), compared
to patients without ICUAP. Two patients remained paralyzed after 6
months. In multivariate logistic regression, the number of days with
organ failure ³ 2 (OR 1.28 [1.11–1.49]), duration of MV (OR 1.10
[1.00–1.22]), administration of corticosteroids (OR 14.90
[3.20–69.8]) prior to day 1, and female sex (OR 4.66 [1.19–18.3])
were independent predictors of ICUAP.
Conclusion: Clinically detected ICUAP was a frequent finding
among patients mechanically ventilated ³ 7 days and was associ-
ated with a prolonged duration of MV and ICU length of stay. Both
the peripheral nerve and the muscle were involved in the paralysis.
Some risk factors might be accessible to preventive measures.
Supported by GlaxoWellcome.
P190 The clinical course of acute quadruplegia of the critically ill
J Man
vák*, M Nováková†, Z Lukáš‡, M Schreiber§, P Kunc§, H Matulová§, E Havel*, L Sobotka*, Z Zadák*
*Department of Metabolic Care, †Department of Rehabilitation, and § Department of Neurology, University Hospital, Charles University,
Hradec Králové, Czech Republic; ‡Department of Pathology II, Childrens Hospital, Brno, Czech Republic
Aim of the study: To describe the clinical course of acute quadru-
plegia of intensive care.
Setting: Ten bed medical ICU in university hospital Hradec
Králové.
Patients: Twelve consecutive patients with acute quadruplegia
that occured during critical illness.
Study period: Fifteen months.
Design: Prospective observational study.
Methods: For precise diagnosis of the neuromuscular disorder, clini-
cal, biochemical, electrophysiological examinations and skeletal
muscle biopsies were performed. During the whole stay in the hospi-
tal, skeletal muscle strength was clinically examined and quantifiedS89
by a standard six grade scale (no movement: 0, palpable contraction:
1, movement with help: 2, spontaneous movement against gravity: 3,
reduced muscle strength: 4, full stength: 5). Length of stay in the
ICU and in the hospital, the duration of mechanical ventilation and
need of tracheostomy were recorded. None of the patients recieved
any neuromuscular blocking agents or corticosteroids.
Results: Out of the 12 patients, 4 had to be excluded due to con-
commitant focal cerebral laesion impairing motor functions. Two
patients had to be referred to another hospital and thus were lost
for the study. In the remaining six patients, a combination of axonal
sensory-motor polyneuropathy in electrophysiology and myopathy
in histological specimen was found. The mortality in these patients
was 50% (3 of 6). The complete muscle strength examination was
performed in three survivors. The clinical course of these patients
is summarized in the Table.
Conclusions: Neuromuscular failure during critical illness is a
serious medical and economical problem. All the surviving patients
with acute quadruplegia of intensive care recieved mechanical ven-
tilation for more than 3 months, requiring a very long stay in the
ICU and a prolonged rehabilitation. On discharge, peroneal paresis
was present in all survivors. In our ICU, more than one bed is per-
manently occupied by patients with severe neuromuscular failure.
These neuromuscular disorders developed in patients who were
not treated with neuromuscular blocking agents or corticosteroids. Supported by grant IGA No. NB 5197-3.
Table
Patient Patient  Patient 
No 1 No 2 No 3
Primary diagnosis Aortic valve  Aortic valve  Mediastinitis
replacement replacement empyema
Maximum daily SOFA 18 13 18
Mechanical ventilation (days) 112 114 98
Tracheostomy (days) 126 204 120
Muscle strength 3° on day 160 56 58
First ambulation with help  174 196 136
on day
ICU stay (days) 150 236 114
Length of stay in hospital  198 254 154
(days)
On discharge, peroneal paresis was present in all the patients.
P191 Clinical assessment of level of sedation in the intensive care unit: a correlation study
JE Colomé-Ruiz, D Rubio-Payán, JC Lescas-Vásquez, L Natera-Ramírez, E Rivero-Sigarroa, M Méndez-Beltrán, 
JC Robledo-Pascual, J Pedroza-Granados, G Domínguez-Cherit
División de Medicina Crítica, Instituto Nacional de Ciencias Médicas y Nutrición ‘Salvador Zubirán’, México, DF Mexico
Background: Sedation and analgesia are common techniques
widely used in the intensive care unit. Since complications such
as prolonged sedative effects and associated long-term mechani-
cal ventilation use are common, a careful assessment of level of
sedation is warranted to avoid such complications. Nowadays,
noninvasive devices like Bispectral Analysis (BIS) recorders are
commercially available and are actually considered gold standard
tests in level of sedation assessment; however, clinical scales
(Ramsay’s and the Observer’s assessment of Alertness/Sedation
[OAA/S] scales) are cheaper and more widely performed in criti-
cally ill patients. In the present study we compared clinical assess-
ment scales with BIS recordings.
Methods: Prospectively we analyzed nine mechanically ventilated
patients under deep sedation. We excluded patients with muscle
relaxants, metabolic encephalopathy or primary central nervous
disease. All patients were simultaneously evaluated with a BIS
device, and with clinical assessment scales (Ramsay and OAA/S).
At least 9 periodic measurements in 24 hours were performed in
each patient, recording neuronal activity level and the signal quality
index (SQI) with the BIS device, excluding all measurements with a
SQI more or equal to 50%. Data comparisons among BIS record-
ings and each clinical scale were analyzed with Pearson’s and
Spearman’s correlation, and determination coefficients, consider-
ing significant a 0.75 and a 0.11 value for each category (accord-
ing to Colton), with a significance level set on 0.05.
Results: Eighty-five measurements were analyzed. Correlation and
determination coefficients are shown in the following Table.
Correlation coefficients
Clinical Determination 
scale Pearson’s Spearman’s coefficient P
Ramsay –0.319 –0.340 0.115 0.001
OAA/S –0.153 –0.137 0.018 0.2
Conclusions: According to our statistical results, no clinical scale
is strongly correlated to Bispectral Analysis in our sedated
patients. Bispectral analysis is advised over clinical assessment to
evaluate level of sedation in intensive care unit patients.
P192 Bispectal Index (BIS) correlates with Ramsay and Cook Sedation Scores in intensive care unit patients
A Melissaki, T Kyriakopoulou, E Kupcova, A Efthymiou, G Kribeni, M Sartzi, Ch Kardamis
ICU, Agios Savvas General Hospital, 171 Alexandras Ave, GR-11522 Athens, Greece
Introduction: It is well known that the administration of sedation
and analgesia constitute an inseparable section of the therapeutic
approach of patients of the ICU. The follow-up and evaluation of
the level of sedation has been considered indispensable, both for
obtaining the desirable clinical objectives and, also, to avoid clini-
cal complications. In an effort of creating a stable and objective
system of evaluation of the level of sedation, we used various
methods, the known scales and, recently the Bispectral Index (BIS)
which constitutes a variable modification, a variant of the EEG. The
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aim of this study was to investigate the probable correlation
between BIS and the Ramsay and Cook scales.
Material and methods: Twenty-six patients (18 males and 8
females) of a mean age of 55.46 ± 21.25, APACHE II Score 13.50
± 5.21, who were hospitalized from August 4 to October 31, 2000
and were subjected to respiratory mechanical support were investi-
gated. Patients who had damage of the neurological system or
those who had received muscle relaxants were excluded from the
study. All the patients, during evaluation and measurements were
under stable sedation and analgesia (Fentanyl, Propofol or Myda-
zolam) under continuous intravenous infusion. The evaluation of the
level of sedation was carried out during the same time period by
means of two different scales: The Ramsay (0–6), Cook’s (4–19)
and BIS (0–100). The BIS registration lasted 60 min and the final
value was calculated from the average of the total recorded 10 min
values. The measurements were taken under consideration if the
SQI (Signal Quality Index) was higher than 80%. The statistical
analysis was carried out by the Jonckheere–Terpstra test.
Results: The results are depicted analytically in Table 1. Between
BIS and the Ramsay Scale, a correlation or a degree statistically
significant (P = 0.012) were observed. The Cook Scale was not
statistically significant (P = 0.091).
Conclusions: BIS is satisfactory correlated with the Ramsay scale
and its indications correspond to the clinical condition of the
patient, where the sedation level is concerned, as opposed to the
Cook scale for which no significant correlation was established.
The BIS values in the ICU and the corroboration of our results
require further study.
Table 1
BIS vs Ramsay P = 0.012
BIS vs Cook P = 0.091
P193 Assessment of sedation level and EEG recovery after major operation by spectral entropy
H Yppärilä*, S Westeren-Punnonen*, T Musialowicz†, M Särkelä‡, J Karhu*, J Partanen*, H Viertiö-Oja‡
*Department of Clinical Neurophysiology, and †Department of Anesthesiology and Intensive Care, Kuopio University Hospital, PO Box
1777, 70211 Kuopio, Finland; ‡Datex-Ohmeda Division, Instrumentarium Corp, PO Box 900, FIN-00031 Datex-Ohmeda, Finland
Entropy quantifies the amount of disorder in a system and charac-
terizes chaotic behaviour. The complexity of a signal can be char-
acterized by spectral entropy, which gives the amount of disorder
in frequency space [1]. If an EEG signal includes a wide spectrum
of frequencies, its spectral entropy has a high value (near one), and
in case of few relevant frequencies spectral entropy is low (near
zero). Spectral entropy has been shown to be an effective tool in
measuring depth of anaesthesia [2].
In this study, we investigated whether spectral entropy can distin-
guish between the different sedation levels corresponding to the
Ramsay Scores 2, 4, and 6. In order to study spectral entropy
during different sedation levels, EEG was recorded from 26
patients scheduled for an elective cardiopulmonary bypass opera-
tion with propofol/alfentanil/isoflurane/pancuronium anaesthesia
[3]. Postoperative sedation was maintained with propofol to keep
the sedation level at Ramsay Score 6 (not responding to any com-
mands) until the patients were hemodynamically stable. EEG was
recorded 5 times for each patient: 1 day before the operation
(Ramsay Score 2), after premedication 1 hour before the operation
(Ramsay Score 2 or 3), immediately after the operation (Ramsay
Score 6), after the patient had opened his eyes for the first time
(Ramsay Score 4), and the following morning (Ramsay Score 2 or
3). The EEG signal was recorded bipolarly between electrodes
Fz–M1, Cz–M2, C3–P3 and C4–P4. It was amplified and digitized
continuously at 100 Hz using the Datex-Ohmeda EEG module and
stored to a PC for off-line analysis. Spectral entropy values were
evaluated for 5 s epochs in two frequency bands: 0.5–32 Hz and
7–32 Hz. Epochs including artefacts were removed from the data
before the calculation.
Spectral entropy for the range 0.5–32 Hz differentiated statistically
significantly whether the patient was awake (Score 2) or asleep
(Scores 4–6) (P < 0.05). Spectral entropy for 7–32 Hz was able
to differentiate the sedation levels 4 and 6 (P < 0.001). Sedation
levels 2, 4, and 6 could thus be distinguished by using spectral
entropy. For comparison, we analyzed whether spectral edge fre-
quency or auditory evoked potentials can distinguish between
these levels. These methods failed in separating levels 6 and 4.
There was considerable variation in spectral entropy values
between the patients having the same Ramsay Score. This may be
due to the physiological variation of different EEG-patterns
between individuals.
We divided the patients into two groups according to how the
EEG, measured the following morning after the operation, was
recovered compared to the EEG 1 day before the operation. In
both recordings the patients were awake. The spectral entropy
values 1 day after the operation were significantly lower in the
group in which the EEG was not at all recovered compared to the
group in which the EEG was almost recovered.
Our results indicate that spectral entropy can be a useful tool for
assessment of the sedation level of a patient. The performance of
spectral entropy in distinguishing Ramsay Score levels 2, 4, and 6
was superior in comparison to spectral edge frequency and audi-
tory evoked potentials. However, in patients with postoperative
EEG significantly slower compared to preoperative EEG, spectral
entropy remained at a low level and was not able to indicate
whether the patient had waken up. A relation between postopera-
tive EEG slowing and mild subclinical cerebral injuries has been
discussed by Vanninen et al [4]. Our results suggest that spectral
entropy might provide diagnostic information of such a state.
References:
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3. Jakob S et al: Comp Methods Programs Biomed 2000, 63:161.
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P194 One center’s experience with the phase IIIb randomized multi center study comparing the safety and efficacy of
dexmedetomidine to propofol for ICU sedation following coronary artery bypass graft surgery
SK Appavu, TR Haley, A Khorasani, SR Patel, V Bhargava
Division of Surgical Critical Care, Cook County Hospital, Chicago, IL, USA
The criteria for an ideal ICU sedative agent includes rapid onset of
sedation, a short half life, easy arousability, anxiolysis, and absence
of respiratory depression or hemodynamic side effects. Dexmedeto-
midine, an alpha 2 adrenergic receptor agonist has been demon-
strated to induce sedation with easy arousability and have no
respiratory depression or hemodynamic compromise. We partici-
pated in a Multi center open label study to compare the safety and
efficacy of dexmedetomidine (Dex) to propofol (Prop) based stan-
dard of care for ICU sedation following coronary artery bypass graft
(CABG) surgery. The study was formally approved by our institu-
tional review board. Adults with coronary artery disease, scheduled
to undergo CABG surgery and signed the informed consent were
randomized to receive either Dex or Prop. At the end of the opera-
tive procedure, at the time of the last sternal suture, patients in the
Dex group received a 20 min infusion of Dex at a rate of 3
mg/kg/hour. followed by a continuous infusion at 0.4 mg/kg/hour.
The patients in the Prop group received a Prop infusion at 10
mg/kg/min. The patients were then transferred to the SICU, where
the medication dose was titrated to maintain a Ramsay sedation
score of 2–3 for 24 hours. Data collection included vital signs, level
of consciousness, hemodynamic parameters, hematologic and bio-
chemical surveys, Ramsay sedation score, and the nurse’s assess-
ment of the following: patient’s anxiety level, quality of sedation, the
patient’s ability to tolerate the ICU environment, the ability to toler-
ate weaning and extubation, ease of communication with the patient
and ease of patient management.
Results: Twenty patients were enrolled. Eighteen were studied
and two were excluded because their scheduled surgery was can-
celled. Ten patients received Dex; eight males and 2 females. Their
mean age was 55.2 years. Eight patients received Prop; seven
males and one female. Their mean age was 61.25 years. No signifi-
cant hematologic or biochemical abnormality was noted in any of
the patients. All the Dex patients received the highest scores for
ease of sedation, ability to tolerate the ICU environment, ability to
tolerate ventilator weaning and extubation, ease of communication
and ease of patient management. Among patients receiving propo-
fol, 75% received the highest scores for quality of sedation and
ability to tolerate ICU environment. Fifty percent received the
highest scores for ability to tolerate ventilator weaning and extuba-
tion and 62% received the highest scores for ease of communica-
tion and ease of patient management.
Conclusion: Dexmedetomidine is a safe agent for ICU sedation. It
is superior to propofol for sedation among patients undergoing
CABG surgery.
P195 A comparison between dexmedetomidine and propofol for sedation in the intensive care unit
RM Venn, RM Grounds
St George’s Hospital Intensive Care Unit, Blackshaw Road, London SW17 0QT, UK
Introduction: This study compares the highly selective alpha-2
agonist, dexmedetomidine, with propofol for the sedation of post-
operative patients requiring mechanical ventilation in the ICU.
Methods: Twenty adult patients expected to require at least 8 h arti-
ficial ventilation following major abdominal/pelvic surgery, were ran-
domised to receive sedation with either dexmedetomidine or
propofol. Additional analgesia was provided by alfentanil infusions if
clinically indicated. Patients received a loading dose of dexmedeto-
midine 2.5 mg/kg/h over 10 min followed by a maintenance infusion
of 0.2–2.5 mg/kg/h. Propofol and alfentanil were infused according
to the manufacturers’ recommendations. Patients were maintained
at a Ramsay Sedation Score > 2 by adjustments to the sedative
regimen. Heart rate, arterial and central venous pressures were
monitored continuously and recorded at 10 min intervals for the first
30 min and then hourly. Venous samples were taken for haemato-
logical and biochemical profiles immediately on arrival in the ICU,
and then at 24 h and 48 h. Extubation was performed when clini-
cally indicated and time from cessation of sedation infusion to extu-
bation was recorded. Patients completed a questionnaire [1],
48–72 h following discharge from the ICU.
Results: There were no differences in patient and ICU characteris-
tics between the two groups.
Heart rates were significantly lower (P = 0.034) in the dexmedeto-
midine group. There were no differences in arterial pressure,
central venous pressure and haematological/biochemical profiles
between the groups.
Conclusion: Dexmedetomidine appears to be safe and acceptable
to both clinician and patient in the ICU. Depth of sedation is com-
parable to propofol and extubation time equally rapid. Furthermore
dexmedetomidine provides analgesia and attenuation of the cardio-
vascular responses to stress, with the potential to minimise
ischaemic events.
Supported by Abbott UK.
Reference:
1. Hewitt PB: BMJ 1970, 4:669–673.
Dexmedetomidine (n = 10) Propofol (n = 10) P value
Sedation, median (IQR) Ramsay score  5 (4–6) 5 (4–5) 0.68
Bispectral Index 46 (36–58) 53 (41–64) 0.32
Analgesia (Alfentanil), median (IQR) (mg/h) 0.8 (0.7–1.2) 2.5 (2.2–2.9) 0.004
Extubation time mean (SD) (min) 27.5 (12) 25 (10) 0.63
Patient experiences Amnesia for ICU 8 3
Amnesia for IPPV 3 2
Pleasant experience 10 6
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Introduction: To date the pharmacokinetics of the sedative agent,
dexmedetomidine, has only been reported in volunteers [1,2]. This
study investigated the pharmacokinetic profile of dexmedetomidine
infusions in human patients requiring postoperative sedation and
ventilation in the ICU.
Methods: Ten adult patients who were expected to require a
minimum of 6 hours of postoperative sedation and ventilation were
studied. Patients received a loading dose of dexmedetomidine
(DEX) of 2.5 mg/kg/h over 10 min (approx 0.42 mg/kg) followed by
a maintenance infusion rate of 0.7 mg/kg/h. Alfentanil infusion was
commenced if additional analgesia was required. The Ramsay
sedation score and Bispectral Index (BIS) were used to measure
depth of sedation. Blood samples were obtained for measurement
of plasma concentrations of DEX immediately prior to infusion start
(t = 0), at 5, 10, 20, 30, 45, 60, min, 2, 3.5, 6, 10, 14, 19 and 24 h
if the patient was still receiving a DEX infusion. Samples were also
obtained at 0, 10, 25, 40, 60, 90 min and 2, 3, 4, 5, 6, 12, 24 h
post infusion termination. Plasma DEX concentrations were mea-
sured using a gas chromotographic-mass spectrometer method
(Oneida Research Services Inc, Whitesboro, NY, USA). Pharma-
cokinetic parameters were estimated by noncompartmental
methods [3].
Results: Median (interquartile range) Ramsay, BIS and APACHE II
scores were 4.5 (4.2–4.6), 53 (45–58), 13 (12–16) respectively.
Tabular results are expressed as mean (SD).
Conclusion: Previously reported [2] DEX subjects’ clearances
range from 46.3 (8.3) to 35.3 (6.8) l/h, Vss range from 88.7 (22.9)
to 102.4 (20.3) l and t1/2 from 1.78 (0.30) to 2.5 (0.61) h. Although
these patient pharmacokinetic values appear slightly greater, the
results are generally comparable to those previously reported for
subjects.
Supported by Abbott UK.
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P196 Pharmacokinetics of dexmedetomidine infusions for patients in the intensive care unit
RM Venn*, MD Karol†, RM Grounds*
*St George’s Hospital Intensive Care Unit, Blackshaw Road, London SW17 0QT, UK; †Clinical Pharmacokinetics Department, Abbott
Laboratories, IL 60064-6104, USA
Duration of  Volume of  Mean residence 
Weight (kg) DEX infusion (h) Half-life (h) Clearance (l/h) distribution (l) time (h)
74 (14) 10 (4) 3.14 (0.62) 48.3 (15.9) 173 (52.5) 3.86 (1.59)
P197 Short-term propofol sedation increases serum levels of parathyroid hormone independent of calcium levels in normal
subjects
GP Zaloga*, D Teres†, E Youngs‡
*Suburban Hospital, Bethesda, MD 20814, USA; †AstraZeneca, Wilmington, DE 19850, USA; ‡Tufts University School of Medicine,
Boston, MA, and Palo Alto VA Medical Center, Palo Alto, CA 02111, USA
Introduction: Propofol (Diprivan®, AstraZeneca) is a surgical anes-
thetic and an intensive care sedative that contains 0.005% disodium
edetate (EDTA) as an antimicrobial agent. EDTA is also a chelating
agent that may affect the function of the parathyroid-calcium axis,
predisposing patients to the development of hypocalcemia.
Purpose: To compare the effect of propofol with and without
EDTA on the parathyroid-calcium axis in normal healthy volunteers.
Methods: In a randomized, double-blind, age-stratified, crossover
trial, 50 normal subjects were randomly treated with propofol or
propofol EDTA as a bolus containing 2 mg propofol/kg iv (1 mg/kg
if aged > 65 years), followed by randomly selected infusions (25,
50, 100, or 200 mg/kg per min). The alternate treatment was given
15 to 29 days later. Changes in ionized Ca, total Mg, and intact
parathyroid hormone (PTH) levels were measured. The normal
range for PTH is 9 to 46 pg/ml.
Results: Eighteen women and 32 men were equally distributed
among 3 age groups (19–34, 35–65, > 65 years). Ionized Ca and
total Mg remained within the normal range for both treatments
throughout the study. However, PTH levels significantly increased
from baseline (40.7 ± 19.8 pg/ml and 40.4 ± 16.7 pg/ml for
propofol and propofol EDTA, respectively) to 54.3 ± 24.7 pg/ml
and 55.8 ± 23.0 pg/ml, respectively, (P < 0.05) 4 min after the
bolus injection and returned to baseline within 60 min. Propofol
infusions significantly (P < 0.05) increased PTH levels in a step-
wise fashion. PTH levels increased 31% and 43% for the 100 and
200 mg/kg per min infusions of propofol, respectively. These PTH
levels are similar to those seen in hyperparathyroidism and
hypocalcemia. Age did not affect PTH responses.
Conclusion: Propofol was associated with a dose-dependent
increase in PTH levels that were not related to changes in ionized
Ca, total Mg, or EDTA.S93
P198 The effect of morphine on the immune system of ventilated ICU patients
M Hersch, B Perl, B Rudensky
Departments of Anesthesiology Intensive Care, Medicine and Immunology, Shaare Zedek Medical Center, Jerusalem, Israel
Introduction: Morphine (MO) was shown to depress immune func-
tion in animal models and cell cultures [1]. Virtually no data exist
regarding the in vivo effect of MO in human beings. MO is often
used for sedation of ventilated ICU patients. We therefore evalu-
ated the effect of MO on the immune system of these patients.
Methods: The project was a prospective, self-controlled study.
Ventilated ICU patients who were in the Unit > 24 hours and
demonstrated no signs of acute infection and considered clinically
stable were included. Following exclusive sedation with continuous
Midazolam infusion, the first blood sample was taken and MO was
added to the regimen, keeping sedation at level 3–4 of Ramsay
scale. Twenty-four hours after the addition of the MO, the second
blood sample was collected. Leukocytes were analyzed for phago-
cytosis, oxidative burst and the presence of membrane markers of
activation by flow cytometry. Forty-eight and 72-hour blood
samples under MO sedation were also analyzed in some patients.
Results: Thirteen patients met the inclusion criteria. The leukocyte
membrane activation markers CD11b and CD11c showed signifi-
cant decrease after 24 hours of MO infusion, 26 ± 13.6% (P =
0.05) and 27 ± 10.0 (P = 0.025), respectively. Other membrane
activation markers, CD14, CD18 and oxidative burst, demon-
strated a non-significant trend toward decrease in 6 patients with
72 hours exposure to MO.
Conclusions: These human data suggest that MO, which is a
standard sedative agent in the ICU, might compromise the immune
efficacy of these patients.
Reference:
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P199 An investigation of the efficacy and safety of remifentanil for the provision of optimal sedation in adult ICU patients
requiring short-term mechanical ventilation: preliminary results
B Muellejans, A Lopez, MH Cross, C Bonome, L Morrison, A Kirkham
Klinikum Karlsburg, Herzzentrum Mecklenburg Vorpommern, Karlsburg, Germany
Introduction: Remifentanil HCl is a m-opioid agonist which has an
onset of action of about 1 min and rapidly achieves steady-state.
Metabolism by non-specific blood and tissue esterases results in a
terminal half-life of < 10 min which is independent of the duration
of infusion.
Methods: In this randomised trial, 152 ICU patients (post-cardiac
surgical [60%], post-general surgical [34%], medical [6%])
without significant renal dysfunction received an initial infusion of
either remifentanil (9 mg/kg/h) or fentanyl (1 mg/kg bolus + 1.5
mg/kg/h) in a double-blind manner. Optimal sedation, defined as a
Sedation Agitation Scale (SAS) score of 4 (patient was calm, and
easily arousable), with no or mild pain was achieved by initial titra-
tion of the opioid infusion (fentanyl patients also received bolus
doses of 1 mg/kg) followed by administration of propofol (0.5
mg/kg/h), if required, according to a pre-defined dosing algorithm
specifically designed to reflect the advantages that the study drug
offered. Assessments of SAS, pain intensity, mean arterial pres-
sure and heart rate were made every 20 min for the first 6 hours
after starting the opioid infusion and then hourly.
Results: See Table.
Conclusions: The dosing algorithm allowed effective provision of
optimal sedation with remifentanil without the addition of propofol
in the majority of patients. The similarity of the results for fentanyl
probably reflects the stringent conditions of the dosing algorithm,
which demanded frequent monitoring and adjustment of the level
of sedation to ensure that a SAS score of 4 was maintained. The
remifentanil regimen was well tolerated and the safety profile was
similar to fentanyl. The titratability and predictable duration of
action make remifentanil a very effective opioid for the provision of
analgesia/sedation in ICU patients.
This study (USA30206) was supported by a grant from Glaxo
Wellcome.
Table
Remifentanil Fentanyl 
(n = 77) (n = 75)
Mean modified ICU 
admission SAPS II score 28.2 27.7
Duration of assessment of  13.7 (3–73) 14.2 (< 1–73)
optimal sedation (hours;
mean, range)
% hours of optimal sedation  88.3 (14.1) 89.3 (15.1)
(mean, SD)
Number (%) of patients  27 (35%) 30 (40%)
requiring propofol
P200 An investigation of the offset of pharmacodynamic effects of remifentanil following prolonged infusion in ICU patients with
varying degrees of renal dysfunction: preliminary results
A Wilmer, A Bodenham, D Breen, V Bach, J Bonde, P Kessler, S Albrecht, S Shaikh
UZ Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium
Introduction: Remifentanil HCl (R) is a mu-opioid agonist with a
rapid onset (~ 1 min) and offset of action (t1/2 < 10 min) due to its
organ-independent metabolism by non-specific tissue and blood
esterases. These properties make it readily titratable and even after
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prolonged infusion the effects of R do not accumulate. Its major
metabolite, remifentanil acid (RA) is eliminated by the kidneys and
its elimination is prolonged as a result of increasing renal dysfunc-
tion. However RA has been reported to have 1/4600 mu-opioid
potency of the parent compound. This study assessed the offset of
pharmacodynamic (PD) effects of R in ICU patients with varying
degrees of renal dysfunction receiving R for provision of sedation
and analgesia.
Methods: R (starting rate 6–9 mg/kg/h) was administered as a con-
tinuous infusion for up to 72 hours in 40 ICU patients (10
normal/mild renal impairment, creatinine clearance ³ 50 ml/min: 30
moderate/severe renal impairment, creatinine clearance < 50 ml/min)
who required sedation and analgesia. At scheduled times (8, 24, 48
and 72 hours) R was down titrated until the offset of PD effects (eg
changes in sedation, pain intensity, respiratory function or haemody-
namic variables) were seen. On confirmation of the offset of PD
effects, R was continued at the original rate.
Results: See Table.
Conclusions: The offset of the PD effects of R were consistent
and independent of the duration of infusion even in patients with a
significant degree of renal dysfunction. R was well tolerated in
these patients. R may therefore be an ideal agent for provision of
sedation and analgesia to patients with varying degrees of renal
dysfunction in the ICU.
This study (USA30212) was supported by a grant from Glaxo
Wellcome.
Table
Renal status:  Renal status: 
normal/mild PD  moderate/severe PD 
Time of down offset (min) offset (min) 
titration (h) (mean, SD) (mean, SD)
8 15.6 ± 7.4 (n = 10) 19 ± 15.7 (n = 27)
24 13.8 ± 7.7 (n = 10) 20.3 ± 11.7 (n = 20)
48 16.1 ± 7.2 (n = 8) 15.4 ± 7.4 (n = 12)
72 14.8 ± 5.7 (n = 6) 25.3 ± 12.6 (n = 11)
P201 Phenobarbital: a good choice for long-term sedation
G Fahron, F Martens, U Frei
Department of Nephrology and Medical Intensive Care, Charité — Campus Virchow Klinikum and Deutsches Herzzentrum Berlin, 13353
Berlin, Germany
Sedation is an essential part of intensive care medicine. The most
common agents used for sedation in intensive care units are mida-
zolam or propofol in combination with opioids. This sedatives have
short half-life times, rapid onset after application and a short dura-
tion depending on the dose that is given.
A small part of patients in our intensive care unit need long-term
sedation. Most of this patients have multiple organ failure caused
by septic shock or cardiac shock.
Short working sedatives are very expensive and a relevant econom-
ical factor in intensive care units.
Drugs used in long term sedation should be as safe and as com-
fortable for the patient as continuous given midazolam or propofol.
Patients ventilated for two or more weeks often need some days to
awake after discontinuation of sedation and they awake with dis-
comfort from sedation with midazolam.
In long-term sedation we used phenobarbital in combination with fen-
tanyl since more than 5 years in about 40 adult patients. After stabili-
sation of the patient we switch from continuous application of
midazolam to bolus application of phenobarbital 200 mg given every
6–8 hours. A patient with 70 kg bodyweight needs about 1000 mg
per day phenobarbital for a deep sedation. The level of sedation
could be controlled easily. The Ramsey sedation scale should be
used to measure the level of sedation. Plasma levels could be con-
trolled. Phenobarbital is a safe drug and the patient are comfortable
sedated. There is no significant decrease in blood pressure after
bolus application. There is no prolongation of sedation in contrast to
continuous given midazolam. All patients waked up comfortable.
Cost of sedation with midazolam 240 mg/day (10 mg/h): 85
Euro/day. Cost of sedation with Phenobarbital 1000 mg/day: 6.2
Euro/day. Phenobarbital has an important cost-benefit.
Conclusion: Phenobarbital is a recommendable drug for long-term
sedation.
P202 Repetition of self-poisoning and self-injury: a retrospective 4-year study
Y Ikegami, K Kawamae, C Tase
Department of Emergency Medicine, Fukushima Medical University, School of Medicine, Hikarigaoka-1, Fukushima-city, Fukushima 
960-1295, Japan
Objectives: Repetition of self-poisoning and self-injury presents us
serious problems because there are some important reasons. Not
only may it represent the establishment of a maladaptive pattern of
coping, but it also the probability of fatal suicide. The purpose of
this study was to investigate characteristics of patients who
attempted suicide repeatedly.
Methods: This study was undertaken in the emergency depart-
ment of Fukushima Medical University Hospital. We conducted a
retrospective cohort study of consecutive patients with attempting
suicide for over 4-years period between April 1996 and March
2000. Patients who attempted suicide were picked up from the
records of emergency room and then all records where the attend-
ing doctor diagnosed self-poisoning and self-harm were identified.
Results: The total number of attempters of suicide was 215
(0.38%, whom 74 were men and 141 women (male to female ratio
1:1.9). Of these, the number of repeaters was 41, whom 5 wereS95
men and 36 women. Repeaters tend to be younger, particularly,
64% of repeaters in women were under 30 years old. Overdoses of
drug and poison were most frequently in single presenters. In
repeaters, repetition of overdose was most frequent combinations,
particularly, 63.9% of repeaters in women attempted overdose of
drugs. Significantly more repeat presentation in women were
triaged to the low priority categories and survival ratio of this group
was highest. There were no tendencies in psychiatric diagnosis of
repeaters, however, young women were frequently diagnosed per-
sonality disorder. First repeats were found to occur more frequently
in the 3 months following the original attempt for the half of patients.
Conclusions: This study concludes that there are some significant
differences between patients who attempt suicide repeatedly and
those who attempt on one occasion only. To arrange suitable after-
care, the doctors who are in charge of emergency department
should train to assess and manage patients of self-poisoning or
self-harm in collaboration of the psychiatric services.
P203 Combined verapamil and atenolol poisoning: resolution of cardiogenic shock with enoximone
F Gallizzi, G Ferro, F Cavallaro, C Addario, C Sandroni
Department of Anaesthesiology and Intensive Care, Catholic University, Rome, Italy
Case report: A 57-year-old man (b.w. 75 kg), two previous
myocardial infarctions and major depressive disorders, was admit-
ted to the emergency room about 1 hour after suicidal ingestion of
2800 mg atenolol and 1600 mg verapamil. The patient was pale,
cold, comatose and showed respiratory insufficiency which
needed intubation and mechanical ventilation. Hemodynamic moni-
toring was started, including heart rate (HR), invasive blood pres-
sure (BP) measurement, pulmonary artery pressures and cardiac
output (CO). Despite aggressive inotropic therapy with dopamine
30 mg/kg/min, adrenaline 10 mg/kg/min and calcium chloride (4 g
total), clinical conditions progressively worsened: BP was 80/60
mmHg, HR was 65 bpm, CO 1.4 l/min, SVR 3371 dyne/s/cm–5,
central venous pressure (CVP) 16 mmHg and PCWP 18 cmH2O;
urine output dropped to zero.
Four hours after ingestion, a bolus dose of enoximone 1 mg/kg
was administered, followed by a continuous infusion at 0.5
mg/kg/h. During the following hours the patient’s clinical condition
markedly improved: CO increased up to 6 l/min, HR stabilized at
80 bpm, PCWP reduced to 11 mmHg and CVP to 8 mmHg, blood
pressure raised to 135/75 mmHg, SVR decreased 1045
dyne/s/cm–5, urine output was stable at 150 ml/h. Adrenaline infu-
sion was progressively reduced and stopped after 24 hours, while
enoximone was discontinued on 5th day. Dopamine infusion was
maintained at low rates for 10 days after the ingestion. The patient
recovered a normal neurological and hemodynamic status, was
extubated and dismissed from the ICU on 14th day.
Discussion and conclusions: Most common features of acute
beta-blockers poisoning are hypotension, bradycardia and depres-
sion of level of consciousness. Calcium channel blockers, particu-
larly verapamil, have an additive effect with beta-blockers and
therefore enhance their cardiovascular toxicity, causing severe car-
diogenic shock, which can be, as in this case, unresponsive to
even high doses of cathecolamines [1,2].
The use of a phosphodiesterase III inhibitor, as enoximone, can
bypass the effect of beta-blockers and restore a sufficient cardiac
output, without increasing myocardial oxygen consumption, which
should be avoided when past history includes angina pectoris or
myocardial infarction, as in this case [3,4].
This report strongly supports the use of enoximone in combined
beta-blockers and CCBs intoxication and suggests its adminis-
tration particularly when cathecolamines have been showed inef-
fective.
References:
1. Packer M, Meller J, Medina N, et al: Hemodynamic consequences of
combined beta-adrenergic and slow calcium channel blockade in
man. Circulation 1982, 65:660–668.
2. Love JN, Litovitz TL, Howell JM, et al: Characterization of fatal beta
blocker ingestion: a review of the American Association of Poison
Control Centers Data from 1985–1995. J Toxicol Clin Toxicol 1997,
35:353–359
3. Vincent JL, Leon M, Berré J: The role of enoximone in the treatment
of cardiogenic shock. Cardiology 1990, 77:21–26
4. Moore NA, Tarr TJ, Fraser RS, Shearer E: A comparison of enoxi-
mone, dopamine and dobutamine in weaning from cardiopul-
monary bypass, following mitral valve surgery. J Cardiothor Vasc
Anaesth 1992, 6 (suppl):67.
P204 Organophosphate poisoning: 10 years experience in a paediatric intensive care unit
L Verhulst, Z Waggie, M Hatherill, L Reynolds, N Brathwaite, A Argent
Red Cross War Memorial Children’s Hospital, Cape Town 7701, South Africa
Objective: To review our experience of organophosphate poisoning
in the paediatric intensive care unit (PICU) of a university hospital.
Methods: Retrospective review of the hospital records of all chil-
dren admitted to the PICU with organophosphate poisoning for the
period January 1990–May 2000. Fifty-four children were admitted,
median age 43 months (5–170) and weight 15 kg (7–36). Data
are presented as median (range), and analysed by the
Mann–Whitney and Fisher’s Exact tests.
Results: Fifty-four per cent (n = 29) were from the Cape Town
urban area, and 46% (n = 25) from rural areas, significantly
more than expected for our PICU referral pattern (25% rural,
P = 0.0075). Sixty-nine percent (n = 37) were boys and 31%
(n = 17) girls (P = 0.039). There was no seasonal variation
(winter, n = 25 vs summer, n = 29). The routes of poisoning
were ingestion (n = 27, 50%), topical skin contamination (n = 8,
15%), a combination of the above (n = 5, 9%), and unknown
(n = 14, 26%). Presenting clinical features included bronchor-
rhoea (n = 31, 57%), miosis (n = 30, 56%), seizures (n = 16,
30%), and sinus bradycardia (n = 2, 4%). Complications
included acute respiratory distress syndrome (ARDS) (n = 2,
4%) and tachyarrhythmia (n = 9, 17%). Patients were treated
with atropine median total dose 0.3 mg/kg (0.03–16.7) and
obidoxime 4–8 mg/kg. Twenty-nine children (53%) required
mechanical ventilation for median duration 2 days (1–39). Dura-
tion of PICU stay (survivors) was median 3 days (1–83). Four
children (7%) died.
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Decontamination prior to PICU admission was associated with a
shorter hospital stay (median 3 vs 5 days) for survivors (P = 0.028),
but not with a lower rate of complications (P = 0.73) or mortality (P
= 0.34). The presence of a tachyarrhythmia was associated with an
increased mortality (n = 4/9; 44% vs n = 0/45; 0%) (P = 0.0004).
Conclusion: More children than expected were from rural areas.
Mortality in children with organophosphate poisoning is related to
the presence of tachyarrhythmias. Early decontamination is associ-
ated with shorter hospital stay but not with decreased mortality.
P205 End-tidal CO2 (EtCO2) and QTc period: can it help us in the prognosis of patients with organophosphate poisoning?
S Grmec, S Mally, P Klemen
PHU Maribor, Ulica talcev 9, 2000 Maribor, Slovenia
Introduction: In our area, organophosphate poisoning is a frequent
method of commiting suicide, with a relatively high mortality rate
(12–16%, data from literature). Defining and observing the QTc
period and EtCO2 enables us to make an additional estimate of the
handicap and prognosis, or better the possibility of complications
(respiratory failure).
Methods: The contribution presents our experience in the period
from February 1997 to September 2000. During this period, either
in the emergency ward or during interventions we met 61 patients
(37 male and 24 female; age varied from 18 to 75 years with a
mean 57.4 ± 18.3), for whom the diagnosis organophosphate poi-
soning was confirmed by means of anamnesis/heteroanamnesis
and laboratory analysis (serum cholinesterase). In prehospital
setting we collected from each patient EtCO2, SaO2, QTc period,
pre- and postintervention values of the MEES. The APACHE II
score was recorded on the day of admission to the hospital. We
compared two groups (with complications [group I] and without
complications [group II]). A P value < 0.05 was chosen to rejected
null hypothesis.
Results: See Table.
Conclusion. In the initial nursing of patients with organophosphate
poisoning, monitoring (ECG, capnometry) and observation of the
QTc period and EtCO2 is essential, for it helps us in the prognosis
of the patient and suggests precaution due to the danger of com-
plications (respiratory failure).
Table
Group I Group II P value
End-tidal CO2 (mmHg) 38.3 ± 8.5 56.4 ± 10.3 < 0.05*
SaO2 (%) 75.3 ± 9.2 89.5 ± 6.3 < 0.05*
QTc (s) 0.69 ± 0.17 0.45 ± 0.11 < 0.05*
MEES (postintub.) 18.3 ± 6.1 22.4 ± 3.3 < 0.05*
APACHE II 32.7 ± 9.4 20.6 ± 5.8  < 0.05*
Intubation-Y/N 22/7 11/21 < 0.05†
Ratio dead/survive 11/19 3/28 < 0.05†
* Student’s t-test; † c2 test.
P206 Cardiac troponin I as a marker of myocardial injury in paracetamol induced acute liver failure
S Mahadeva, N Parekh, M Bosomworth, CE Millson, KE Berkin, MC Bellamy
Intensive Care Unit, St James’s University Hospital, Leeds LS9 7TF, UK
Background: Anecdotal case reports and necropsy studies have
suggested that severe paracetamol poisoning may cause cardiac
injury in addition to fulminant hepatic failure. Cardiac troponin I
(cTnI) is a regulatory protein highly specific for myocardial injury
which has not been evaluated in paracetamol poisoning.
Aim: To assess the incidence of myocardial toxicity in paracetamol
induced fulminant hepatic failure in a prospective, controlled trial.
Methods: Patients admitted with paracetamol (POD) and non-
paracetamol acute hepatic failure were studied (subjects and posi-
tive controls). Healthy volunteers were enrolled as negative
controls for serum sampling. Patients with pre-existing cardiac
disease, chronic liver disease or chronic alcoholism were excluded
from the study. Cardiac investigations included baseline ECG and
transthoracic echo (TTE) on admission, invasive haemodynamic
monitoring and daily cardiac output studies in those in whom a pul-
monary artery floatation catheter was clinically indicated. Serum
creatinine kinase MB isoenzymes and cTnI were followed for the
first week of admission.
Results: Nineteen patients were enrolled from September 1999 to
October 2000. Eleven had paracetamol induced liver failure and
eight had other aetiologies. Thirteen were female and the mean
age was 35.79 (range 17–59). Fourteen patients were admitted to
ICU, 12 were ventilated and underwent invasive haemodynamic
monitoring. Eleven had intracranial pressure (ICP) monitoring.
None of the 13 patients who had TTEs showed evidence of
myocardial dysfunction. ECG was normal in 11 patients and
showed sinus tachycardia in 7 patients. One patient had terminal
ventricular tachycardia. 53% of patients (subjects and positive
controls) had cTnI above the upper limit of the laboratory normal
range on day 1 and subsequent days of admission (0.67 + 1.01).
cTnI was higher in the paracetamol group than the positive con-
trols, but this difference was not statistically significant, 1.02 ± 1.2
(POD) versus 0.23 ± 0.24 (non-POD). Negative control values fell
within the normal range. By multivariate analysis there was an inde-
pendent significant correlation between noradrenaline require-
ments and cTnI (P = 0.004). In addition, cTnI levels above the
normal range were associated with a low LVSWI (P < 0.01), an
increased heart rate (P < 0.05) and CVP (P < 0.05).
Conclusions: In this study, we have demonstrated that previously
fit young patients with acute hepatic failure developed myocardial
injury. This was more severe in those treated with noradrenaline.
There was a trend towards worse myocardial injury as evidenced
by raised cTnI, but not by TTE, in patients with paracetamol
induced hepatic failure. A larger study is required to establish
whether myocardial damage seen in acute liver failure is a direct
effect of paracetamol.S97
P207 Magnesium in the intensive care unit
A Abraham*, A Bachwani*, DM Gamadia*, BB Ichhaporia*, P Singer†, J Cohen†
*Intensive Care Unit, Parsee General Hospital, Mumbai (Bombay) 400036, India; †General Intensive Care Unit, Beilinson Hospital, Petah
Tikwa, Israel
Introduction and aims: Magnesium has been used since time
immemorial as a purgative and uterine relaxant. Magnesium regu-
lates many life processes and is the key factor in the production of
ATP, the source of life energy. It is a natural calcium channel
blocker and neutralizes the effect of catecholamines, it works very
well on supraventricular and ventricular arrhythmias. We obtained
excellent results on cardiac arrhythmias and drug induced
supraventricular tachycardia (dopamine, dobutamine, noradrena-
line, adrenaline and aminophylline). The aim of this prospective
study is to know the affects of magnesium therapy on different criti-
cal conditions in the ICU.
Methods: Administer magnesium 5 g in D5W over 6–8 hours. The
heart rate is monitored at 15, 30, 45, 60, 75 and 90 min, and then
at 6 and 12-hour interval. To give the same dose for 5 consecutive
days. Other parameters like urine output, creatinine and patient’s
survival were noted.
Results: Prospective study: 115 cases treated with magnesium
(50 drug induced SVT, 20 SVT, 5 ARDS, 16 CCF, 7 CPR, 7 Dia-
betic ketoacidosis, 1 carpopedal spasm, 1 chronic alcoholism
induced hypokalemia).
Benefits seen after magnesium therapy: 1. Heart rate came
down within an avg of 45 min, rhythm improved from irregular to
regular and to good volume. 2. Urine output increased from almost
oliguria to 30–40 ml/hour. Creatinine reduced or did not rise any
further. 3. Pulmonary edema resolved in 24 hours. 4. Lactic acido-
sis disappeared with in 4–5 hours.
Table
Results after the use of magnesium in patients having different pathology
Pathology No of patients Heart rate Urine output Creatinine Died  Survived
Drug induced 50 164–108/min Improved Not studied Not studied Not studied
SVT 20 180–84/min (45 min) Improved Normal 0 20
ARDS 5 130–84/min Improved Reduced 3 2
CCF 16 144–102/min Improved 7–1 8 8
CPR 7 Vent. Tach. — normal rhythm Improved (later on) Not studied 2 5
Diabetic ketoacidosis 7 150–96/min Improved Reduced (N) 2 5
Carpopedal spasm 1 NA NA 0 1
Alcoholic hypokalemia 1 Bradycardia (corrected) 0 1
Base deficit 9 Came to normal in 4–5 hours 0 9
Table
Inotropes (dopamine, dobutamine & noradrenaline) induced SVT after the use of magnesium
0 min 15 min 30 min 45 min 60 min 75 min 90 min 6 hours 12 hours
164 138 129 108 101 100 96 92 94
In 45 min, the average heart rate comes down to 108.
Figure
Graphical presentation (average heart rate).
Figure
Serum creatinine (after Mg therapy over 5 days).
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Discussions: 1. Tachycardia induced by positive inotropes or
cardiac pathology comes down to an acceptable rate when
Magnesium is given in an average of 45 min. 2. Patients are pro-
tected from Tachyarrhythmia (Atrial and Ventricular arrhythmia).
Incidences of drug-induced arrhythmias when Magnesium is
given concomitantly with inotropes or bronchodilators are nil. 3.
Magnesium improves energy production (ATP) and stimulates
metabolism. This is advantageous as patients requiring
ionotropes are always in shock. 4. The affect of Magnesium
therapy on Base Deficit (Lactic Acidosis) is to be studied
further, because we got normal base values within 5–6 hours of
Magnesium.
P208 Critical illness is associated with elevated parathyroid hormone
GP Zaloga*, D Teres†
*Suburban Hospital, Bethesda, MD 20814, USA; †AstraZeneca, Wilmington, DE 19850, and Tufts University School of Medicine, Boston,
MA 02111, USA
Introduction: Propofol (Diprivan®, AstraZeneca) is a reliable seda-
tive frequently used in critically ill patients (pts). The modified for-
mulation contains 0.005% disodium edetate (EDTA) as an
antimicrobial agent. EDTA is also a chelating agent and may
impact calcium balance; therefore, three clinical trials were per-
formed in which ionized calcium (Ca2+) and parathyroid hormone
(PTH) levels were assessed. PTH plays a major role in calcium
homeostasis but is generally not considered to be a stress
hormone.
Purpose: Evaluate PTH levels in critically ill pts sedated with
propofol or propofol EDTA.
Methods: Serum intact PTH, total Mg, Ca2+, and total Ca were
measured in 212 pts in 3 randomized, double-blind, controlled
trials (85 medical ICU, 37 renal impaired ICU, and 90 cardiac sur-
gical pts).
Results: See Table. For the medical ICU pts, baseline PTH levels
were unexpectedly increased above the normal range (unrelated to
propofol and Ca2+). Baseline PTH levels in pts undergoing elective
cardiac surgery were normal. Pts with impaired renal function had
high PTH values presumably secondary to hyperparathyroidism.
Conclusion: PTH levels were elevated at baseline in critically ill
medical ICU pts without renal failure. This finding was not related to
propofol or low Ca2+ levels. The explanation is unknown, but perhaps
PTH should be reconsidered as being a stress hormone. Patients
with impaired renal function had high PTH values, presumably sec-
ondary to decreased Ca2+ levels and/or hyperparathyroidism.
Table
Intact PTH Levels in pg/ml (mean ± SEM; normal range: 9–46 pg/ml)
Medical ICU pts Renal impaired pts Cardiac surgery pts
24 h after  48 h after  1 h after 
Baseline sedation Baseline sedation Baseline extubation
Propofol 84.9 ± 15.1  69.2 ± 19.2  126.3 ± 23.6  119.9 ± 44.7  40.6 ± 2.4  62.3 ± 5.3 
(n = 26) (n = 22) (n = 19) (n = 15) (n = 46) (n = 46)
Propofol EDTA 92.0 ± 18.6 72.1 ± 26.4  234.4 ± 52.2  141.1 ± 33.6  40.0 ± 2.9  67.6 ± 5.5 
(n = 21) (n = 14) (n = 18) (n = 13) (n = 44) (n = 44)
P209 Hypocalcemia in children with septic shock
CMP Buysse, DCM van der Kaay, E van der Voort, M de Hoog, JA Hazelzet, KFM Joosten
Sophia Children’s Hospital, Dr Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands
Introduction: Ionized calcium is essential for maintenance of
myocardial function and vascular tone. Ionized hypocalcemia is
seen frequently in critically ill patients and is associated with poorer
prognosis. It is unclear whether calcium administration is beneficial
in these patients.
Objective: To evaluate the incidence of ionized hypocalcemia
(Ca2+-level < 1.0 mmol/l), the time course of serum ionized calcium
(Ca2+) in children with septic shock, the effect of calcium adminis-
tration and the relationship with survival.
Methods: We retrospectively studied 37 children with septic
shock. We analyzed Ca2+ levels on admission and after 8 and 24
hours, the dose of intravenous calcium administration in the first 24
hours and survival.
Results: The group consisted of 22 boys and 15 girls with a
median age of 2.3 years (0.2–16.1 years). The median PRISM-
score was 23. There were nine non-survivors. On admission 26
patients (68%) were hypocalcemic (19 survivors and 7 non-sur-
vivors). There was a significant negative correlation between
PRISM-score and Ca2+ levels on admission (r = –0.46, P < 0.01).
On admission there was not a significant lower Ca2+ level in non-
survivors compared to survivors (0.89 mmol/l vs 0.96 mmol/l, NS).
During the first 24 hours after admission 14/28 survivors and 8/9
non-survivors received calcium administration intravenously. All 22
patients received calcium in a slow infusion during the first 24
hours, 3/14 survivors and 3/8 non-survivors also received a bolus
of 0.1 mmol/kg in 30–60 minutes. There was a significant differ-
ence in the Ca2+ level on admission between survivors with and
without Ca2+ administration (0.91 mmol/l vs 1.00 mmol/l,S99
P < 0.05) but no significant increase in Ca2+ levels was found 24
hours later in these groups (resp 0.20 mmol/l vs 0.28 mmol/l, NS).
For the non-survivors Ca2+ levels 8 hours after admission were not
significantly higher than Ca2+ levels at admission (0.95 mmol/l vs
0.89 mmol/l, NS).The dose of calcium varied between 0.07 and
1.8 mmol/kg/day with a mean of 0.55 mmol/kg/day and in non-sur-
vivors the dose was significantly higher compared to survivors
(0.64 mmol/kg/day vs 0.2 mmol/kg/day, P < 0.01).
Conclusion: The incidence of ionized hypocalcemia in children
with septic shock was high (68%), but Ca2+ levels were not
related to survival at the time of admission in the PICU. However
there was a negative correlation with the PRISM-score. In the sur-
vivors 24 hours after admission there was no significant increase of
Ca2+ levels between children with or without Ca2+ administration.
Non-survivors received more calcium intravenously compared to
survivors, but Ca2+ levels 8 hours after admission were not signifi-
cantly higher compared to Ca2+ levels at admission despite
calcium administration. The question remains if calcium administra-
tion leads to significant changes in Ca2+ levels and because of the
potential adverse effects of calcium administration this treatment
should be reconsidered.
P210 Bone resorption and acute renal failure in the hypercalcaemic critically ill
JF Ledson*, GR Masterson*, SM Mostafa*, T Hankin*, N Gratton*, E Manning†, WD Fraser†
*Department of Intensive Care, and †Department of Clinical Chemistry, Royal Liverpool University Hospital, Prescot Street, Liverpool L7 8XP, UK
Introduction: We have reported increased bone resorption
without elevated bone formation in both hypercalcaemic and nor-
mocalcaemic critically ill patients. The extent to which acute renal
failure (ARF) is a factor in the development of hypercalcaemia in
this group is unknown.
Aims: To investigate the contribution of (ARF) to hypercalcaemia in
the critically ill.
Methods: Twenty-three hypercalaemic (Gp 1) were compared to
six normocalcaemic (Gp 2) mechanically ventilated, critically ill
adults. Urinary pyridinoline (Pyr), deoxypyridinoline (Dpyr) and
plasma carboxyterminal cross-linked telopeptide of type 1 collagen
(ICTP) were measured as markers of bone resorption. Plasma car-
boxyterminal propeptide of type 1 procollagen (P1CP), bone spe-
cific alkaline phosphatase (BAP) and osteocalcin were measured
as markers of bone formation. ARF was defined as the need for
renal replacement therapy. For analysis the Mann–Whitney U and
Fisher’s exact tests were used (significance = P < 0.05).
Results: Medians (ranges) for indices of bone resorption and for-
mation together with the prevalence of acute renal failure are pre-
sented in the Table.
Increased bone resorption without an increase in bone formation
was demonstrated in both groups, with no significant difference
between the groups. ARF was significantly more prevalent in Gp 1.
Conclusion: Increased bone resorption leads to efflux of calcium
from bone into the plasma pool in hypercalcaemic and normocal-
caemic critically ill patients. Our results suggest that ARF may be a
contributory factor to the development of hypercalcaemia.
Table
Gp 1 Gp 2 P value
Bone resorption Pyr (nmol/mmol creat) 85.42 (31.8–351.6) 142 (55.1–216) 0.69
Dpyr (nmol/mmol creat) 19.27 (8.4–112.7) 22.7 (7.2–31.5) 0.69
ICTP (mg/l) 83 (31–178) 85.5 (26.5–139) 0.75
Bone formation P1CP (mg/l) 325 (156–1733) 393.5 (165–683) 0.94
BAP (U/l) 17.6 (12.5–29.9) 15.65 (11.1–41) 0.71
Osteocalcin (mg/l) 4.5 (0.6–12.2) 2.85 (0.85–9.5) 0.11
ARF 19/23 1/6 0.0053
P211 Shock, acute renal failure and MODS as mortality indicator in acute pancreatitis
V Segura, D Chicas, Y Bonilla
Critical Medicine Unit, Internal Medicine Department, Hospital Médico Quirúrgico (ISSS), Alameda Juan Pablo II, San Salvador, El Salvador
Introduction: It has been described some scores to establish the
prognosis in patients with acute pancreatitis. The Balthasar CT
classification (1) allows to establish with a lot of certainty the mor-
tality according to the gland compromise that its seen in the CT,
however the certainty of the prognosis is improved if these
combine with other severity criteria as the Ramson criteria. These
associations could show that the degree of SIRS has a more
closer direct relation with the prognosis then the lesion seen in
the CT.
Objetive: To evaluate if the Balthasar classification has a high
power of prognosis in those cases with a CT, classification of C, D,
and E. In addition other factors that could be associated to morbil-
ity and mortality in patients with acute pancreatitis were evaluated.
Methods: The records of 49 patients with acute pancreatitis were
reviewed. These patients entered to our unit in the period of July 1,
1999 to June 30, 2000. Every CT was reviewed with two radiolo-
gists to determine the Balthasar classification and in case of dis-
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agreement a third evaluation was asked. The kappa value was
established for the CT evaluation. The variables shock, renal failure,
MODS and Balthasar for the mortality prognosis were evaluated.
Results: (See Table.) The review of the Balthasar score had a
kappa of 0.88, our results show a low specificity and predictive
positive value of Balthasar score C, D, and E, to predict the proba-
bility of mortality. The variables shock, renal failure and MODS
show more certainty to the prediction of mortality.
Conclusion: The Balthasar score does not predict with certainty
the probability of mortality by itself. Other variables related with the
severity of SIRS as shock more certainty the mortality in patients
with acute pancreatitis.
Reference:
Balthasar EJ et al: Radiology 1985, 185:767–772.
Table
Predictive Predictive
positive negative
Sensitivity Specificity value value
Balthasar score  87.7% 45.2% 20% 95%
(C, D, and E)
Shock 85.7% 92% 66% 97%
Renal failure 85.7% 92% 66% 97%
MODS 85.7% 90% 60% 97%
P212 Acute renal failure due to crush injury and prolonged positional compression on a muscle group
D Bilskiene, D Reingardiene, A Jankauskas, A Jonusas
Intensive Care Clinic, Kaunas Medical University Hospital, Eiveniu 2, LT-3007 Kaunas, Lithuania
Introduction: Widespread muscle crush injury and prolonged
positional compression on a muscle group are often associated
with myoglobinuric acute renal failure (ARF). Treatment consists of
early massive volume replacement and forced alkaline solute diure-
sis. With this regimen it is possible to increase survival of life and
limbs, and prevent myoglobinuric ARF.
Methods: The present study was carried out to describe clinical
pattern of ARF caused by crush injury and prolonged positional
compression on a muscle group. Clinical and laboratory data of 61
crush or positional compression injury patients transferred to ICU
were analyzed. All patients were evaluated by physical examination,
determinations of serum levels of electrolytes, urea, creatinine,
acid–base balance. Also we recorded the following data: a) the
period from the onset of injury to the commencement of treatment;
b) the form of ARF; c) need of hemodialysis; d) complications; e)
the mortality rate. The only indications for fasciotomy were lack of a
distal pulse or open lesions.
Results: Sixty-one patients were admited to our ICU with ARF
caused by crush injury (25 patients) or prolonged positional com-
pression on a muscle group (36 patients). These patients con-
sisted of 55 men and 6 women with a mean age of
40.9 ± 13.4 years, ranging from 19 to 85. All the patients demon-
strated kidney failure with increased concentrations of serum urea
(13.22–79.40 mmol/l) and creatinine (172–1398 mmol/l). ARF
was highly associated with massive muscle damage and insuffi-
cient initial fluid resuscitation. The period from the onset of symp-
toms and signs of the injury to the commencement of treatment
with hemodialysis varied from 4 hours to 9 days. Fifty-nine (97%)
patients were oliguric. Fifty-eight (95%) of these patients were
treated with hemodialysis from 1 to 21 days. Hyperkalemia
(5.6–8.1 mmol/l) was present in 38 (62%) patients. More than in
half cases hyperkalemia was diagnosed before azotemia. Six
(9.8%) patients underwent fasciotomies and 6 (9.8%) patients
underwent amputations. The outcome was favorable in 43 (70%)
patients, 18 (29.5%) patients died. The half causes of death were
infection and sepsis.
Conclusions: 1. Hyperkalemia, and metabolic acidosis appear
before azotemia and within hours of the rescue of casualties with
traumatic rhabdomyolysis. 2. Very early, aggressive volume
replacement followed by forced solute-alkaline diuresis therapy
may protect the kidney against acute renal failure.
P213 Experience with continuous venovenous hemofiltration (CVVH) in the ICU: a report from a single center
V Nalbandi, T Natse, C Iasonidou, F Kodonas, G Bamichas, V Tsiora, D Riggos, K Sombolos
ICU and Renal Unit, GH ‘Papanikolaou’, Exochi, 57010 Thessaloniki, Greece
During the last 7 years in our ICU, CVVH was used as renal
support in 101 critically adults (79 M, 22 F, median age 57, range
17–86) with acute renal failure (ARF). Patients who were treated
with CVVH for less than 24 hours were excluded from this report.
APACHE score at admission was 23 (median, range 8–42). The
majority of the patients was on mechanical ventilation (98%) and
needed vasopressor support (91%). Vascular access was per-
formed with the use of a blood pump. Conventional heparin was
used for anticoagulation in the most of the cases (90%).
In 31 of the patients (group A) CVVH was initiated upon their first day
of admission while in the rest 70 pts (group B) CVVH was started on
the 9th day, median (range 2–32) of their hospitalization in the ICU.
Uremia was satisfactory controlled in most of the cases with a mean
amount of ultrafiltrate of 38.7 ± 0.6 SEM, l/day (range 27–49.5).
Patients of group A remained on CVVH treatment for a median of 5
days (range 1–40), while those of group B for 4.5 days (range 1–29),
P = NS. Although serum creatinine levels at the initiation of CVVH did
not show any difference between the groups (group A 4.9 ± 0.4
SEM, group B 5.2 ± 0.5 SEM, P = NS), the corresponding BUN level
were lower in patients of group A (86.0 ± 7.1 SEM vs 112.8 ± 6.9
SEM, P= 0.021). The duration of hospitalization (days) in the ICU
was also lower in the group A patients (10.7 ± 2.2 SEM vs 24.2 ±
2.0 SEM, P = 0.0001). Ten (10) patients of group A (32.2%) and 15
pts of group B (21.4%) were survived and discharged from the ICU,
c2 = NS, with a mean serum creatinine and BUN levels that did not
differ between these two groups. The overall mortality was 75.2%.S101
It is concluded that in the ICU the mortality rate of critically ill adults
patients with ARF demanding renal support treatment remains high
despite the use of CVVH and that the timing of ARF occurrence
and CVVH initiation does not exert any major influence on the
outcome of these patients.
P214 Does biocompatibility of dialysis membranes affect survival in patients with acute renal failure?
R Venkataraman, S Subramanian, JA Kellum
Department of Anesthesiology/CCM and Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
Introduction: During hemodialysis, contact between blood and
dialysis membranes leads to complement and neutrophil activation.
This effect is known as bioincompatibility and is most pronounced
with older, less expensive, cellulose-based membranes. However,
there is considerable controversy as to whether synthetic (more
biocompatible) dialysis membranes improve survival in patients
with acute renal failure (ARF) compared to cellulose-based mem-
branes. Numerous trials have been conducted but have yielded
conflicting results. Although the discordant results of existing
studies could be explained by the varying degrees of biocompati-
bility among the different membranes used, these studies were
also of low statistical power. Thus we sought to determine whether
combining results from all published trials would provide a better
estimate of the effect of membrane on survival in ARF.
Methods: Studies were identified through a Medline search, authors’
files and bibliographies of review articles. Studies were included if
they were done prospectively, compared synthetic and cellulose-
based membranes, and specified mortality rates for each group.
Results were expressed as the cumulative odds ratio (OR) of survival
over time where a P < 0.05 was considered significant. The entire
sample was then analyzed for homogeneity using a Mantel–Haenszel
(M–H) test, the OR recalculated using the weights from the M–H
test and final M–H combined odds ratio determined.
Results: Eight prospective studies were included (n = 857) and an
improvement in survival with biocompatible membrane was demon-
strated (OR = 1.37, 95% CI = 1.03–1.84, P = 0.03).
Conclusion: Use of biocompatible membranes for dialysis in ARF
is associated with improved patient survival compared to the use of
bioincompatible dialysis membranes.
Figure
P215 Effects of bicarbonate- and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients
RM Schaefer, M Hausberg, F Matzkies, M Barenbrock
Department of Internal Medicine, University of Muenster, Albert-Schweitzer-Str 33, 48129 Muenster, Germany
Background: Bicarbonate-buffered replacement fluid (RF-bic) in
continuous venovenous hemofiltration (CVVH) may be superior to
lactate-buffered replacement fluid (RF-lac) in acute renal failure. In
an open, randomized, multicenter study, we investigated the
effects of RF-bic and RF-lac on cardiovascular outcome in patients
requiring CVVH following acute renal failure.
Methods: 117 patients between the age of 18 and 80 years were
randomized to CVVH either with RF-bic (N = 61) or RF-lac (N =
56). Patients were treated with CVVH for 5 days or until either
renal function was restored or the patient was removed from the
study. Data were analyzed on day 5 or according to the ‘last obser-
vation carried forward’ (LOCF) option.
Results: Blood lactate levels were significantly lower and blood
bicarbonate levels were significantly higher in patients treated with
RF-bic than in those treated with RF-lac (lactate, 17.4 ± 8.5 vs
28.7 ± 10.4 mg/dl, P < 0.05; bicarbonate, 23.7 ± 0.4 vs 21.8 ±
0.5 mmol/l, P < 0.01). The number of hypotensive crises was lower
in RF-bic-treated patients than in RF-lac-treated patients (RF-bic
14 out of 61 patients, RF-lac in 29 out of 56 patients; 0.26 ± 0.09
vs 0.60 ± 0.31 episodes per 24 h, P < 0.05). Nine out of 61
patients (15%) treated with RF-bic and 21 out of 56 patients
(38%) treated with RF-lac developed cardiovascular events during
CVVH therapy (P < 0.01). A multiple regression analysis showed
that the occurrence of cardiovascular events was dependent on
replacement fluid and previous cardiovascular disease and not on
age or blood pressure. Patients with cardiac failure died less fre-
quently in the group treated with RF-bic (7 out of 24, 29%) than in
the group treated with RF-lac (12 out of 21, 57%, P = 0.058). In
patients with septic shock, lethality was comparable in both groups
(RF-bic, 10 out of 27, 37%; RF-lac, 7 out of 20, 35%, P = NS).
Conclusions: The results show that the administration of RF-bic
solution was superior in normalizing metabolic acidosis without the
risk of alkalosis. The use of RF-bic during CVVH reduced cardiovas-
cular events in critically ill patients with acute renal failure, particularly
in those with pre-existing cardiovascular disease or heart failure.
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P216 Dosing patterns for continuous renal replacement therapy in the United States
R Venkataraman, JA Kellum
Department of Anesthesiology/CCM and Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
Introduction: There is evidence that increasing the dose of continu-
ous renal replacement therapy (CRRT) is associated with improved
survival in critically ill patients with acute renal failure (ARF) [1]. In the
US, CRRT is usually provided with an ultrafiltrate (UF) and/or dialysis
flow rate of 2 l/h irrespective of the patient’s weight. Patients under-
going CRRT frequently have their therapy interrupted and hence
receive a much lower dose than prescribed. Hence we retrospec-
tively reviewed the records of all patients with ARF, who received
CRRT in our hospital in the past year, to determine dosing patterns.
Methods: Computerized records of all patients (n = 115) who
received CRRT for ARF in our institution from September 1999 to
August 2000 were reviewed. Patients were included in analysis if
they received CRRT for at least 2 days and their hospital discharge
outcome was known. All but four patients met these inclusion crite-
ria. The patient’s CRRT dose for each day was inferred from the
hourly UF/dialysis flow rate and the duration (in hours) of CRRT for
that day. A mean UF/dialysis flow rate (in l/h) for each patient was
then calculated. Other patient demographic characteristics includ-
ing age, weight and duration of therapy were obtained from the
patient’s records.
Results: The average number of hours/day on CRRT was 16.1,
with a mean flow rate of 1.36 l/h. The mean CRRT dose for these
patients was only 16.50 ml/kg/h, much lower than the lowest dose
(20 ml/kg/h) used by Ronco et al [1].
Table
CRRT characteristic Mean value
Age 55.50
Weight (kg) 88.90
Number of days on CRRT 9.23
Number of hours/day on CRRT 16.10
Hourly flow rate (l/h) 1.36
Dialysis dose (ml/kg/h) 16.50
Hospital mortality (%) 65.76
Conclusion: In the US, many patients are prescribed a lower dose
of CRRT than supported by current evidence. Moreover, the actual
dose delivered is much lower than that prescribed. Immediate
changes in dosing practices are necessary to achieve the doses
recently shown to be beneficial in patients with ARF [1]. A weight-
based dosing regime may enable physicians to achieve increased
dosing of CRRT in such patients.
Reference:
1. Ronco C et al: Lancet 2000, 355:26–30.
P217 A preliminary investigation of the nephroprotective effects of the adenosine antagonist aminophylline in patients
undergoing abdominal aortic aneurysm repair
G O’Callaghan*, N Dalton†, RJ Beale*, P Taylor‡, A Bersten§
*Department of Intensive Care, †Department of Paediatrics, and ‡Department of Vascular Surgery, Guy’s and St Thomas’ Hospital, London
SE1 9RT, UK; §Department of Critical Care Medicine, Flinders Medical Centre, SA 5042, Australia
Infra-renal clamping of the abdominal aorta during aneurysm repair
is associated with a significant reduction in renal blood flow.
Adenosine has been implicated as a mediator of renal ischemia in
a number of human and animal models and its antagonism with
theophylline has lead to the attenuation of these effects. In order
to investigate the possible attenuation of renal arterial vasocon-
striction associated with infrarenal cross clamping of the aorta we
prospectively randomised 8 consecutive patients undergoing
abdominal aortic aneurysm repair to receive aminophylline
5 mg/kg (n = 5) in 500 ml normal saline or placebo (n = 3) on the
morning of surgery followed by an infusion of 6 mg/hour of amino-
phylline or placebo for 24 hours. Staff, investigators and patients
were blinded. Inulin clearance as an indicator of glomerular filtra-
tion rate (GFR) was measured pre-operatively and again on the
2nd post-operative day. N-Acetyl-b-glucosaminidase (NAG) activ-
ity (mmol PNP/hour/mol creat) and Retinol Binding Protein (RBP)
excretion (mg/mol creat) were measured to assess renal tubular
damage and albumin excretion (mg/mol creat) as a marker of
glomerular injury.
Results: There was a significant increase between the pre and post
operative measurements in NAG activity (45.53 to 248.96,
P = 0.0078), RBP excretion (10.68 to 3851.92, P = 0.0078) and
albumin excretion (1.165 to 7.88, P = 0.0078) however there was
no difference between the treatment and control groups. Contrary to
expectation inulin clearance was marginally increased in the postop-
erative period (80 vs 76 ml/min/1.73 m2, P = 0.36) in spite of a sig-
nificant reduction in urinary volumes (85 vs 40 ml/hour, P = 0.05).
Table
Characteristic Pts
Sex M/F 6/2
Age (median) 70
IHD (%) 6 (75)
LVF (%) 1 (12.5)
Diabetes (%) 1 (12.5)
Hypertension (%) 4 (50)
ACE inhibition (%) 2 (25)
Calcium channel antagonists (%) 4 (50)
Conclusions: 1. Infrarenal aortic aneurysm repair is associated
with significant renal ischemia that does not result in a sustained
fall in GFR. 2. Urine volumes are not an accurate reflection of GFR
in this setting. 3. Measurement of perioperative GFR is not a suit-
able way to assess the effects of adenosine antagonism in this
model of renal ischemia.S103
P218 The renal function tests: a key to understanding of osmolal disorders in cerebral injury?
M Balik*, A Kazda†, J Pazout*, A Hendl†
*Department of Intensive Care and Anaesthetics, University Hospital Vinohrady, Prague 10, Srobarova 50, Czech Republic; †Department of
Clinical Biochemistry, Postgraduate Medical School, Faculty Policlinic, Prague, Czech Republic
Introduction: Hyponatremia in cerebral injuries often associates
with Cerebral Salt Wasting Syndrome (CSWS) or Inappropriate
Antidiuretic Hormone Secretion Syndrome (IADHS). Typical cause
of hypernatremia is central diabetes insipidus (DI). The group of
available calculated renal function parameters is applied in the dif-
ferential diagnosis of these syndromes.
Methods: The aim of the retrospective study is to clarify whether
the changes of the renal function parameters predict the develop-
ment of classic serum changes in the IADHS, CSWS and DI.
Twenty patients with cerebral injury were evaluated during 3 days
before they developed hypo- or hypernatremia with the aid of the
original computer programe calculating renal function parameters.
Urine was collected for 24 hours. Patients with renal insufficiency
(Ckr < 0.8 ml/s), haemodynamicaly unstable and those who were
treated with dose of furosemide higher than 1 mg/kg/day or with
thiazide diuretics were excluded from the study. The courses of
electrolyte free water clearence (EWC), electrolyte clearence (Cel)
and natremia (SNa) in IADHS, CSWS and in DI were statistically
evaluated using paired t-test (NCSS v.4).
Results: CSWS was diagnosed in nine patients. Cel (l/24 h) was
gradually increasing above normal levels: 4.67 ± 3.45 vs 6.00 ±
2.70 (P > 0.05) vs 6.35 ± 4.99 (P > 0.05). Nevertheless the
changes during the development of hyponatremia (141.2 ± 2.9 vs
136.4 ± 3.0 [P < 0.01] vs 132.0 ± 4.2 [P < 0.01]) were not statis-
tically significant. EWC (l/24 h) was in normal range. Cel was
stable at the normal to slightly increased levels in six IADHS
patients. There was progresive decrease of SNa (139.3 ± 3.3 vs
136.9 ± 1.8 [P > 0.05] vs 133.1 ± 1.7 [P < 0.05]) accompanied
by the inappropriate negative but nonsignificantly decreasing levels
of EWC: –0.31 ± 2.12 vs –0.11 ± 1.44 (P > 0.05) vs –0.94 ±
0.69 (P > 0.05). Cel was found at normal levels in five patients
who developed DI. EWC was grossly elevated: 1.46 ± 0.63 vs
2.85 ± 3.25 (P > 0.05) vs 2.30 ± 1.03 (P > 0.05) however the
increase during the studied period did not reach statistic signifi-
cance. The same time SNa increased: 141.5 ± 4.7 vs 152.5 ± 7.3
(P < 0.06) vs 157.4 ± 5.1 (P < 0.05).
Conclusions: The changes in selected renal function tests are not
predictive for the development of the tonicity shifts in cerebral
injury patients. Despite these preliminary results the renal function
tests remain a valuable and cheap aid for the early diagnosis of the
syndromes. An early correction of the infusion and diuretic therapy
can minimize the disorder developing later.
P219 The relationship between renal function and renal urodilatin excretion immediately after cardiac surgery
M Heringlake, T Uhlig, L Bahlmann, A Pietsch, H Vogelsang, P Schmucker
Universitätsklinikum Lübeck, Klinik für Anaesthesiologie, Lübeck, Germany
Introduction: The precise pathophysiological role of the natriuretic
and diuretic peptide urodilatin remains to be defined. We hypothe-
sized that there is a relationsship between renal function and the
course of renal urodilatin excretion (UUROV) immediately after
cardiac surgery (CS) and — specifically — that a lower UUROV may
be observed in patients (pts) showing an increase in PCREA.
Methods: We determined UUROV, urine flow (UV), plasma creati-
nine (PCREA) and creatinine clearance (CLCREA) in 61 consecutive
pts immediately after cardiac surgery. Blood samples were taken
after arrival at the ICU (P0) and after 4–8 h (P1) and 12–16 h (P2)
hours, urine was sampled from P0 to P1 and from P1 to P2,
respectively. URO was measured with a commercially available RIA
(Immundiagnostik, Germany). Pts were divided into subgroups
showing an increase in PCREA of more than 25% (PCREA + group: n
= 10) or not (PCREA ± group: n = 51).
Results: Baseline variables at P0 were not different between both
groups. UUROV was tremendously increased in comparison with
historical data from healthy volunteers and did not differ between
both groups during the observation period despite a significant
decrease of CLCREA in the PCREA + group (Table 1). Correlation
analysis of all pts revealed a significant relationship between the
decrease in CLCREA and the decrease in UUROV (r = 0.5,
P = 0.006).
Conclusions: UUROV is tremendously increased immediately after
cardiac surgery. The relationsship between the decrease in UUROV
and CLCREA suggests that URO might play a role in the fluid
homeostatic adaptions after cardiac surgery and cardiopulmonary
bypass. However, pts showing an increase in PCrea and a
decrease in CLCREA cannot be identified by a single determination
of UUROV.
Table 1
UUROV (pmol/min) UV (ml/min) CLCREA (ml/min) PCREA (ml/min)
PCREA +P CREA ±P CREA +P CREA ±P CREA +P CREA ±P CREA +P CREA ±
P0–P1 3.5 ± 4.3 2.9 ± 2.7 4.6 ± 5.1 4.4 ± 2.2 129 ± 131 92 ± 48 71 ± 22 79 ± 21
P1–P2 2.9 ± 2.2 2.9 ± 2.5 3.2 ± 1.3 2.8 ± 1.1 80 ± 41* 106 ± 52 106 ± 55* 90 ± 24
For abbreviations see text. Data are median ± quartiles. * P < 0.05 Mann–Whitney test.
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P220 Trends in post-operative mortality in patients requiring renal replacement therapy following cardiothoracic transplantation
M Ostermann*, R Chang*, L Reynolds†, A Murday†, B Madden†, S Nelson*
*Renal Unit, and †Cardiothoracic Intensive Care Unit, St George’s Hospital, London, UK
Renal failure requiring renal replacement therapy (RRT) increases
mortality after any operation. Cardiothoracic surgery carries a high
risk of post-operative renal failure, but the effect of the management
of RRT on mortality is unclear in these patients. The aim of this
study was to determine the changes in mortality over a 15-year
period in patients requiring RRT following cardiothoracic transplan-
tation. We performed a retrospective review of all 406 patients who
received a heart (n = 359) or lung (n = 49) transplant in a single
tertiary care centre from November 1986 to October 1999. Two
patients underwent a second heart transplantation and one patient
received a combined heart/renal transplant during this period.
The requirement for RRT has not significantly altered over the time
period of the study. However there has been a dramatic reduction
in the 30-day mortality in patients treated with RRT which is sus-
tained through to the end of the first year. This is likely to be due to
earlier implementation of RRT with its associated improvements in
nutrition and homeostasis.
30-Day 1-Year 
Need for RRT mortality in  mortality in 
in first  patients  patients 
Date of Tx 30 days requiring RRT requiring RRT
1986–1990 12/71 10/12 11/12 
(16.9%) (83.3%) (91.1%)
1991–1995 29/202 19/29 24/29 
(14.4%) (65.5%) (82.8%)
1996–10/1999 26/135 11/26 15/26 
(19.3%) (42.3%) (57.7%)
1986–10/1999 67/408 40/65  50/65 
(16.4%) (61.5%) (76.9%)
P221 Outcome of renal transplant recipients and graft survival in the ICU
L Nicolet, AE Heng, B Souweine, G Mahnès, B Aublet, N Gazuy, PY Glanddier, P Deteix
Hôpital G Montpied, BP 69, 63003 Clermont-Ferrand Cedex 1, France
Objective: To determine renal transplant recipients outcome and
graft survival in ICU setting.
Design: Retrospective cohort study.
Setting: Ten-bed adult medical ICU in a university hospital.
Patients: Consecutive adult renal transplant recipients admitted to
an ICU over a period of 13 years. In our institution postoperative
monitoring is not performed in ICU.
Measurements: For each patient the following data were
recorded: demographic characteristics, prior duration of trans-
plantation, immunosuppressive therapy, indications for admission
to ICU, data necessary for the calculation of SAPS II and
APACHE II, duration of mechanical ventilation, length of stay in
ICU, mortality and graft survival at both ICU and hospital dis-
charge. Patient and graft survival were also collected 6 months
after ICU discharge.
Results: Thirty ICU admissions in 26 adult renal transplant recipi-
ents were studied. The median of prior post-transplant duration was
3 months (10 days–90 months), and of end-stage renal disease
was 68 months (5–340). Reasons for admission were: sepsis (n =
11), hemorrhage (n = 4), cardiopathy/fluid overload (n = 4), coma
(n = 4), abdominal crisis (n = 4), others (n = 3). The overall ICU
mortality was 33%. There was no difference between the observed
hospital mortality (40%) and the expected mortality as predicted by
SAPS II (36.6%) or APACHE II (50%). The area under the receiver
operating characteristic curve was 0.85 ± 0.08 for SAPS II and
0.84 ± 0.08 for APACHE II. The variables associated with ICU mor-
tality were: (i) ICU admission without hospital discharge after trans-
plantation (RR = 2.5), (ii) mechanical ventilation requirement (RR >
20), (iii) vasoactive drugs use (RR = 5.6). Use of immunosuppres-
sive drugs was not different between survivors and nonsurvivors. At
ICU discharge, graft survival among survivors was 48%. At 6
months, 5 additional renal transplant recipients had died.
Conclusion: The mortality of renal transplant recipients admitted in
ICU is high and graft loss during ICU stay is frequent.
P222 ICU acquired acute renal failure carries a higher mortality than acute renal failure on admission to ICU
M Ostermann, S Nelson, R Chang, for the RIP Users Group
Department of Nephrology, St George’s Hospital, London SW17 0QT, UK
Acute renal failure (ARF) has a significant impact on outcome of
critically ill patients [1]. The aim of this study was to identify any dif-
ferences between patients with ARF on admission to the intensive
care unit (ICU) and patients developing ARF during their stay in the
ICU. We retrospectively analysed data from The Riyadh Intensive
Care Program (RIP) database which contains demographic data of
26,669 patients admitted to 21 ICUs in the United Kingdom (UK)
during the time period June 1989 until September 1996. ARF was
defined according to the organ system failure scoring system by
Knaus et al [2]. Patients with chronic renal failure were excluded.
Comment: Our study confirms that ARF increases mortality in ICU
patients with a further marked increase amongst patients who
require renal replacement therapy (RRT). Patients who develop
ARF during their stay in the ICU have a significantly worse
outcome compared to patients with ARF on admission to ICU.
References:
1. Levy EM, Viscoli CM, Horwitz RI: The effect of acute renal failure on
mortality — a cohort analysis. JAMA 1996, 275:1489–1494.
2. Knaus WA, Draper EA, Wagner DP, Zimmermann JE: Prognosis in
acute organ-system failure. Am Surg 1985, 202:685–693.S105
Total  All patients with ARF ARF on admission to ICU ARF during stay in ICU
Number of patients 26 669 (100%) 2395 (9.0%) 1394 (5.2%)  1001 (3.8%)
Female:male  1 : 1.7 1 : 1.9 1 : 1.8 1 : 2.1
Mean age (SD) 59.1 (17.4) 59.7 (17.3) 59.6 (17.7) 59.7 (16.9)
APACHE II score on admission (SD) 12.9 (8.3) 19.7 (9.5) 20.97 (7.2) 17.8 (6.4) *
APACHE II score on day of ARF (SD) N/A N/A 20.97 (7.2) 23.1 (7.3) *
Mean length of stay in ICU (days) 3.9 8.0 8.7 7.2
Need for RRT (%) 769 (2.9%) 769 (32.1%) 384 (27.5%) 385 (38.5%) *
Mean duration of RRT (days) N/A 2.1 1.7 2.7
Hospital mortality of patients on RRT 505 (65.7%) 505 (65.7%) 241 (62.8%) 264 (68.6%) *
Hospital mortality 6633 (25%) 1340 (56%)  734 (52.7%) 606 (60.5%) *
* P < 0.001 (comparison between ARF on admission to ICU and ARF during stay in ICU); N/A = not applicable; SD = standard deviation.
P223 Simplified therapeutic intervention scoring system (TISS 28) to assess intensive care unit (ICU) costs and the efficiency of
the admission process to a medical ICU
J Graf, C Graf, P Hanrath, U Janssens
Medical Clinic I, RWTH Aachen, Pauwelsstr 30, 52057 Aachen, Germany
Background: Besides evaluation of the severity of illness, quantifi-
cation of nursing workload, and ICU cost evaluation, TISS has also
been proposed a valuable tool analysing the utilisation of ICU facili-
ties. Purpose of this study was to assess the efficiency of the ICU
admission process of a medical ICU of a tertiary care centre.
Methods: Over a period of 3 months TISS 28 [1] was prospec-
tively determined for all patients staying > 24 hours in the ICU.
According to Knaus et al [2] TISS 28 items were categorised as
active (AT) or non-active (NAT) treatment variables. Related costs
were calculated using a modified ‘top down’ method.
Results: 303 patients with a hospital mortality of 14.5% were
included in the study. Overall 241 patients (79.5%), including all
non-survivors, received AT during their ICU stay. ICU and hospital
mortality, ICU LOS, costs, admission diagnosis, and source of
admission were different in AT vs NAT patients (P < 0.05).
Conclusion: Since ICUs consume a large proportion of hospital
budgets for a minority of patients admission should be limited to
those depending on these facilities. Categorisation into AT and
NAT using TISS 28 may well serve to identify these patients. Our
data suggest superfluous ICU admission in 20% of all patients
staying longer than 24 hours in the index ICU. Identification and
careful analysis of this patients might help to optimise ICU admis-
sion and discharge processes and thus improve resource utilisa-
tion among ICU, intermediate care unit, and ward in the future.
References:
1. Miranda DR et al: CCM 1996, 24:64.
2. Knaus et al: JAMA 1981, 246:2711.
P224 Usefulness of the Logistic Organ Dysfunction (LOD) system to predict outcomes in a population of patients at a critical
care unit in Argentina
W Vazquez, R Fernández, H Lamacchia
Hospital Español de Mendoza, Eusebio Blanco 237, 5500 Mendoza, Argentina
Introduction: Various clinical indexes are used in clinical practice
throughout the world to assess critically ill patients and to predict
their outcome. Some of the most popular tools, however, have not
had proper validation in populations different from those in which
the tools were developed. We review our experience at a critical
care unit in Mendoza, Argentina, with the Logistic Organ Dysfunc-
tion (LOD) system, developed by LeGall in 1996.
Objective: To evaluate the ability of the LOD system to predict
total patient mortality.
Materials and methods: We prospectively evaluated all patients
admitted to the critical care unit (CCU) of our 200-bed tertiary care
hospital, from July of 1999 to August of 2000. Patients younger
than 16 years of age and those whose admission to the CCU was
shorter than 24 hours, were excluded. Clinical data collected
included: age, sex, admitting diagnosis, length of stay, physiologi-
cal variables and Glasgow coma scale. Laboratory data included:
WBC, BUN, creatinine, total bilirrubin, prothrombin time, serum
sodium and potassium and arterial pO2. We also documented
need for mechanical ventilation, FIO2, and final outcome at time of
discharge (dead or alive).
The chi-square test was used for qualitative variables, and ANOVA
was used for continuous variables. A P < 0.05 was assigned sta-
tistical significance. Results were expressed as percentages, confi-
dence intervals (CI 95%), means and standard deviations (SD).
We analysed the observed mortality vs predicted mortality ratio
(OM/PM), sensitivity, specificity and percentage of accurate pre-
diction for a cut off point of 50% of probability of death. The
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Receptor Operator Curve (ROC) was used to determine the
LOD’s power of discrimination. The ‘Goodness of Fit’ test
(Hosmer–Lemeshow) was applied to evaluate the calibration in our
population.
Results: 448 patients were included in the study. Thirty percent of
patients who met LOD criteria developed severe multiple organ
failure (MOF). The average LOD score was 1.83 ± 2.26 with a pre-
dicted probability of death of 9.47 ± 11.30%. The global mortality
rate was 17.6% (80 patients); therefore the OM/PM ratio was
1.85. The global percentage of accurate prediction was 85.71%
for a cut off point of 50% of probability of death. The area under
the ROC was 0.834 (CI 95% 0.781–0.886). The Hosmer–
Lemeshhow test showed a GOF of 20.59.
Conclusion: In our hands, the LOD system proved to be capable of
discriminating among critically ill patients those likely to die. It,
however, did not prove an appropriate calibation in our population
of patients. We emphasize the need for proper regional validation in
populations different from those in which the tools were developed.
P225 Value of SOFA (Sequential Organ Failure Assessment) score and total maximum SOFA score in 812 patients with acute
cardiovascular disorders
U Janssens, R Dujardin, J Graf, W Lepper, J Ortlepp, M Merx, M Zarse, T Reffelmann, P Hanrath
Medical Clinic I, RWTH Aachen, Pauwelsstr 30, 52057 Aachen, Germany
Objectives: The SOFA score is composed of scores from six
organ systems (respiratory [R], cardiovascular [C], hepatic [H],
coagulation [Co], renal [Re], and neurological [N]) graded from 0
to 4 according to the degree of dysfunction/failure. The aggregate
score (total maximum SOFA score [TMS]) is calculated summing
the worst scores for each of the organ systems (TMSOrg) during
the ICU stay. We investigated the outcome discrimination of the
TMS and the association with ICU length of stay (ICU-LOS) in
patients (pts) with acute cardiovascular disorders.
Methods: 812 consecutive pts (age 62 ± 13 years, 69.7% male,
SAPS II 29 ± 14, 266 pts acute myocardial infarction, 161 pts
unstable angina, 96 pts rhythm disturbances, 63 pts heart failure, 47
pts cardiac arrest, 179 pts other admission diagnosis) were included
between 4/99 and 4/00. SOFA score was determined daily and
TMS was calculated. Discrimination power of TMS for survivors (S)
and non-survivors (NS) (hospital mortality [HM]) was assessed by
the area under the Receiver Operating Characteristic (AUROC)
curve. Survival curves were determined for TMS £ and > 6 (criterion
value) and compared with log-rank test. Association between TMS
and survival was assessed with Cox regression analysis.
Results: 130 (16%) pts died. ICU-LOS was 3.8 (1–80) days.
SOFA score was significantly higher for NS on day 1 to day 10.
TMSOrg for N, Re and H correlated significantly with ICU-LOS.
TMSORG for R, C, N and Re were significantly associated with
HM (risk ratio [RR] + 95% confidence interval [CI]: R 1.8
[1.3–2.5], C 1.5 [1.2–1.9], N 1.4 [1.2–1.7], Re 1.5 [1.2–2.0]).
TMS correlated only moderately with ICU-LOS (r = 0.45,
P < 0.001) but was strongly associated with HM (RR 1.5
[1.4–1.6]). The AUROC for TMS was 0.915 ± 0.015. Log-rank
test demonstrated a significant difference (P < 0.001) between
pts with TMS £ 6 and TMS > 6. RR for HM was 13.2 [8.6–20.1]
in pts with a TMS > 6.
Conclusion: SOFA score is an excellent tool to describe the
extent of organ dysfunction in critically ill cardiovascular pts. More-
over, the degree of organ dysfunction is associated with ICU-LOS
and mortality. Survival rates were higher in pts with TMS £ 6, pts
with a TMS > 6 were 13.2 times more likely to die.
Therefore SOFA score may be utilised for quality assessment or
appraisal of new therapeutic strategies.
P226 Short-term prognosis in critically ill patients with liver cirrhosis: use of the SOFA score
M Wehler*, J Kokoska*, U Reulbach†, EG Hahn*, R Strauss*
*Department of Medicine I, and †Department of Medical Informatics, Biometry and Epidemiology, University Erlangen-Nuremberg, PF 3560,
91023 Erlangen, Germany
Introduction: In patients with liver cirrhosis who develop extra-
hepatic organ failure hospital mortality rates of 63–100% have
been reported [1]. For ethical reasons but also due to limited
resources physicians need early and reliable outcome predictors to
identify cases where aggressive treatment for cure or potential liver
transplantation is merited, as well as those where such care is
likely futile. We therefore analysed the prognostic accuracy of the
Child–Pugh (CP) classification, the Acute Physiology and Chronic
Health Evaluation (APACHE) II prognostic system and the Sequen-
tial Organ Failure Assessment (SOFA) [2] in predicting hospital
mortality of cirrhotic patients on the first day after admission to a
medical ICU.
Patients and methods: All patients with hepatic cirrhosis admitted
to our medical ICU were eligible. Prospectively collected data
included demographics, reason for ICU admission, acute diagnosis
and mortality rates. Prognostic data were assessed 24 hours after
ICU admission. Discriminative power of the scores was evaluated
using the area under the receiver operating characteristic
(AUROC) curve.
Results: 143 consecutive patients with hepatic cirrhosis were
enrolled. 62% were male, median age was 53 years. Hospital mor-
tality was 46%. CP category (A/B/C; n) was 6/40/97, mean CP
points 10.1 ± 2, mean APACHE II 20.6 ± 10.7, mean SOFA 8.6 ±
4.7. The total SOFA score on the first ICU day had the best predic-
tive ability (AUROC 0.94, standard error (SE) 0.02). No significant
differences were seen between APACHE II (AUROC 0.79, SE
0.04) and CP points (AUROC 0.74, SE 0.04). A cut-off of 8 SOFA
points had an overall correctness of 91%, a positive predictive
value (PV) of 87% and a negative PV of 96% with regard to hospi-
tal mortality.
Conclusion: In our population of critically ill patients with cirrhosis
the total SOFA score on the first ICU day was found to be a very
reliable scoring system to discriminate between hospital survivors
and non-survivors.
References:
1. Zimmerman JE: Hepatology 1996, 23:1393.
2. Vincent JL: Intens Care Med 1996, 22:707.S107
P227 Severity stratification of septic shock according to noradrenaline requirement
G Hernández, A Bruhn, D Acuña, FJ Larrondo, R Martinez, S Medeiros, C Fierro, R De La Fuente, L Castillo, G Bugedo
Programa de Medicina Intensiva, Dept de Anestesiología, Pontificia Universidad Católica de Chile, PO Box 114-D, Santiago, Chile
Introduction: Septic shock (SS) is associated with 50% mortality.
Severity is usually estimated from indexes of multiorgan dysfunction,
but hemodynamic dysfunction, despite its main role, has traditionally
been underscored. The aim of this study was to test a severity clas-
sification for SS according to noradrenaline (NA) requirements.
Methods: An algorithm for hemodynamic treatment in SS, which
established NA as the first drug (followed by dobutamine or adren-
aline as required), was followed prospectively in all SS patients
from December 1999 to August 2000. We evaluated Apache II
and SOFA scores, maximum values for C-reactive protein (CRP)
and lactate, hemodynamic profiles, and renal, respiratory and
hepatic dysfunction. Patients were classified in three groups
according to the maximum NA requirement: G1 (mild shock), NA
< 0.1 mg/kg/min; G2 (moderate shock), NA from 0.1 to
0.3 mg/kg/min; and G3 (severe shock), NA > 0.3 mg/kg/min.
Results: Results are shown in the Table, expressed as mean ±
standard deviation.
Conclusion: Septic shock severity as assessed by noradrenaline
requirement could aid in selecting patients for future trials. A NA
requirement higher than 0.3 mg/kg/min is associated with high
mortality.
Table
Mild (n = 15) Moderate (n = 17) Severe (n = 24) P
Age years 64.4 ± 20.6 62.8 ± 14.1 58.5 ± 14.5 NS
Sex (F/M) 5/10 9/8 14/10 NS
Apache II 15.2 ± 6 13.7 ± 7 20.8 ± 6.2 **/***
Max SOFA 6.8 ± 3.3 7.5 ± 3.3 11.9 ± 3 **/***
Max lactate (mg/dl) 3 ± 2.1 2.6 ± 1.7 7.5 ± 3.9 **/***
Max CRP (mg/dl) 27.8 ± 13.5 29.1 ± 8.1 26.7 ± 12.5 NS
Days in MV 4 ± 4.2 7.2 ± 9.7 5.2 ± 4.7 NS
Max Creat (mg/dl) 1.7 ± 0.6 2.9 ± 3.2 2.3 ± 1.4 NS
Mortality (%) 3 (20%) 4 (23.5%) 17 (70.8%) **/***
NS: not significant. MV: mechanical ventilation. Max: maximum. Creat: creatinine. P < 0.05: mild vs moderate*, moderate vs severe**, mild vs severe***.
P228 Is there any difference between SOFA and LODS scores to discriminate outcome in septic patients?
E Silva, S Blecher, AG Garrido, MH Kai, MC Assunção, PS Martins, F Cardoso, E Knobel
ICU, Hospital Israelita Albert Einstein and Santa Marcelina Hospital, Sao Paulo, Brazil
Introduction: Organ failure scores were designed to describe
organ dysfunction more than to predict outcome. The main differ-
ence between these systems is how they evaluate cardiovascular
dysfunction, which is the main cause of mortality in septic patients.
Objectives: a) to compare the effectiveness of Sequential Organ
Failure Assessment (SOFA) score and of Logistic Organ Dysfunc-
tion System (LODS) score to discriminate outcome in septic
patients; b) to determine the best cut-off value for both scores.
Design: Prospective, observational study.
Setting: Two large general ICUs.
Patients: Forty-seven adult septic patients.
Table 1
Time course of median (with interquartile range) of SOFA and
LODS score in survivors and non-survivors septic patients
Survivors Non-survivors P
SOFA Day 0 8 (7–11) 11 (8.5–12) < 0.05
Day 1 9 (7–10) 13 (9–13) < 0.01
Day 2 8 (6.5–9) 12 (10–14.5) < 0.001
Day 3 8 (6–10) 12 (11–14) < 0.001
Day 10 3 (3–8) 11 (8–11) < 0.01
LODS Day 0 6 (4.5–7) 8 (5–9) < 0.05
Day 1 4 (2.5–7) 7 (6–9) < 0.01
Day 2 4 (2–7) 6 (3–9) < 0.01
Day 3 4 (2–6) 7 (6–8) < 0.01
Day 10 2 (1–6) 7 (6–8) < 0.01
Table 2
Risk relative of death of each variable on day 0, 1, 2 and 3
D 0 D 1 D 2 D 3
SOFA 1.75 2.79 3.20 4.74 RR
³ 11 0.98–3.16 1.41–5.51 1.61–6.38 1.89–11.85 IC
LODS 1.46 3.17 2.67 3.17 RR
³ 6 0.72–2.97 1.27–7.87 1.17–6.12 1.26–7.96 IC
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Method: We measured SOFA and LODS scores at ICU admission
and daily. Survivors and non-survivors median scores for both
descriptors were compared using Mann–Whitney U-test; the rela-
tive risk (RR) was also calculated.
Results: The mean age was 51 ± 18 years and mean APACHE II
was 19.8 ± 6. The best cut-off value for SOFA and LODS score
were 11 and 6, respectively. The overall mortality rate was 48.9%.
Conclusion: Both SOFA and LODS score discriminated ade-
quately survivors and non-survivors septic patients.
P229 Outcome prediction in ICU admitted end-stage renal disease patients
G Mahnès, B Souweine, B Aublet, AE Heng, L Nicolet, N Gazuy, P Deteix
Hôpital G Montpied, BP 69, 63003 Clermont-Ferrand Cedex 1, France
Objective: To determine predictors of ICU mortality in end-stage
renal disease (ESRD) patients treated with haemodialysis or peri-
toneal dialysis and requiring ICU admission.
Design and setting: Retrospective/prospective cohort study in an
adult 10-bed medical ICU in a university hospital.
Mesasurements and main results: Over a 4-years period, out of
104 ICU admissions, 92 ESRD patients were studied. The etio-
logic diagnosis of ESRD was diabetes mellitus (n = 23), glomeru-
lonephritis (n = 19), hypertension (n = 13), polycystic kidney
disease (n = 11), pyelonephritis and obstructive uropathy (n = 6),
interstitial nephritis (n = 5), congenital abnormalities (n = 5), others
or unknown (n = 10). The prior mean duration of dialysis was 68 ±
83 months, 86 patients were on hemodialysis and 18 on peritoneal
dialysis. The admission diagnosis was sepsis (n = 32), cardiac
failure/fluid overload (n = 19), hemorrhage (n = 12), postoperative
(n = 10), mesenteric ischemia and peripheral arterial thrombosis
(n = 7), stroke (n = 6), cardiac arrest (n = 6), hyperkalemia (n = 5),
others (n = 7). The mean length of stay in ICU was 6 ± 9 days. The
overall ICU mortality was 29.8% (31/104). The survival rate for
patients requiring mechanical ventilation was significantly less than
for those not mechanically ventilated 13/36 (36%) vs 8/68 (12%),
respectively (P < 0.0001). There was no significant difference
between ICU survivors and nonsurvivors according to prior dura-
tion of dialysis, type of dialysis, and etiology of ESRD. In this target
population, the mean SAPS II and APACHE II were 50.3 ± 20.9
and 24.9 ± 9.1, respectively. The discrimination as determined by
the area under the receiver operating characteristic curve was not
different between SAPS II and APACHE II: 0.859 vs 0.878,
respectively (P = 0.62). For both models, the Hosmer–Lemeshow
goodness-of-fit test revealed a poor performance. The H test result
was P = 0.013 for SAPS II and P = 0.0006 for APACHE II. The C
test result was P = 0.008 for SAPS II, and P = 0.005 for APACHE
II. The ICU mortality among ESRD patients trend to be higher than
that of other ICU admitted patients during the same period
(21.8%),  P  = 0.063.
Conclusions: SAPS II and APACHE II were not well calibrated in
ESRD patients. These models probably need to be customized to
accurately predict mortality and analyse quality of care or perfor-
mance among ICUs when applied to this target population.
P230 Comparison of prediction of hospital mortality by ICU medical staff and referring parent team doctors
SJ Ramsay, CD Gomersall, GM Joynt, TA Buckley, C Lam
Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, China
Introduction: There is much interest in outcome prediction for ICU
patients and many studies have evaluated the accuracy of predic-
tions made by ICU medical staff [1]. There is little data on the
accuracy of outcome prediction made by the ward-based doctors
who refer these patients for ICU admission.
Method: As part of an on-going prospective study comparing the
accuracy of prediction of hospital mortality by ICU medical staff
and referring parent team doctors we analysed the first 100 com-
pleted data sets. The most senior doctor from both the referring
parent team and receiving ICU team were asked to give their pre-
diction of the likely hospital mortality for all emergency adult admis-
sions to our 22 bedded ICU. Predictions as a percentage chance
of dying in hospital were made at the time of referral to ICU, there
was no conferring between the ICU and parent team and all results
were confidential. MPM II0 was scored in all patients.
Table 1
ICU doctors’ prediction
Decile Av. predicted mortality (%) Observed mortality (%)
1 0.0 10.0
2 2.8 10.0
3 9.5 10.0
4 11.0 10.0
5 20.0 50.0
6 28.0 30.0
7 42.0 50.0
8 54.0 60.0
9 76.0 70.0
10 92.0 80.0
Table 2
Referring doctors’ prediction
Decile Av. predicted mortality (%) Observed mortality (%)
1 0.0 0.0
2 4.8 0.0
3 10.0 20.0
4 12.5 40.0
5 20.0 50.0
6 23.5 10.0
7 34.0 50.0
8 50.0 90.0
9 57.5 60.0
10 89.0 60.0S109
Results: Data was analysed on all patients who had either died in
hospital or been discharged. The mean age was 59.6 years, 59%
were males, and the overall mortality rate was 38%. The case mix
was medical 55%, neurosurgical 18%, and other surgical special-
ties 28%. Data was ranked in order of predicted mortality and
divided into equal deciles. Average predicted mortality (%) and
observed mortality (%) were calculated for patients in each decile.
Table 1 shows ICU doctors were better able to predict outcome
over a wide range of mortalities compared to referring doctors
(Table 2). The latter tended to under predict mortality except for
the patients most at risk of death. The Hosmer–Lemeshow good-
ness of fit test showed a good fit for ICU doctors’ prediction
(c2 = 10.24, P = 0.25), but not for referring doctors (c2 = 31.32,
P < 0.001). MPM II0 predicted mortality poorly in this cohort
(c2 = 18.62, P = 0.02).
Conclusion: Doctors who refer patients to ICU for emergency
admission are not able to predict accurately the hospital mortality
of these patients and tend to underestimate mortality when com-
pared to ICU doctors.
Reference:
1. Cullen DJ, Chernow B: Predicting outcome in critically ill patients.
Crit Care Med 1994, 22:1345–1347.
P231 Inclusion criteria in sepsis trials should include severity of organ dysfunction
R Taneja, MS Read
Department of Intensive Care, University Hospital of Wales, Heath Park, Cardiff CF14 4XW, UK
Limitations of study entry criteria may be a crucial factor in the
failure of immunomodulatory trials in sepsis. Several studies have
used very broad inclusion criteria such as septic shock < 12 hours,
sepsis syndrome, severe sepsis or more recently various combina-
tions of SIRS criteria with at least one organ dysfunction. These
criteria may include patients with a wide range of illness severity,
reducing the sensitivity of studies using them.
Methods: Data analysis was performed for 5400 patients admitted
to the Intensive Care Unit from 1994–1999. Patients fulfilling SIRS
criteria were stratified according to the number of organ systems
that had failed [1] and the duration of failure of those systems on
the first day of SIRS. Mortality within the groups was compared
using the chi-square test. Numbers of organs failed (and duration
of those organ failures) at the onset of SIRS were compared in sur-
vivors and non-survivors of ICU using the Mann–Whitney U-test.
Results: 3259 (60.4%) patients developed SIRS; 1077 (33%)
died. Presence of temperature, WBC count, heart rate or respira-
tory criteria alone or in combination did not influence ICU outcome.
Of the 1192 patients manifesting with no organ system failure
(OSF) on the day of onset of SIRS, 140 (11.7%) died. Organ dys-
function evolved frequently in association with SIRS (63.4%). Non-
survivors exhibited increased numbers of organ systems failed (1.7
± 1.0 vs 0.7 ± 0.8, P < 0.001 [mean ± standard deviation]) and
numbers of days of organ failure (0.87 ± 0.3 vs 0.5 ± 0.5 days, P
< 0.001). Although individual organ system dysfunction had low
specificity and sensitivity, the extent of OSF had significant impact
on outcome (Table).
Conclusions: Organ dysfunction occurs commonly with SIRS and
in close temporal proximity with it; its duration and magnitude are
strongly associated with increased mortality. Inclusion criteria
employing the severity of organ dysfunction may help limit selection
bias in sepsis trials.
Reference:
1. Knauss WA et al: Ann Surg 1985, 202:685–693.
Table
SIRS + 1 OSF + 2 OSF + 3 OSF + 4 OSF + 5 OSF
Number of patients 1192 1139 640 240 41 6
ICU mortality (%) 140 (11.7)* 360 (31.6)* 356 (55.6)* 177 (73.8)* 38 (92.7) 5 (83)
* P < 0.001 for comparisons between all combinations of pairs of marked groups.
P232 Hormones and not gender influences outcome in severe infection
M Angstwurm, J Schopohl, R Gaertner
Medizinische Klinik Innenstadt, Ziemssen Street 1, 80336 Munich, Germany
Previous clinical and experimental studies examining gender-
related differences in infectious complications and mortality have
provided inconsistent results. Some have shown a better, some a
worse prognosis in women. In a small study an increase in b-estra-
diol has been demonstrated in men. Therefore our purpose was to
study gender hormones in patients with severe infection with
regard to 28 day mortality in a prospectively study.
Methods and results: We have included 145 patients (39.3%
women) with a median age of 60 years, APACHE II Score of 19
and a survival rate of 64.7% in men and 62.1% in women. At
admission, there was no significant difference in demographic
data, laboratory signs of infection (temperature, C-reactive protein,
procalcitonin, leukocyte count, platelets), location of infection or
incidence of chronic immunosuppression, APACHE score or
outcome between men and women. In addition hormonal analysis
revealed no difference between sexes in b-estradiol, testosterone,
cortisole, thyroidea stimulating hormone, whereas the
gonadotropines were significantly higher in women, indicating that
they were post menopausal (67% older than 55 years).
In a univariant analysis we found significant difference between
survivor and non-survivor in b-estradiol (P < 0.001) without differ-
ence between gender, in temperature, C-reactive protein and
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procalcitonin at the day of admission, whereas testosterone, cor-
tisone, dehydroepiandrostendiole, thyroidea stimulating hormone,
gonadotropines or prolactin were not different between groups.
We have compared the results of the radio-immuno-assay with
HPLC and found perfectly matched results. b-Estradiol was ele-
vated up to 25-times the normal range even at day of admission.
b-Estradiol increased further in the next days reaching a
maximum at day 4–7 and decreased thereafter. Patients on
chronic steroid therapy had no different b-estradiol level than
untreated patients. b-Estradiol was not influenced by body
weight. Even women after hysterectomy and ovarectomy had ele-
vated b-estradiol levels in plasma indicating that the gonads are
not the source of b-estradiol.
In the survival analysis with Kaplan–Mayer analysis, increasing b-
estradiol was highly associated with increasing mortality for both
sexes, men and women (P < 0.001).
Conclusion: Men and women had similar survival rates. In men and
women b-estradiol influence outcome.
P233 Incidence and risk factors for mortality in acute respiratory distress syndrome. Do we have the same predictors?
D Rubio-Payán, J Robledo-Pascual, G Domínguez-Cherit, M Méndez-Beltrán, E Rivero-Sigarroa, L Natera-Ramírez, 
JE Colomé-Ruíz, JC Lescas-Vázquez
Department of Critical Care, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
Objectives: To know the density of incidence and annual punctual
prevalence, mortality and main factors for death in Acute respira-
tory distress Syndrome (ARDS) in our patients.
Materials and methods: Cohorte study, retrolective and prolective.
Secular period: All the admissions of the intensive care unit (ICU)
in 1 year (March-1-99 to Feb-29-00). Zero point was considered
the admission of the ICU continuing follow up until the outcome:
discharge from the ICU or death. We included all those patients
that completed criteria of ARDS according to the American–Euro-
pean consensus (1994). The risk factors were defined to all factors
associated with ARDS during the first 24 hours and were classi-
fied as direct or indirect. The following variables were defined: age,
gender, number of days in ICU and hospital, comorbility, APACHE
II (admission), factors associated to the development of ARDS,
time between risk factors and start of mechanical ventilation and
duration of the same with complications, less PaO2/FiO2, maximum
PEEP, use of Swan–Ganz catheter and amines (dopamine
>5mg/kg/min, norepinephryne and epinephryne), type of nutrition
and causes of death.
Statistical analysis: Program SPSS 9.0 was used, unvaried analysis
with c2 and exact Fisher tests. P was considered significant < 0.05.
Results: 550 cases were reviewed. Forty fullfilled criteria of ARDS
(18 men and 22 woman). The punctual prevalent was 8.8% and
the incidence was 19 per 100 anual. The mortality was 55%. Of
the evaluated variables P < 0.05 was found between living and
death: the number of days in ICU and hospital stay, APACHE II
(admission) and less PaO2/FiO2. The risk factors found asociated
were direct (30%), indirect (45%) and both (25%).
Conclusions: The punctual prevalence was 8.8%. The Incidence
was 19 per 100 anual. ARDS is an important cause of death
(55%) and the independent variables for mortality found were:
APACHE II > 18 and less PaO2/FiO2 < 100 with OR 50.66 and CI
95% (7.51–341).
P234 Acute lung injury in paediatric intensive care: course and outcome
S Gupta, W Chimbira, S Watkins, H Crawford, B Marden, J Legg, MJ Marsh
Paediatric Intensive Care Unit, Southampton General Hospital, Southampton SO16 6YD, UK
Introduction: Acute lung injury (ALI) and acute respiratory distress
syndrome (ARDS) carry a high morbidity and mortality (10–90%).
ALI is characterised by non-cardiogenic pulmonary oedema and
refractory hypoxaemia of multifactorial aetiology [1]. There is limited
data about outcome particularly in children.
Methods: This retrospective cohort study of 85 randomly selected
patients with respiratory failure recruited from a prospectively col-
lected database represents 7.1% of 1187 admissions. They
include those treated with High Frequency Oscillation Ventilation
(HFOV). The patients were admitted between 1 November 1998
and 31 October 2000.
Results: Of the 85, 49 developed acute lung injury and 47 had
ARDS. There were 26 males and 23 females with a median age and
weight of 7.7 months (range 1 day–12.8 years) and 8 kg (range
0.8–40 kg). There were 7 deaths giving a crude mortality of 14.3%,
all of which fulfilled the Consensus I [1] criteria for ARDS. Pulmonary
occlusion pressures were not routinely measured. The A–a gradient
and PaO2/FiO2 ratio (median + [95% CI]) were 37.46 [31.82–43.1]
kPa and 19.12 [15.26–22.98] kPa respectively. The non-survivors
had a significantly lower PaO2/FiO2 ratio (13 [6.07–19.93] kPa)
compared to survivors (23.85 [19.57–28.13] kPa) (P = 0.03) and
had a higher A–a gradient (51.05 [35.68–66.42] kPa) compared to
survivors (36.07 [30.2–41.94]) kPa though not significant (P =
0.06). Twenty-nine patients (59.2%) were oscillated (Sensormedics
3100A) including all 7 non-survivors. There was no difference in ven-
tilation requirements for CMV prior to oscillation. Seventeen of the
49 (34.7%) were treated with Nitric Oxide including 5 out of 7 non-
survivors (71.4%). The median (95% CI) number of failed organs
was 3 (1.96–4.04) for non-survivors compared to 1 (0.62–1.62) for
survivors (P = 0.03). There were 27 patients with isolated respiratory
failure all of whom survived. Six (85.7%) of the non-survivors also
required cardiovascular support.
Conclusion: A crude mortality of 14.3% compares favourably to pub-
lished data. The A–a gradient and PaO2/FiO2 ratio may be of help in
morbidity scoring in paediatric ARDS. Use of Nitric Oxide and HFOV
is associated with increased mortality, which probably relates to the
severity of disease. Multiple organ failure particularly respiratory and
cardiac disease is associated with increased mortality. ARDS with
isolated respiratory failure carries a good prognosis in children.
Reference:
1. Bernard GR, Artigas A, Brigham KL: The American–European Con-
sensus Conference on ARDS. Am J Respir Crit Care Med 1994,
149:818–824.S111
P235 Acute lung injury: a 1 year study at an intensive care unit of a university hospital
SRR Vieira, L Fialkow, AK Fernandes, DR Silva, and ARDS research group*
Intensive Care Division from Hospital de Clínicas de Porto Alegre, UFRGS, São Luis 1127, Porto Alegre, RS, Brazil
Introduction: In 1994 a North American–European Consensus
Conference published new criteria defining Acute Lung Injury (ALI)
and Acute Respiratory Distress Syndrome (ARDS). However, few
epidemiological studies regarding ALI/ARDS have been published
since then. Our objectives were to determine the incidence of
ALI/ARDS, its mortality and the influence of risk factors, comorbidi-
ties and organ dysfunction on mortality in ALI/ARDS patients.
Methods: A prospective cohort study enrolled all patients admitted
to the Intensive Care Unit (ICU) of a general university hospital that
remained for more than 24 hours at the ICU. They were evaluated
regarding the presence/development of ALI/ARDS according to
the Consensus criteria. All patients were analyzed regarding mor-
tality, risk factors, comorbidities and organ dysfunction.
Results: 1202 patients were studied (mean age: 56 ± 17 years;
674 males, 528 females; Apache II: 13.4 ± 8.7). The incidence of
ALI was 3.9% (n = 47), of which, ARDS was 2.4% (n = 29) and
ALI non-ARDS was 1.5% (n = 18). The ICU mortality of patients
with ALI was 45% (ARDS = 48%; ALI non-ARDS = 39%, not sig-
nificantly different). A multivariate analysis suggested that acute
renal failure (P = 0.001); hematological dysfunction (P = 0.035)
and prolonged hypotension (P = 0.001) were associated with
higher mortality in ALI patients.
Conclusions: 1) The total incidence of ALI was 3.9%; the inci-
dence of ARDS was slightly higher than that of ALI non-ARDS. 2)
The total mortality of ALI patients was 45%; the mortality of ARDS
patients was slightly higher than that of ALI non-ARDS patients. 3)
Acute renal failure, hematological dysfunction and prolonged
hypotension were associated with mortality. This report is, to our
knowledge, the first epidemiological report in South America study-
ing ALI/ARDS using the Consensus criteria.
Reference:
1. The American–European Consensus Conference on ARDS. Am J
Respir Crit Care Med 1994, 149:818–824.
*G Torres, R Butteli, JF Pires, F de la Veja, JH Diehl, M Premaor, 
AR Vacari, T Rosito, V Diemen, F Fernandes, C Marc, C Peukert, 
C Stapenhorst, C Borges, C Schneider, C Bete, C Ortiz, M Furtado, 
E Silveira, E Cappelari, R Melo, D Ughini, W Weishaimer Jr, M Bozzetti.
Introduction: Pathophysiology of respiratory failure in COPD is
highly different from other diseases caused chronic respiratory
failure. Respiratory muscle dysfunction detoriated by dynamic
hyperinflation, malnutrition and electrolyte disturbances is major
contributor to weaning failure and prolonged mechanical ventilation
in these patients. The aim of this study is to investigate if there is
any difference in patients’ characteristics in ICU between COPD
and nonCOPD diseases caused chronic respiratory failure and
require mechanical ventilation during acute exacerbations.
Method: Forty-six patients with chronic respiratory failure and
acute exacerbation were included in the study. Twenty-eight of
them had COPD (group 1) and 18 patients had chronic respiratory
failure caused by nonCOPD diseases (group 2) (Bronchiectasia
[3], asthma [3], diffuse interstitial fibrosis [6], neuromuscular dis-
eases [6]). All patients required mechanical ventilation.
Results: Patients’ characteristics assesed in this study are given in
the Table. Noninvasive mechanical ventilation (NIMV) were tried in
56% of patients in group 1 and 48% of patients in group 2. 58%
of patients in group 1 and 40% of patients in group 2 were taking
long term O2 therapy. Patients with COPD were significantly older
and had significantly higher APACH II scores than group 2. Their
blood phosphorus level were significantly lower than group 2. In
COPD patients duration of mechanical ventilation and requirement
of tracheostomy were significantly lower than group 2. While there
was no significant difference between Pseudomonas infections
between the groups, ventilator associated pneumonia (VAP)
caused by Acinetobacter species in group 1 significantly lower
than group 2. There was no significant differences between the
groups in hospital mortality rates, length of ICU and hospital stay
and sepsis rates.
Conclusion: These results showed that there might be some dif-
ferences in weaning process and ICU infections between COPD
and nonCOPD diseases in the ICU but they do not cause any sig-
nificant difference in mortality, sepsis rates, and length of ICU and
hospital stay.
Table
Characteristics Group 1 Group 2 P
Age, years 67.1 ± 6.4 60.5 ± 18.5 *
APACHE II 20.5 ± 3.7 17.7 ± 3.6 *
Albumin, g 3.1 ± 0.5 2.8 ± 0.7
Phosphorus, g 2.3 ± 0.8 3.1 ± 1.8 *
VAP-Acinetobacter, % 11 44 *
VAP-Pseudomonas, % 35 17
Sepsis, % 15 17
Hospital mortality, % 29 40
Duration of MV, days 13.6 ± 11.2 19.8 ± 12.5 *
Length of hospital stay, days 41.3 ± 45.5 36.2 ± 22.1
Length of ICU stay, days 18.1 ± 14.6 23.9 ± 15.3
Tracheostomy, % 7 33 *
* P < 0.05.
ç
P236 ICU characteristics of patients with chronic respiratory failure during acute exacerbations
G Gürsel, C Kirisog
vlu, S Bilgin, N Dorgutçetin
Departmentt of Pulmonary Medicine, Gazi University School of Medicine, Besevler, Ankara, Turkey
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P237 The impact of demographics, chronic health status and severity of disease on outcome from mechanical ventilation: a
prospective cohort study
P Revuelta Rabasa, C Naranjo Jarillo, JJ Jiménez Rivera, F Prieto Valderrey
Department of Intensive Unit, Hospital Universitario de Canarias, 38320 La Laguna, S/C Tenerife, Spain
Objectives: 1) To descibe the characteristics of the ICU patients
undergoing prolonged mechanical ventilation (MV) and estimate its
incidence. 2) To evaluate the impact of demographics, chronic
health status and severity of disease on the duration of MV and on
short-term mortality.
Setting: A 20 bed multidisciplinary ICU of a 650 bed tertiary uni-
versity hospital.
Design: A prospective dynamic cohort study. Impact on outcome
was analyzed by univariate (attributable risk, relative risk increase
and survival analysis), and multivariate analysis (relative risk of dis-
connection [HR] and of mortality [OR], by the Cox proportional
hazards and logistic regression models).
Patients: From a whole population of 591 patients admitted to the
ICU between November 1998 and October 1999, we enrolled
205 patients who received MV for more than 12 hours.
Results: Incidence of MV 34.7%. Age 57.8 ± 1.2 years. Males
136 (66%). SAPS II scoring: 42.01 ± 1.23 (mean ± EE), APACHE
II scoring: 17.78 ± 0.53 (mean ± EE), multisystem organ failure
(MSOF): 1 (0–2) (median and 25–75% interquartile range), a sim-
plified organ failure index (s-OFI): 1 (1–2) (median and 25–75%
interquartile range). ICU mortality: 25.4% (52), hospital mortality:
33.7% (69). Duration of MV: 13.9 ± 2.4 days. Weaning time: 8.8 ±
2.2 days (62.3% of total ventilation time). The mean duration of MV
was longer in respiratory pathology (29.6 ± 13.9 days), followed
by neurologic (14.9 ± 6.3 days) and trauma (12.8 ± 1.9 days). It
was longer in nonsurvivors 15.6 ± 5.1 versus 10.8 ± 1.6 days in
survivors (log-Rank, P < 0.00005). ICU length of stay (LOS) 16.6
± 2.1 days, hospital LOS 41.9 ± 3.3 days.
APACHE II (hazard ratio [HR] 0.92; 95% CI: 0.89–0.95), body
mass index (HR 0.97; 95% CI: 0.93–0.99), sepsis with or without
associated pneumonia (HR 0.36; 95% CI: 0.19–0.70), and ARDS
(HR 0.20; 95% CI: 0.06–0.68) reduced independently the rate of
disconnection from MV. Surgical vs medical category (HR 1.68;
95% CI: 1.1–2.56), and the presence of chronic respiratory
disease (HR 1.71; 95% CI: 1.02–2.90) increased the rate of dis-
connection.
Female gender with an attributable risk of hospital mortality of
14.8% (95% CI: 1.0–28.7%), an attributable fraction in exposed
population of 34.0% (95% CI: 3.8–54.8%); c2 4.49, P = 0.034),
and an adjusted odds ratio (OR) of 2.80 (95% CI: 1.22–6.41),
degree of malnutrition (OR 2.80; 95% CI: 1.35–5.84), SAPS II
(OR 1.07; 95% CI: 1.03–1.10), cardiac arrest on arrival (OR
34.42; 95% CI: 6.90–171.58), postoperative respiratory failure
(OR 3.65; 95% CI: 1.20–11.03), and cardiac failure (OR 5.93;
95% CI: 1.56–22.48) increased hospital mortality risk, whereas
age (OR 0.97; 95% CI: 0.94–0.99) decreased it.
Conclusions: ICU patients undergoing prolonged MV represented
an important subset of the whole ICU population (one third of total
admissions, half of them medical category). Prolonged MV was
associated with a relatively high short-term (ICU and hospital) mor-
tality and prolonged ICU and hospital LOS. Gender category,
chronic health condition and several early-acquired clinical data
successfully predicted both the duration of MV and short-term mor-
tality. Severity scoring indexes behaved as useful tools to predict
the duration of MV (APACHE II) and the risk of mortality (SAPS II).
Increasing age was not necessarily associated with an adverse
outcome.
P238 Management of hematological patients in ICU: a retrospective study of 110 patients
J Larché, P Maurer, T Jacques, A Gérard
Department of Intensive Care, CHU Brabois, 54500 Vandoeuvre-Les-Nancy, France
Introduction: Intensive care in hematological patients remains
challenging. In despite of an agressive and sometimes prolonged
treatment, outcome in ICU remains poor, particularly in septic
patients.
Methods: A retrospective review of hematological patients suffer-
ing from acute leukemia (AL), non-Hodgkin’s lymphoma (NHL) and
Hodgkin’s lymphoma (HL), hospitalized in our ICU from January
1995 to October 2000, has been performed. We studied demo-
graphic data, mortality rates and risk factors associated to mortality
both for all patients (excepted allogeneic transplants patients) and
for septic patients.
Results: 110 patients have been included in our study and 10 of
them beneficiated from an allogeneic bone marrow transplantation.
Mean age was 47.49 years (range 16–77), and sex-ratio
male/female was 1.08. 58% suffered from AL, 36% from NHL and
6% from HL. Sepsis, respiratory and neurologic failures repre-
sented the most frequent causes of admission. Mean SAPS II,
SOFA max and OSF scores were respectively 51.41, 9.07 and
2.40. Mean OSF decreased significantly between 1997 and 2000
(2.66 vs 1.90; P = 0.04). Mean mortality rate was 56%. In univari-
ate analysis, SAPS II, SOFA max, OSF scores, mechanical ventila-
tion, extrarenal replacement and use of amines were significantly
associated with mortality. Renal, hepatic, neurologic and circula-
tory failures at admission were also significant.
Among the 110 patients, 53 (48.18%) had septic conditions
(severe sepsis and septic shock). Mean age was 47.51 years.
Mean SAPS II, SOFA max and OSF scores were respectively
59.11, 10.68 and 2.98. Mean mortality rate was 75.47%. Compar-
isons between septic patients during these 5 years showed no sta-
tistical differences, excepted for mean SAPS II which increased
significantly between 1995 and 1999 (40.71 vs 77.63; P = 0.04).
Severity-of-illness scores, use and duration of mechanical ventila-
tion, extrarenal replacement (ERR) and amines were significantly
associated with mortality. Interestingly, only hepatic, neurologic
and circulatory failures at admission were also significantly associ-
ated to a poor outcome. Mortality rates in patients with no organ
supply, with 1, 2 and 3 supplied organs were respectively 0%,
66.66%, 86.66% and 92.59%. Type of disease was not associ-
ated to an increased mortality rate. Performing chemotherapy inS113
ICU, with ERR if necessary, seems possible with no harmful conse-
quences.
Conclusion: These results could suggest that hematological
underlying disease has no major influence on early outcome, but
that prognosis is mainly determined by acute physiologic changes
induced by sepsis, and reflected in severity-of-illness scores [1].
New therapeutic strategies based on earlier referral in ICU, reliable
markers of organ dysfunction and agressive treatment, should be
tested prospectively to ensure an optimal management and a
better prognosis for these patients.
Reference:
1. Sculier JP et al: Scoring systems in cancer patients admitted for an
acute complication in a medical intensive care. Crit Care Med
2000,  28:2786–2792.
P239 Leukopenia predicts outcome in haemato-oncological patients requiring intensive care
MP Margarson, AC Gordon, R A’Hern, D Skewes
Intensive Care Unit, Royal Marsden Hospital, London SW3 6JJ, UK
Introduction: Patients with haematological malignancy who
develop respiratory failure have a very poor prognosis [1,2]. The
presence of leukopenia at the time of admission has long been
suspected to be associated with worse outcome but no published
study has convincingly demonstrated this.
Method: Prospectively entered admission and 12 month follow up
data from 1222 admissions to an oncological ICU over a 7 year
period ending June 1998 were reviewed. We identified 231
haematological (Leukaemia, Lymphoma or Myeloma) admissions.
Patients who had received stem cell transplants (SCT) were identi-
fied from a separate database and sub-set analyses were per-
formed.
A cross-query of the central haematology laboratory database was
set up to determine the total white cell count of each patient prior
to and on admission. Leukopenia was defined as an absolute white
cell count of < 1.5 × 106/ml. Statistical analyses were by Fisher’s
exact test.
Results: 152 (66%) of the 231 patients died on the unit, a further
26 died within 30 days of leaving the ICU, a total hospital mortality
of 77%.
50/107 (48%) of the neutropenic patients were SCT recipients.
Excluding 20 patients with acute leukaemia (white cell counts
49.5–850 × 106/ml), 37/100 (37%) of non-neutropenic patients
were SCT recipients (P = 0.16).
Conclusion: Haemato-oncological patients have a significantly
greater mortality if they are leukopenic at the time of ICU admission:
this is not solely attributable to the increased proportion of stem cell
transplant recipients in this group. There is an extremely poor prog-
nosis and a strong trend toward increased mortality in patients with
pre-admission leukopaenia of more than 7 days duration.
References:
1. Brunet F et al:, Is intensive care justified for patients with haema-
tological malignancies? Intensive Care Med 1990, 16:291–297.
2. Rubenfeld G, Crawford SW: Withdrawing life support from
mechanically ventilated recipients of bone-marrow transplants.
Ann Int Med 1996, 125:625–633.
Admission  30 day  12 month 
WCC ICU deaths mortality mortality
< 1.5 83/107 (78%) 91/107 (85%) 98/107 (92%)
> 1.5 69/126 (55%) 86/126 (68%) 107/126 (85%)
P value < 0.003 < 0.003 ns
Duration of pre-
admission 
leukopaenia ICU deaths 30 day mortality
< 7 days 38/54 (70%) 43/54 (80%)
³ 7 days 45/53 (85%) 48/53 (91%)
P value 0.10 0.17
P240 Haematological malignancy on the ICU — can we identify survivors?
S Shah*, P Mehta†, M Read*, A Saayman*, N Stallard*
*Critical Care Directorate, and †Department of Haematology, University Hospital of Wales, Cardiff, UK
Introduction: Early and accurate identification of patients with a
haematological malignanacy, with a poor outcome on the intensive
care, would allow appropriate utilisation of limited resources.
Aim: The aim of our study was to evaluate factors that would help
predict survivors in-patients with haematological malignancy who
required admission to intensive care unit.
Methods: We retrospectively analysed data on patients with
haematological malignancy admitted to the intensive care over a
5 year period.
Results: We identified 65 haematological patients, admitted for
> 1 day to the intensive care. (Table overleaf.)
Discussion: There were differences in terms of the demographic
data or severity of illness scores on day 1, ie APACHE II and organ
failure scores, organ failure days and the P/F ratios between the
two groups survivors and non-survivors. However by day 3, there
was a significant difference between the survivors and the non-sur-
vivors in terms of improvement of the APACHE II and organ failure
scores, organ failure days and the P/F ratios.
Conclusion: An improved outcome was associated with an
improvement in the day 3 APACHE II and organ failure scores,
organ failure days and the P/F ratios, however a failure to do so
was associated with a poorer outcome. All survivors could be iden-
tified by day 3 of ICU admission.
Reference:
Gruson D, Hilbert G, Vargas F et al: Severe respiratory failure requiring
ICU admission in bone marrow transplant recipients. Eur Respir J 1999,
13:883–887.
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Survivors Non-survivors
Numbers Day 1 (n = 33) Day 3 (n = 23) Day 1 Day 3 (n = 32)
Age (years) 51 (16–76) 52 (15–74)
Sex 1:2 1:2.1
APACHE II 26.5 (11–35) 22 (9–30) 27 (10–44) 26 (14–38)
Organ failure score 26.3 (11–37.8) 20 (9.2–32.4) 27.6 (10–47.5) 27.3 (14.4–41)
Number of organ failure 2 (0–3) 1 (0–3) 2 (0–4) 2 (0–4)
P/F ratio  187.5 (52–497) 206 (67–543) 190 (48–520) 134 (42–324)
P241 Outcome of neonates operated on for congenital diaphragmatic hernia
F Chabab-Talbourdel*, S Cantagrel*, M Gasmi†, H Lardy†, V Tessier*, M Robert†, J Laugier*
*Paediatric Intensive Care Unit, and †Paediatric Surgery Department, Hôpital Clocheville, 49 Bd Béranger, 37000 Tours, France
Introduction: Congenital diaphragmatic hernia (CDH) is a severe
disorder in neonates. The prognosis has been improved in the past
10 years by a combination of HFO ventilation, sedation and anal-
gesia, nitric oxide and delayed surgery. Extracorporeal oxygenation
(ECMO) has been proposed by certain teams. A decrease in mor-
tality from 70% to approximately 40% has recently been reported
[1,2]. However, little is known about the outcome of such patients.
We report the outcome of a group of patients after 10 years’
follow-up.
Patients and methods: A retrospective review was undertaken of
neonates admitted to the paediatric intensive care unit after 1
January 1992 (date at which new treatment methods were intro-
duced in the department) and operated on for congenital hiatus
hernia.
Results: Nineteen neonates were reviewed, of whom seven died
(36%) and 74% had left hernia. Two of the 12 remaining survivors
had other malformations (cardiac and urogenital). Mean age at the
time of surgery was 17 hours. Median ventilation duration was 6
days. Median duration of intensive care was 12.5 days. 58% chil-
dren were discharged from intensive care unit with oxygen therapy
and median hospitalization duration was 31days. Mean age at the
last consultation was 18 months (SD 18). Six infants required
readmission and four had severe respiratory disorders (one with
severe bronchiolitis, one with asthmatiform bronchitis and one with
chronic clinical respiratory insufficiency). One infant was hospital-
ized for more than 12 months and required left pneumonectomy
and tracheotomy. Six infants had gastro-esophageal reflux, of
whom one required surgery. This infant also had residual hiatus
hernia and scoliosis. Three infants had neurological sequelae (one
with psychomotor retardation and two with overall hypotonia, one
of whom had problems with swallowing).
Discussion: Our results showed that 1) the mortality was similar to
those reported by the other two French series [1,2] (36%) despite
the lack of use of ECMO and 2) middle-term morbidity was low
compared to the mortality reported after ECMO [1].
References:
1. Dubois A et al: Arch Pediatr 2000, 7:132–142.
2. Desfrere L et al: Int Care Med 2000, 26:934–941.
P242 The intensive care unit in paediatric oncology: 10 years experience
NS Parekh, AT Cohen, M O’Meara
Intensive Care Unit, St James’s University Hospital, Leeds LS9 7TF, UK
We report the results of a retrospective study of the intensive care
outcome of 196 children admitted with malignancy at a tertiary
referral institution over a period of 10 years from 1988 to 1997. A
total of 165 children required 196 admissions for a median of 3
days. Their mean age was 5.82 years and there were 100 boys
(51%) and 96 girls (49%). Their admission median Apache II score
was 18. A total of 150 children (76.5%) survived intensive care.
Nonsurvivors had a higher Apache II score than survivors (23 vs 15
respectively, P < 0.001). Patients were divided into those needing
postoperative care (n = 55), patients with respiratory infection (n =
39), systemic infection (n = 30), neurological complications (n =
20), respiratory failure with no evidence of infection (n = 17), meta-
bolic effect (n = 13), tumour mass effect (n = 9), GI bleed (n = 5),
cardiac failure (n = 4), post cardiac arrest (n = 3). The overall sur-
vival, defined as those who survived 1 week after discharge from
PICU, was 73.4%. Invasive monitoring including arterial and central
venous pressure line were inserted in 143 (72.9%), mechanical
ventilation was required for 133 (67.8%), ionotropic support for 66
(33%), pulmonary artery floatation catheter insertion and monitor-
ing in 23 (11.7%) and renal replacement therapy for 13 (6.6%)
children. The profile of diseases in children admitted in PICU
appears to be changing since last report from this unit in 1992 [1].
The most common reason for admission was need for postopera-
tive care (28%) and survival in this group was 100%. There also is
a significant improvement in survival rate of patients with systemic
infections (63%) needing ventilatory support and children with res-
piratory (with or without infection) failure (67%) [2].
Reference:
1. Heney D, Lewis IJ, Lockwood L, Cohen AT, Bailey CC: The intensive
care unit in paediatric oncology. Arch Dis Child 1992, 67:294–298.
2. Keengwe IN, Stansfield F, Eden OB, Nelhans ND, Dearlove OR,
Sharples A: Paediatric oncology and intensive care treatments:
changing trends. Arch Dis Child 1999, 80:553–555.S115
P243 Epidemiology and early predictive factors of outcome in children with severe head injury
S Ducrocq*†, P Meyer*,G Orliaguet*, S Blanot*, A Laurent-Vannier‡, P Carli*
*Department d’Anesthésie-Pédiatrique, Hôpital Necker-Enfants Malades 75 005 Paris, France; †UPSI Hôpital Clocheville, 37 000 Tours, France;
‡Hôpital National de St Maurice, 94 St Maurice, France
Background: Severe traumatic brain injurie (TBI), defined by a
GCS  £ 8, is quite rare in children but carries a high risk of mortality
and bad outcome. Early recognition of factors predicting outcome
is important for quality assessment and could contribute to a more
selective management of the most severe injuries.
Objective: To describe a large population of children with severe
TBI admitted to a level I Pediatric Regional Trauma Center with a
standardized protocol of care, and identify early predictors of their
outcome.
Materials and methods: We retrospectively analyzed the data of a
trauma data bank, including, over a 9 years period, all the children
(1 month–15 years) with severe TBI (GCS £ 8). All these children
were followed until death or for at least a 6 months period after dis-
charge. Univariate and further multivariate analyses were per-
formed to determine independent predictive factors of death,
outcome at discharge and 6 months later. Receiver Operating
Characteristic (ROC) curves were used to determine the threshold
values of independent predictors of death or outcome.
Results: Analysis concerned 585 children, 67% were boys, 33%
were girls. Mean age was 7 ± 5 years. Mean values for GCS, PTS
and ISS were respectively 6 (3–8), 3 (–4 to +10) and 28 (4–75).
Mortality rate was 22.4%, GOS was < 3 in 53% of the cases at
discharge and 60% at 6 months. Multivariate analysis identified
GCS, ISS and initial collapsus as independent predictors of death,
bad outcome at discharge and at 6 months. Threshold values for
death were 28 for ISS and 6 for GCS. The same values were
found for bad outcome, except for outcome at 6 months where
threshold value for GCS was 5.
Conclusion: Initial collapsus, GCS, and ISS are independent predic-
tors of outcome in children with TBI. Threshold values can be calcu-
lated for predicting bad outcome. These variables can be easily and
early detected in this population and used for quality assessment.
P244 Prediction of neurological outcome after cardiac arrest
E Gomes, A Tuna, R Araújo
Intensive Care Unit (UCIP), Hospital Geral de Santo António, 4099-001 Porto, Portugal
Background: Modern resuscitation helps to save many lives
across the world. Unfortunately, despite the great development
and sophistication of emergency systems, lots of patients die, and
many of the survivors persist with different degrees of neurological
handicaps. Early determination of outcome after cardiopulmonary
resuscitation (CPR) is a common problem with clinical, ethical,
economic and social consequences.
Objective: To predict cerebral outcome after CA by clinical neuro-
logical examination.
Methods: We conducted a prospective study, started in August
2000, including all patients that had a return of spontaneous circu-
lation (ROSC) after CA. All the resuscitation attempts were regis-
tered using a form based in the Utstein Style template. A
neurological evaluation was performed using a protocol that
included GCS, brain steam reflex, spontaneous eyes movements,
spontaneous mobility, breathing and seizures immediately after
CPR; at 12, 24, 48, 72 hours, 8 days later and at discharge.
Results: Twenty-three patients were included in the protocol, cor-
responding to 68 resuscitation attempts (corresponding to a
ROSC of 47%). We found 72 hours the better time for evaluation
because before that most of the patients were sedated. All patients
with either GCS < 5, absence of one or more brain steam reflex, in
any time of evaluation died without any neurological recovery. The
patients that had at the third day a GCS > 9 and or oriented eye
movements and or oculocefalic reflexes were discharged from hos-
pital in 63,6% of cases. Seven patients, all from the last group of
patients, had a complete neurological recovery at discharge. The
mean duration of cardiac arrest was 4.7 min in group with GCS
score superior to 13; 11 min in the group with GCS score
between 5 and 13, and 12 min in group with GCS inferior to 5.
Conclusion: Neurological prognostic depends on cardiac arrest
duration. In our study the existence of a GCS < 5; absence of
spontaneous eyes movement or absence of brains reflex at any
time after cardiopulmonary resuscitation was indicative of poor
neurological and overall outcome.
P245 The outcome of neuro-trauma. A 1 year retrospective study in an intensive care unit
MJ Mpe, K Mathekga, MO Mzileni
Department of Medicine, Division of Pulmonology and Critical Care, Medical University of Southern Africa, PO Box 105, Medunsa 0204,
South Africa
Introduction: Head injuries are frequent affecting many patients in
the prime of life. About 10 million head injuries occur annually in
the USA. 20% of these are severe enough to cause brain damage.
An initial low GCS 4 has a grave prognosis. Associated injuries
may compound the clinical picture. The majority of deaths from
head injuries due to raised ICP.
Objectives: To describe our experience with Neuro-Trauma in the
ICU.
Design: A retrospective study over 1 year (1999).
Setting: Intensive Care Unit — an academic hospital.
Study population: Patients admitted primarily for the management
of head injury.
Results: The total number of admissions was 47, with 37 (87%)
males and 10 (21%) females. The mean age of the group was 29.3
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± 14.9 years. Sixteen (34%) patients died. Of the 16, 11 (68.8%)
were admitted with a GCS £ 4.11 (35.5%) of the survivors had an
admission GCS £ 4. MVA’s accounted for 66% of head injuries,
followed by assault injuries at 25.5%. 81.25% of the patients died
as a result of the primary brain damage. No association could be
established between poor outcome and the presence of concomi-
tant injuries, non-operative management and the number of brain
lesions.
Conclusion: Mortality from head trauma is high. An initial low GCS
£ 4 is associated with poor outcome. A few patients with an initial
low GCS do recover fully.
P246 Factors influencing the functional outcome in a neurointensive care unit
E Anastasiou, A Euthimiou, A Lavrentieva, G Tsaousi, E Geka, M Yannakou
Intensive Care Unit of Anesthesiology, AHEPA General University Hospital, Thessaloniki, Greece
Introduction: The aim of the present study was to investigate the
factors that affect the outcome of patients with central nervous
system pathology.
Method: One hundred and thirty patients (head injury [n = 43], mul-
tiple trauma [n = 40], cerebral hemorrhage [n = 36] and emergency
cerebral aneurysm repair [n = 11]) were investigated for age, GCS,
CT-Scan grade, ISS, and APACHE II. Male to female ratio was
96/34. The patients were divided in five groups according to
Glasgow Outcome Scale: 1) group A, n = 50 (GOS 1, death), 2)
group B, n = 5 (GOS 2, severe brain damage), 3) group C, n =1 7
(GOS 3, moderate brain damage), 4) group D, n = 28 (GOS 4,
mild disability) and 5) group E, n = 30 (GOS 5, full recovery).
Results: Total mortality was 38.4%. There was a statistically signif-
icant difference (one way analysis of variance ANOVA) regarding:
1) age: groups A, B and C versus E, 2) GCS: group A versus E, 3)
CT-Scan grade: group A versus D and E, 4) ISS: group C versus D
and E and 5) APACHE II score: group C versus E (Table). Patients
with head injury or multiple trauma had better outcome than
patients with cerebral hemorrhage (Fig.).
Conclusion: Age, GCS and CT-Scan grade were related to the
patient outcome regarding life or death whereas diagnosis, age,
ISS and APACHE II determined the severity of disability.
Figure
Relation of diagnosis to GOS
Table
Age 
Groups (years) GCS CT-Scan grade ISS APACHE II
A 42.3 ± 17.5** 6.1 ± 2.5* 3.5 ± 0.5* 29.1 ± 9.3 19.9 ± 4.5
B 53 ± 20.8* 5.8 ± 1.0 3.2 ± 0.8 25 ± 0 15.6 ± 6.8
C 43.7 ± 19.7* 6.6 ± 3.0 3 ± 0.8 36.6 ± 8.3* 21.5 ± 4.5*
D 37.6 ± 16.2 7.0 ± 3.1 2.7 ± 0.7 24.6 ± 6.1 18.4 ± 4.8
E 28.2 ± 15.1 8.2 ± 3.4 2.8 ± 0.8 26.1 ± 8.2 16.9 ± 4.9
Mean ± SD. * P < 0.05, ** P < 0.01.
P247 Prolonged intensive care unit stay: predictors and impact on resource utilization
S Haddad, Y Arabi, R Goraj, A Al-Shimemeri
Intensive Care Department 1425, PO Box 22490, King Fahad National Guard Hospital, Riyadh 11426, Saudi Arabia
Objective: To evaluate the predictors of prolonged ICU stay its
impact on resource utilization.
Methods: We collected the following data prospectively on all ICU
admissions between 2/1999 and 9/2000: demographics, ICU
stay, APACHE II and SAPS II scores, the main reason for ICU
admission, re-admissions and ICU outcome. We documented the
presence of coma, oliguria, coagulopathy and infection as well as
the need for mechanical ventilation or vasopressors in the first 24
hours. ICU stay was considered prolonged if it exceeded 14 days.
We calculated the utilization of ICU days and ventilator days. We
identified predictors of prolonged stay using univariate analysis.
Results: Eleven percent of patients (104/947) stayed in ICU > 14
days. This group of patients used 45% (2880/6392) of ICU days
and 56% (2556/4604) of ventilation days. Prolonged stay patients
had higher APACHE II (21 ± 8 vs 19 ± 9, P = 0.016) and SAPS II
scores (43 ± 16 vs 37 ± 20, P = 0.003), although ICU mortality was
not different (19% vs 21%). Patients were more likely to have pro-
longed stay if the main reason for admission was respiratory (OR
2.2, CI 1.4–3.6) or trauma (OR 2.1, CI 1.4–3.4) and less likely if it
was non-trauma surgical (OR 0.27, CI 0.13–0.54). Prolonged stay
occurred more likely with re-admissions (OR 2.1, CI 1.1–3.8) and in
patients with oliguria (OR 1.8, CI 1.1–3.1), coagulopathy (OR 1.5,
CI 1.01–2.3), infection (OR 2.3, CI 1.5–3.5), mechanical ventilation
(OR 1.9, CI 1.3–2.9) and vasopressor therapy (OR 1.8, CI 1.2–2.7).
Conclusions: Although patients with prolonged stay constitute a
small fraction of ICU patients, they consume a significant proportion
of ICU resources. Patients admitted for respiratory or trauma indica-
tions are more likely to have prolonged stay. Attempts to shorten
ICU stay, such as by development of clinical pathways, should
especially target these patients. Caring after some of these patients
in a step-down unit may have a great impact on resource utilization.S117
P248 Comparing Gray’s and Cox models in sepsis survival
J Kasal*, Z Jovanovic†, G Clermont*, V Kaplan*, RS Watson*, L Weissfeld†, DC Angus*
*Division of Critical Care Medicine, and †Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, USA
Background: A difficulty in modeling survival after sepsis is that
hazards may not be proportional, thus violating a key assumption of
traditional Cox survival models. We modeled survival after sepsis
using Gray’s approach, a new spline-based technique that does
not rely on the proportional hazards assumption. We then com-
pared hazard ratios over time between Gray’s and Cox models.
Hypothesis: Gray’s model will yield different estimates of hazards
over time in sepsis when compared to Cox.
Methods: We analyzed 1090 patients recently enrolled in a US
multicenter sepsis trial. We considered 26 potential baseline
demographic and clinical risk factors and modeled survival over the
first 28 days from the onset of sepsis. We tested proportionality in
univariate Cox analysis using Schoenfeld residuals and log–log
plots. We then constructed a standard multivariate Cox model and
a Gray’s model. We evaluated the validity of the proportional
hazards assumption in the predictors selected by the Cox model.
We compared the selection of predictors by both models.
Results: Twenty-eight day Cox univariate analysis demonstrated 9 of
26 factors had non-proportional hazards. A multivariate Cox model
identified 7 significant predictors, 4 predictors with non-proportional
hazards (presence of comorbidity, hypotension, acute renal failure,
and chronic liver disease) and 3 predictors with proportional hazards
(Pseudomonas etiology, no identified etiology and pulmonary site of
infection). Gray’s model also identified seven risk factors. Age was a
significant predictor, while a urinary site of infection portended a sig-
nificantly better prognosis. Three of the common risk factors
between the two models had non-proportional hazards (presence of
comorbidity, hypotension, and acute renal failure [ARF]). The figure
demonstrates that the Gray’s model captured the large variation (ie
non-proportionality) of the hazard ratio for ARF over time.
Conclusion: Accurate survival models must take into account the
observation that mortality risk factors have non-proportional
hazards. Of several alternatives to a standard Cox model, Gray’s
model appears particularly promising.
Figure
P249 The outcome of the geriatric patients in the ICU
A Topeli
Department of Internal Medicine, Intensive Care Unit, Hacettepe University School of Medicine, 06100, Ankara, Turkey
The aim of the study was to compare the outcome of the geriatric
patients (³ 65 years of age; Group 1) with young ones (< 65 years
of age; Group 2), and to compare the outcome of the elderly
patients (65–74 years of age; Group A) with the very old ones (³
75 years of age; Group B) in the intensive care unit (ICU).
In a 12 month period, data of the 245 patients who were hospital-
ized more than 24 hours in the ICU was prospectively collected.
The patients were followed till death or discharge from the hospital.
Disease severity was assessed by using the APACHE II score from
which age factor was subtracted (APACHE II – age), and the pre-
dicted mortality was calculated by using the original APACHE II
score.
The comparison of the Group 1 and 2 is shown in the Table, with
the results as mean ± SE or as n (%).
Although Group A (N = 69) and B (N = 50) had similar APACHE II
scores (22.1 ± 0.9 vs 23.5 ± 1.1), Group B tended to have
increased ICU mortality rate and had higher hospital mortality rate
when compared with Group A (48% vs 32%; P = 0.06; 60% vs
33%; P = 0.003).
In conclusion, geriatric patients, in general, had ICU and hospital
mortality rates similar to that of the young patients with comparable
disease severity. However, the ICU and hospital mortality rates of
the patients more than 74 years of age were found to be higher
than those of the patients who were 65–74 years of age.
Table
Group 1, Group 2, 
n = 119 n = 126 P
Age 74.0 ± 0.6 46.0 ± 1.2 < 0.001
Male gender 65 (54.6%) 61 (48.4%) 0.33
APACHE II – age 17.3 ± 0.7 16.5 ± 0.7 0.44
Predicted mortality rate, %  41.1 ± 2.3 30.0 ± 2.2 0.001
ICU mortality rate 46 (38.7%) 41 (32.5%) 0.32
Hospital mortality rate 53 (44.5%) 48 (38.1%) 0.31
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P250 Incidence and course of early cardiac failure in long term ICU patients
V Sramek,V Zvonicek, R Vyhlidalova, I Sas, R Kraus
Department of Anaesthesia and Intensive Care, St Ann’s University Hospital, Pekarska 53, Brno, CZ-65691, Czech Republic
Introduction: Cardiac failure is a potential motor of multiple organ
failure in long term ICU patients [1]. The aim of our study was to
monitor incidence on admission of cardiac failure in long term ICU
patients. The early course (first 72 hours) of cardiac failure was
also evaluated.
Materials and methods: ICU database was used for data acquisi-
tion. Long term patients were defined as those who survived > 3
days in the ICU. Cardiac failure was defined as cardiac SOFA
points  ³ 3.
Statistics: Chi-square, Fisher exact test, Mann–Whitney U-test
and Manova for repeated measures when appropriate. Data are
presented as means ± SD. P < 0.05 was considered significant.
Results: Out of 110 patients admitted from January 1 to October
15, 72 (65%) stayed in the ICU > 3 days. Forty-six patients (65%)
survived and 26 died. Survivors (S) and non-survivors (NS) did not
differ in age (55.2 ± 15.9 and 60.5 ± 15.9 years, respectively;
P = 0.18). S had significantly higher APACHE II score on admis-
sion than NS (24.2 ± 7.2 and 29.2 ± 7.0, respectively; P < 0.01).
S had significantly lower incidence of cardiac failure on admission
(< 24 hours) compared to NS (13 [28%] and 17 [65%], respec-
tively, P < 0.001). This difference was attenuated but remained
significant by day 2 when additional 5 S developed cardiac failure
(8 developed, 3 recovered) and there was no change in NS
(P < 0.05). Non-survivors had a trend to more severe forms
(cardiac SOFA points 4) of cardiac failure in the first two days of
hospitalisation (P = 0.1). The course of cardiac failure during the
first 3 days of ICU stay did not differ between S and NS (Manova
time effect P = 0.23). Only 2 survivors without cardiac failure
during the first 48 hours (n = 25) developed cardiac failure during
their further ICU stay (both later than 72 hours after admission).
Conclusions: Long term ICU patients who do not survive have
greater incidence of cardiac failure on admission. Nevertheless the
course of cardiac failure during the first 3 ICU days does not differ-
entiate between survivors and non-survivors.
Reference:
1. Nalos M et al: Incidence, severity and mime course of cardiovascu-
lar failure in patients requiring prolonged intensive care. Intensive
Care Med 1997, 23 (suppl 1):52.
P251 Premature discharge of patients from ICU increases mortality
MC Blunt, KR Burchett
Queen Elizabeth Hospital, King’s Lynn, Norfolk, PE30 4ET, UK
The pressure on intensive care beds has led to the discharge of
patients before clinically indicated. It has been shown that dis-
charging patients with high TISS scores increases mortality [1],
and it has been stated that ‘premature’ discharge is likely to
worsen outcome [2]. We postulated that premature discharge
would increase mortality, and that this would be independent of the
different TISS scores that were likely to occur.
All ICU patients discharged alive to the ward during 1997–1999,
whose reason for discharge had been recorded by the ICU consul-
tant as fully fit or premature were studied. We excluded those dis-
charged for palliative care. We compared the groups APACHE II,
admission risk of death, length of ICU stay and last TISS using
ANOVA. We then assessed the relative risk of hospital mortality and
investigated the association between TISS on day of ICU discharge,
reason for discharge and mortality using ordinal regression analysis.
552 patients were identified (Premature Group 145, Fully Fit
Group 407). ANOVA identified a significant difference in last TISS,
but no significant difference in APACHE II, risk of death or ICU
length of stay (Table 1). The hospital mortality was greater in the
premature group (relative risk 2.1, 95% CI 1.3–3.5). Both last
TISS and discharge reason were found to be independent indica-
tors of hospital mortality (Table 2).
Patients who leave ICU before they are considered fit for discharge
are twice as likely to die, despite minimal difference in their risk of
death on ICU admission. Although they are receiving more care
when they are discharged the excess mortality in those discharged
prematurely is equivalent to that associated with a further increase
in last TISS of 14 points.
References:
1. Smith L, Orts CM, O’Neil I et al: Intensive Care Med 1999,
25:1061–1065.
2. Goldhill DR, Sumner A: Crit Care Med 1998, 26:1337–1345.
Table 1
ICU data for patients
Risk of ICU
Hospital APACHE death stay Last
deaths II (%) (days) TISS
n (n) mean mean median median
Premature 145 24 17.1 26 1.80 24
Fully fit 407 32 16.3 23 1.60 22
P 0.18 0.1 < 0.001 0.73
P values from ANOVA.
Table 2
Ordinal regression for hospital mortality using last TISS and
premature discharge
Threshold Last TISS Premature
Parameter 3.69 0.034 0.738
P < 0.001 0.006 0.012S119
P252 Early postoperative intensive care in cadaveric liver transplantation: factors affecting the length of intensive care unit stay
S Ulukaya, HO Ayanoglu, E Olgun, AR Moral
Department of Anesthesiology and Reanimation, Ege University School of Medicine, Izmir, Turkey
Liver transplantation (LT) patients have problems involving different
organ systems which have a critical role in the success of the pro-
cedure. The purpose of this study is to evaluate the factors con-
tributing to the duration of mechanical ventilation (MV) and the
length of stay in ICU after LT.
Materials and methods: We evaluated 53 cadaveric liver trans-
plantation operated by using simple cross clamping technique
without venovenous bypass. All the patients were transferred to the
multidisciplinary ICU for early postoperative care where all vital
organ systems were monitored. Twenty-one different factors were
evaluated by Mann–Whitney U, Student’s t-tests and by regression
analysis. All values are as mean ± SD.
Results: The mean age of the patients was 36.6 ± 15.4 years (F:M
18/35). Preoperative mean Child–Pugh scores of the patients was
10.9 ± 2.3, the perioperative course had a mean operation time of
342 ± 113 min and a mean anhepatic period of 80 ± 36 min.
Mean duration of MV and length of stay in ICU were 22 ± 22 hours
and 50 ± 39 hours respectively. Factors on Table 1 prolonged the
duration of MV and the length of ICU stay. The analysis of regres-
sion showed no correlation between duration of MV and/or the
length of ICU stay with age, Child–Pugh scores, duration of opera-
tions and anhepatic periods, total protein, glucose and bilirubine
levels, prothrombin times and the need for transfusion except for
the SGOT (r2 = 0.18, P < 0.001) and SGPT (r2 = 0.22,
P < 0.001) levels which caused longer durations of MV.
Conclusion: During early postoperative course of the OLT patients,
clinical factors such as presence of a hypoxemic and/or hypercap-
nic period, difficulties in weaning from MV, hemodynamic instability,
increase in plasma urea and/or creatinine levels, decrease in plasma
calcium levels, and postoperative fever might be indicative for a pro-
longed ICU stay and a possible increase in morbidity.
Table 1
Factors that affect the durations of MV and the length of ICU stay (hours, mean ± SD)
Presence Absence P values
Hypoxemia and/or Hypercapnia MV 36 ± 27 12 ± 7 0.003
ICU 69 ± 52 27 ± 52 0.009
Weaning difficulties from MV MV 52 ± 54 15 ± 15 0.0008
ICU 102 ± 62 52 ± 24 0.011
Hemodynamic instability MV 34 ± 28 15 ± 14 0.013
ICU 70 ± 54 38 ± 21 0.019
Increase in blood urea and/or creatinine levels MV 28 ± 26 13 ± 6 0.0027
ICU 58 ± 46 36 ± 17 0.011
Fever MV 36 ± 28 13 ± 10 0.001
ICU 70 ± 54 37 ± 17 0.01
Hypocalcemia MV 35 ± 30 18 ± 16 0.001
ICU 74 ± 58 40 ± 24 0.02
P253 ICU nursing workload is not related to hospital survival
CD Gomersall, GM Joynt, P Tan, SJ Ramsay, TA Buckley, C Lam
Department of Anaesthesia & Intensive Care, The Chinese University of Hong Kong, Shatin, Hong Kong, China
Introduction: A previous study in a small (six beds) ICU in the
United Kingdom indicated that high nursing workload is associated
with increased hospital mortality [1]. However the multiple logistic
model fitted the data poorly and the use of APACHE II to assess
severity of illness would have introduced confounding.
Method: We performed a retrospective analysis of prospectively
collected data. The patient cohort consisted of all adult emergency
admissions to our 22 bed ICU between 0800 h on December 1st,
1997 and 0800 h on July 1st 1998 except in-patients transferred
from other hospitals directly to ICU. The following data were col-
lected for all patients in the cohort: time between hospital and ICU
admission, the data required to calculate predicted mortality based
on the Mortality Prediction Model II0 (MPM II0) and hospital mortal-
ity. Over the same time period nursing dependency scores
(= number of nurses required, according to UK Intensive Care
Society recommendations [2]) and numbers of nurses on duty
were recorded for every shift. From this the average and peak
nursing dependency:nurses on duty ratios during the time each
patient was in the ICU were calculated. Logistic regression analy-
sis was performed using hospital mortality as the dependent vari-
able and age, sex, MPM II0, ICU admission on the day of hospital
admission, average nursing dependency:nurses on duty ratio, peak
nursing dependency:nurses on duty ratio and interactions between
the latter two and MPM II0 as potential independent variables.
Results: The cohort consisted of 388 patients. Twenty-seven
patients were excluded from the analysis because of incomplete
data. Independent variables in the final logistic regression model
and their coefficients are given in Table 1. The Hosmer and
Lemeshow goodness of fit test indicated that the model fitted the
data well (c2=4.3, P = 0.83).
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Table 1
Variable b (SE) r
Age 0.017 (0.0074) 0.0893
Sex –0.409 (0.25) –0.0394
MPM II0 2.25 (0.77) 0.1236
Constant –1.94 (0.56)
Conclusion: Our data suggest that in a large ICU age, sex and
MPM II0 but not ratio of nursing workload to nurses on duty are
related to outcome. The difference between our findings and those
of Tarnow-Mordi et al [1] may reflect differences in size and organi-
zation of the respective units.
References:
1. Tarnow-Mordi WO, Hau C, Warden A, Shearer AJ: Hospital mortality
in relation to staff workload: a 4-year study in an adult intensive-
care unit. Lancet 2000, 356:185–189.
2. Intensive Care Society. Intensive Care Audit. London: Intensive Care
Society, 1990.
P254 Terminal weaning from mechanical ventilation in critically ill patients with or without severe brain damage
R Parizkova, V Cerny, P Dostal
Department of Anaesthetics and Intensive Care, Charles University, Hradec Kralove 500 05, Czech Republic
Introduction: The withdrawal of mechanical ventilation as a termi-
nal care process occurs with increasing frequency. The aim of the
study was to evaluate patients undergoing terminal weaning (TW)
with or without severe brain damage.
Methods: A prospective, descriptive study of all patients experi-
enced TW during 2 years period was conducted. Apache II,
SOFA, length of ICU stay (days) before decision of TW (LOS),
method (step-wise reduction or withdrawal of ventilatory support),
using analgesia/sedation during TW procedure and length of TW
(LTW) in minutes were recorded. Data as mean (SD), median
(25–75%), t-test, Mann–Whitney Rank Sum Test (SigmaStat Sta-
tistical Software) were used, P < 0.05 was considered statistically
significant.
Results: Sixteen patients were studied, Apache II and SOFA score
were 32 (6.9) resp. 12.9 (3.7). Eleven patients with severe brain
damage (group BD), five patients without brain damage (group
NBD). All patients died during TW. The LOS was shorter in BD
group comparing to NBD group, 2.9 (1.9) resp. 17 (9.3),
P < 0.0001. The TW procedure was step-wise reduction of ventila-
tory support in 5 patients and as a ventilator withdrawal in 11
patients. The length of TW was 17 (12–87) in BD group and 187
(16–605) in NBD group. Analgesia/sedation was employed in
eight patients, there were no statistically significant differences in
LTW between patients with or without analgesia/sedation (223,
13–662, resp. 15, 12–43, P = 0.232).
Discussion: LOS before decision of TW was significantly longer in
patients without brain damage. There were no significant differ-
ences in length of TW as between groups BD and NBD as
between patients with or without analgesia.
Reference:
Campbell LM, Bizek KS, Thill M: Patients responses during rapid termi-
nal weaning from mechanical ventilation: a prospective study. Crit Care
Med 1999, 27:73–77.
Supported by IGA MZ CR 4530-3.
P255 Limitation of life-support therapy in critically ill patients: family response and attitudes
GM Joynt, A Lee, FHY Yap, OM Ho, ELY Wong, C Gomersall
Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Peoples Republic of China
Introduction and aim: Despite modern intensive therapy, 10–20%
of patients admitted to ICU will not survive [1,2]. Dealing with
family issues surrounding death is therefore an important aspect of
ICU care. The purpose of this study was to record aspects of the
experience of families whose relative had undergone LOT and
identify the views of the family regarding who should be involved in
the process of LOT.
Methods: Consent for a telephone interview and demographic
data were obtained from the representative of all families whose
relative had died in the ICU. Four weeks later, the representative
was contacted for a structured telephone interview. Questions
explored the respondents experience of anxiety related to the
process of LOT, their understanding of the explanation and the
reasons for LOT, and the adequacy of time to participate in the
decision. Respondents were asked who should be involved in the
decision process.
Results: The relatives of 88 patients who died were interviewed.
Sixty-six (75%) patients had undergone LOT. The majority of
respondents (90%) expressed that the explanation of LOT was
clear and understood, but 18% felt pressurized into decision
making, and 16% felt that inadequate time was allowed for discus-
sion before the decision was made. Participating in the LOT deci-
sion provoked anxiety in 45% of respondents. However, when
compared with respondents whose relatives did not undergo LOT,
the expression of anxiety was lower (P < 0.01). Respondents indi-
cated that LOT decisions should be made by the doctor and
patient and/or family group (41%), family and/or patient alone
(32%), or doctor alone (22%).
Discussion and conclusion: While most family members under-
stand the process of LOT, it is still associated with significant
anxiety. Allocating more time to the decision making process and
improving communication techniques may be important. Family
members believe that they should be part of the decision making
process.
References:
1. Smedira NG et al: Withholding and withdrawal of life support from
the critically ill. N Engl J Med 1990, 322:309–315.
2. Turner JS et al: Limitation of life support: frequency and practice in
a London and a Cape Town intensive care unit. Intensive Care Med
1996, 22:1020–1025.S121
P256 Withholding and withdrawing therapy at the intensive care units of the University Hospital of Innsbruck, Austria
D Fries, W Hasibeder, M Mittermayr, A Klingler, V Antretter, JM Hackl, W Schobersberger
Department of Anaesthesia and Intensive Care Medicine, University Hospital Innsbruck, Austria
Introduction: With increasing technical and medical possibilities,
the ICU physician is more often confronted with the situation to
withhold (WH) or withdraw (WD) life sustaining treatment in
patients with poor prognosis. Apart from the legal situation, the
practical management of limiting ICU-therapy continues to be
indistinct. Aim of the study was to examine the various procedures
as well as the different points of view of intensive care physicians
to limit therapy in patients with poor prognosis.
Methods: We interviewed 49 physicians working at 5 different
ICUs by a questionnaire about practicing WH and WD of ICU-
therapy.
Results: The interviewed physicians gave WH preference over
WD. The potential reversibility of disease was estimated more
important than the patients own wish in regard to the decision
making process. In the sequence to WH or WD, antibiotics and
hemodialysis/hemofiltration were mentioned first, ventilation at last.
63% responded to continue, 27% to increase and 10% to reduce
sedation and analgesia in case of WH/WD of ICU-therapy. 83%
voted for an obligatory DNR-Order in case of WH/WD.
Conclusion: The strategies of the ICU-physicians to WH or WD
therapy in critically ill patients were heterogeneous. To establish a
more homogenous procedure, it is crucial to establish specific
patient orientated guidelines.
Figure
Sequence of WH and WD ICU-therapy in patients with poor prognosis
from 1 (first) to 8 (last). These data show the statistical mean value.
P257 Current practice of Do-Not-Resuscitate (DNR) orders in a Saudi Arabian tertiary care center
M Rahman, Y Arabi, N Adhami, B Parker, S Al Malik, A Al Shimemeri
King Fahad National Guard Hospital, ICU Mail Box 1425, PO Box 22490, Riyadh, 11426 Saudi Arabia
Background: DNR is a new concept in Saudi Arabia. King Fahad
National Guard Hospital has been a national leader in raising the
awareness about the futility of aggressive life support in terminally
ill patients. The purpose of the study is to identify the factors asso-
ciated with DNR status in our institution.
Methods: We reviewed records of all adult patients who died in
1998. We evaluated patients’ demographics, underlying chronic ill-
nesses, admission diagnosis, length of stay, the timing of writing
DNR orders and whether death occurred in the ward or in the ICU.
Univariate analysis was performed to identify predictors of DNR
status. Results are displayed as odds ratios (OR) and 95% confi-
dence intervals.
Results: DNR orders were written for 318/420 deaths (76%).
One third (34%) of all deaths occurred in ICU. DNR orders were
written for 66% of ICU deaths and 82% of ward deaths. There
were no differences in age, gender and length of stay between
DNR and fully supported patients. Patients with cancer and cirrho-
sis were more likely to get DNR orders (OR 2.7 [CI 1.4–4.9], OR
2.6 [CI 1.3–5.1], respectively), while patients with chronic cardiac
disease were less likely to be made DNR (OR 0.4 [CI 0.3–0.8]).
DNR orders were less likely to be written for patients admitted with
acute cardiac disease or trauma (OR 0.3 [CI 0.2–0.5], OR 0.3 [CI
0.1–0.8], respectively) and more likely for patients with sepsis (OR
1.3 [CI 1.2–2.9]). DNR orders were more likely to be written on
day 1 of hospitalization in cancer patients (OR 2.5 [1.4–4.5]) and
on the last hospital day in cirrhotic and GI bleed patients (OR 2.8
[CI 1.6–5.1], OR 3.7 [CI 1.6-8.4], respectively).
Conclusions: 1. The majority of the patients dying in our hospital
have DNR orders by the time of death. 2. Dying patients with
cancer, cirrhosis and those admitted with sepsis are less likely to
be resuscitated, whereas dying cardiac and trauma patients are
more likely to continue receiving full support. 3. DNR status tends
to be initiated early in cancer patients reflecting the awareness of
limited value of aggressive life support in this group of patients. 4.
The delay in DNR orders in cirrhotic patients in our institution
reflects the fact that the majority of cirrhosis patients were referred
for possible liver transplantation.
P258 Cost of care associated with early sepsis (first 24-hours of ICU admission) in a United States medical center
D Teres*, J Rapoport†, S Lemeshow‡, S Kim‡, K Akhras§
*Tufts University School of Medicine, Boston, MA 02111, USA; †Mount Holyoke College, South Hadley, MA 01075, USA; ‡Ohio State
University, Columbus, OH 43210, USA; §Pharmacia Corporation, Skokie, IL 60077, USA
Objective: This study documents the hospital costs of ICU
patients diagnosed with early sepsis (first 24 hours of ICU admis-
sion) and compares their costs to those of other patients admitted
to the ICU.
Data: Clinical and cost information on 1088 consecutive ICU
admissions during 1999–2000 to the general medical/surgical
ICU at Baystate Medical Center, the western campus of Tufts Uni-
versity School of Medicine, a community teaching hospital in
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Springfield, MA. Data collected in the ICU for the Project IMPACT
database was merged with cost data from the hospital’s cost
accounting system to obtain costs based on actual use, not
cost/charge ratios.
Methods: Patients were identified as early sepsis based on one of
the following criteria; 1) primary acute ICU admission diagnosis of
SIRS, septic shock, or Multi Organ Dysfunction Syndrome
(MODS); 2) notation in the ICU log book of sepsis on admission;
3) infection at 24 hours plus evidence of hypotension, hypoperfu-
sion or multiple organ dysfunction. Resource use measures com-
puted for each patient included: a) total hospital costs incurred
during the ICU stay, b) mean costs per ICU day, c) total costs
incurred from ICU admission to hospital discharge, d) costs per
day during ICU stay for specific cost categories (pharmacy, lab,
imaging, respiratory therapy), e) ICU and total hospital (from ICU
admission) length of stay (LOS).
Results: 14.2% of patients admitted to ICU had early sepsis (n =
155). Comparison groups were respiratory diagnosis at ICU
admission (n = 273, 25.1%) and all others (n = 660, 60.7%).
Mean (±SD) cost of the ICU stay for early sepsis patients
($29,582 ± 39,399) was greater than for respiratory ($16,757 ±
15,439) and all other ($17,544 ± 23,712). Mean ICU LOS for
early sepsis was 10.4 (± 12.6) days compared to 6.8 (± 6.1) days
for respiratory and 5.8 (± 8.2) days for all other. Mean cost per ICU
day for early sepsis was $2844 compared to $2464 for respiratory
and $3025 for all other. Mean total costs and LOS (ICU admission
to hospital discharge) for early sepsis patients ($39,949 ±
45,278), (19 ± 19.4 days) was greater than that for respiratory
($24,824 ± 21,347), (13.3 ± 11.7 days) and all others ($26,022
± 29,870), (12.6 ± 12.7 days). Results for specific costs are as
follows.
Mean cost for ICU stay
Early Respiratory  All  other 
sepsis patients patients patients
Pharmacy 2625 ± 3555 1443 ± 1767 1436 ± 2495
Lab 2463 ± 3109 1127 ± 1220 1224 ± 2009
Imaging 1217 ± 1389 683 ± 653 784 ± 1100
Respiratory 2387 ± 3245 1791 ± 1809 1213 ± 2117
therapy
Conclusion: Compared to respiratory and other patients, mean
total costs for patients admitted to ICU with early sepsis is 50%
higher.
P259 The cost in different subgroups of critically ill patients: a multicentric study in Czech Republic
R Parizkova, V Cerny, P Dostal
Department of Anaesthetics and Intensive Care, Charles University, Hradec Kralove, 500 05, Czech Republic
Introduction: Intensive care units account for a large proportion of
hospital expenditures. The aim of the study was to evaluate differ-
ent subgroups of patients for clinical outcome and cost of care.
Methods: 1368 patients were prospectively studied. Demographic
data, APACHE II and SOFA score, diagnostic group (TR = trauma,
TBI = traumatic brain injury, COPD = chronic obstructive pul-
monary disease, CPR = cardiac arrest, ARDS = acute respiratory
distress syndrome, INTOX = intoxication), length of ICU stay
(LOS), clinical outcome and cost of care in CZK were recorded.
Relationship among between cost, diagnostic groups and severity
score were evaluated. Data as mean (SD), median (25–75%), t-
test, Mann–Whitney Rank Sum Test, z-test, ANOVA, linear regres-
sion (SigmaStat Statistical Software) were used, P < 0.05 was
considered statistically significant.
Results: Selected results are presented. The longest LOS and
most expensive care were observed in ARDS patients. The inde-
pendent variable of cost is LOS (r = 0.679, P < 0.001).
Discussion: There were significant differences among selected
groups of patients concerning clinical outcome, LOS and cost of
care. Obtained data may be of importance in ICU budgeting and in
comparing different intensive care units.
Reference:
Ingelhart JK: The American health care system: expenditures. N Engl J
Med 1999, 340:70–76.
Supported by IGA MZ CR 4530-3.
Number of patients  Apache II SOFA Mortality
All  1368 24 (8.9) 8.1 (5.1) 258 (18.8%)
TR  115 21.8 (8.2) 8.6 (3.8) 16 (13.9%)
TBI  137 23.3 (7.7) 6.8 (3.3) 12 (10.9%)
COPD 86 23.3 (6.8) 7.1 (3.4) 11 (12.7%)
CPR 184 32.1 (7.9) 10.3 (3.4) 53 (28.8%)
ARDS 76 25.6 (8.1) 10.7 (3.9) 15 (19.7%)
INTOX 425 21.2 (8.7) 7.5 (4.4) 83 (19.5%)
TR TBI COPD CPR ARDS INTOX
Apache II 19 (17–26) 23 (18–29) 22 (19–23) 32 (27–38)* 26 (19–31) 21 (15–27)
SOFA 7 (6–11) 6 (4–9) 7 (4.5–9) 10 (8–13)† 10.7 (8–13) 6 (4–11)
LOS (days) 10.5 (3–19) 5.5 (4–9) 12.5 (5–21) 5 (2–17) 14 (8–21) 3 (2–7)
Cost  (CZK) 168,951 127,835 213,223  63,054 322,913‡ 41,720 
(55,910– (29,950– (98,711– (22,748– (143,822– (15,567–
329,056) 263,849) 363,445) 169,757) 519,927) 127,117)
35 CZK = 1 EUR. * vs all subgroups (P < 0.05), † vs COPD, INTOX (P < 0.05), ‡ vs COPD, TBI, INTOX (P < 0.05).S123
P260 Quality assessment in German ICUs: first results of a cross sectional survey of the DIVI interdisciplinary working group for
quality assessment on ICUs
E Schäfer*, R Stiletto*, C Waydhas†
*Philipps University, Marburg, Germany; †University of Essen, Essen, Germany
The current economic climate in the health care system makes it
necessary to contain costs while maintaining a high-quality standard
in the treatment of critically ill patients. Hospitals and ICUs are being
more and more compared to industrial production sites. Physicians
have a considerable influence on both medical performance and
costs. For a better operative controlling and management of ICUs
under these new conditions cost–benefit analyses, effective
resource utilization and the implementation of a quality control
concept are required. To create a reliable data base, the interdiscipli-
nary quality assessment research group of the German interdiscipli-
nary society for intensive care medicine (DIVI) carried out a
multicentre evaluation from November 1999 to February 2000 in
German ICUs. In a prospective cohort study of all 1368 German
hospitals having ICU units with 21,918 ICU beds were evaluated by
a standardized 53-item questionnaire for their structural data, techni-
cal assessment and quality control concepts. If not indicated other-
wise, numbers are given as mean ± SD. 400 data sheets returned.
Only complete data sheets where used for analysis resulting in the
inclusion of 349 ICUs (25.5%). Data of 353,503 patients treated in
349 ICUs per year were available for data evaluation. The mean
number of patients per ICU was 1032 (± 887). The number of days
with artificial ventilation were 361,071 representing 88,375 patients
which corresponds to an average of 1097 (± 1778) ventilation days
per ICU. The total number of ICU treatment days was 1,071,112
corresponding to 3353 (± 7542) days per unit. Concerning ICU per-
sonnel the data showed that 3.4 (± 3.3) physicians and 22.6 (±
15.9) nurses are working on the average ICU in Germany. Regarding
the availability of technical equipment (echocardiography, lab units
on the ICU, arterial blood gas analysis, Swan catheter, ICP monitor-
ing, cardiac pacing, renal replacement therapy, IABP and ECMO)
there was no statistical difference between day and night services.
For quality assessment mortality and morbidity conferences are held
in 93 centres (27%). Worst cases are analyzed in 311 centres
(89%). Staff education is institutionalized in 333 (95%) ICU units.
Microbiological monitoring by a microbiologist is standard procedure
in 91 centres (26 %). Based on this reliable data material a current
quality assessment concept can be developed to optimize both cost
strategies and medical structure.
P261 Diagnostic accuracy in the medical intensive care unit
M Podbregar, G Voga, B Krivec, R Skale, R Parez
vnik, L Gabrs
vc
vek
Department for Intensive Internal Medicine, General Hospital Celje, Oblakova 5, 3000 Celje, Slovenia
Objective: To evaluate the frequency of diagnostic errors
assessed by autopsies.
Design: Retrospective review of medical and pathological records.
Setting: An 11-bed medical ICU at a 860-bed General Hospital.
Patients: Patients who died in ICU between January 1998 and
December 1999.
Methods: Pre mortem diagnosis, length of stay and presence of
chronic disease were determined from medical records. Medical
diagnosis were rated into three levels of clinical diagnostic cer-
tainty as complete (‘golden standard’) certainty (Group L1), minor
diagnostic uncertainty (Group L2), and major diagnostic uncer-
tainty (Group L3). Autopsy results were obtained from final pathol-
ogy report. A panel of three intensivists reviewed the findings and
distributed patients into three error groups: Group A — the autopsy
confirmed the clinical diagnosis (fully correct diagnosis), Group B
— the autopsy demonstrated new active diagnosis, which would
have probably not influenced the therapy (non-fatal diagnostic
error), Group C — the autopsy demonstrated new active diagnosis,
which  would have probably changed the therapy (fatal, but
potentially treatable error).
Main results: The overall mortality in the treated population was
20.3% (270/1331 patients). Autopsies were performed in 126
patients (46.9% of deaths), more often in younger patients
(66.6 ± 13.9 years vs 72.7 ± 12.0 years, P < 0.001), in patients
staying less then 24 h in ICU stay (4.7 ± 5.6 days vs 6.7 ± 8.7,
P = 0.0549) and in patients in Group L3 without chronic diseases
(15 vs 1, P < 0.001). According to pre mortem clinical level of
diagnostic certainty 46.0%, 24.6% and 29.4% of patients were in
group L1, L2 and L3 respectively (ns between groups). After analy-
sis of pathological findings, fully correct diagnosis (group A, 60
patients [47.6%]) was found in 60.3%, 40.0%, 34.2% of patients
in group L1, L2 and L3 respectively (ns between groups). Non-fatal
diagnostic errors (group B, 54 patients [42.9%]) were found in
31.0%, 50%, 55.3% of patients in group L1, L2 and L3 respec-
tively (ns between groups). Fatal, but potentially treatable errors
(group C, 12 patients [9.5%]) were found in 8.7%, 10.0% and
10.5% of patients in Group L1, L2 and L3 respectively (ns
between groups). ICU length of stay shorter than 24 h was not
related with frequency of group C errors.
Conclusion: The autopsies are performed more often in younger
patients without chronic disease, in patients with shorter ICU stay
and in cases with low clinical diagnostic certainty. No level of clini-
cal diagnostic certainty could predict the pathological findings.
Autopsy remains the essential verification of clinical diagnostic cer-
tainty in critically ill patients.
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Objective: To determine accidental withdrawal (AW) of tubes,
sounds and catheters.
Design: Prospective observational study.
Setting: A 20-bed medical-surgical Intensive Care Unit (ICU).
Patiens: All patients admitted in ICU from 1-5-2000 to 31-10-2000.
Results: 253 patients were admitted (64.03% males). Mean age
was 57.64 ± 16.71 years. APACHE-II was 12.48 ± 5.52. Mortality
was 15.81%. Patients distribution was: 48% cardiac surgery, 14%
cardiologic, 10% neurologic, 8% traumathology, 7% pulmonary, 6%
digestive and 7% others. Patients need the following monitoring:
88.14% orotracheal tube (OT), 99.20% central venous catheter
(CVC), 26.87% drum catheter (DC), 67.98% internal yugular vein
catheter (IYVC), 34.38% subclavian vein catheter (SVC), 16.14%
femoral vein catheter (FVC), 91.69% artery catheter (AC), 86.95%
radial artery catheter (RAC), 13.83% femoral artery catheter (FAC),
91.69% nasogastrical sounds (NGS), 96.09% vesical sound (VS),
48.22% epicardial temporary pacemaker electrode (ETPE), 2.76%
intraaortic balloon counter pulsation catheter (IABC), 54.54% tho-
racic drainage tube (TDT), 8.30% abdominal drainage tube (ADT)
and 6.71% intracraneal pressure catheter (IPC).
Conclusions: This study permit to know our current levels of acci-
dental withdrawals and comparing them with other ICU and with
our results in the future.
Number of patients  Number  Number of  Number of  Number of AW  Number of AW 
with catheter of catheters catheter-days AW per 100 catheter per 100 catheter-days
OT 223 245 1802 14 5.71 0.77
CVC 251 454 3212 12 2.64 0.37
DC 68 96 717 2 2.08 0.27
IYVC 172 195 1112 6 3.07 0.53
SVC 87 117 1007 3 2.56 0.29
FVC 36 46 376 1 2.17 0.26
AC 232 348 2031 28 8.04 1.37
RAC 220 310 1702 23 7.41 1.35
FAC 35 38 329 5 13.15 1.51
NGS 232 380 2114 148 38.94 7
VS 246 334 2444 1 0.29 0.04
ETPE 122 122 400 0 0 0
IABC 7 7 16 0 0 0
TDT 138 270 575 0 0 0
ADT 21 41 316 0 0 0
IPC 17 21 199 0 0 0
P262 Accidental withdrawal of tubes, sounds and catheters
L Lorente Ramos, J Málaga Gil, JL Iribarren Sarrias, N Serrano Hernández, M Santana Ramos, ML Mora Quintero
Intensive Care Unit, Hospital Universitario de Canarias, La Laguna, Tenerife, Spain
P263 Evaluation of daily fluid balance during continuous hemodialysis and filtration (CHDF)
H Dohgomori*, K Arikawa*, Y Kanmura†
*Division of Emergency Medicine, Kagoshima University Hospital, and †Department of Anesthesiology and Critical Care, Faculty of
Medicine, Kagoshima University, 8-35-1, Sakuragaoka, Kagoshima 890-8520, Japan 
Introduction: In critical care, accurate assessment of daily fluid
balance is both necessary and important. We evaluated the accu-
racy of the calculated daily fluid balance during continuous
hemodialysis and filtration (CHDF) by checking the relationship
between two values: (a) daily fluid balance calculated from the
balance sheet, and (b) daily body-weight change, a standard way
of evaluating daily fluid balance. 
Materials and Methods: We studied data obtained from patients
who underwent CHDF using one of two machines, CHF-1 or JUN-
500 (Ube Medical Corporation, Tokyo, Japan). CHDF patients
were randomly assigned to one or other of the machines: Group-A
(14 patients) to CHF-1 and Group-B (7 patients) to JUN-500. We
also studied the relationship between the two values, (a) and (b),
above in 10 patients (Group C) not undergoing CHDF. WithinS125
each group, the correlation between values (a) and (b) was studied
by regression analysis. Significance was defined as P < 0.05. 
Results: The number of time-points studied was 32 in Group A, 22
in Group B, and 45 in Group C. Within each group, we saw a sig-
nificant relationship for (a) versus (b), the coefficient numbers (r2)
being 0.400 in Group A, 0.663 in Group B and 0.757 in Group C. 
Discussion: JUN-500 has three pumps, providing a stricter regula-
tion of rates of infusion and removal of fluids; this may have given
more accurate management under CHDF than that achieved with
CHF-1. During CHDF, a large amount of water may be infused
and/or removed, and so a slight error in pump calibration can lead
to a considerable inaccuracy in the daily fluid balance calculated
from the balance sheet. This would result in a fairly low correlation
number for (a) versus (b). In our Groups A and B, although we
found significant relationships between the two values, the r2
numbers were not particularly high. Therefore, using the above rea-
soning, we would have been unwise to draw conclusions about
changes in daily fluid balance using balance-sheet data alone. 
Conclusion: During CHDF, daily fluid balance still needs to be
based on data obtained by measurement of daily weight change,
not solely on data obtained from the fluid-balance sheet.
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